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Abstract 
 
Small non-coding RNAs (sRNAs) are important regulators of gene expression and 
play fundamental roles in many different organisms. During the last decade, next 
generation sequencing (NGS) has become a powerful tool for sRNA profiling and 
several classes of novel regulatory sRNAs with potential biological functions have 
been discovered. Among them, sRNAs derived from longer non-coding Y RNAs were 
identified. 
Y RNAs are non-coding RNAs (~ 100 nt) that are evolutionarily conserved in 
vertebrates. Human Y RNAs bind to the autoimmune proteins Ro60 and La forming 
ribonucleoprotein complexes. Y RNAs are involved in the initiation of chromosomal 
DNA replication, regulation of RNA stability and cellular stress response. During 
apoptosis, Y RNAs produce smaller RNA fragments from the 3’ and 5’ ends. However, 
the biogenesis, processing and the biochemical functions of Y RNA derived sRNAs 
remain elusive. 
In previous work a high throughput mutagenesis analysis on the 3’ end of hY5 RNA 
was performed. In this work, I confirmed that Y RNA cleavage on the 3’ end of hY5 
RNA correlated with the secondary structure of the mutated hY5 RNA. Furthermore, 
I clearly showed that the nucleotide sequence in the loop was not important and a 
bulge of one nucleotide was sufficient for Y RNA cleavage to occur.  
In this thesis I designed and performed a high throughput mutagenesis approach on 
the 5’ end of hY5 RNA. This revealed a nucleotide motif UUAU located in an internal 
loop at the position 22-25 which contributed to Y RNA cleavage at both the 3’ and 5’ 
end of hY5 RNA.  
In order to identify ribonucleases involved in Y RNA cleavage, I confirmed that Ro60 
was essential for YsRNA production in mouse embryonic stem cells. Interestingly, I 
could show that RNase L contributed to Y RNA cleavage in mouse embryonic 
fibroblast cells and human lung cancer cells.  
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Chapter 1 Introduction 
 
1.1 The central dogma of molecular biology 
 
The central dogma is a fundamental concept of molecular biology that was initially 
proposed by Francis Crick in 1958. It describes the flow of genetic information from 
DNA via RNA to proteins (Crick, 1958). In 1970 the central dogma had to be redefined 
due to the discovery of retroviruses that contain RNA genomes and generate DNA by 
reverse transcription. The restated dogma emphasized that genetic information 
cannot be transferred from proteins to other proteins or nucleic acids (Crick, 1970).  
Intriguingly, the human genome project revealed that the majority of the human 
genome is comprised of non-coding DNA regions and only 1.5% of the human 
genome encode for proteins. It was shown that around 98% of the human 
transcriptome consists of non-protein coding RNA. Initially it was thought that these 
non-coding regions are “junk DNA” and not functional (Mattick, 2001; Venter et al., 
2001; International Human Genome Sequencing Consortium, 2004; Birney et al., 
2007).  
However, with advances of sequencing technologies in the last decade it became 
apparent that intronic and other non-protein coding RNAs fulfil vital functions (Mattick, 
2004). Consequently, the central dogma has been challenged because these 
regulatory non-coding RNAs represent an additional layer of gene regulation (Mattick, 
2003). Non coding RNAs play key roles in RNA metabolism and are involved in almost 
all cellular processes including development, differentiation, stress response, 
epigenetics, maintaining genome stability and diseases (Morris and Mattick, 2014). 
 
1.2 The non-coding RNA world 
 
1.2.1 Ribosomal RNAs and transfer RNAs 
 
Ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs) were initially discovered in the 
1950s and have been intensively studied due to their high abundance in cells. The 
majority of total RNA in cells is comprised of rRNAs (80-90%) and tRNAs (10-12%) 
whereas messenger RNAs (mRNAs) only make up a small proportion (3-7%) and all 
other non-coding RNAs together constitute less than 2% of the total cellular RNA 
mass (Palazzo and Lee, 2015).  
INTRODUCTION 
 
21 
 
Ribosomal RNAs were discovered by electron microscopy as part of the ribosome 
which is essential for protein synthesis (Palade, 1955). In 1958 transfer RNAs were 
described as adaptor molecules and mediators between mRNA and amino acid 
sequence of proteins during translation (Crick, 1958; Hoagland et al., 1958).  
 
1.2.2 Small nuclear RNAs 
 
Apart from rRNAs and tRNAs that are infrastructural components of protein synthesis 
small nuclear RNAs (snRNAs) were among the first discovered non-coding RNAs. 
Small nuclear RNAs were identified as components of ribonucleoprotein particles in 
patients with the autoimmune disorder systemic lupus erythematosus (Lerner and 
Steitz, 1979). These ncRNAs included U1, U2, U4, U5 and U6 snRNAs and have 
been shown to be part of the spliceosome machinery and mRNA splicing (Kruger et 
al., 1982; Krämer, 1996).  
 
1.2.3 Small nucleolar RNAs 
 
Small nucleolar RNAs (snoRNAs) are another important class of non-coding RNAs 
that were described in the 1990s (Maxwell and Fournier, 1995; Balakin et al., 1996; 
Weinstein and Steitz, 1999). SnoRNAs are ~ 70-250 nt in length, are highly abundant 
in the nucleolus and Cajal bodies of eukaryotic cells and have been shown to guide 
chemical modifications and processing of several RNA species including rRNAs, 
snRNAs and tRNAs. SnoRNAs can be classified based on their structural features 
and chemical RNA modification they mediate into C/D box snoRNAs and H/ACA box 
snoRNAs. C/D box snoRNAs are responsible for the 2’ O-methylation of rRNAs, 
snRNAs and tRNAs whereas H/ACA box snoRNAs direct pseudoruridylation of RNAs 
(Kiss, 2001, 2002). SnoRNAs have also been shown to be involved in alternative 
splicing (Kishore and Stamm, 2006; Falaleeva et al., 2016), chromatin remodelling 
(Leung et al., 2009; Schubert et al., 2012) and diseases such as cancer (Mannoor et 
al., 2012).  
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1.2.4 Vault RNAs 
 
Vault RNAs (vtRNAs) are part of a 13 MDa vault ribonucleoprotein complex and range 
in sizes between 80-150 nts (Kedersha and Rome, 1986; Stadler et al., 2009). In 
humans there are four paralogues described (vtRNA1-1, 1–2, 1–3 and 2–1). Vault 
ribonucleoprotein complexes RNAs are transcribed by RNA polymerase III, are highly 
conserved among most eukaryotes and are characterized by a hollow barrel-shaped 
structure. The function of vault RNAs is still not very clear but evidence suggested 
that they play a role in chemotherapy resistance of cancer cells (Kickhoefer et al., 
1998; Steiner et al., 2006), nuclear transport (Vollmar et al., 2009), immunity (Berger 
et al., 2008; Nandy et al., 2009), signalling, (Kim et al., 2006; Steiner et al., 2006; 
Berger et al., 2008), DNA damage repair (Shimamoto et al., 2006) and apoptosis 
(Amort et al., 2015). Recently, vault RNAs have been reported to regulate autophagy 
(Horos et al., 2017).  
In the last decades many other novel classes of non-coding RNAs have been 
identified due to the further advances and improvement of next generation 
sequencing technologies. Non coding RNAs represent key molecules that define and 
contribute to the eukaryotic complexity (Mattick, 2001). The discovery of non-coding 
RNAs has revolutionized the RNA world and adds an additional layer of regulation 
and complexity (Mattick, 2003; Hall and Dalmay, 2013).  
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1.3 Small non coding RNAs 
 
Historically, the term small RNA was used to describe all RNA molecules between 
100-200 nt in prokaryotes (Wassarman et al., 1999; Storz, 2002).  
However, due to the discovery of RNA interference (RNAi) and small non-coding 
RNAs in plants and animals in the 1990s and 2000s all RNA molecules less than 200 
nucleotides (nt) were named small non-coding RNAs. More recently the term small 
RNA (sRNA) was used for the really small RNA molecules, i.e. 20-30 nt (Rother and 
Meister, 2011).  
In contrast, long non-coding RNAs are usually longer than 1 kilobase (1 kb) up to 
several thousands of nt (Storz, 2002; Rother and Meister, 2011). 
 
1.3.1 Discovery of small non-coding RNAs 
 
The first small non-coding RNAs lin-4 and let-7 (~22 nt) were discovered in the 
nematode Caenorhabditis elegans (C. elegans) through genetic mutant screening 
(Lee et al., 1993; Reinhart et al., 2000). These RNAs were expressed in a 
developmental stage-specific manner and were termed as short temporal RNAs 
(stRNAs). They were shown to control the timing of transition during the development 
of C. elegans by binding to complementary sequences in the 3’ untranslated regions 
(3’-UTR) of development-specific mRNAs resulting in the inhibition of gene 
expression (Pasquinelli et al., 2000). 
In 1998, Fire and Mello found in C. elegans that long double stranded (ds) RNA results 
in the sequence-specific mRNA degradation and inhibition of gene expression 
through a phenomenon called RNA interference (RNAi) (Fire et al., 1998). Later RNAi 
turned out to be the same process as what was called post-transcriptional gene 
silencing in plants (Jorgensen, 1990; Napoli et al., 1990). 
One year later Hamilton and Baulcombe discovered an abundant class of small 
dsRNAs (21-24 nt) that were correlated with post-transcriptional gene silencing 
(Hamilton and Baulcombe, 1999). Further biochemical studies on Drosophila cell 
extracts demonstrated that long dsRNA molecules were processed into small 
interfering RNAs (siRNAs) by endonucleolytic cleavage through the RNase III 
enzyme Dicer in both animals and plants (Hammond et al., 2000; Zamore et al., 2000; 
Bernstein et al., 2001; Elbashir et al., 2001). Interestingly, stRNAs had the same size 
INTRODUCTION 
 
24 
 
as siRNAs and the let-7 gene was shown to be conserved across the animal kingdom. 
Therefore, it was hypothesized that Dicer might produce stRNAs which would mean 
that they are not unique to C. elegans and that there could be more stRNAs in different 
species. These hypotheses were tested by looking for 20-24 nt small RNAs in several 
species including C.elegans, Drosophila and the human HeLa cell line.  
In 2001, three laboratories identified over one hundred new sRNAs (~21-25 nt) in 
Drosophila embryos, C. elegans and human HeLa cells by cloning size-fractionated 
sRNAs and sequencing the cDNA libraries. Some of these newly identified sRNAs 
were similar in size to the previously discovered stRNAs lin-4 and let-7. These RNAs 
were encoded by the genome, were expressed in specific tissue- and/or at 
developmental stages and were conserved among species. Interestingly, a few of 
these identified sRNAs were constitutively expressed independent of developmental 
stage or tissue. Therefore, this novel class of small non-coding RNAs was termed 
microRNAs (miRNAs) instead of stRNAs (Lau et al., 2001).  
 
1.3.2 MiRNAs 
 
The intensive cloning of small RNAs (sRNAs), the improved sequencing of cDNA 
libraries and bioinformatics analysis revealed hundreds of miRNA genes in animals, 
plants, and viruses (Bartel, 2004; Pfeffer et al., 2004). Data from the miRNA database 
(miRBase 21) revealed that there are 2588 predicted miRNAs in human (Griffiths-
Jones, 2006; Ha and Kim, 2014). 
MiRNAs constitute one of the most abundant and best studied classes of small non-
coding RNAs in human. Intriguingly, around 30% of mammalian protein-coding genes 
are regulated by miRNAs (Filipowicz et al., 2008). MiRNAs are around 19-23 nt in 
length and regulate gene expression by binding to partially complementary (animals) 
or near perfectly complementary sequences (plants) of target mRNAs which results 
in translational repression and degradation of mRNAs (Huntzinger and Izaurralde, 
2011).  
The majority of miRNA genes are transcribed by RNA polymerase II from intergenic 
regions or from introns of protein coding genes. Primary miRNA transcripts (pri-
miRNAs) are cleaved in the nucleus by the microprocessor complex which includes 
the RNase III enzyme Drosha, the dsRNA-binding domain protein DiGeorge 
syndrome critical region 8 (DGCR8) and further auxiliary proteins resulting in the 
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generation of precursor miRNAs (pre-miRNAs) (Denli et al., 2004; Han et al., 2004). 
These pre-miRNAs are transported from the nucleus via the nuclear core complex 
into the cytoplasm by Exportin-5 via a Ran-GTP dependent mechanism (Bohnsack et 
al., 2004). In the cytoplasm the RNase III enzyme Dicer cleaves the pre-miRNAs into 
short ~ 22 nt miRNA duplex intermediates with 5’ phosphates and 2 nt 3’ overhangs 
(Hutvágner et al., 2001; Ketting et al., 2001). The miRNA duplex structures are 
comprised of a guide strand and passenger strand (miRNA/miRNA*) (Kim et al., 
2009).  
During assembly of the RNA induced silencing complex (RISC) the miRNA duplex 
structure gets unwound and only one strand is incorporated into the RISC complex, 
whereas the other strand is usually removed and degraded. However, there are 
reports that the miRNA*sequences can be loaded into RISC and act as functional 
miRNAs (Okamura et al., 2008; Ghildiyal et al., 2010). 
The determination which strand gets incorporated and retained in the RISC complex 
correlates with its thermodynamic stability and is mainly based on the asymmetry rule. 
The strand with the lower thermodynamic stability at the 5’ end will be incorporated 
into the RISC complex and guides the complex to the mRNA target (Khvorova et al., 
2003; Schwarz et al., 2003; Okamura et al., 2008).  
In the RISC complex the mature miRNA binds to a member of the Argonaute protein 
family.  
Argonaute proteins are characterized by four domains, N-, PIWI Argonaute Zwille 
(PAZ), middle (MID) - and PIWI domains. The N-domain is involved in loading of the 
sRNAs into the RISC complex and functions in the unwinding of the miRNA duplex 
during the RISC assembly process (Kwak and Tomari, 2012). The PAZ domain 
interacts with the 3’ end of sRNAs and the MID domain recognizes the 5’ end of 
sRNAs (Hutvagner and Simard, 2008). The PIWI domain has structural similarities to 
RNase H, which cleaves RNA in DNA-RNA hybrids and was shown to have 
endonuclease activity (Rivas et al., 2005).  
In human only Ago2, but not Ago1, Ago3 and Ago4 have been shown to have 
endonucleolytic activity (Meister, 2013). After loading into the RISC complex, 
posttranscriptional gene silencing is mediated through binding of miRNAs to partially 
complementary target sites within the 3’ untranslated region (3’ UTR) of their target 
mRNAs resulting in translational repression and/or mRNA destabilization of mRNAs 
(Filipowicz et al., 2008; Bartel, 2009).  
During the last decade several novel classes of sRNAs apart from miRNAs have been 
discovered due to advancing next generation sequencing technologies. Interestingly, 
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many small RNA fragments derived from longer non-coding RNAs have been 
identified and it was shown that some of these sRNAs are functional and not 
degradation products (Wittmann and Jäck, 2010; Rother and Meister, 2011). In recent 
years it has been shown that small RNA fragments can be generated from several 
classes of non-coding RNAs, including snoRNAs, snRNAs, rRNAs, tRNAs, vault 
RNAs or Y RNAs (Li et al., 2012; Chen and Heard, 2013).  
In the next section I will briefly give an overview to the most intensively studied sRNA 
fragments that are generated from non-coding RNAs.  
 
1.4 Small RNAs derived from longer transcripts 
 
1.4.1 SnoRNA derived small RNAs 
 
Small RNAs derived from snoRNAs (sdRNAs) have been initially discovered by next 
generation sequencing of immunoprecipitated RNAs associated with Ago1 and Ago2 
using HEK293 cells. Among the sequencing reads, the sdRNA ACA45 was identified. 
Interestingly, this sRNA was dependent on Dicer, but independent of Drosha/DGCR8. 
Luciferase experiments revealed that this sdRNA mediated post transcriptional gene 
silencing and was acting such as miRNAs (Ender et al., 2008). In animals, sdRNAs 
derived from H/ACA box snoRNAs are mainly 20-24 nt and are generated from the 3’ 
end. C/D box sdRNAs are 17-19 nt or longer than 27 nt and are mainly derived from 
the 5’ end of snoRNAs (Taft et al., 2009; Brameier et al., 2011). In the last decade 
several sdRNAs with miRNA-like functions have been identified. They have been 
shown to be involved in alternative splicing (Kishore and Stamm, 2006; Kishore et al., 
2010) and have been associated with cancer (Martens-Uzunova et al., 2011; 
Patterson et al., 2017; Chow and Chen, 2018).  
 
1.4.2 Transfer RNA derived small RNAs 
 
Transfer RNAs (tRNAs) are transcribed by RNA polymerase III and are characterized 
by a clover leaf tertiary structure, five structural features (acceptor stem, D-loop, TΨC 
loop, anticodon loop, variable loop) and 5’ leader and 3’ trailer sequences (Kumar et 
al., 2016; Shen et al., 2018). During tRNA maturation the 5’ leader sequences of the 
pre-tRNA is removed by the endoribonuclease RNase P (Frank and Pace, 1998) 
whereas the 3’ trailer sequence is cleaved by RNase Z (ELAC2) (Schiffer et al., 2002). 
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This is followed by the addition of the nucleotides CCA to the processed 3’ end via 
the tRNA nucleotidyl transferase and nuclear export to the cytoplasm (Maraia and 
Lamichhane, 2011). 
Advances in next generation sequencing technologies and bioinformatics analysis 
revealed that tRNAs are cleaved into smaller RNA fragments (Lee et al., 2009). These 
tRNA derived sRNA fragments can be classified depending on their origin and 
biogenesis into stress-induced tRNA fragments termed tiRNA or tRNA halves and 
regulatory tRNA fragments (tRFs).  
The tRNA halves are fragmented upon various stress conditions, such as oxidative 
stress, nutrient starvation, hypothermia, UV irradiation (Fu et al., 2009; Yamasaki et 
al., 2009) but are also present under normal conditions in low abundance (Thompson 
et al., 2008). These tRNA fragments have been initially identified in Escherichia coli 
(E. coli) during bacteriophage infection. Later these fragments were found in 
Tetrahymena thermophila during nutrient starvation (Lee and Collins, 2005). From 
then on, tRNA halves were discovered in more species of bacteria (Haiser et al., 
2008), fungi (Jöchl et al., 2008) and eukaryotes (Thompson et al., 2008). The tRNA 
halves are 31-40 nt in length and are generated primarily by specific cleavage in the 
anticodon loop of the mature tRNA by the ribonuclease angiogenin in humans 
(Thompson et al., 2008; Yamasaki et al., 2009) and Rny1p in yeast (Thompson and 
Parker, 2009). Depending on the position of the cleavage site at the anticodon loop 
tRNA halves can be classified into 3’ and 5’ end derived tRNA halves (Thompson et 
al., 2008; Kumar et al., 2016). It was shown that tRNA halves are involved in the 
inhibition of translation independent of the phosphorylation of the translation initiation 
factor eIF2α by displacing eIF4G/eIF4A from mRNA (Ivanov et al., 2011) and 
formation of stress granules (Emara et al., 2010). Interestingly, only the 5’ end derived 
tRNA halves and not the 3’ end derived tRNA halves were able to repress protein 
translation (Yamasaki et al., 2009; Emara et al., 2010).  
Apart from stress-induced tRNA halves, next generation sequencing of prostate 
cancer cell lines revealed that there are three classes of regulatory tRFs, tRF-1, tRF-
3, tRF5 that are between 17-26 nt in length (Lee et al., 2009). In addition to these 
three described classes of tRFs internal tRFs (itRFs) have been recently described. 
It was shown that itRFs are generated by a combination of cleavages in the anticodon 
loop and either D arm or TΨC arm of the tRNA (Keam and Hutvagner, 2015; Telonis 
et al., 2015).  
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The tRF-1 fragments are generated by removal of the 3’ trailer of a pre-tRNA by 
cleavage mediated by the ribonuclease RNaseZ/ELAC2 (Lee et al., 2009). The tRNA 
fragment tRF-1001 was the most abundant tRF in the prostate cancer lines. In 
knockdown experiments it was observed that tFR-1001 was essential for cell 
proliferation and was required in the transition between G2 and M phase during cell 
cycle (Lee et al., 2009).  
It is reported that Dicer and other ribonucleases such as angiogenin are involved in 
the specific cleavage and generation of tRF-3 and tRF-5 fragments. The tRF-3 
fragments are either ~18 nt or ~22 nt in length and are produced by cleavages in the 
TΨC loop. The tRF-5 fragments vary in length between 14-30 nt and are cleaved at 
the D-loop or the stem region between the D-loop and anticodon loop (Kumar et al., 
2014). Several studies showed that the processing of tRFs can be Dicer dependent 
(Cole et al., 2009; Lee et al., 2009; Haussecker et al., 2010; Pederson, 2010) or can 
occur Drosha and Dicer independent (Li et al., 2012; Kumar et al., 2014). However, 
the ribonucleases and mechanisms involved in the generation of tRFs still remain 
elusive (Kumar et al., 2014). 
Next generation sequencing experiments of sRNAs immunoprecipitated with Ago1, 
Ago2, Ago3 and Ago4 in human cells revealed that tRF-3 fragments preferentially 
associate with Ago1, Ago3 or Ago4, instead of Ago2 (Haussecker et al., 2010; Kumar 
et al., 2014). It was observed that some tRFs are involved in RNA silencing 
mechanisms and act in a similar way to miRNAs and repress translation (Haussecker 
et al., 2010). However, only tRF-5 fragments have been shown to be involved in gene 
silencing mechanisms and translational repression (Sobala and Hutvagner, 2013).  
Depending on their association with different Ago proteins tRFs function in several 
biological processes such as cell growth, cell proliferation, apoptosis, DNA damage 
response, assembly of stress granules, genome stability, epigenetic inheritance and 
various diseases such as cancer (Shen et al., 2018; Zhu et al., 2018).  
Recently it was shown that the endoribonuclease RNase L is responsible for tRNA 
cleavage in response to viral infection in human A549 lung cancer cells. Donovan et 
al. demonstrated that dsRNA induced tRNA cleavage by RNase L resulted in 
translation arrest and inhibition of protein synthesis (Donovan et al., 2017).  
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1.4.3 Vault RNA derived small RNAs 
 
Bioinformatics analysis of next generation sequencing experiments led to the 
discovery of vault RNA derived sRNAs (svRNAs). Vault RNAs have a characteristic 
stem loop structure and produce fragments from the 3’ end and 5’ end of the terminal 
stem. Persson et al. demonstrated that human svRNAs are processed in a different 
way than canonical miRNAs. The generation of svRNAs was reported to be 
independent of Drosha, but Dicer dependent. Interestingly, one svRNA was reported 
to be loaded into Ago2 and act like a miRNA by regulating the gene expression of 
CYP3A4 which is involved in drug resistance (Persson et al., 2009).  
With the recent advances in next generation sequencing technologies vault RNA 
derived sRNAs have been found highly enriched in extracellular vesicles derived from 
immune cells (Nolte-'t Hoen et al., 2012).  
Recently, it was shown that RNA modifications play an important role in the 
processing of vault RNAs into smaller RNA fragments. It was reported that the RNA 
methyltransferase NSun2 is responsible for the cytosine-5 methylation (m5C) of vault 
RNAs which affects the generation of svRNAs. In this study it was demonstrated that 
svRNA4 associates with Ago2 and Ago3 and acts in a miRNA like manner (Hussain 
et al., 2013). In humans the loss of NSun2 is correlated with neurodevelopmental 
diseases (Abbasi-Moheb et al., 2012; Martinez et al., 2012). Interestingly, in NSun2 
deficient cells in which the processing into svRNAs is affected an increase of mRNAs 
related to neurodevelopmental disorders was observed. This suggested that the 
altered processing of vault RNAs into svRNAs in NSun2 deficient cells may contribute 
to developmental disorders (Hussain et al., 2013).  
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1.5 Y RNAs 
 
1.5.1  Y RNAs in general 
 
Another class of non-coding RNAs that generate sRNA fragments are Y RNAs which 
are subject of this thesis. Y RNAs were initially discovered in 1981 as components of 
the Ro60 and La ribonucleoprotein complexes (RoRNP) in sera of patients with the 
autoimmune disorders systemic lupus erythematosus (SLE) and Sjögren’s syndrome 
(Lerner et al., 1981a; Wolin and Steitz, 1984). Y RNAs were shown to associate with 
the 60 kDa protein Ro60 and the 47 kDa protein La. Both Ro60 and La auto-antigens 
have a RNA binding motif that consists of 80 amino acids. Ro60 is conserved among 
vertebrates and orthologues have also been described in prokaryotes. Ro60 is mainly 
involved in RNA quality control, RNA stability and cellular stress response.  
The La auto-antigen was identified in a subset of RoRNPs (Hendrick et al., 1981). 
The La protein associates with RNA polymerase III transcripts and is involved in the 
accurate and efficient termination of RNA polymerase III transcription. The La protein 
binds to the 3’ polyuridine tail of newly synthesized transcripts in the nucleus.  
Y RNAs were discovered by Lerner and colleagues who identified small cytoplasmic 
RNAs by immunoprecipitation of total cell extracts from mouse Ehrlich ascites and 
serum from SLE patients containing antibodies against Ro and La proteins. The prefix 
“Y” was attributed to this class of non-coding RNAs and these RNAs were termed Y 
RNAs because of their cytoplasmic localization in contrast to snRNAs (URNAs) which 
were found in nuclear extracts of Ehrlich ascites cells. Hendrick et al. confirmed by 
immunofluorescence experiments that Y RNAs are cytoplasmic (Hendrick et al., 
1981).  
Y RNAs are transcribed by RNA polymerase III from single copy genes and range in 
length between 84-112 nt (Hendrick et al., 1981; Wolin and Steitz, 1983; Maraia et 
al., 1994a). Human Y RNAs were found highly abundant in heart and brain tissues 
and low abundant in liver tissues (Wolin and Steitz, 1984).  
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1.5.2 Evolution of Y RNAs 
 
Y RNAs have been identified so far in vertebrates, insects, nematodes and their 
orthologues have been described in prokaryotes, but not in yeast or higher plants. In 
several green algae such as Chlamydomonas reinhardtii, Volvox carteri and 
Tetrabena socialis as well as at least one fungus Allomyces macrogynus Ro60 
orthologues have been identified (Wolin, 2019).  
Y RNAs are highly evolutionarily conserved among vertebrates and the number of 
distinct Y RNAs varies between one and four Y RNAs. Y3 seems to be the most 
conserved Y RNA among all Y RNAs (Farris et al., 1996). It was proposed that all Y 
RNA genes are derived from a common single ancestral Y RNA gene (Wolin and 
Steitz, 1983). It was suggested that gene duplication events resulted in the 
development of Y1/Y3 and Y4/Y5 paralogues (Mosig et al., 2007).  
In humans there are four Y RNAs, named hY1, hY3, hY4 and hY5 RNA, while hY2 is 
a truncated version of hY1 (Wolin and Steitz, 1983). In contrast to humans, rodents 
only possess Y1 and Y3 homologues (mY1 and mY3), while they have a redundant 
“fossil” Y5RNA gene which is not expressed anymore (Pruijn et al., 1993).  
Moreover, bioinformatics analysis revealed that humans and chimpanzees contain 
more than 1000 Y RNA pseudogenes, whereas mice only have a few pseudogenes 
(Perreault et al., 2005; Perreault et al., 2007). Sequence analysis of the flanking 
regions suggested that the human Y RNA pseudogenes were generated by the 
integration of mutated Y RNAs through L1 retro transposition. Interestingly, hY1 and 
hY3 gave rise to the majority of hY RNA pseudogenes whereas hY5 RNA resulted 
only in a few pseudogenes (Perreault et al., 2005).  
Sequence homology analysis of Y RNAs and Y RNA pseudogenes across various 
different metazoans suggested that the different Y RNA species evolved from a 
common single ancient ancestor Y RNA gene through tandem gene duplication 
events. This original ancient Y RNA gene might have diverged into two putative Y 
RNAs in nematodes and Y1 and Y3 in the ancestor of fish. The Y4 and Y5 RNA gene 
might have evolved later in evolution and were first present in amphibians. Thus, there 
exist four major clades of Y RNAs Y1, Y3, Y4 and Y5 in vertebrates, including the 
teleost Y1/Y3 RNAs and amphibian Y5 RNAs (Mosig et al., 2007; Perreault et al., 
2007; Duarte Junior et al., 2019).  
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In humans, all Y RNA genes are located and clustered together within 45 kb at a 
single locus on chromosome 7q36 and all Y RNA genes are transcribed by RNA 
polymerase III from distinct promoters.  
Y3, Y4 and Y5 RNA are transcribed from the plus strand whereas Y1 is transcribed 
from the minus strand (Maraia et al., 1994b; Maraia et al., 1996, Hendrick et al., 1981; 
Wolin and Steitz, 1983). 
The four Y RNA genes are highly conserved among vertebrates and the number of Y 
RNA genes varies among species (Pruijn et al., 1993). Frogs have four Y RNA genes 
xY3, xY4, xY5 and Yα (O'Brien et al., 1993). Interestingly the Y1 gene might have 
gone lost during evolution and through gene duplication of the Y5 gene the paralogue 
Yα gene was gained (Perreault et al., 2007).  
In C. elegans one ceY RNA was identified (Van Horn et al., 1995). However, it was 
shown that this ceY RNA is not essential as nematodes are viable when the ceY RNA 
gene was deleted (Boria et al., 2010). In addition, the ceY RNA is not involved in the 
initiation of DNA replication and has no structure and/or sequence similarity to 
vertebrate Y RNA (Boria et al., 2010; Gardiner et al., 2009). Thus, ceY RNAs might 
be involved in other cellular processes in nematodes.  
Interestingly, a class of small non-coding stem bulge RNAs (sbRNAs) has been 
discovered in nematodes (Deng et al., 2006; Aftab et al., 2008; Boria et al., 2010). 
During recent years sbRNA homologues have been identified in the insect Anopheles 
gambiae (Perreault et al., 2007), the silkworm Bombyx mori (Duarte Junior et al., 
2015) or Branchiostoma floridae (Mosig et al., 2007). 
Interestingly, these sbRNAs were identified as homologues of vertebrate Y RNAs and 
are conserved in both their sequence and secondary structure. Phylogenetic analysis 
showed that nematode sbRNAs are not related to Y1, Y3 or Y4, but are more closely 
related to Y5. Intriguingly, the sbRNAs identified in Bombyx mori contained a highly 
evolutionarily conserved sequence motif (GTGGCTTATC) with hY5 RNA and 
Chinese hamster chY5 RNA. This suggested that these sbRNAs may function as Y 
RNAs but further investigations are needed in the functions of sbRNAs in Bombyx 
mori (Duarte Junior et al., 2015; 2019).  
Y RNAs and sbRNAs are expressed in vertebrates and nematodes around ten times 
less than ribosomal 5S RNAs (Christov et al., 2006). It was shown that most sbRNAs 
were differentially expressed during early embryonic development. Interestingly, in 
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adult worms, dauer larvae and nematodes under heat stress most of the sbRNAs 
were upregulated (Deng et al., 2006, Boria et al., 2010).  
Recently Kowalski et al. reported that sbRNAs are essential for cell proliferation and 
early embryonic development of C. elegans. Knockout of sbRNAs by antisense 
morpholino oligonucleotides resulted in defects during the initiation of DNA replication 
and increased lethality of C. elegans embryos (Kowalski et al., 2015).  
Both nematode sbRNAs and Y RNAs have a characteristic stem-loop structure with 
a bulged double-stranded stem domain and a pyrimidine-rich single-stranded loop 
domain. The single-bulged cytosine separates the lower stem from the upper stem 
domain. The upper stem domain is characterized by a highly conserved A/GUG-CAC-
U nucleotide sequence motif which was shown to be essential for the initiation of 
chromosomal DNA replication (Boria et al., 2010; Christov et al., 2006; Gardiner et 
al., 2009; Kowalski et al., 2015; Wang et al., 2014). Interestingly, both sbRNAs and Y 
RNA have a central loop domain that allows flexibility. Remarkably, this central loop 
also includes a highly conserved sequence motif of UUAUC at the 5’ end of the loop 
domain downstream of the GUG-motif. By substitution mutations of this penta-
nucleotide motif UUAUC it was shown that the upper stem domain and the UUAUC 
motif downstream of the GUG sequence motif of sbRNAs are important for the 
initiation of DNA replication (Boria et al., 2010; Wang et al., 2014; Kowalski et al., 
2015).  
Recently, two functional sbRNAs named Dm1 and Dm2 were identified and 
characterized in Drosophila melanogaster for the first time. Phylogenetic analysis 
showed that these sbRNAs are evolutionarily closer related to nematode sbRNAs 
than to vertebrate Y RNAs. Interestingly, Dm1 and Dm2 sbRNAs have similar 
secondary structure features to nematode sbRNAs and both contain a GUG-CAC 
motif and a UUUAC penta-nucleotide motif which is similar to the UUAUC motif in 
vertebrate Y RNA sequences. Intriguingly, it was shown that Dm1 and Dm1 sbRNA, 
but not Dm2 sbRNA was able to initiate DNA replication in a human cell-free system 
when vertebrate Y RNA were depleted. Thus, it was suggested that Dm1 sbRNA has 
similar functions than vertebrate Y RNAs and can be considered as a functional 
homologue of vertebrate Y RNAs (Duarte Junior et al., 2019). 
Y RNA have also been discovered in various prokaryotes such as Deinococcus 
radiodurans (D. radiodurans) (Chen et al., 2000), Salmonella enterica serovar 
typhimurium (S. typhimurium) (Armour et al., 2009) or Mycobacterium smegmatis 
(Chen et al., 2014).  
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1.5.3 Secondary structure of Y RNAs 
 
All human Y RNAs show evolutionary conservation in their sequence and secondary 
structures and fold into characteristic stem-loop structures (Wolin and Steitz, 1983). 
The secondary structures of human Y RNAs were initially predicted based on 
sequence alignment and computational minimum-free energy (Kato et al., 1982; 
Wolin and Steitz, 1983, 1984).  
However, these minimum-free energy based calculated predictions were limited and 
some important structural features were further determined using both enzymatic 
cleavage and nucleotide chemical modification experiments (Wolin & Steitz, 1984; 
van Gelder et al., 1994). 
Van Gelder et al. investigated the structural features of hY1 and hY5 biochemically in 
more detail by further enzymatic cleavage and chemical probing of hY3 and hY4 RNA. 
The human Y RNAs were digested with several RNases under native and denaturing 
conditions in order to determine stacked, double-stranded or single-stranded RNA 
regions. The RNase V1 cleaves double stranded RNAs (dsN), RNase A cleaves 
single-stranded RNA regions after C and U (ssC and ssU), RNase T1 cleaves single-
stranded RNAs after G (ssG) and RNase T2 single-stranded RNAs (ssN) (van Gelder 
et al., 1994).  
In the chemical probing experiments the nucleotides were chemically modified by 
dimethylsulfide (DMS), 1-cyclohexyl-(2-morpholinoethyl) carbodiimide metho-p-
toluene sulfonate (CMCT) and kethoxal treatment. DMS mainly reacts with the N1 
atom of adenosines (N1-A), while CMCT modifies N3-U and kethoxal is reactive with 
N1-G and N2-G. Primer extension analysis was performed to identify the chemically 
modified nucleotides and get the exact positions of all Watson-Crick bases (van 
Gelder et al., 1994).  
The structure probing experiments of hY1 and hY5 revealed that the secondary 
structures of hY1 and hY5 were in general similar to the minimum-free energy 
calculated secondary structure predictions of hY1 and hY5 RNA (van Gelder et al., 
1994). However, the pyrimidine rich region of hY1 RNA was not found single stranded 
as previously anticipated from earlier computational based sequence alignment 
(Figure 1.1). The hY1 RNA was resistant to structure probing chemicals and enzymes 
under native conditions but not under semi-denaturing conditions. The authors 
suggested that tertiary interactions or base stacking were involved which might be 
important for RNA binding protein recognition (van Gelder et al., 1994).  
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Intriguingly, under native conditions the hY5 RNA formed a large internal loop which 
was contradictory to the minimum-free energy based calculated secondary structure 
(shown in Figure 1.1 A). In this computational prediction using Mfold (Figure 1.1 A) 
it was suggested that base pairing between U23-G46 (Figure 1.1, shown in red) as 
well as between A24-U45 (Figure 1.1, shown in green) occurred. This base pairing 
resulted in the formation of a smaller internal loop and a mismatch between U25-U44 
(Pruijn et al., 1991) whereas in the enzymatic and chemical structure probing 
experiments there was no base pairing between U23 and G46 (Figure 1.1 B, shown 
in red) and A24 and U45 (Figure 1.1 B, shown in green) and an internal loop was 
formed (van Gelder et al., 1994). 
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A      B 
 
 
 
 
 
 
 
 
 
 
A, Predicted secondary structure of hY5 RNA using Mfold after Pruijn et al., 1991.  
The predicted structure using Mfold suggested that base pairing between U23 and G46 
(shown in red) and A24 and U45 (shown in green) occurred, which resulted in a smaller 
internal loop and a mismatch between U25 and U44. The shaded region shows the highly 
conserved Ro60 binding site whereas the dotted region indicates the La binding site. The 
figure was taken from Pruijn et al., 1991 and modified. 
B, Enzymatic and chemical structure probing of hY5 RNA after van Gelder et al., 1994. 
In contrast to the computationally predicted secondary structure of hY5 using Mfold (A) the 
enzymatic and chemical structure probing experiments indicated that under native conditions 
the internal loop 2 is completely accessible and no base pairing between U23 and G46 (shown 
in red) and A24 and U45 (shown in green) was observed.  
Bold and light circles around the individual nucleotides mean strong and moderate reactivity 
to DMS under native conditions. Squares around the nucleotides indicate the nucleotides that 
were unreactive under native conditions, but showed reactivity towards CMCT under semi-
denaturing conditions. Asterisks mark the positions where the reverse transcription was 
stopped. The enzymatic cleavage sites of single strand-specific RNases (T1, A, T2) under 
native conditions are marked by small solid circles and are bold for strong reactivity and open 
circles for moderate reactivity. The cleavages by RNase VI are indicated by triangles and a 
bold triangle symbol means strong reactivity whereas open triangle suggests moderate 
reactivity. The figure was taken from van Gelder et al., 1994 and modified. 
Figure 1.1. Secondary structure predictions of hY5 RNA using Mfold and chemical 
structure probing experiments.  
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In a later study performed by Teunissen et al. the secondary structures of Y3 and Y4 
RNA from human, frog and iguana were investigated in vitro using enzymatic and 
chemical probing experiments and compared with phylogenetic data. The obtained 
structure probing data for Y3 and Y4 RNA were partly different compared to the 
computationally predicted secondary structures but all Y RNAs showed highly 
conserved structural elements in human, frog and iguana Y RNAs (Teunissen et al., 
2000).  
Previous phylogenetic analysis using a novel secondary structure prediction 
algorithm also revealed that the secondary structure of Y1, Y3 and Y4 RNA was highly 
conserved in rabbit, duck, trout, guinea pig and cow suggesting that the secondary 
structure of Y RNAs is conserved among vertebrates (Farris et al., 1999).  
All Y RNAs are characterized by at least two conserved stem structures. The stem 
formed by extensive base pairing between the 3’ and 5’ region of the Y RNAs is the 
most conserved. This region contains a single bulged cytosine within a conserved 
helix and an internal loop which separates the lower stem from the upper stem 
(Figure 1.2, A).  
Y RNAs are characterized by an internal single-stranded pyrimidine-rich loop domain 
which is least conserved and varies in nucleotide sequence and size between 13-36 
nt. From the structure probing experiments it was suggested that the central part of Y 
RNAs is rather dynamic and accessible to interaction partners such as other nucleic 
acids or proteins. This would suggest that this region might be important for the 
functionality of Y RNAs (van Gelder et al., 1994; Teunissen et al., 2000). In overall, 
eukaryotic and prokaryotic Y RNAs are modular and the binding site of Ro60 
orthologues in the lower stem region is highly conserved among vertebrates, 
nematodes and prokaryotes (Figure 1.2, B). 
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Figure 1.2. Secondary structures and modular composition of eukaryotic and 
prokaryotic Y RNAs.  
A, Secondary structures of human Y RNAs. Human Y RNAs are evolutionarily conserved 
in their sequence and secondary structure. The region highlighted in red shows the conserved 
stem domain where Ro60 binds. The blue highlighted upper stem was shown to be involved 
in DNA replication.  
B, Modular structure of Y RNAs. The region shown in red is the highly conserved binding 
site of Ro60 orthologues of vertebrate, nematode and prokaryotic RNAs that is composed of 
a lower stem that is formed by extensive base pairing of the 3’ and 5’ end. The upper stem is 
highlighted in blue and plays an essential role in DNA replication. The internal single-stranded 
pyrimidine-rich loop domain is least conserved. In prokaryotes the exoribonuclease 
polynucleotide phosphorylase PNPase shown in grey interacts with the Ro60 orthologue Rsr 
forming the RNA degradation complex RYPER (Ro60/Y RNA/PNPase exoribonuclease RNP). 
The figure was taken from Kowalski and Krude 2015.   
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Ribonuclease protection experiments revealed that Ro60 binds to the lower stem 
region of the conserved stem that contains a bulged helix. Deletion experiments 
showed that a single cytidine bulge is essential for Ro60 binding (Wolin and Steitz, 
1984; Pruijn et al., 1991; Green et al., 1998) (Figure 1.2, highlighted in red).  
Green et al. demonstrated by mutagenesis and chemical structure probing 
experiments that Ro60 recognizes specific base pairs within the bulged conserved 
helix and binds to the major groove of Y RNAs. It was observed that a single bulged 
nucleotide and a bulge of 3 nt on the opposite strand of the helix are required for 
Ro60 binding. In addition, it was shown that the base pairing between C9 and G90 is 
critical for Ro60 binding and the bulge at C8 is required for Ro60 recognition (Green 
et al., 1998).  
In previous structure probing experiments of naked hY1 and hY5 RNAs performed by 
van Gelder et al. it was reported that in the majority of Y RNA molecules the cytosine 
at position 9 was bulged out.  
However, in a few molecules base-pairing between C9-G102 occurred and C8 was 
bulged out which suggested that two conformations of Y RNAs bound to Ro60 exist 
(Figure 1.1 B) (van Gelder et al., 1994).  
Interestingly, Green et al. performed structural analysis of naked and protein-bound 
RNA and found that Ro60 binding resulted in a structural change of Y RNAs. From 
these results it was suggested that in the naked Y RNA the cytidine at position 9 is 
unpaired whereas in the Ro60 bound form the cytidine at position 8 is bulged out and 
a base pair between C9 and G90 in the xY3 RNA is formed (Green et al., 1998).  
Furthermore, Y RNAs seem not have posttranscriptional modifications (Kato et al., 
1982) and are characterized by an oligo-uridine stretch at the 3’ terminus which is the 
binding site for the La protein. At the 5’ end Y RNAs have a tri-phosphorylated guanine 
residue (pppG), whereas hY5 shows a tri-phosphorylated adenine residue (pppA) 
(Hendrick et al., 1981; Kowalski and Krude, 2015).  
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1.6 Y RNAs in RoRNPs 
 
1.6.1 Ro60 protein 
 
During investigations of the autoimmune disorders SLE and Sjögren’s syndrome it 
was shown that the 60 kDa protein Ro60 (SSA) and the 47 kDa protein La (SSB) are 
the major autoantigens that associate with Y RNAs forming RoRNPs. It was found 
that in patients with SLE, anti-Ro antibodies are linked to photosensitivity and 
neonatal lupus in which mothers give birth to children suffering from cardiac 
conduction defects or complete heart block. Xue et al. showed that mice lacking Ro60 
developed a lupus-like syndrome which proposed that Ro60 might play a role in the 
prevention of autoimmunity (Xue et al., 2003).  
Ro60 is evolutionarily conserved among vertebrates and has been characterized in 
mammalian cells (Deutscher et al., 1988). Its orthologues have been described in 
Xenopus laevis (O'Brien et al., 1993) and nematodes (Van Horn et al., 1995; Labbé 
et al., 1999) and prokaryotes such D. radiodurans and Salmonella (Wolin et al., 2013). 
Although RoRNPs have been detected in sera of SLE patients over 30 years ago, the 
precise functional role of RoRNPs and Y RNAs has yet to be elucidated.  
The crystal structure of full-length Xenopus laevis Ro60 that was resolved with and 
without ligands revealed that Ro60 has a doughnut-shaped structure. Ro60 has two 
domains. One domain of the Ro60 protein shows a similar structure to the van 
Willebrand factor A (vWFA) domain whereas the second domain is composed of 
several α-helical HEAT repeats that form the toroid structure and a central cavity 
which is positively charged. It was shown that the single stranded 3’ ends of misfolded 
RNAs bind via this central cavity and not dsRNAs. Interestingly, Y RNAs bind to the 
outer ring domain along with misfolded RNAs. Y RNAs might sterically prevent 
binding of misfolded RNAs on the outer surface of Ro60 via competition for the same 
binding site. Hence, it was suggested that Y RNAs regulate the access of misfolded 
RNAs and other RNA molecules to the Ro60 protein (Stein et al., 2005; Fuchs et al., 
2006). Further, a metal ion dependent adhesion site (MIDAS) motif was identified in 
the vWFA domain. This motif was proposed to be responsible for the conformational 
change of Ro60 during opening and closing of the toroid structure. Therefore, this 
motif might also be involved in the recruitment of other protein interaction partners or 
ribonucleases and regulate the accessibly of misfolded RNAs to Ro60 (Stein et al., 
2005).  
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1.6.2 Role of RoRNPs in RNA quality control  
 
Several studies revealed that Ro60 is involved in quality control pathways of 
misfolded RNAs. Immunoprecipitation experiments of X. laevis oocyte nuclei showed 
that Ro60 associates with defective 5S rRNA precursors (O'Brien and Wolin, 1994). 
These variants of 5S rRNA contain an extra 8-10 nt at the 3’ end which are generated 
by a failure of RNA polymerase III transcription termination. The misfolded 5S rRNA 
precursors cannot be efficiently processed to mature 5S rRNAs. The variant 5S rRNA 
molecules fold into alternative secondary structures, which are recognized by Ro60 
resulting in the degradation of defective 5S rRNA precursors (O'Brien and Wolin, 
1994; Shi et al., 1996).  
In mouse embryonic stem cells it was observed that Ro60 also binds misfolded U2 
small nuclear RNAs (snRNAs) that have important functional roles in pre-mRNA 
splicing. When wild type and variant U2 small nuclear RNAs were injected into X. 
laevis oocytes at the same time, Ro60 associated with the misfolded U2 snRNA in 
the nucleus (Chen et al., 2003).  
The binding of Ro60 to misfolded 5S rRNA precursors in X. laevis oocyte nuclei and 
variant U2 snRNAs in mouse embryonic stem cells in X. laevis oocytes suggests that 
Ro60 plays an important role in quality control pathways of small non-coding RNAs.  
One Y RNA homologue, called ceY RNA was identified in C. elegans which 
associates with ROP-1. Intriguingly, ceY RNAs were drastically downregulated in rop-
1 mutants which indicates that ceY RNAs are stabilized by binding to the Ro protein 
(Labbé et al., 1999). Also, in mouse cells it was shown that the number of Y RNAs 
was decreased in cells lacking Ro60 which strengthens the possibility that binding to 
Ro stabilizes Y RNAs (Chen et al., 2000). 
Interestingly, Hogg and Collins suggested that Y RNAs recruit defective and 
misfolded RNAs to Ro60. They showed that human Y5 RNAs interact with variant 5S 
rRNAs via the ribosomal protein L5. It was observed that Y5 RNA has a preference 
for binding to 5S rRNA variants compared to the correctly processed 5S rRNA 
transcripts. Consequently, the Y5 RNA might assist Ro60 to differentiate between 
correctly folded and misfolded 5S rRNAs, suggesting that it facilitates the access of 
RNA variants to the outer surface of Ro60 (Hogg and Collins, 2007).  
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1.6.3 Role of RoRNPs in stress response 
 
Ro60 is also involved in the survival of cells upon various types of environmental 
stress, such as UV irradiation in bacteria and animal cells (Sim and Wolin, 2011; Chen 
et al., 2014). An orthologue of Ro60, called Rsr (Ro-sixty related) and a single Y RNA 
have been identified in the radiation-resistant bacteria D. radiodurans. When the D. 
radiodurans strains were subjected to UV irradiation both the Ro60 homologue Rsr 
and the associated Y RNA were upregulated in the cells. Bacterial strains lacking Rsr 
(Δrsr) were shown to be more sensitive following UV irradiation, compared to the wild 
type D. radiodurans strains (Chen et al., 2000). Both Rsr and Y RNA were 
accumulated upon different environmental stress conditions such as ionizing 
radiation, heat stress or during the stationary phase of D. radiodurans growth. In 
addition, mouse cells lacking the Ro protein were more sensitive to UV irradiation 
compared to normal cells and both Ro60 and mY3 were found accumulated in the 
nucleus (Chen et al., 2003). 
A further important finding in D. radiodurans revealed that during stress Y RNAs and 
Ro are involved in maturation and decay pathways of structured RNAs including 
exoribonucleases (Wurtmann and Wolin, 2010). It was shown that Y RNAs tether the 
Ro60 ortholog Rsr to the 3’ to 5’ exoribonuclease polynucleotide phosphorylase 
PNPase forming the RNA degradation machinery RYPER (Ro60/Y RNA/PNPase 
Exoribonuclease RNP). The ring shaped Rsr interacts with single-stranded structured 
non-coding RNAs via its central cavity where PNPase degrades structured RNAs. Rsr 
interacts with the exoribonucleases RNase II and RNase PH during heat stress in 
23S rRNA maturation. Biochemical experiments showed that Y RNA binding to Rsr 
inhibits rRNA maturation. Ribosomal RNAs are only processed when Y RNAs are not 
bound to Rsr. Y RNAs tether the Ro60 ortholog Rsr to other proteins in order to form 
either the degradation complex RYPER in rRNA decay pathways or to interact with 
other exoribonucleases in rRNA maturation during stress (Chen et al., 2007; Chen et 
al., 2013; Wolin et al., 2013; Chen et al., 2014).  
In conclusion, RoRNPs are involved in quality control pathways and RNA stability. As 
part of RoRNPs Y RNAs play an important role in the regulation of the access of other 
RNAs to the central cavity of Ro and can be seen as “gate keepers” (Chen et al., 
2013). Both Ro60 and Y RNAs are important for cell survival under stress conditions 
(Chen et al., 2000). However, the function of Ro60 and Y RNAs correlated with the 
pathogenesis of autoimmune disorders is still not clear. 
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1.6.4 Subcellular localisation of RoRNPs 
 
Intriguingly, the Ro60 protein has been localized in both the cytoplasm and nucleus. 
In contrast, Y RNAs are primarily localized in the cytoplasm of mammalian cells and 
X. laevis oocytes (O'Brien et al., 1993; Peek et al., 1993). Simons et al. suggested 
after microinjection of X. laevis oocytes and immunoprecipitation experiments that 
Ro60 and La protein are transported into the nucleus after translation and associate 
with Y RNAs in the nucleus where the RoRNP assembly occurs (Simons et al., 1994). 
The RoRNP complex is then exported to the cytoplasm. For the nuclear export of Y 
RNAs into the cytoplasm the Ro60 binding site needs to be intact (Simons et al., 
1996). Further it was shown that when Ro60 protein was mutated, Ro60 was primarily 
localized in the nucleus and not associated with Y RNAs (Sim et al., 2009). In this 
study it was found that Ro60 has a nuclear accumulation signal that is masked by the 
binding of Y RNAs to Ro60. During stress Ro60 accumulates in the nucleus and the 
nuclear accumulation signal becomes accessible. This suggested that Y RNAs play 
an important role in the regulation of the subcellular distribution of Ro60 under normal 
and stress conditions (Sim et al., 2009; Sim and Wolin, 2011).  
A later study showed that out of all human Y RNAs, only the hY5 RoRNP was retained 
in the nucleus which suggested that it has an additional function that other human Y 
RNAs lack (Gendron et al., 2001).  
Due to the different techniques that were applied the subcellular localisation of Y 
RNAs still remains controversial. In situ hybridization and electron microscopy of 
cultured human cells suggested that Y RNAs are present in both the nucleus and 
cytoplasm (Farris et al., 1997). In proliferating cells it was observed that hY1, hY3 and 
hY5 are localized in the perinucleolar compartment (Matera et al., 1995).  
In a recent study it was reported that during DNA replication all Y RNAs interact 
dynamically with chromatin and replication proteins in G1 phase nuclei. This was 
shown in vitro using fluorescently labelled Y RNAs in a human cell-free system. 
Interestingly, hY1, hY3 and hY4 were associated with early replicating euchromatin, 
whereas hY5 RNA was primarily found in nucleoli (Zhang et al., 2011).  
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1.7 Y RNA binding proteins 
 
Using biochemical approaches several stable or transient Y RNA associated proteins 
have been identified. Interestingly, most of the described Y RNA binding proteins 
have been shown to be involved in alternative splicing and translation.  
1.7.1 La protein 
 
Apart from Ro60 the La protein (SSB) is a major autoantigen which was found in sera 
of patients with SLE and Sjögren’s syndrome in complexes with Y RNAs and a subset 
of RoRNPs (Alspaugh and Tan, 1975; Hendrick et al., 1981). The La protein is a 
phosphoprotein that is highly abundant and primarily found in the nucleus under 
normal conditions, but is also present in the cytoplasm (Pruijn et al., 1991; Slobbe et 
al., 1992). Compared to Ro60 the La protein is almost 50 times more abundant (Peek 
et al., 1993). The human La protein is 47 kDa in size, comprised of 408 amino acids 
and highly evolutionarily conserved (Wolin and Cedervall, 2002).  
The La protein binds all RNA polymerase III transcripts such as pre-tRNAs, pre-
5SRNAs, U6 snRNAs, 7SL RNAs, Alu elements, Y RNAs (Hendrick et al., 1981). 
Some viral encoded RNAs including the Epstein-Barr virus encoded RNAs EBER 1 
or EBER 2 or the adenovirus- RNAs VAI and VAII were also shown in association 
with La protein (Lerner et al., 1981b; Rosa et al., 1981; Rinke and Steitz, 1982; Wolin 
and Cedervall, 2002). The La protein is involved in the accurate termination of RNA 
polymerase III transcription. It was shown that La binds to the 3’ polyuridine tail in the 
nucleus and stabilizes newly synthesized RNA polymerase III transcripts (Stefano, 
1984; Gottlieb and Steitz, 1989; Maraia et al., 1994a).  
Interestingly, it was shown that La is important for the nuclear retention of Y RNAs in 
order to protect them from degradation by exonucleases (Simons et al., 1996). La 
binds to the 3’ polyuridine tail and increases Y RNA stability (Gottlieb and Steitz, 
1989). Notably, after transcription termination Y RNAs stay associated with the La 
protein whereas other RNA polymerase III transcripts dissociate from it (Boire and 
Craft, 1989; Peek et al., 1993) suggesting that the La protein might be important for 
Y RNA function or recruitment of other proteins.  
It was observed that during apoptosis the La protein is rapidly dephosphorylated and 
25% of La proteins are cleaved at the C-terminus in a caspase dependent manner. 
The La protein is a phosphoprotein and synthesis of new RNA polymerase III 
transcripts is regulated by a phosphorylation and dephosphorylation cycle.  
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The induction of apoptosis results in a dysregulation of this phosphorylation cycle. 
This suggests that dephosphorylation of La might be important in the initiation of cell 
death mechanisms (Rutjes et al., 1999b). 
Interestingly, the La protein is involved in the inhibition of interferon induced antiviral 
response. through the protein kinase PKR that gets activated by double stranded 
RNA. The La protein is involved in the unwinding of dsRNA which prevents the 
activation of the protein kinase PKR through dsRNA.  (Xiao et al., 1994). Therefore, 
it was proposed that the dephosphorylation and cleavage of the La protein during 
apoptosis might be a key step to activate PKR and interferon induced antiviral 
response mechanisms (Rutjes et al., 1999b).  
1.7.2 Nucleolin 
 
Nucleolin is a phosphoprotein localized in the nucleolus and plays key roles in 
chromatin structure, rRNA biogenesis and maturation, ribosome assembly and 
nucleocytoplasmic transport. Nucleolin was shown to be associated with cell 
proliferation and cell growth (Ginisty et al., 1999; Srivastava and Pollard, 1999; 
Fouraux et al., 2002). 
In order to identify novel RoRNP associated proteins Ro60 and La 
immunoprecipitation experiments and mass spectrometry were performed. In this in 
vitro experiment Nucleolin was identified as a new RoRNP associated protein. 
Surprisingly, nucleolin was only in complex with hY1 and hY3, but not with hY4 and 
hY5.  
Deletion mutants on hY1 RNA revealed that a pyrimidine-rich internal loop structural 
feature and not the nucleotide sequence is required for efficient nucleolin association. 
The hY3 RNA has a similar pyrimidine-rich internal loop to hY1 RNA. However, hY4 
and hY5 lack this structural feature and therefore cannot bind nucleolin.  
It was hypothesized that nucleolin is involved in the shuffling of hY1 and hY3 from the 
nucleus to the cytoplasm since nucleolin was reported to be involved in 
nucleocytoplasmic transport (Fouraux et al., 2002).  
Controversially, Langley et al. observed using a human cell-free system and 
immunoprecipitation experiments that nucleolin binds all four human Y RNAs but 
preferentially associates with hY1. This result might be due to the fact that different 
experimental set ups (Northern blotting versus quantitative reverse transcription-
PCR) and antibodies were used for this study.  
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Further, it was shown that Ro60, La and nucleolin are not involved in the initiation of 
DNA replication. Intriguingly, using real-time PCR it was observed in the same study 
that 50% of all Y RNAs were not associated with Ro60, La or nucleolin (Langley et 
al., 2010). Langley et al. suggested that naked Y RNAs that are not bound to proteins 
are involved in DNA replication in vitro, whereas the protein bound Y RNAs fulfil 
different functions including RNA quality control, RNA stability or stress response 
(O'Brien and Wolin, 1994; Chen et al., 2003; Sim et al., 2009).  
Interestingly, by Garcia et al. it was reported that the Moloney murine leukemia virus 
(MLV) selectively incorporates host mY1 and mY3 RNAs without the requirement of 
Ro60 and La binding. This study further confirmed that Y RNAs can be functional 
independent of Ro60 or La (Garcia et al., 2009; Langley et al., 2010).  
1.7.3 Ro52 
 
Ro52 has been identified in sera of patients with SLE and Sjögren's syndrome. This 
protein was previously reported to interact with Y RNAs and to be part of RoRNPs 
with Ro60 and La (Ben-Chetrit et al., 1988). By immunofluorescence microscopy it 
was shown that Ro52 and Ro60 co-localize in both the cytoplasm and nucleus 
(Slobbe et al., 1991). Immunoprecipitation experiments using HeLa cell extract and 
monospecific antisera against Ro60, La and Ro52 indicated that Ro52 can only 
interact with hY1 RNA in the presence of Ro60 (Slobbe et al., 1992).  
In later experiments using glycerol density gradient fractionation and co-
immunoprecipitation experiments with Ro60 revealed that Ro52 was not part of 
RoRNPs and did not co-localize with Ro60 in vivo (Kelekar et al., 1994; Boire et al., 
1995). Intriguingly, it was shown that Ro52 does not have any RNA recognition motif 
which suggested that Ro52 is not a RNA binding protein (Kelekar et al., 1994). This 
was further confirmed by Frank et al. who reported that Ro52 contained zinc finger 
and leucine zipper motifs in the predicted amino acid sequence. It was proposed that 
it was a DNA binding protein that belongs to the TRIM (tripartite motif) protein family 
(Frank et al., 1995; Ottosson et al., 2006). Ro52 was identified as an E3 ubiquitin 
ligase that plays important roles in cell proliferation, cell death and autoimmunity 
(Espinosa et al., 2006).  
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1.7.4 Heterogeneous nuclear ribonucleoproteins 
 
In order to identify novel Y RNA-associated proteins, in vitro biochemical purification 
of RoRNPs and reconstitution experiments of biotinylated Y RNAs using HeLa S100 
cell extracts were performed. In these experiments several Y RNA binding proteins 
ranging in size between 15-80 kDa were identified. Interestingly, all of these proteins 
preferentially interacted with Y1 and Y3 RNA (Fabini et al., 2000). Later the 
heterogeneous nuclear ribonucleoproteins hnRNP I, also named polypyrimidine tract 
protein (PTB) and hnRNP K were identified by mass spectrometry and the interaction 
with human Y RNAs was validated in vitro using deletion mutants of hY1. It was clearly 
seen that hnRNP I/PTB and hnRNP K preferentially associate with hY1 and hY3, but 
not hY4 or hY5 via the pyrimidine rich central loop like nucleolin. Using a yeast three 
hybrid screen the interaction of hnRNP I/PTB and hnRNP K with hY1 and hY3 was 
confirmed in vivo (Fabini et al., 2001).  
The proteins hnRNP I also named polypyrimidine tract binding protein (PTBP1) and 
hnRNP K are implicated in nucleocytoplasmic transport and have key roles in RNA 
processing, export, RNA stability and translation. Interestingly, La was found to be 
required between the interaction of hnRNP I/PTB and hnRNP K and Y RNAs. 
Therefore, it was hypothesized that La might be molecular chaperone for Y RNAs in 
order to allow the association with hnRNP I/PTB and hnRNP K and regulation of 
translation (Fabini et al., 2001; Belisova et al., 2005).  
 
1.7.5 Zipcode-binding protein 
 
Previous studies indicated that the zipcode-binding protein ZBP1 (also called 
IGF2BP1 and IMP1) was associated with nucleolin, Ro60 and PTB which were 
described as Y RNA binding proteins above (Fabini et al., 2001; Köhn et al., 2010).  
Using near infrared labelled Y RNAs and electromobility shift assay ZBP1 was 
identified as an RNA binding protein of Y3. ZBP1 forms a trimeric complex with Y3 
and La. This ternary complex formation was specific to Y3 since the complex 
dissociated in the presence of Y5 (Köhn et al., 2010).  
Later ZBP1 was found co-purified with mouse Ro60 by tandem affinity purification. 
Interestingly, it was shown that ZBP1 interacts with mY1 and mY3 like nucleolin, 
hnRNP I/PTB or hnRNP K via the Y RNA loop domains (Sim et al., 2012; Köhn et al., 
2013).  
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ZBP1 was reported to be involved in the subcellular localization of Ro60 and mY3 
RNA. Under stress conditions such as UV irradiation it was observed that ZBP1 is 
bound to the mY3/Ro60 complex and accumulates in the nucleus whereas under 
normal conditions Ro60 and mY3 were primarily found in the cytoplasm. Also, after 
depletion of ZBP1 the mY3/Ro60 complex showed high accumulation in the nucleus 
suggesting that ZBP1 might be important for the nuclear export of RoRNPs (Sim et 
al., 2012). Interestingly, in the same study it was reported that apart from ZBP1, the 
Y-box protein YB-1 and a RNA dependent helicase MOV10 which play key roles in 
cellular stress response (Lu et al., 2005) associate with Ro60 and associated RNAs 
(Sim et al., 2012).  
 
1.7.6 APOBEC3G 
 
The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G 
(APOBEC3G) belongs to the family of cytidine deaminases and catalyses the 
deamination of cytidine to uridine. APOBEC3G is also involved in antiviral response. 
Intriguingly, APOBEC3G was reported to be part of the RoRNPs and associated with 
all four human Y RNAs (Chiu et al., 2006; Gallois-Montbrun et al., 2008). However, 
the function of APOBEC3G in RoRNPs remains obscure and it was hypothesized that 
APOBEC3G might function in the RNA editing of Y RNAs and regulate their function 
(Chiu et al., 2006; Köhn et al., 2013).  
 
1.7.7 RoRNP binding protein 1  
 
The Ro RNP binding protein (RoBPI) is also known as poly U binding splicing factor 
(PUF60). RoBPI was reported to be a DNA and RNA binding protein that plays key 
roles in transcription and splicing (Page-McCaw et al., 1999) and can be linked with 
autoimmune diseases (Fiorentino et al., 2016) and cancer (Kobayashi et al., 2016).  
RoBPI was identified by a modified yeast-three hybrid assay called RNA interaction 
trap assay (RITA) which allows the reconstitution of tripartite RNPs. Interestingly, it 
was observed that RoBPI primarily interacted with hY5 RNA in the nucleus, but was 
also reported to bind hY1 and hY3 RNA (Hogg and Collins, 2007).  
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Using the yeast-three hybrid assay it was found that in human cells RoBPI only 
associated with recombinant Ro60 and specifically hY5 RNA together but not to Ro60 
or hY5 RNA alone (Bouffard et al., 2000).  
Previous studies already indicated that hY5 RNA appeared to have different 
biochemical properties or localization compared to the other human Y RNAs. In 
human and mouse cells the hY5 RNA is mostly localized in the nucleus while hY1, 
hY3 or hY4 RNAs are cytoplasmic. Furthermore, it was suggested that the sequence 
of hY5 RNA itself contributes to the nuclear retention (Gendron et al., 2001). Notably, 
anion exchange chromatography showed that the hY5 RNA was found in a different 
fraction compared to hY1, hY3 or hY4 RNAs (Boire et al., 1995). Interestingly, sera 
from two SLE patients with autoantibodies against Ro RNPs contained antibodies 
specifically to hY5 RNA (Boire and Craft, 1989; Boulanger et al., 1995). 
Immunoprecipitation experiments after T1 RNA digestion demonstrated that a 27 nt 
fragment mapping to the 5’ end of hY5 RNA and a 31 nt fragment mapping to the 3’ 
end of hY5 RNA were specifically recognized by anti-hY5 antibodies (Boulanger et 
al., 1995). 
 
1.7.8 Ribosomal protein L5 
 
RNA-based affinity purification of hY1, hY3, hY4 and hY5 RNPs combined with mass 
spectrometry revealed that hY5 RNP specifically associated with the ribosomal 
protein L5 and misfolded 5S RNA. Steitz et al. previously reported that L5 protein is 
complexed with 5S rRNA and plays a role in the ribosome assembly (Steitz et al., 
1988). Mutagenesis experiments revealed that certain structural features of the 
internal pyrimidine loop of hY5 RNA are involved in the recognition of misfolded 5S 
RNA. These results suggested that Y5 RNA might be involved in RNA quality 
mechanism and assists to distinguish between correctly folded and misfolded 
ncRNAs. Further it was indicated that Y5 RNA might be involved in the recruitment of 
other proteins such as the interferon-induced protein with tetratricopeptide repeats 5 
(IFIT5) which plays a role in innate immunity (Hogg and Collins, 2007). IFIT5 was 
reported to bind ssRNAs that have a triphosphate group at the 5’ end like the Y5 RNA 
(Hendrick et al., 1981; Abbas et al., 2013; Katibah et al., 2014).  
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1.7.9 Poly (A) specific ribonuclease 
 
Poly(A) specific ribonuclease (PARN) is a deadenylase and mutations in PARN are 
linked to severe hereditary diseases such as pulmonary fibrosis or the congenital 
disorders which were correlated with telomere shortening (Stuart et al., 2015). 
Interestingly knockdown experiments revealed that PARN is required for Y RNA 
stability and correct 3’ end processing in human cells. During 3’ end processing of Y 
RNAs PARN and the exosome protein EXOSC10 remove the oligo (A) tails that were 
added by PAPD5 and stabilize Y RNAs from degradation. The 3’- to 5’ exonucleases 
DIS3L or TOE1 recognize oligo (A) tails and are involved in RNA degradation. 
Interestingly, after siRNA knockdown of PARN and EXOSC10 a decrease of Y RNA 
levels was observed. Further knockdown experiments confirmed that PARN, 
EXOSC10 and PAPD5 play a key role in the 3’ end processing and stability of Y 
RNAs. (Shukla and Parker, 2017). 
 
1.7.10 Cleavage and polyadenylation specificity factor 
 
The cleavage and polyadenylation specificity factor CPSF is required for the 3’ end 
cleavage of pre-mRNAs (Chan et al., 2011). Intriguingly, by mass spectrometry of 
proteins that interact with biotinylated Y RNAs and copurification experiments CPSF 
was identified to interact with Y3/Y3** RNA (Y3** isomer of Y3). RNA sequencing 
analysis and knockdown experiments confirmed that among all the tested Y RNAs 
only the Y3 isomer Y3** was found in association with mRNA processing factors. In 
particular, it was confirmed that Y3** is essential for the 3’ end processing of histone 
mRNAs (Köhn et al., 2015).  
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1.8 Functions of Y RNAs 
 
1.8.1 Y RNAs in DNA replication 
 
The first direct cellular function of Y RNAs that has been established was that Y RNAs 
are required for chromosomal DNA replication in vertebrates (Christov et al., 2006).  
DNA replication is a vital process in order to ensure genome stability and 
maintenance. During cell division cycle the chromosomal DNA first gets duplicated (S 
phase) which is followed by a segregation into two genetically identical daughter cells 
(M phase). In addition to S phase and M phase the cell cycle includes two transition 
gap phases that allow further cell cycle regulation. The G2 phase occurs between S 
phase and M phase, whereas the G1 phase is between M phase and S phase (Rao 
and Johnson, 1970). During G1 phase the decision if the S phase and hence cell 
proliferation is initiated is tightly regulated. After DNA replication is initiated (S phase) 
several mechanisms control that all chromosomal DNA is duplicated exactly once 
before chromosomal segregation into two identical daughter cells in the M phase can 
occur (G2 phase) (Heichman and Roberts, 1994; Nurse, 1994).  
Hence, a key step of the cell division cycle is the initiation of DNA replication. The 
process of DNA replication is described in detail in several excellent reviews and I am 
giving a short overview about the most important steps (Bell and Dutta, 2002; Takeda 
and Dutta, 2005; Pospiech et al., 2010, Fragkos et al., 2015).  
In the first step of the initiation of DNA replication the coordinated assembly of the 
multiprotein prereplicative complexes (pre-RC) or replication licence in the early G1 
phase takes place. The formation of pre-RCs is initiated by the multiprotein origin 
recognition complex (ORC) containing six related proteins that bind to replication 
origins during all steps of the cell cycle. ORC recognizes autonomously replicating 
sequences (ARS) that are a few hundreds of base pairs in length and are responsible 
for the initiation of DNA replication.  
The initiation factors Cdc6 and Cdt1 bind to the ORC at the origins of replication and 
allow the recruitment of a group of six related minichromosome maintenance proteins 
(MCM2-7) to the ORC complex resulting in the formation of the pre-RC.  
Pre-RCs play an important role in the initiation of DNA replication during S phase as 
they are involved in the unwinding of replication origins and recruitment of DNA 
polymerases.  
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During the transition between G1 phase and S phase the pre-RC needs to get 
activated into active replication forks. This requires another set of replication factors. 
The initiation of DNA replication involves the origin unwinding, stabilization of single 
stranded DNA and finally the recruitment of DNA polymerases. Within the pre-RC the 
MCM2-7 helicase complex forms a ring around the DNA and DNA gets unwound and 
DNA replication is initiated (see Figure 1.3). 
Cyclin-dependent kinase CDK2 and DBF4-dependent kinase CDC7 are required for 
the phosphorylation und hence activation of the replication origins, the conversion of 
the pre-initiation complex (pre-IC) into active replication forks during S phase.  
For the activation of the pre-IC complex the initiation factors Mcm10, the cell division 
control protein CDC45, the ATP-dependent DNA helicase Q4 (RECQL4), Treslin, the 
GINS complex, the DNA topoisomerase 2-binding protein (TOPBP1), DNA 
polymerase ε and replication protein A (RPA) are recruited in order to unwind DNA.  
After the activation of MCM2-7 helicase complex several replication proteins such as 
replication factor C (RFC), proliferating cell nuclear antigen (PCNA) and other DNA 
polymerases (DNA pol α and δ) are recruited and DNA replication is initiated.  
The CMG complex is formed by CDC45, the MCM2-7 helicase hexamer complex and 
the DNA replication complex GINS and comprises the replisome which is only formed 
on activated origins. After the CMG complex gets activated the DNA is unwound and 
DNA replication is initiated.  
The check point Serin/Threonine kinases ATR and Serine protein kinase ATM that 
are involved in the activation of check point kinases CHK1 and CHK2 are involved in 
the check point control of origin activation and repression of origin re-replication which 
is an important regulation mechanism (see Figure 1.3) (Takisawa et al., 2000; 
Takeda and Dutta, 2005; Pospiech et al., 2010; Fragkos et al., 2015).  
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Figure 1.3. Overview of DNA replication.  
A. Formation of the pre-RC complex.  
In the G1 phase the proteins CDC6 and CDT1 bind the multiprotein origin recognition complex 
(ORC) at the origins of replication. This results in the recruitment of minichromosome 
maintenance proteins (MCM2-7) to the ORC complex and the formation of the prereplicative 
complex (pre-RC). 
B. Formation of the pre-initiation complex (pre-IC).  
During the G1-S transition phase the S phase cyclin dependent CDK2 and DBF4 dependent 
kinase CDC7 control the activation of the origins and formation of replication forks by 
phosphorylation of MCM10, the cell division control protein CDC45, the ATP-dependent DNA 
helicase Q4 (RECQL4), Treslin, GINS, DNA topoisomerase 2-binding protein (TOPBP1) and 
DNA polymerase ε. 
C. Activation of origin.  
After the assembly of the pre-IC, in the S phase the replication protein A (RPA), proliferating 
cell nuclear antigen (PCNA), the replication protein C (RPC) and additional replication fork 
proteins are recruited resulting in the formation of replication forks and origin activation. The 
replisome contains the CMG complex (CDC45, MCM hexamer, GINS complex) and is 
responsible for helicase activity and DNA unwinding. The checkpoint kinases ATR, ATM that 
phosphorylate the checkpoint kinases 1 and 2 (CHK1, CHK2) control and prevent the re-
replication of origins. Figure was taken from Fragkos et al., 2015 (permission obtained).  
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In order to identify novel DNA replication factors and associated proteins involved in 
DNA replication a human cell-free system was established. In this approach template 
nuclei of cells that are arrested at late G1-phase are isolated. In these nuclei DNA 
replication can still occur but they lack active DNA replication forks. Interestingly, upon 
incubation of late G1 phase arrested with cytosolic extracts derived from S phase 
replicating cells that contain replication initiation factors DNA replication can be 
initiated in around 50 % of late G1-phase template nuclei (Krude 2000; Krude et al., 
2009).  
Using the human cell free system, the cytosolic extract from proliferating human cells 
was first separated by anion exchange chromatography. The obtained fractions were 
added to the late G1-phase arrested template nuclei. Surprisingly, in these 
reconstitution experiments no protein was identified. However, non-coding Y RNAs 
were discovered as essential factors of chromosomal DNA replication (Christov et al., 
2006).  
It was confirmed that Y RNAs are necessary for the initiation of DNA replication as 
specific knockdown of human Y RNA in cytosolic cell extracts by antisense DNA 
oligonucleotides resulted in the inhibition of DNA replication and cell proliferation. 
Intriguingly, the knockdown of Y RNAs could be rescued by the addition of any of the 
four human Y RNAs and DNA replication could be initiated (Christov et al., 2006).  
Notably, human Y RNAs were able to initiate chromosomal DNA replication in isolated 
mouse cell nuclei while non-vertebrate Y RNAs were not. This suggested that the 
functional role of Y RNAs as essential factors in the initiation of DNA replication is 
conserved among vertebrates (Gardiner et al., 2009).  
Further it was shown by DNA fibre fluorescence microscopy and nascent-strand 
analysis that Y RNAs are specifically required for the initiation of chromosomal DNA 
replication and establishing of new replication forks and were not required for 
elongation of DNA replication forks (Krude et al., 2009).  
Looking at the sequence and structural requirements of Y RNAs during DNA 
replication mutagenesis analysis of hY1 revealed that a conserved, double-stranded 
8 nt consensus sequence motif 5’-GUAGUGGG-3’ in the upper stem domain of the Y 
RNAs is essential for the functional role in chromosomal DNA replication. 
Transfection of a synthetic double-stranded RNA derived from the upper stem of hY1 
alone was sufficient to initiate chromosomal DNA replication (Gardiner et al., 2009).  
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Using biophysical techniques such as solution state nuclear magnetic resonance 
(NMR) and far-UV circular dichroism (CD) spectrometry Wang et al. investigated 
whether there are any sequence and structural requirements of the conserved stem 
of hY1 in order to initiate chromosomal DNA replication. It was shown that mutations 
introduced in the conserved GUG-CAC motif resulted in a destabilization of the A-
form helix and inhibition of chromosomal DNA replication (Wang et al., 2014). 
Since Y RNAs are forming RoRNPs with Ro and La and Nucleolin interacts with the 
pyrimidine-rich internal loops of hY1 and hY3 RNAs it was tested if these proteins are 
required for the initiation of DNA replication. Depletion of Ro60, La and Nucleolin 
proteins from human cell extracts by immune precipitation did not have any effect on 
the initiation of DNA replication. This suggested that Ro60, La and Nucleolin were not 
required for the initiation of DNA replication (Langley et al., 2010).  
Previous mutagenesis experiments on hY1 already showed that the conserved lower 
stem region of Y RNAs, where Ro60 binds, was not essential for the initiation DNA 
replication (Christov et al., 2006). This finding was further confirmed by reconstitution 
experiments which confirmed that the addition of recombinant purified Ro60, La and 
Nucleolin did not have any effect on DNA replication in vitro (Langley et al., 2010). 
Later it was observed that during DNA replication all Y RNAs associate dynamically 
with euchromatin and replication proteins such as ORC, pre-RC and pre-IC proteins 
Cdt1, Mcm2 and Cdc45, but not with DNA replication fork proteins in G1 phase nuclei. 
These results suggested that Y RNAs might act as replication licensing factors (Zhang 
et al., 2011). The licensing of replication origins takes only place once per cell cycle 
in the G1 phase and involves the recognition of the pre-RC complex and this step 
allows to control that DNA is accurately replicated (Fragkos et al., 2015).  
Experiments using X. laevis and D. rerio embryos revealed that Y RNAs are essential 
for chromosomal DNA replication after the mid-blastula transition stage in early 
development dependent on ORC. However, just after gastrulation a knockdown of Y 
RNAs by specific inhibitory morpholino oligonucleotides resulted in the rapid inhibition 
of DNA replication, cell cycle arrest and death of the embryos (Collart et al., 2011). 
This would suggest that Y RNAs are not required for the initiation of DNA replication 
during early development and that other factors are involved.  
Recently, the nucleosome and histone deacetylation complex NuRD isolated from X. 
laevis eggs and pre-MBT embryos was identified to be responsible for the initiation of 
DNA replication in early embryogenesis before MBT in the absence of non-coding Y 
RNAs.  
INTRODUCTION 
 
56 
 
The inactivation of xNuRD led to an inhibition of DNA replication, developmental 
arrest and embryonic lethality. However, it was shown that in contrast to xNuRD 
complexes human NuRD complexes were not able to initiate DNA replication. Taken 
together, it was suggested that the xNuRD complex plays an important role in the 
regulation of DNA replication through chromatin remodelling during early 
development. After MBT Y RNAs might also be involved in chromatin remodelling in 
order to activate replication forks and initiate DNA replication (Christov et al., 2018).  
Another recent study looked more into the detail of the molecular mechanism of Y 
RNA function and localization during cell cycle. Using proliferating cells derived from 
human cancer and non-cancerous cell lines the Y RNAs were quantified in the soluble 
and chromatin-associated fractions by qRT-PCR. Around one million soluble Y RNA 
molecules per cell were quantified and among all Y RNAs it was found that Y3 was 
the most abundant. Interestingly, there was no significant difference in Y RNA 
accumulation between proliferating cancerous and non-cancerous cells. However, in 
quiescent cells the level of Y RNAs was decreased, whereas in proliferating cells the 
Y RNA level was upregulated which is consistent to their role in DNA replication (Kheir 
and Krude, 2017). 
It was shown by fluorescence labelling that Y RNAs preferentially associated with S 
phase chromatin compared to G1 phase chromatin. Furthermore, it was 
demonstrated that Y RNAs are required for the dynamic interaction with the ORC 
complex and initiation of DNA replication. Interestingly, co-localization experiments of 
human Y RNAs revealed that all Y RNAs, except Y5 preferentially interacted with the 
ORC complex. Y5 RNA was primarily associated with Nucleolin and was mostly 
localized in the nucleolus. Since Y5 was previously shown to interact with the 
ribosomal protein L5 it was suggested that Y5 might also be important for other 
nuclear processes apart from the initiation of DNA replication. It was hypothesized 
that another possible function could be in ribosome biogenesis (Kheir and Krude, 
2017). 
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1.8.2 Y RNAs in cancer 
 
One study reported that all human Y RNAs were significantly upregulated (between 
4- and 13-fold) in extracts derived from human solid tumours (n=42) compared to 
corresponding normal tissues (n=24) and cultured cells using quantitative RT-PCR. 
In this study six different tissue types which included urinary bladder, cervix, colon, 
kidney, lung and prostate were analysed and compared to normal tissue. Among all 
the Y RNAs, hY1 and hY3 were most significantly upregulated in the solid tumour 
samples (carcinomas and adenocarcinomas) including all analysed different tissue 
types (Christov et al., 2008). 
In the next step it was investigated if Y RNAs are required for cell proliferation. When 
siRNAs against hY1 and hY3 were transfected into several human cell lines a 
significant reduction in cell proliferation was observed (Christov et al., 2008).  
Recently it was shown that in tumours Y RNAs were upregulated whereas in 
quiescent normal tissues the level of Y RNAs was decreased. Hence, it was proposed 
that the expression of Y RNAs could be used as a potential cell proliferation marker 
instead of a cancer biomarker (Kheir and Krude, 2017).  
In recent years several studies demonstrated that the expression of Y RNAs is altered 
in cancer cells. Using quantitative real time PCR it was observed that all Y RNAs are 
downregulated in urinary bladder cancer (n=88) compared to normal tissues (n=30) 
(Tolkach et al., 2017). In the most recent study the same group found that Y RNAs 
are also downregulated in prostate cancer patients (n=56) compared to normal 
tissues (n=36). This downregulation of Y RNAs in urinary bladder cancer and prostate 
cancer was controversial to the study performed by Christov et al. who saw an 
upregulation of Y RNAs in tumour samples. These contradictory results could be 
either explained by technical issues or the fact that Y RNA expression is different 
among various cancer types (Christov et al., 2008; Tolkach et al., 2018). However, 
the exact functions and molecular mechanisms of Y RNAs in cancer remains obscure 
and needs further investigation.  
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1.9 Y RNA derived small RNAs 
 
Y RNA-derived sRNA (YsRNA) fragments were first described in apoptotic cells by 
Rutjes et al. in 1999. It was shown that during apoptosis human Y RNAs are rapidly 
and specifically cleaved in a caspase-dependent manner generating shorter YsRNA 
fragments between 22-25 nt and a larger fragment of 31 nt (Rutjes et al., 1999a). In 
this study it was suggested that the nucleases that cleave Y RNAs are caspase-
dependent nucleases since Y RNA cleavage was similar to the cleavage of the U1-
70K which was shown to be caspase-3-dependent (Casciola-Rosen et al., 1994; 
Rutjes et al., 1999a). Results from immunoprecipitation experiments showed that 
YsRNAs are bound to Ro60 and La. The 31 nt fragment associated with both Ro60 
and La, whereas the shorter fragments only bound to Ro60 (Rutjes et al., 1999b). 
These YsRNAs were assumed to be degradation products for a long time and it was 
technically difficult to work with these short sRNA fragments (Hall et al., 2013). 
However, little was known about their biological role and mechanisms.  
Next generation sequencing from precursor B cells derived from acute leukaemia 
patients and normal CD34+ cells revealed that sRNA fragments derived from the 3’ 
end of hY3 and hY5 Y RNAs were highly enriched (Schotte et al., 2009). However, 
these sRNA fragments were initially mis-annotated as miRNAs and named miR-1975 
(derived from the 3’ end of hY5) and miR-1979 (derived from the 3’ end of hY3). Meiri 
et al. also identified them in several solid tumours while they realized that the sRNAs 
are derived from Y RNAs. Performing luciferase reporter assays they showed that 
these sRNA fragments had no gene silencing activity which suggested that miR-1975 
and miR-1979 were not miRNAs (Meiri et al., 2010). Consequently, miR-1975 and 
miR-1979 were removed from miRBase and annotated as Y RNA-derived sRNAs.  
It was also shown that YsRNAs are derived from the 3’ and 5’ ends of Y RNAs and 
that the biogenesis of Y RNA derived sRNAs is independent of the canonical miRNA 
pathway (Nicolas et al., 2012). Y RNA fragments were found in both cancerous and 
non-cancerous as well as stress-induced and unstressed cells. The levels of hY5-
derived sRNAs in non-stressed cells are similar to the abundance of miRNAs. 
Northern blot experiments revealed that the levels of Y RNA fragments derived from 
the 3’- and 5’ end of human Y5 were significantly increased during apoptosis. 
Furthermore, immunoprecipitation followed by a pull down assay and anion exchange 
chromatography suggested that hY5 derived sRNAs are not in a complex with 
Argonaute 2 (Nicolas et al., 2012). This indicates that YsRNAs are not directly loaded 
into the RNA induced silencing complex (RISC).  
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Therefore, YsRNAs are not involved in miRNA biogenesis pathways and Y RNA 
derived sRNAs are not miRNAs (Nicolas et al., 2012).  
YsRNAs have also been identified in brain, retina, and other mammalian tissue. 
Further, it was shown that YsRNAs were induced during viral infection (Cui et al., 
2010; Qi et al., 2010). Recently, YsRNA fragments have been identified in human 
serum and plasma as circulating components of larger complexes (100-300 kDa). 
These circulating Y RNA fragments were found cell-free and not included in 
exosomes or microvesicles (Dhahbi et al., 2013). Moreover, YsRNAs are upregulated 
in the serum of breast cancer patients. Hence, YsRNAs circulating in human serum 
and plasma might be involved in cancer and therefore be potential biomarkers 
(Dhahbi et al., 2014).  
RNA sequencing experiments showed that around 95% of serum derived sRNA 
sequencing reads mapped to hY4 RNA and its pseudogenes, whereas only a small 
number of Y RNAs mapped to hY1, hY3 and hY5 RNAs (Dhahbi et al., 2013). The 
hY4 RNAs circulating in the serum were cleaved into 5’ end Y RNA fragments at 
different positions and distinct proportions in the predicted internal loop of the full-
length hY4 RNAs (Dhahbi et al., 2013). Interestingly, in human serum the 5’ end 
derived Y RNA fragments were roughly 20 times more abundant than the 3’ end 
derived Y RNA fragments (Dhahbi et al., 2014). The levels of 5’ end derived Y RNA 
fragments were significantly increased in human serum compared to mouse serum 
(Dhahbi et al., 2013). It needs to be further investigated why the composition of 
circulating sRNAs is different in human and mouse sera. Also, Y RNA fragments have 
been detected in extracellular vesicles (EVs) that were released from human semen 
and immune cells (Nolte-'t Hoen et al., 2012; Vojtech et al., 2014).  
A recent study investigated the processing and transfer of hY5 RNA fragments within 
EVs derived from primary and cancer cell lines. Intriguingly, hY5 RNAs were highly 
abundant and enriched in EVs. Shorter fragments (23, 29 and 31 nt) derived from the 
5’ and 3’ end of hY5 were also detected in EVs (Chakrabortty et al., 2015). In the 
same study hY5 RNA fragmentation occurred in the EVs instead of inside the cells. 
The 5’ end derived hY5 RNA fragments contained part of the conserved 8 nt motif (5’-
GUAGUGGG-3’) which is involved in the initiation of chromosomal replication 
(Gardiner et al., 2009). The same motif was shown to be important for the processing 
of full-length hY5 RNAs into smaller Y RNA fragments (Chakrabortty et al., 2015).  
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Interestingly, the exposure of human healthy cells with EVs derived from cancer cells 
resulted in rapid cell death. However, cancer cells did not show any phenotype when 
they were treated with EVs from normal or cancer cells. A synthetic version of the 23 
nt- and 31 nt 5’ end derived hY5 fragment triggers cell death in primary cells in a 
dose-dependent manner through an apoptotic pathway. Further, it was observed that 
the conserved 8 nt motif in the 5’ end derived Y RNA fragments was required for the 
induction of cell death (Chakrabortty et al., 2015). 
In conclusion, there seems to be a correlation between 5’ end derived Y RNA 
fragments and cancer, since 5’ end derived Y RNA fragments released from cancer 
cell EVs trigger rapid cell death in normal cells. It was hypothesized that the 5’ Y RNA 
fragment induced cell death might help tumours to invade tissues and to establish a 
microenvironment (Chakrabortty et al., 2015). 
 
1.10 Functions of Y RNA derived small RNAs 
 
1.10.1 Y RNA derived small RNAs involved in coronary artery disease 
 
Coronary artery disease (CAD) is one of the most common cardiovascular diseases 
and affects millions of people worldwide. At present it is the one of the leading causes 
of death. CAD is caused by atherosclerosis of heart arteries and it was shown that 
macrophage apoptosis is associated with atherogenesis pathogenesis. In early 
stages of atherogenesis the accumulation of lipoproteins, mainly low-density 
lipoprotein (LDL) results in the activation of immune response and recruitment of 
macrophages. By endocytosis the macrophages ingest lipids and lipoproteins and 
become so called foam cells. The foam cell formation results in the activation of 
cytokines and apoptosis followed by a rapid phagocytic clearance of apoptotic foam 
cells and decrease of atherosclerotic lesion progression. However, when 
macrophage apoptosis and clearance of apoptotic foam cells are not tightly regulated 
the inflammatory response results in atherosclerotic lesions and necrotic plague 
formation.  
Interestingly, next generation sequencing of human and mouse apoptotic 
macrophages revealed that the expression of Y RNA derived sRNAs is induced after 
treatment with pro-apoptotic or atherogenic stimuli.  
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Further, in qRT-PCR experiments the levels of YsRNAs was significantly increased 
in mouse models for atherosclerosis as well as the serum of 263 patients with 
coronary artery disease (CAD) compared to 514 healthy controls. Among of all Y 
RNAs, the hY1 5’ end derived sRNA fragment was the most upregulated Y RNA 
derived sRNA in the serum CAD patient samples. Statistical analysis indicated that 
circulating Y RNA derived sRNA fragments might be used as novel diagnostic 
biomarkers for CAD and other related cardiovascular diseases (Hizir et al., 2017).  
Interestingly, a 31 nt 5’ end derived hY4 derived sRNA was reported to be associated 
with platelet function in patients with acute coronary disease and have been shown 
highly abundant in plasma and enriched in exosomes (Dhahbi et al., 2013). Using 
next generation sequencing and quantitative real time PCR with molecular beacons 
a 31/32 nt 5’ end derived hY4 fragment was detected in saliva of healthy persons 
suggesting that this 5’ end derived hY4 sRNA could be used as a potential biomarker 
to enhance diagnosis of coronary diseases (Ishikawa et al., 2017).  
 
1.10.2 Y RNA fragment involved in cardioprotection 
 
Recently, it was found that Y RNA fragments are highly enriched in extracellular 
vesicles (EV) derived from cardiosphere derived cells (CDC) that were shown to 
reduce myocardial infarct size. CDCs secrete EVs and are involved in inflammatory 
response and regeneration of myocardial infarcts through polarization of 
macrophages. Among all the Y RNAs the 5’ end derived hY4 fragment named EV-
YF1 was the most abundant in CDC EVs. Transfection of fluorescently labelled EV-
Y1 into macrophages induced an upregulation of interleukin IL-10 gene expression 
and led to cardioprotection and a reduction of infarct size (Cambier et al., 2017).  
 
1.10.3 Y RNA derived sRNAs regulate cell death and inflammation in 
monocytes/macrophages  
 
Intriguingly, a recent study demonstrated that Y RNA derived sRNAs regulate 
apoptosis and inflammatory response in monocytes/macrophages. When 
monocytes/macrophages were treated with pro-atherogenic stimuli such as oxLDL or 
palmitic acid (PA) caspase-dependent apoptosis and the NFκβ signalling pathway 
was activated.  
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Interestingly, the co-transfection of 2’-O Me-RNA oligonucleotides that were 
antisense to YsRNAs and the knockdown of YsRNAs using siRNAs resulted both in 
the downregulation of apoptosis in monocytes/macrophages (Hizir et al., 2017). 
In order to investigate if extracellular YsRNA/Ro60 complex is involved in apoptosis 
and inflammation in monocytes/macrophages Y RNA/Ro60 and YsRNA/Ro60 were 
immunopurified either from treated cells or from untreated control cells. Monocytes 
were treated with Y RNA/Ro60 or YsRNA/Ro60 complexes and apoptosis was 
induced after 12 h.  
When the monocytes were cotransfected with antisense YsRNAs apoptosis was 
inhibited, indicating that the extracellular YsRNA/Ro60 activates apoptosis and NFκβ 
signalling. The transfection with YsRNAs or the full-length Y RNA/Ro60 complex did 
not show any activation of apoptosis. From these experiments it can be concluded 
that extracellular YsRNAs need to be in complex with Ro60 in order to be able to 
enter the cells and induce apoptosis and inflammation (Hizir et al., 2017).  
In previous experiments it was shown that Ro60 is associated with endogenous 
retroelements and plays an important role in the regulation of inflammatory gene 
expression. When Ro60 was knocked down the expression of endogenous Alu 
transcripts and IFN response related genes were upregulated. Since the upregulation 
of Alu transcripts activated the secretion of cytokines it was tested whether the 
inflammatory response was activated through Toll-like receptors (TLR). Treatment of 
cells with chloroquine that inhibits the signaling pathway of TLR3, 7, 8 and 9 and 
IRS954-thioate that blocks TLR7/9 revealed that the cytokine secretion was TLR7 
dependent (Hung et al., 2015).  
In order to test if TLRs are also involved in the YsRNA induced apoptosis and 
inflammation in monocytes/macrophages the human and mouse monocytes were 
treated with chloroquine and IRS954, subjected to flow cytometry and validated by 
western blot analysis. It was shown that chloroquine and IRS954 inhibited the YsRNA 
induced activation of caspase-dependent apoptosis and NFκβ inflammatory 
response. These results indicate that intracellular and extracellular YsRNAs stimulate 
TLR7 to mediate apoptosis and inflammation in both human and mouse 
monocytes/macrophages. The sequence and secondary structure of Y RNAs is highly 
evolutionary conserved among vertebrates (Pruijn et al., 1993). Interestingly, the 
conserved function of YsRNAs between human and mouse monocytes also indicates 
that the function of YsRNAs might be evolutionary conserved and might underlie a 
similar mechanism (Hung et al., 2015).  
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1.10.4 Human Y4 RNA fragment can act as a guide for tRNase Z 
 
Next generation sequencing of plasma derived sRNAs from three healthy persons 
and three myeloma patients revealed that a 31 nt 5' end derived hY4 fragment was 
significantly more abundant in myeloma patients compared to the healthy control 
persons. Intriguingly, this hY4-derived sRNA can adopt the structure of a 5’-tRNA half 
and associate with a target RNA in order to form a pre-tRNA-like structure. This 
structure is then recognized and cleaved by tRNase Z (Ninomiya et al., 2015).  
Interestingly, recently a new class of bacterial Y RNAs named Y RNA-like A (YrlA) 
RNAs was discovered. By crystal structure of S. thyphimurium YrlA it was shown that 
this bacterial Y RNA is able to fold like a tRNA (Wang et al., 2018). By Chen et al., it 
was already previously observed that bacterial Y RNAs can mimic tRNAs and can be 
processed like tRNAs. Additionally, they could demonstrate that these Y RNAs had 
nucleotide modifications which allowed the recognition of ribonucleases involved in 
tRNA cleavage (Chen et.,2014). 
 
1.10.5 PTBP1  
 
Notably, during apoptosis Y RNAs are cleaved into smaller fragments in a caspase 
dependent manner (Casciola-Rosen et al., 1994; Rutjes et al., 1999a; Chen et al., 
2014). Next generation sequencing of Epstein-Barr virus (EBV) positive lymphoma 
cells revealed a new class of small RNAs named AGO-taxis small RNAs (ASRs) that 
were specifically bound to Ago1. These ASRs were highly upregulated during lytic 
EBV infection and it was suggested that they are involved in apoptosis. Further it was 
observed in siRNA mediated knockdown experiments that the biogenesis of ASRs 
was independent of Drosha, Dicer and RNase L. ASRs were shown to have gene 
silencing activity and CLASH (crosslinking, ligation, and sequencing of hybrids) data 
revealed that ASRs primarily bound the coding sequence of the identified targets 
(Yamakawa et al., 2014).  
Recently, the same group reported that Y RNAs might be the precursors of ASRs and 
that ASRs are generated by Y RNA cleavage during apoptosis. Cell fractionation 
experiments using saturated ammonium sulfate (SAS), ion exchange 
chromatography (IEC) and gel filtration chromatography resulted in the identification 
of a cytoplasmic endoribonuclease and its inhibitor PTBP1 which is also known as 
hnRNP1 and binds to the loop region of Y RNAs (Fabini et al., 2000; Ogata et al., 
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2018). It was shown that PTBP1 inhibited Y RNA cleavage by blocking the access of 
endoribonuclease (s) to the central loop.  
During apoptosis, PTBP1 gets cleaved by caspase 3 which results in Y RNA cleavage 
and production of ASRs. However, the endoribonuclease involved in the generation 
of the 3’ end derived ASR could not be identified and further investigation will be 
needed (Ogata et al., 2018).  
 
1.10.6 RNase L 
 
During viral infection dsRNA triggers the activation of the innate immune response 
through type-I interferons (IFNs) which result in the activation of 2’ 5’ oligoadenylate 
synthetase genes (OAS) (Hovanessian et al., 1977). These OAS genes function as 
pathogen pattern recognition receptors (PPRs) in order to initiate interferon induced 
antiviral response. The activation of OAS genes by viral dsRNA leads to the synthesis 
of small molecules named 2-5 A oligoadenylates in the presence of ATP (Silverman, 
2007; Chakrabarti et al., 2015).  
The endoribonuclease RNase L was shown to bind 2-5A with low affinity at 
subnanomolar levels. The binding of 2-5A leads to the formation of catalytically active 
homodimers. RNase L only cleaves ssRNAs preferentially after U-rich sequences but 
not dsRNA molecules (Dong and Silverman, 1995). RNase L belongs to the family of 
metal ion independent ribonucleases (Cooper et al., 2014). RNase L preferentially 
cleaves ssRNAs after UpAp and UpUp dinucleotides (Wreschner et al., 1981) and 
has sequence specificity for the consensus sequence UN^N (N = A, C, G, U). It was 
observed that RNase L produces 5’-hydroxyl and 2’, 3’ cyclic phosphate termini at the 
3’ end of cleaved RNAs (Han et al., 2014).  
In order to be able to sequence small RNAs with 2’ 3’ cyclic phosphates Donovan et 
al. used a cDNA library construction method based on RtcB ligase which allows the 
ligation of RNAs with 2’ 3’ cyclic phosphates to the adapter sequence (Tanaka et al., 
2011).  
Next generation sequencing of HeLa cells treated with poly (I:C) which mimics viral 
infection and untreated cells revealed that tRNAs and Y RNAs were specifically 
cleaved at UN^N position. Y RNA cleavage primarily occurred at the 5’ end of Y RNAs 
between the positions 24-32 nt. However, hY4 RNA was exceptional and was cleaved 
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after CA^G and it was suggested that hY4 RNA might be cleaved by another 
ribonuclease.  
For the most abundant tRNAs in the dataset tRNA-His, tRNA-Gln and tRNA-Pro it 
was shown that the tRNAs were cleaved specifically in the anticodon stem loop region 
during antiviral response. Further overexpression experiments of wild type RNase L 
and RNase L mutant H672N revealed that tRNAs and Y RNAs were only cleaved in 
cells in which wild type RNase L was overexpressed. Treatment of cells with 2-5A 
also resulted in tRNA and Y RNA cleavage. Using human RNase L -/- cells tRNA and 
Y RNA cleavage could only be detected by Northern blotting in RNase L wild type 
cells. These results indicated that RNase L is directly responsible for tRNA and Y 
RNA cleavage (Donovan et al., 2017). 
Interestingly, it was reported that RNase L contributes to the early arrest of translation 
during dsRNA response. Previously it was shown that the protein kinase PKR is 
activated by dsRNA during antiviral response and is involved in translational inhibition 
through the phosphorylation of the translation initiation factor eIF2α (Smith et al., 
2005). By the analysis of nascent protein synthesis in wild type and RNase L -/- cells 
it was demonstrated that RNase L is critical to inhibit protein synthesis. Intriguingly, it 
was shown that translational arrest occurs rapidly, whereas components of the 
translation machinery including rRNAs or mRNAs are degraded much later. It was 
proposed that tRNA and Y RNA derived fragments might be involved in a signalling 
like mechanism with RNase L and regulate translational inhibition. However the exact 
mechanism how Y RNA and tRNA fragments are involved in this process is not clear 
(Donovan et al., 2017).  
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1.11  Aims and objectives of the thesis 
 
Although YsRNAs were initially discovered in apoptotic cells almost two decades ago 
and YsRNAs have been described in many different biological aspects during the last 
two years, the exact biogenesis and mechanisms of YsRNAs are still remain poorly 
characterized and further investigation is needed. It is currently unknown, what role 
YsRNAs play in normal cells and how they function mechanistically during apoptosis, 
stress, or cancer.  
In this thesis, I took two approaches in order to understand the mechanisms 
underlying the biogenesis of YsRNAs:  
As Y RNAs are highly evolutionary conserved in vertebrates in the first two result 
chapters of this thesis I investigated if the nucleotide sequence or conserved 
structural features contribute to the size-specific Y RNA cleavage.  
The aim of the first two thesis chapters was to establish sequence and structural 
requirements for Y RNA cleavage into YsRNAs in order to understand how Y RNAs 
are processed during stress response. Within this investigation I aimed to address 
the question if the nucleotide sequence or the secondary structure is more important 
in respect to determine where the Y RNA cleavage occurs.  
In the first result chapter I aimed to further validate and analyse the next generation 
sequencing results from a high throughput mutagenesis approach on the 3’ end of 
the human Y5 RNA (Figure 1.4, A). The cDNA libraries of the 3’ end hY5 RNA 
mutants were generated by a previous PhD student Carly Turnbull (Turnbull, 2013).  
I took over this project and my aim was to experimentally validate the sequencing 
results of the 3’ end hY5 RNA mutagenesis approach by generating individual hY5 
RNA mutants and testing their expression and cleavage pattern by Northern blot 
analysis. 
Additionally, the aim of the first thesis chapter was to explore if there was a minimal 
nucleotide requirement for Y RNA cleavage to occur. In particular, in subsequent 
experiments I investigated if the sequence of the internal L2a loop (Figure 1.4, B) 
was important for 3’ end hY5 RNA cleavage.  
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Due to advances of next generation sequencing technologies it became apparent that 
5’ end derived hY5 RNA fragments are functional.  
Hence, in the second result chapter of this thesis my objectives were to design and 
to perform a high throughput mutagenesis approach on the 5’ end of hY5 RNA.  
My goal was to validate and further analyse the sequencing results by cloning and 
testing the expression levels of individual hY5 RNA mutants by Northern blot analysis. 
In addition, my aim was to investigate if the sequence and/or structure of the internal 
loop L2b (Figure 1.4, C) was involved in Y RNA cleavage.   
In the last chapter of this thesis I tried to use a biochemical approach in order to 
understand which protein(s) or ribonuclease(s) are involved in Y RNA cleavage. In 
particular, my goal was to examine of role of Ro60 and RNase L on Y RNA cleavage 
(Figure 1.4, D) in more detail.  
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Figure 1.4. Overview of aims and objectives performed in this thesis.  
This figure gives an overview about the aims and objectives of this thesis.  
A. High throughput mutagenesis approach on the 3‘ and 5’ end of hY5 RNA.  
The secondary structure of hY5 RNA was predicted with RNAfold and visualized using Varna. 
The human Y5 RNA has a characteristic stem loop structure. Three different regions near the 
cleavage sites at the 3’/5’ end of the hY5 RNA were selected for random mutagenesis. The 
cleavage sites on the 3’ and 5’ end of hY5 RNA are indicated with red arrows and unknown 
RNases involved in hY5 RNA cleavage are depicted as scissors. In each of these regions 
close to the 3’ and 5’ end cleavage sites 5N substitution mutations were introduced resulting 
in 1024 (45) possible combinations for each library. Each library is shown in different colors. 
For the 3’ end high throughput mutagenesis analysis library 1 (red), library 2 (green) and library 
3 (dark blue) were generated. The 5’ end high throughput mutagenesis involved the 
generation of library 4 (blue), library 5 (yellow), library 6 (purple). 
B. Mutagenesis of the hY5 RNA internal loop L2a.  
The secondary structure of hY5 RNA was predicted with RNAfold and visualized using Varna. 
The human Y5 RNA has a characteristic stem loop structure. One aim of the thesis was to 
mutate the internal loop 2a (shown in red) in order to investigate if the length or nucleotide 
sequence of this internal loop is important for 3’ end hY5 RNA cleavage.  
C. Mutagenesis of the hY5 RNA internal loop L2b.  
The secondary structure of hY5 RNA was predicted with RNAfold and visualized using Varna. 
The human Y5 RNA has a characteristic stem loop structure. One aim of the thesis was to 
mutate the internal loop L2b (shown in turquoise) in order to investigate if the sequence or 
secondary structure of the internal loop L2b is important for human Y RNA cleavage length or 
nucleotide sequence of this internal loop is important for 3’ end hY5 RNA cleavage 
D. Investigation of which proteins/ribonucleases are involved in Y RNA cleavage.  
In the last chapter it was examined in more detail if Ro60 and RNase L are involved in Y RNA 
cleavage. 
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Chapter 2  Materials and Methods  
 
2.1 Cell culture  
 
2.1.1 Cell lines and cell culture media  
 
NIH 3T3 cells were purchased from the European Collection of Authenticated Cell 
Cultures (ECACC) and were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) (Gibco, 10938) supplemented with 10% heat inactivated fetal bovine serum 
(FBS) (Gibco, 10500), 1% L-Glutamine (200 mM) (Gibco, 25030) and 1% Penicillin-
Streptomycin (10000 U/ml) (Gibco, 15140).  
HeLa cells and MCF7 cells were kindly provided by the laboratory of Dylan Edwards. 
The cell lines were subjected to cell line authentication and mycoplasma testing by 
ECACC (European Collection of Authenticated Cell Cultures). HeLa cells were 
cultivated in Eagle’s Minimum Essential Medium (M2279, Sigma), supplemented with 
10% heat inactivated fetal bovine serum (FBS), 1% MEM Non-Essential Amino Acid 
Solution (100x) (Gibco, 11140), 1% L-Glutamine (200 mM) and 1% Penicillin-
Streptomycin (10000 U/ml) (Gibco, 15140).  
MCF7 cells were cultured in low glucose DMEM + GlutaMAX medium (Gibco, 21885) 
that was supplemented with 10% heat inactivated fetal bovine serum (FBS) (Gibco, 
10500, 1% MEM Non-Essential Amino Acid Solution (100x) and 1% Penicillin-
Streptomycin (10000 U/ml) (Gibco, 15140). 
The wild type and Ro60 -/- mouse embryonic stem cells (mES) were a kind gift from 
Prof. Sandra Wolin (NCI, US) (Chen et al., 2003). The mES cells were cultured in 
Knockout DMEM (Gibco, 10829), 15% ES cell FBS (Gibco, 10439), 1% L-Glutamine 
(200 mM) (Gibco, 25030), 1% MEM Non-Essential Amino Acid Solution (100x) 
(Gibco, 11140), 100 U/ml ESGRO leukemia inhibitory factor (Millipore, ESG 1107) 
and 0.1 mM 2-Mercaptoethanol (Sigma, M6250).  
The wild type and RNase L -/- mouse embryonic fibroblast cells (mEFs) were kindly 
provided by Prof. Robert Silverman. The RNase L -/- mEF cells were generated by the 
insertion of a neomycin resistance gene into the 5’ end of RNase L gene (Zhou et al., 
1997).  
The human wild type and CRISPR RNase L -/- A549 lung cancer cells were a kind gift 
of Prof. Susan Weiss (Cleaveland Clinic, US) (Li et al., 2016).  
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The mouse and human wild type and RNase L -/- cell lines were cultivated in RPMI 
1640 medium (Gibco, 11975-001) supplemented with 1% L-Glutamine (200 mM) 
(Gibco, 25030) and 1% Penicillin-Streptomycin (10000 U/ml) (Gibco, 15140).  
2.1.2 Sub-culturing and cell culture conditions 
 
All cell lines used in this thesis were cultivated in a humidified CO2 incubator under 
standard conditions at 5% CO2 and 37°C. All cell culture work was performed in a 
microbiological safety cabinet using aseptic technique.  
For passaging the cells, the cell culture media was removed and the cells were once 
washed with PBS (Gibco, 10010). For NIH 3T3, HeLa and MCF7 cells 0.25% Trypsin- 
EDTA (Gibco, 25200) was added to the flask and pipetted gently to cover all the cells. 
The flask was placed in the incubator for 2-5 min at 37°C. After incubation the flask 
was gently tapped a few times to ensure all the cells were detached. The Trypsin-
EDTA was inactivated by adding an equal volume of the appropriate cell culture 
media to the flask. The cell suspension was centrifuged for 5 min at 1,500 rpm. The 
supernatant was carefully removed and the cells were resuspended in 10 ml fresh 
cell culture media. The cell number was counted using a haemocytometer. For that 
100 μl of cell suspension was added to 400 μl of 0.4% Tryphan blue and mixed gently. 
Tryphan blue was used to calculate the cell viability because it can enter dead cells 
and live cells do not take up the dye. To calculate the number of viable cells 20 μl of 
the cell suspension was applied to the haemocytometer and the number of cells was 
counted accordingly. 
The cell suspension was diluted at the appropriate seeding density with fresh cell 
culture media and transferred to a new flask containing the required volume of media.  
The wild type and Ro60 -/- mouse embryonic stem cells were passaged using 0.05% 
Trypsin-EDTA.  
 
2.1.3 Freezing cells  
 
For freezing the cells were trypsinized and centrifuged for 5 min at 800 rpm. The cell 
pellet was resuspended in cell freezing medium containing 80% media, 10% FBS and 
10 % dimethyl sulfoxide (DMSO) (Sigma, D2650). In each cryovial 1 ml of cell 
suspension ranging in concentration from 2-5 x 106 cells/ml was added and placed 
into an isopropanol bath at -80°C overnight. The next day the cryovials were placed 
into a liquid nitrogen Dewar for long term storage.  
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2.1.4 Transfection of NIH 3T3 cells with plasmid DNA  
 
The transfections were carried out in 6-well plates (Sarstedt). The cells were seeded 
at 200,000 cells/well the day before transfection using cell culture media without 
antibiotics. The cells were transfected using Fugene 6 (Promega, E2691) according 
to the manufacturer’s manual. For the transfection of a 6-well plate 60 μl of Fugene 6 
was diluted in serum-free OptiMEM I reduced-serum medium (Gibco, 51985), gently 
mixed and incubated for 5 min at room temperature. The recommended ratio between 
transfection reagent and DNA ratio for NIH 3T3 cells was 3:1, which means for each 
1 μg of DNA 3 μl of Fugene 6 reagent was used. For one 6 well plate 20 μg of plasmid 
DNA was added to the transfection mix, pipetted several times and incubated for 15 
min at room temperature. During incubation the cell culture media of the 6 well plate 
was replaced with fresh media without antibiotics and 150 μl of the transfection 
mixture was added drop wise to the cells. For each transfection experiment 
appropriate control experiments such as transfection with mock or empty vector were 
conducted.  
 
2.1.5 Transfection of MCF7 and mES wild type and Ro60 -/- cells with 
poly (I:C) 
 
Polyinosinic: polycytidylic acid potassium salt (poly (I:C)) (Sigma, P9582) was 
prepared in sterilized filtered water at a concentration of 2.5 mg/ml and was used in 
the experiments at a final concentration of 10 μg/ml.  
For the poly (I:C) transfection experiments MCF7 and mES wild type and Ro60 -/- cells 
were seeded in 6-well plates at a cell density of 200,000 cells/well in cell culture media 
without antibiotics the day before transfection.  
The cells were transfected using Lipofectamine TM 2000 transfection reagent (Thermo 
Fisher Scientific, 11668027). For one 6-well plate 32 μl Lipofectamine was gently 
mixed with 4 ml Opti-MEM reduced-serum medium. In another 15 ml falcon tube 32 
μl poly (I:C) were mixed with 4 ml Opti-MEM and incubated for 5 min at room 
temperature. After the incubation the Lipofectamine-Opti-MEM mixture was added to 
the tube containing poly (I:C)-Opti-MEM and incubated for 20 min.  
The cell culture media was removed, the cells were washed three times with PBS and 
fresh OptiMEM was added to the 6-well plate. After 5 h of transfection the Opti-MEM 
was replaced with fresh cell culture media. The cells were treated with poly (I:C) in a 
total of 8 h and cells were harvested after 3 h for RNA extraction.  
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2.1.6 Treatment of NIH 3T3 cells with staurosporine 
 
NIH 3T3 cells were seeded at 200,000 cells/ml in a 6-well plate one day before 
transfection. The cells were transfected with plasmid DNA using Fugene 6 or 
Lipofectamine and after 24 h the cells were treated with staurosporine.  
Staurosporine (Cell Signalling Technology, #9953) was prepared in DMSO at a 
concentration of 100 μM. The cells were treated with staurosporine at a final 
concentration of 1 μM for 4-8 h. After the treatment the cells were harvested for RNA 
extraction.  
 
2.2 Protein extraction  
 
For cell lysis and protein extraction of wild type and Ro60 -/- mouse embryonic stem 
cells RIPA buffer (Sigma, R0278) was used according to the manufacturer’s 
instructions. In order to prevent protein degradation a protease inhibitor cocktail was 
added to the lysis buffer. After removal of the growth medium the cells were washed 
with cold Phosphate Buffered Saline (PBS) (Gibco, 14190). Then 300 μl of RIPA 
lysis buffer was added per well of a 6-well plate and incubated in the cold room 
under rotation for 30 min.  
After the incubation the cells were removed with a cell scraper and vigorous pipetting 
and incubated on ice for another 5 min. The protein lysate was clarified by 
centrifugation at 12,000 rpm for 20 min at 4°C. The lysate was frozen in liquid nitrogen 
and stored at -80°C.  
The protein concentration was determined in triplicates using Pierce bicinchoninic 
acid (BCA) protein assay kit (Thermo Scientific, 23227) following the manufacturer’s 
protocol. The standard curve was prepared using Bovine Serum Albumin (BSA) of 
known concentrations. The protein concentration was calculated from the standard 
curve.  
  
MATERIALS AND METHODS 
 
74 
 
2.3 RNA extraction  
 
For the work with RNA all the surfaces, pipettes and gloves were cleaned with 10% 
Distel (VWR) as a surface detergent in order to avoid RNA degradation by RNases. 
For preparing RNase-free solutions analytical reagent grade water (Fisher Scientific) 
was autoclaved and filter sterilized using a 0.2 μm filter (Sartorius).  
Total RNA was extracted using TRI Reagent (Thermo Fisher Scientific, AM9738) 
according to the manufacturer’s instructions.  
The cell culture media of the 6-well plate was removed and the cells were washed 
once with PBS. When cells were treated with poly (I:C) or staurosporine the floating 
cells were centrifuged at 800 rpm for 5 min and combined later with the cells attached 
to the plate.  
500 μl of TRI Reagent was added per well of the 6-well plate, pipetted up and down 
several times and cells from three wells were combined to one 2 ml centrifuge tube 
on ice. The tubes were spun at 13,000 rpm for 5 min at 4°C and the supernatant was 
transferred to a new 2 ml centrifuge tube. The samples were incubated for 5 min at 
room temperature. Then 300 μl of Chloroform (Fisher Scientific) was added and the 
tubes were vortexed for 20-30 s. After incubation at room temperature for 5-10 min 
and clear phase separation the samples were centrifuged at 13,000 rpm for 15 min 
at 4°C. After centrifugation 750 μl of the aqueous phase was carefully pipetted into a 
new 1.5 ml centrifuge tube without touching the organic phase. For isopropanol 
precipitation an equal volume of isopropanol was added to the aqueous phase. The 
samples were vortexed briefly and incubated at -20°C overnight. 
The next day the samples were centrifuged at 13,000 rpm for 15 min at 4°C. In order 
to remove salt, the RNA pellet was washed twice with 80% ethanol and centrifuged 
each time at 13,000 rpm for 5 min at 4°C. After the last wash step the samples were 
spun again at 13,000 rpm for 1 min and the remaining drops were removed with 10 
μl filtered tips. The RNA pellets were air-dried for 10 min, resuspended in 30 μl of 
RNase-free water and stored at -80°C.  
The RNA concentration was measured using the Nanodrop 8000 spectrophotometer 
(Thermo Fisher Scientific). The quality of the RNA was deemed good if the 280/260 
ratio was ~2.0, and the 260/230 ratio was between 2-2.2.  
In order to check the quality and integrity of the RNA the samples were run on a 1.5% 
(w/v) agarose gel prepared in 0.5 x Tris-Borate-EDTA buffer (TBE) and stained with 
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10 mg/ml ethidium bromide (Fisher Scientific). For running the RNA on the gel 1 μg 
of RNA was added to 5 μl gel loading buffer II (Thermo Fisher Scientific, AM8546G). 
The buffer contains 95% formamide that stabilizes the RNA. Before running on the 
gel the RNA was denatured at 70°C for 2 min. The gel electrophoresis was performed 
at 100 V for 30 min and the gel was imaged using the Typhoon Scanner (GE 
Healthcare). The integrity of the RNA was assessed by checking the 28S and 18S 
ribosomal RNA bands.  
 
2.4 Detecting small RNAs by Northern blotting 
 
2.4.1 Separation of small RNAs by denaturing polyacrylamide gel 
electrophoresis 
 
Before the preparation of the denaturing polyacrylamide gels all the equipment was 
soaked for at least 30 min with 10% Distel in order to destroy any RNases.  
The separation of small RNAs was performed using 15% denaturing polyacrylamide 
gels. To prepare a single gel 2.1 g urea (Fisher) was measured and 1.25 ml RNase-
free water and 0.5 ml 5 x TBE was added to a 50 ml centrifuge tube. The mixture was 
heated in the microwave for 20-40s in order to dissolve the urea completely. After the 
solution cooled down, 1.85 ml 40% acrylamide/bis solution 19:1 (Biorad, 16110144) 
was added and the mixture was filled up with RNase-free water to a final volume of 5 
ml. The centrifuge tube was gently inverted several times and the polymerisation 
reaction was initiated by adding 2.5 μl Tetramethylethylenediamine (TEMED) (Biorad, 
1610800) and 50 μl of 10 % ammonium persulfate solution (APS) (Sigma, A3678) 
which acts as a radical initiator molecule in the polymerization process.  
The gel solution was quickly poured between two 1.0 mm thin glass plates and a 10 
well comb was inserted. The gel was polymerized for about 30 min. If more than 10 
samples were loaded on the gel the gel solution was poured into a precast gel 
cassette and let it polymerize. The gel electrophoresis of small gels was performed 
using the mini PROTEAN III system (Biorad). The bigger gels with more than 10 wells 
were casted into Criterion cassettes (Biorad, 3459902) and the Criterion vertical 
electrophoresis cell (Biorad) was used for gel electrophoresis. 
After the gel was polymerized the gel was pre-run in 0.5 x TBE at 100V for 30 min 
and the wells were washed with syringe and a 20-nauge needle.  
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For Northern blotting of small RNAs 10 μg of RNA was mixed with an equal volume 
of Gel loading buffer II (Thermo Fisher Scientific, AM8546G), denatured at 70°C for 
2 min and kept on ice. Before loading on the gel, the wells were again rinsed with a 
syringe and a 20-nauge needle in order to remove some urea residues. The samples 
were carefully loaded on the gel and the gel electrophoresis was performed at 110 V 
for 2-3 h. After that, the gel was stained in a square petri dish with 10 mg/ml ethidium 
bromide in 0.5 x TBE for 5 min. The gel was imaged using the Typhoon scanner and 
RNA integrity and RNA separation was assessed before transfer.  
 
2.4.2 Transfer of small RNAs onto a nylon membrane using semi-dry 
transfer  
 
For the transfer six whatman filter paper (Thermo Fisher Scientific, 3030-335) and 
one piece of Hybond-NX nylon membrane (GE Healthcare, RPN202T) were cut at 
the same size as the gel and soaked in water. A neutral Hybond-NX membrane was 
used because positively charged nylon membranes are not compatible with the 
following chemical crosslinking using 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(EDC).  
For the semi-dry transfer the membrane and the gel were placed in between of six 
whatman filter paper. First three soaked whatman filter paper were positioned on the 
semi-dry apparatus (Fisher) and air bubbles were removed by a pipette. Then the 
membrane and the gel were placed on the three whatman filter paper followed by 
another layer of three whatman filter paper. Remaining air bubbles were carefully 
removed. The semi-dry transfer was performed at 20 V for 60 min at 4°C.  
 
2.4.3 Chemical cross-linking  
 
Before cross-linking the polyacrylamide gel was scanned using the Typhoon Scanner 
in order to ensure that all the RNA was transferred successfully. The small RNAs 
were crosslinked to the membrane by chemical cross-linking using EDC. It was 
previously shown that Carbodiimide-mediated cross-linking enhanced the sensitivity 
for the detection of small RNAs by Northern blotting up to 50-fold compared to 
conventional UV-cross-linking (Pall and Hamilton, 2008). For the cross-linking 
solution 122.5 μl 12.5 M 1-Methylimidazole (Sigma, M50834) and 10 μl concentrated 
hydrochloric acid (HCl) was added to 10 ml water. The pH of the solution was checked 
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using the pH meter and adjusted to pH 8.0. Then 0.373 g of EDC (Thermo Fisher 
Scientific, 22980) was added to the solution, gently mixed and filled up with water to 
a final volume of 12 ml.  
A whatman filter paper that was slightly bigger than the membrane was soaked in 
cross-linking solution and placed on a Saran wrap. The membrane was placed with 
the RNA facing up on the soaked whatman filter paper, sealed tightly with Saran wrap 
and incubated in a hybridization oven for at 60°C for 1-2 h.  
After cross-linking the membrane was washed twice in water on an orbital shaker for 
5 min at room temperature, sealed with Saran wrap and stored at -20°C until 
hybridization.  
 
2.4.4 Hybridization  
 
For pre-hybridization the hybridization buffer (Sigma, H7033) was pre-warmed at 
37°C. Then the membrane was placed in a hybridization tube containing 5-10 ml 
hybridization buffer while the RNA side of the membrane was facing inside the tube. 
The membrane was incubated at 37°C in a HB-1000 hybridization oven (UVP) under 
rotation. 
While the membranes were incubated, the probe for Northern blotting was prepared 
in a screw-cap centrifugation tube. The antisense DNA oligonucleotide (without 5’ end 
phosphate) was ordered and synthesized by Sigma. For preparing and end labelling 
the antisense DNA oligonucleotide probe 2 μl of a 10 μM oligonucleotide (Sigma), 2 
μl of T4 Polynucleotide Kinase buffer (PNK) (NEB, M0201S), 14 μl nuclease-free 
water, 3 μl of [γ-32P]-ATP (~1.1 MBq) (Perkin Elmer, BLU502A500UC) and 1 μl of T4 
Polynucleotide Kinase (PNK) (NEB, M0201S) were gently mixed in a screw-cap 
centrifugation tube. PNK transfers the terminal phosphate from [γ-32P]-ATP to the 5’ 
end of the DNA oligonucleotide. The reaction was incubated in the radioactivity 
laboratory at 37°C for 1 h. 
After 1 h 30 μl water was added to the tube and the whole reaction mixture was 
carefully added to the hybridization tube without touching the membrane. The 
membrane was incubated at 37 °C in the hybridization oven under rotation overnight.  
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2.4.5 Washing of the membrane and signal detection  
 
Following overnight hybridization the membrane was washed twice with wash buffer 
containing 0.2 x Saline-Sodium citrate (SSC), 0.1% Sodium dodecyl sulphate (SDS) 
at 37°C for 30 min under rotation. If the background of the membrane was too high 
the washing was repeated in order to remove the non-specific radioactive signal. The 
membrane was wrapped in Saran wrap, placed in a cassette and exposed to a 
phosphorimager screen (Fujifilm) between 30 min and 5 days depending on the 
signal. The phosphorimager screen was imaged using the Typhoon Scanner and the 
Image Quant Software (GE Healthcare, Typhoon Scanner) was used for 
quantification.  
 
2.4.6 Stripping of Northern blot membranes  
 
In order to hybridize the membrane with another oligonucleotide probe, the hybridized 
labelled probe was removed from the membrane by incubating the membrane in 0.1% 
SDS for 30 min to 5 h at 90°C in a hybridization oven under rotation. Successful 
removal of the probe was checked by exposing the membrane to a phosphorimager 
screen and imaging using the Typhoon Scanner.  
 
2.4.7 Oligonucleotide probe sequences used for Northern blotting  
 
The following DNA oligonucleotides reverse complementary to the small RNA of 
interest (Sigma) were used for Northern blotting (Appendix II, Table 0.12). For some 
hY5 3’ end mutants a locked nucleic acid (LNA) probe had to be used because the 
sequence was too short for the hybridization with a normal synthesized DNA 
oligonucleotide. In an LNA probe the LNA nucleotide (shown in Appendix II, Table 
0.12 by *) is modified by a methylene bridge between the 2’ oxygen atom and the 4’ 
carbon atom of the ribose. This modification locks the ribose in the 3’ endo 
conformation by the bicyclic ring formation. The use of LNA probes increases the 
hybridization sensitivity and detection of small RNAs. The LNA probe was 
synthesized by Exiqon.  
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2.5 Western blotting 
 
2.5.1 Polyacrylamide gel electrophoresis of proteins 
 
For western blotting 10 μg of total protein extract was used. An equal volume of 
Laemmli buffer (Sigma, S3401) was added to the protein lysate, denatured at 100°C 
for 5 min and then immediately put back on ice until the gel was ready to be loaded. 
The proteins were separated on precast 4-12% gradient Bis-Tris polyacrylamide gels 
using the XCell Surelock mini-cell electrophoresis system (Invitrogen). The proteins 
were run in NuPAGE MOPS SDS running buffer (Thermo Fisher Scientific, NP0001) 
at 120 V for 1-2 h. As protein standard the PageRuler prestained protein ladder 
(Thermo Fisher Scientific, #SM0671) and MagicMark XP Western Protein Standard 
(Thermo Fisher Scientific, LC5603) were used.  
 
2.5.2 Western blot transfer 
 
After gel electrophoresis, the proteins were transferred onto a nitrocellulose 
membrane (Protran BA85, VWR, 732-4174) by wet-transfer using the XCell II blot 
module (Invitrogen).  
For the transfer, six whatman paper were cut at the same size as the gel and soaked 
together with six sponge pads in 1x NuPAGE transfer buffer containing 10% methanol 
(Thermo Fisher Scientific, NP0006). For the wet-transfer first three soaked sponge 
pads and whatman filter paper were placed on the transfer machine, followed by the 
gel, nitrocellulose membrane and another layers of three whatman filter paper and 
sponge pads. The transfer was carried out at 300 mA for 2-4 h at 4°C.  
 
2.5.3 Blocking of membrane and antibody hybridization  
 
After the transfer the membrane was blocked for 1h at room temperature in TBS (Tris-
buffered saline) buffer containing 0.1% Tween 20 (TBST) and 5% milk powder.  
After blocking the membranes were incubated with the primary antibody in TBST-
buffer containing 5% milk powder overnight at 4°C. The following day the membranes 
were washed three times in TBST buffer for 5 min at room temperature. After that, 
the membranes were incubated with a horseradish peroxidase (HRP) conjugated 
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secondary antibody in TBST-buffer supplemented with 5% milk powder for 1 h at 
room temperature. The membranes were washed again three times with TBST buffer 
and the western blot signal was detected using enhanced chemiluminescence (ECL) 
SuperSignal West Pico Chemiluminescence Substrate (Thermo Fisher Scientific, 
34080). The Western blots were visualized using the SYNGENE gel documentation 
system.  
 
2.5.4 Western blot antibodies 
 
The antibodies used for the Western blots were diluted according to the 
manufacturer’s instructions. The antibody for the detection of mouse Ro60 was kindly 
provided from the laboratory of Sandra Wolin and was described by Chen et al., 2003. 
For the detection of β-actin the membrane was incubated with a primary antibody 
against mouse β-actin from Abcam (ab6276). In order to detect mouse Ro60 and β-
actin a rabbit polyclonal secondary antibody against mouse IgG conjugated with HRP 
(Abcam, ab6728) was used.  
 
2.6 Generation of DNA constructs 
 
2.6.1 DNA extraction from HeLa cells  
 
Genomic DNA was extracted from 2 x 106 HeLa cells using the GenElute Mammalian 
Genomic DNA Miniprep Kit (G1N10, Sigma) according to the manufacturer’s 
instructions. The genomic DNA was stored in -20°C until use.  
2.6.2 Amplification of the human Y5 RNA gene from genomic DNA  
 
The human Y5 RNA gene was amplified from genomic DNA as described in (Turnbull, 
2014).  
As a template for polymerase chain reaction (PCR) 100 ng of genomic DNA was 
used. The PCR reaction was set up in a 20 μl reaction using Phusion High-Fidelity 
DNA polymerase according to the manufacturer’s instructions (Thermo Fisher 
Scientific, F530L). For PCR set up 100 ng genomic DNA was mixed with a final 
concentration of 1 x Phusion HF (high fidelity) buffer, 0.4 mM dNTPs, 0.5 mM forward 
primer, 0.5 mM reverse primer (see Appendix II, Table 0.1) and 2 U Phusion DNA 
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Polymerase. In order to amplify the human hY5 gene including the RNA polymerase 
III promoter sequence and terminator region the forward primer was designed to bind 
specific to the promoter region and the reverse primer to bind to the terminator region 
of the human Y5 RNA gene. The human Y5 RNA gene was amplified including a 2.9 
kb promoter region upstream the hY5 encoding region and 30 bp downstream of the 
terminator signal.  
The PCR cycling conditions were as follows: 98°C for 3 min, followed by 30 cycles of 
98°C for 1 min, 64°C for 45 s and 72°C for 3 min, followed by a final extension of 72°C 
for 10 min and 4 °C hold. 
 
2.6.3 Agarose gel electrophoresis  
 
The PCR products were separated by agarose gel electrophoresis. The percentage 
of the agarose gel varied between 0.8 % and 2% depending on the expected size of 
the PCR. The agarose was dissolved in 0.5 x TBE by heating up in the microwave. 
The gel was poured and 10 mg/ml ethidium bromide was added. The PCR products 
were mixed with 6 x DNA loading dye (NEB). The gel was run at 120 V for 30-60 min 
and imaged using the UV transilluminator or Typhoon Scanner.  
 
2.6.4 Purification of PCR products by gel extraction 
 
After visualization of the gel with the UV transilluminator the DNA bands were excised 
from the agarose gel with a sterile scalpel at the expected size and transferred to a 
1.5 ml centrifugation tube. For the purification of PCR products from the agarose gel 
the Zymoclean Gel DNA Recovery Kit (Zymo Research, D4007) was used according 
to the manufacturer’s instructions. The excised gel slices were dissolved at 55°C for 
10 min and the DNA was eluted in 6-10 μl sterile water.  
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2.6.5 Adenosine tailing of PCR products for TA cloning 
 
The High fidelity Phusion DNA polymerase generates blunt-ended DNA fragments. 
In order to use blunt ended DNA fragments for TA cloning, the PCR products need to 
have a 3’ terminal deoxyadenosine. For the tailing reaction 1-7 μl purified PCR 
product was mixed with dATP at a final concentration of 0.2 mM, 1 μl of GoTaq G2 
DNA Polymerase 10 x reaction buffer containing MgCl2 and 5 U of GoTaq G2 DNA 
polymerase (Promega, M7801) in a final volume of 10 μl. The react ion mixture was 
incubated at 70°C for 30 min.  
 
2.6.6 Cloning of PCR products into pGEMT easy vector  
 
The pGEMT easy vector system I (Promega, A1360) was used for TA cloning of the 
purified PCR products. The pGEMTeasy vector (see Error! Reference source not 
found.)  is a high-copy vector system that is linearized and contains 3’ terminal 
deoxythymidine at both ends. The 3’-T overhangs at the insertion site create 
overhangs for the efficient ligation of PCR products that have a 3’ terminal 
deoxyadenosine. The multiple cloning region of the pGEMT easy vector is flanked by 
the T7 and SP6 RNA polymerase promoter. Another feature of the pGEMT easy 
vector is the β-galactosidase gene in the multiple cloning region which allows the 
blue/white screening of recombinant bacteria. If an insert was cloned successfully in 
the multiple cloning region of the pGEMT easy vector the coding sequence of the β-
galactosidase gene gets disrupted which results in white colonies whereas bacteria 
that only contain empty vector without any insert will appear blue. The ampicillin 
resistance gene in the pGEMT easy vector is used as another selection marker to 
screen for positive recombinant bacteria.  
The A-tailed PCR product of the hY5 RNA gene including a 2.9 kb pol III promoter 
upstream the hY5 RNA gene (Figure 2.1 B, shown in dark blue) and a 30 bp 
terminator region downstream (shown in Figure 2.1  in dark red) of the hY5 RNA 
gene (Figure 2.1 B shown in dark green) was ligated into the pGEMT easy vector 
(Figure 2.1 A) and the pGEM-hY5-WT plasmid was generated (Figure 2.1 B). 
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Figure 2.1. Vector map of pGEMTeasy and pGEM-hY5 WT plasmid DNA vector.  
A. Vector map of pGEMT easy vector (Promega).  
The vector map shows the circularized pGEMT easy vector with the origin of replication (ori), 
the Ampicillin resistance gene (Ampr), the β-galactosidase gene (lacZ), the multiple cloning 
region including the restriction sites that is flanked by the T7 and SP6 promoter. The figure 
was taken from the pGEMT easy manual (Promega, A1360). 
B. Vector map of the pGEM-hY5 WT plasmid.  
The map shows the pGEM-hY5 plasmid that was generated by the ligation of the A-tailed PCR 
product of the hY5 RNA gene (shown in dark green) including a 2.9 kb RNA polymerase III 
promoter (shown in dark blue) upstream of the hY5 RNA gene (shown in green) and 30 bp 
terminator region downstream of the hY5 RNA gene (shown in red) into the pGEMT easy 
vector.  The Amplicillin resistance (Amp) is shown in green. The LacZ gene for blue-white 
selection is shown in light blue. The T7 promoter is depicted in turquoise and the origin of 
replication is shown in grey. The vector map was generated using ApE the plasmid editor.  
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2.6.7 Preparation of supercompetent DH5α bacterial cells  
 
An aliquot of DH5α E.coli bacterial cells was plated on a LB-agar plate and incubated 
at 37°C overnight. A single colony of DH5α cells was streaked onto a M9 minimum 
plate and incubated for 48-72 h. After that, a single colony was plated on an LB agar 
plate supplemented with 10mM MgCl2. As a contamination control the single colony 
was also plated on an LB plate supplemented with 100 mg/ml Ampicillin. The plates 
were incubated at 37°C overnight. The next day the LB Ampicillin plate was checked 
for contamination and if nothing had grown a single colony from the LB/MgCl2 plate 
was inoculated in 5 ml TYM media and incubated overnight at 37°C under shaking at 
200 rpm. One ml of the overnight culture was added to 125 ml TYM broth in a 500 ml 
flask and incubated at 37°C under shaking at 300 rpm for an additional 3-4 h until the 
optical density (OD550) reached 0.5. The culture was poured into 50 ml falcon 
centrifugation tubes and spun for 12 min at 1500 x g at 4°C.  
The pellet was resuspended very gently in 40 ml of ice cold TfbI resuspending buffer 
and incubated on ice for 10 min. The suspension was centrifuged at 1500 x g for 8 
min and resuspended in 4 ml of TfbII buffer. The supercompetent cells were aliquoted, 
frozen in liquid nitrogen and stored in -80°C. The competent cells were checked for 
transformation efficiency by transforming 0.1 ng of pUC19 vector control (NEB, 
N3041S). The transformation efficiency of DH5α cells was calculated to range 
between 1 x 107 to 1 x 108 cfu/μg of DNA.  
2.6.8 Transformation of bacterial cells 
 
For the transformation 100 µl of homemade supercompetent DH5α E. coli cells were 
thawed on ice for each transformation reaction. Then 5 µl of ligation reaction were 
added to each tube of competent cells, mixed gently and incubated on ice for 30 min. 
The mixture was then heat shocked at 42°C for 42 s and put on ice for 2 min. After 
that 900 µl of LB-media was added to the transformation reactions and incubated at 
37°C with shaking for 1-2 h.  
In order to determine positive clones with the insert by using blue-white screening, 
0.5 mM X-Gal (5-bromo-4-chloro-3-indolyl-D-galactoside) and 80 mg/mL IPTG 
(Isopropyl-D-1-thiogalactopyranoside) were spread on the plates before the 
transformation reactions were plated. Of each transformation reaction 100, 150 and 
200 µl were spread on LB plates supplemented with 100 mg/ml ampicillin. The 
bacteria plates were incubated at 37°C overnight.  
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2.6.9 Colony PCR 
 
The transformation success and positive clones were determined by blue-white 
screening. Colony PCR was performed in order to confirm that the transformed 
bacteria contained an insert and if the insert is at the expected size. The pUC M13 
forward and reverse primers were used for colony PCR. The pUC M13 forward and 
reverse primers bind to the flanking regions of the multiple cloning region and amplify 
the whole insert if it was successfully cloned into the pGEMT easy vector.  
The PCR reaction was set up in a final volume of 10 µl using GoTaq G2 Flexi DNA 
Polymerase (Promega, M7801) according to the manufacturer’s instructions.  
The PCR reaction was set up with a final concentration of 1 x GoTaq Flexi DNA 
Polymerase buffer, 2 mM MgCl2, 0.2 mM dNTPs, 0.2 mM forward primer, 0.2 mM 
reverse primer (see Appendix II, Table 0.2) and 0.5 U Phusion DNA Polymerase.  
The PCR programme was chosen according to the manufacturer’s instructions and 
the following conditions were used: 94°C for 2 min, followed by 29 cycles of 94°C for 
30 s, 58°C for 30 s and 72°C for 90 s, followed by a final extension of 72°C for 10 min 
and 4°C hold. 
The products of the colony PCR were analysed on a 1% agarose gel (110 V, 45 min) 
in order to confirm the presence and size of the insert. Positive colonies were 
inoculated in 5 ml LB-media supplemented with 100 mg/ml ampicillin as selection 
marker and incubated at 37°C overnight under shaking at 180 rpm.  
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2.6.10 Purification of plasmid DNA 
 
The plasmid DNA purification was performed using the QIAprep Spin Miniprep Kit 
(Qiagen) following the manufacturer’s instructions. The plasmid DNA was eluted in 
30 μl water. The concentration of the plasmid DNA was measured using the 
nanodrop.  
 
2.6.11 Sanger sequencing 
 
In order to determine the sequence of the plasmids, the plasmid DNA sample was 
mixed at a concentration of 50-100 ng/μl with water to a final volume of 17 μl. For 
sequencing 2 µl of the sequencing primer (10 μM) was added and the samples were 
sent to Eurofins MWG Operon (Ebersberg, Germany) for Sanger Sequencing.  
 
2.7 High throughput mutagenesis approach on the 3’ end of 
the human Y5 RNA  
 
2.7.1 Generation of the 3’ end hY5 RNA mutant pool small RNA cDNA 
libraries 
 
The generation of the 3’ end hY5 RNA mutant pool cDNA libraries was performed by 
a previous PhD student (Turnbull, 2014). For the 3’ hY5 mutagenesis analysis three 
different regions close to the 3’ end cleavage site were chosen for random 
mutagenesis. In each of these regions five nucleotide substitution mutations were 
introduced resulting in 1024 possible combinations of hY5 mutants. The mutations 
were introduced using long primers containing random nucleotides, generating a pool 
of hY5 mutants for each of the three regions. The primers were synthesized in a way 
each of the bases was mixed equally with a proportion of 25% at each of the five 
mutated positions (IDT) in order to ensure that each hY5 mutant will be distributed 
equally. The PCR for mutant pool 1, 2 & 3 was performed in three replicates. The 
PCR products were A-tailed, ligated into pGEMT easy vector and transformed into 
E.coli. Statistical analysis revealed that for each mutant pool replicate a minimum of 
around 5000 colonies had to be harvested in order to be sure that each of the 1024 
possible hY5 mutant will be represented at least once with a probability of 99% 
(Statistical analysis was performed by Dr. Irina Mohorianu and Carly Turnbull).  
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The colonies were harvested and the plasmid DNA was purified using the HiSpeed 
Midi Prep kit. The hY5 mutant pools 1, 2 and 3 were transfected into NIH 3T3 cells 
for 24 h. The cells were treated with staurosporine for 4 h. RNA was extracted and 
sRNA production was checked by Northern blot analysis.  
The small RNA cDNA libraries were constructed using 2 μg of total RNA using High 
Definition (HD) adapters (Sorefan et al., 2012) with some modifications. For cDNA 
library construction a FAM-labelled 3’ HD-adapter and 5’ Illumina adapter were used. 
For PCR a longer RP-1 Index primer was designed in order to enrich for 3’ end derived 
hY5 RNAs.  
The sRNA cDNA libraries were sent for NGS to BaseClear (Netherlands) using a 
customized sequencing primer.  
 
2.7.2 Generation of the 3’ end hY5 RNA mutant pool full length cDNA 
libraries and plasmid libraries 
 
Apart from the hY5 3’ end mutant pools small RNA cDNA libraries, full length cDNA 
libraries and plasmid libraries were also prepared as controls (Turnbull, 2013). Full 
length hY5 RNA mutant cDNA libraries were generated in order to look at the 
transcription level and stability of hY5 RNA mutants. The libraries generated from the 
mutant plasmid pools itself were prepared to check if all the 1024 hY5 mutants are 
present and equally distributed.  
The full length cDNA and plasmid libraries were sequenced on one lane using a 
customized sequencing primer. Since both full length and plasmid library sets have 
the same sequence it was impossible to sequence these libraries with the standard 
Illumina protocol because for successful clustering at the Illumina sequencing the first 
15 nucleotides need to be different. For this reason a so called balancing DNA was 
generated by PCR (see Appendix II, Table 0.4 ) using the Phusion protocol in order 
to introduce heterogeneity and create a variety of different sequences. The balancing 
DNA contained a 20 nt stretch where random nucleotides were incorporated therefore 
sequence heterogeneity was ensured. 
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2.7.3 Bioinformatics analysis of hY5 3’ end mutant sRNA libraries 
 
The bioinformatics analysis was carried out by Dr. Simon Moxon. As a first step, the 
Fastq files were converted to Fasta format and all reads containing ambiguous bases 
(“Ns”) were discarded. HD adapters containing four degenerate nucleotides were 
used for 3’ end ligation and for each individual library replicate a different index primer 
was used for library preparation.  
Next, the first 8 nt of the 3’ HD adapter (5’-TGGAATTC-3’) were identified using 
perfect sequence match and trimmed off. The four degenerate nucleotides of the 3’ 
HD adapter at the ligation site of each sRNA read were trimmed. From the 5’ end of 
sequencing reads the Illumina adapter sequence was removed. The adapter trimming 
was performed using the UEA sRNA Workbench (Stocks et al., 2012). A Perl script 
was written in order to generate all possible 3’ end hY5 mutant sequences for each 
mutated region 1, 2 and 3 resulting in a total of 3072 possible hY5 mutant sequences. 
The reads were mapped full length and without allowing any mismatches to the 3072 
possible hY5 mutant combinations using PatMaN (Prüfer et al., 2008). Each library 
replicate was ranked by abundance and for further analysis the mean rank across all 
the three replicates was taken. 
However, PCR duplication is a huge problem during NGS library preparation and 
occurs through biases in the PCR amplification step. In this bioinformatics analysis 
the PCR duplicates were not removed. In order to remove PCR duplicates the 
degenerate nucleotides of the 3’ HD adapter could be used to identify the PCR 
duplicates. For that, any identical sequences with the same random nucleotides that 
are likely to be PCR duplicates would be removed and collapsed. Then, the adapter 
sequences would be trimmed off and aligned to all possible hY5 mutant combinations.  
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2.7.4 Bioinformatics analysis of the full-length cDNA and plasmid 
libraries  
 
The bioinformatics analysis was carried out by Dr. Simon Moxon. For the analysis a 
Perl script was used to generate all possible 3’ end hY5 mutant sequences for each 
mutated region 1, 2 and 3 resulting in a total of 3072 possible hY5 mutant sequences. 
The reads were aligned to all the possible hY5 RNA mutants without mismatch using 
PatMaN. The plasmid libraries contained extra 6 nucleotide TAACAC before the hY5 
coding sequence in order distinguish the plasmid library reads from the full length hY5 
mutant cDNA library reads. Each library replicated was sorted by abundance and the 
mean rank of all the three replicates was used for further analysis.  
 
2.7.5 Secondary structure predictions and visualization 
 
For secondary structure prediction of hY5 RNA mutants the programme RNAfold 
under default parameters was used (Hofacker, 2003). The visualization of the 
predicted hY5 RNA mutants was carried out using Varna (Darty et al., 2009).  
 
2.7.6 Generation of individual hY5 3’ end mutants and loop mutants  
 
After bioinformatics analysis the top ten most abundant sequences of each mutant 
pool were cloned individually into the pGEMT easy vector.  
The sequences of each oligonucleotide that was used for generating individual hY5 
3’ end mutants and deletion mutants can be found in appendix II. 
The PCR was set up in a final volume of 20 μl using Phusion High-Fidelity DNA 
polymerase according to the manufacturer’s instructions (Thermo Fisher Scientific, 
F530L) with some modifications. 1 ng of wild type hY5 plasmid (pGEM-WT) was set 
up with 1 x Phusion HF buffer, 0.4 mM dNTPs and 2 U Phusion DNA Polymerase 
without primers for 10 cycles at a lower annealing temperature. After 10 cycles 0.5 
mM forward primer, 0.5 mM reverse primer (see Appendix II, Table 0.3) were added 
to the PCR mixture and the annealing temperature was raised to 69 °C for another 
25 cycles. The PCR had to be modified that way because long reverse primers 
spanning the downstream region of the human Y5 RNA had to be used for the PCR 
reaction in order to amplify the whole hY5 mutant sequence.  
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The cycling conditions for the first PCR reaction were the following: 98°C for 30 s, 
followed by 9 cycles of 98°C for 10 s, 54°C for 30 s and 72°C for 2 min, followed by 
a final extension of 72°C for 10 min and 4°C hold. 
After adding the primers the PCR reaction was run for another 25 cycles under 
following conditions: 98°C for 30 s, followed by 25 cycles of 98°C for 10 s, 69°C for 
30 s and 72°C for 2 min, followed by a final extension of 72°C for 10 min and 4°C 
hold. 
The PCR products were run on a 1% agarose gel and purified using the Zymoclean 
Gel DNA Recovery Kit according to the manufacturer’s protocol. The purified PCR 
products were tailed and ligated into pGEMT easy vector as described before. The 
ligation products were transformed into E. coli. The plasmid DNA was purified using 
the QIAprep Spin Miniprep Kit according to the manufacturer’s instructions. After 
checking the sequence and successful mutation by Sanger Sequencing a single 
colony was inoculated in 5 ml LB medium supplemented with 100 mg/ml ampicillin for 
5-8 h at 37°C and shaking at 200 rpm. After that the starter culture was diluted 1/1000 
in 100 ml LB medium containing 100 mg/ml ampicillin as a selection antibiotics. The 
culture was grown at 37 °C with shaking at 200 rpm overnight. The next day the 
culture was centrifuged at 4,000 x g at 4 °C and the plasmid DNA was purified using 
the HiSpeed Midi Prep kit (Qiagen, 12643). The plasmid DNA was eluted in 500 μl 
water and the concentration was determined by nanodrop.  
2.7.7 Transfection of hY5 mutants into NIH 3T3 cells 
 
The transfection of hY5 mutants was carried out as described in 2.1.4. For the 
transfection 20 μg of plasmid DNA was transfected using Fugene 6 for 24 h. For each 
transfection experiment a mock transfection control and empty vector control was 
included. 
 
2.7.8 Treatment of NIH 3T3 cells with staurosporine 
 
In order to induce apoptosis and hY5 derived small RNAs the cells were treated with 
staurosporine for 8 h at a final concentration of 1 μM.  
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2.7.9 RNA extraction and Northern blot analysis  
 
The RNA was extracted as described in section 2.3 and the RNA integrity was 
checked on a 1.5 % agarose gel. The RNA concentration was measured using the 
Nanodrop.  
For Northern blotting 10 μg of RNA was used and the Northern blot protocol was 
followed as previously detailed in section 2.4.  
 
2.8 High throughput mutagenesis approach on the 5’ end of 
the human Y5 RNA  
 
2.8.1 Generation of 5’ end hY5 mutant pools-first strategy 
 
For the 5’ hY5 mutagenesis approach a similar strategy like for the 3’ end hY5 
mutagenesis was designed. Three different regions near the 5’ hY5 RNA cleavage 
site were selected for mutagenesis. In each of these regions five nucleotides were 
substituted by random nucleotides that would result in 1024 different hY5 mutants per 
mutated pool. The random mutations were introduced by overlap extension PCR 
using primers containing degenerate nucleotides. The primers had to be synthesized 
in a way that the five random nucleotides at each of the mutated regions were hand 
mixed at an equal proportion of 25% in order to ensure each base is equally 
distributed and less bias will be introduced by PCR. The PCR for mutant pool 4, 5 
and 6 was carried out in three replicates. For PCR first 1 ng of wild type pGEM-WT 
was used as a template to generate the two fragments (long and short) for overlap 
extension PCR. The PCR was performed according to the manufacturer’s 
instructions. 1 ng of pGEM-hY5 WT was mixed with a final concentration of 1 x 
Phusion HF buffer, 0.4 mM dNTPs, 0.5 mM forward primer, 0.5 mM reverse primer 
and 2 U Phusion DNA Polymerase (see Appendix II, Table 0.5). 
The cycling conditions for the long fragment of mutant pool 4, 5 and 6 were as follows: 
98°C for 30 s, followed by 30 cycles of 98°C for 10 s, 54°C for 30 s and 72°C for 2 
min, followed by a final extension of 72°C for 10 min and 4°C hold. 
For generating the short fragment for mutant pool 4, 5 and 6 following PCR cycling 
conditions were used: 98°C for 30 s, followed by 30 cycles of 98°C for 10 s, 52°C for 
30 s and 72°C for 30 s, followed by a final extension of 72°C for 10 min and 4°C hold. 
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The PCR products of the long fragment and short fragment were purified using 
Zymoclean Gel DNA Recovery Kit according to the manufacturer’s instructions. The 
purified PCR products were quantified using the nanodrop. For setting up the overlap 
extension PCR 100 ng of the long fragment (2.9 kb) and 5 ng of the short fragment 
was used. First the PCR reaction was set up without the addition of primers and final 
extension for 5 cycles in order that both fragments can anneal to each other. 100 ng 
of long fragment and 5 ng of short fragment were added to 1 x Phusion HF buffer, 0.4 
mM dNTPs and 2 U Phusion DNA Polymerase. 
The PCR conditions were as follows: 98°C for 30 s, followed by 4 cycles of 98°C for 
10 s, 52°C for 30 s and 72°C for 2 min and 4°C hold. 
After 5 cycles 0.5 mM forward primer and 0.5 mM reverse primer (see Appendix II, 
Table 0.8) were added to the PCR reaction. The annealing temperature was raised 
to 69 °C and the PCR was run for another 25 cycles. The PCR was run under the 
following conditions for another 25 cycles: 98°C for 30 s, followed by 25 cycles of 
98°C for 10 s, 69°C for 30 s, 72°C for 2 min, followed by a final extension of 72°C for 
10 min and 4°C hold. 
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The PCR for mutant pool 4, 5 & 6 was performed in three replicates. The PCR 
products were A-tailed, ligated into pGEMT easy vector and transformed into E.coli. 
In order to check successful mutagenesis 50 purified plasmid DNA samples of each 
mutant pool were sent for Sanger Sequencing.  
For generating the large mutant pools around 9000-10000 colonies per mutant pool 
was harvested in order to ensure that each mutant will be present. Previous statistical 
analysis for the 3’ end hY5 mutagenesis approach revealed that for each mutant pool 
replicate a minimum of around 5000 colonies had to harvested in order to be sure 
that each of the 1024 possible hY5 mutant will be represented at least once with a 
probability of 99% (Statistical analysis was performed by Dr. Irina Mohorianu and 
Carly Turnbull). The colonies were harvested and the plasmid DNA was purified using 
the HiSpeed Midi Prep kit.  
 
2.8.2 Generation of hY5 5’ end mutant pool plasmid libraries 
 
For generating the hY5 5’ end mutant pool plasmid libraries 5 ng of each mutant 
plasmid pool replicate was used for PCR. In order to introduce the Illumina adapter 
sequences and indices for Illumina sequencing two separate PCR reactions were 
carried out. The first PCR reaction was set up according to the Phusion protocol (see 
Appendix II, Table 0.6) using 5 ng of template. 98°C for 30 s, followed by 25 cycles 
of 98°C for 10 s, 55°C for 30 s, 72°C for 30 s, followed by a final extension of 72°C 
for 10 min. 
The samples were separated on an 8 % native polyacrylamide gel. For preparing the 
2 gels 10 ml water, 1.5 ml 5 x TBE, 3 ml of 40 % acrylamide/bis solution 19:1 were 
mixed and filled up with water to a final volume of 15 ml. For polymerisation 7.5 μl 
TEMED and 150 μl 10% APS were added and the gels were set for 30 min. The PCR 
reaction were mixed with 5 x Novex Hi-Density TBE Sample buffer (Thermo Fisher 
Scientific, LC6678) and run in 0.5 x TBE at 120 V for around 2 h. The gels were 
stained with SYBR Gold (Thermo Fisher Scientific, S11194) in 0.5 x TBE with a 
dilution of 1/10000 for 1 min at room temperature and visualized using the Typhoon 
Scanner. The DNA bands were purified from the gels using sterile razor blades and 
the gel slices were placed into a gel breaker centrifugation tube and centrifuge at 
20,000 x g for 5 min. The gel pieces were eluted with 1 x NEB2 buffer overnight at 
4°C under rotation. The next day the soaked gel pieces were centrifuged in a Costar 
Spin X column (Corning, CLS8160-96EA) at 2,600 rpm for 5 min at room temperature 
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in order to filter out the solid gel debris. The eluted DNA was concentrated by ethanol 
precipitation overnight at -20°C by adding 2.5-3 volumes of 100 % ethanol, 1/10 of 
the eluted volumes 3M sodium acetate, pH 5.2 and 15 mg/ml glycoblue coprecipitant 
(Thermo Fisher Scientific, AM9515). The next day the samples were centrifuged for 
30 min at 20,000 x g at 4°C. The pellet was washed once with 80 % ethanol and 
centrifuged for another 5 min at 20,000 x g at 4°C. The pellet was air dried for 5-10 
min at room temperature and resuspended in 12 μl water.  
For introducing the Illumina index primer sequences to the first PCR product another 
PCR was set up using the Phusion protocol and Illumina index primer sequences (see 
Appendix II, Table 0.6). The first purified PCR product was diluted to 1 ng and used 
as a template.  
The PCR conditions were as follows: 98°C for 30 s, followed by 25 cycles of 98°C for 
10 s, 55°C for 30 s, 72°C for 30 s, followed by a final extension of 72°C for 10 min 
and 4°C hold. 
The PCR product was separated on a native 8 % PAGE gel and purified as described 
above in detail. The plasmid libraries were resuspended in 12 μl nuclease-free water. 
After quantification and verification by Sanger Sequencing the plasmid libraries were 
sent for next generation sequencing and bioinformatics analysis was carried out.  
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2.8.3 Generation of the hY5 5’ end mutant pools- second cloning 
strategy  
 
Next generation sequencing and bioinformatics analysis revealed that the hY5 wild 
type sequence was overrepresented in the 5’ end mutant plasmid pools. To overcome 
this problem another cloning strategy was performed. The previous cloning was 
based on a plasmid containing the wild type hY5 full length sequence. The mutations 
were introduced by overlap extension PCR and the fragments were purified by gel 
extraction. One possibility could be that small traces of the full length hY5 wild type 
sequence was carried over to the stage of overlap extension PCR and this wild type 
sequence got amplified more efficiently in the overlap extension PCR compared to 
the mutant hY5 sequences.  
The cloning strategy was changed in a way that two different plasmids that contained 
a disrupted version of the hY5 full length sequence were used as templates instead 
of the plasmid encoding the full length hY5 RNA sequence. The PCR reactions for 
the truncated wild type hY5 sequences to generate the two template plasmid 
constructs were set up using the Phusion protocol (see Appendix II, Table 0.7). 1 ng 
of wild type hY5 plasmid and primer sets to create disrupted hY5 wild type sequences 
were used.  
The PCR conditions for plasmid DNA template 1 were as follows: 98°C for 30 s, 
followed by 25 cycles of 98°C for 10 s, 52°C for 30 s, 72°C for 2 min, followed by a 
final extension of 72°C for 10 min and 4°C hold.  
The PCR conditions for plasmid DNA template 2 were as follows: 98°C for 30 s, 
followed by 25 cycles of 98°C for 10 s, 52°C for 30 s, 72°C for 30 s, followed by a 
final extension of 72°C for 10 min and 4°C hold. 
The PCR products were purified using the Zymoclean gel extraction kit, A-tailed, 
ligated into pGEMT easy vector and transformed into E. coli. The plasmid DNA 
constructs were sent for Sanger Sequencing and checked that the full length hY5 wild 
type sequence was not over-represented anymore.  
The two plasmid DNA constructs with the confirmed truncated version of the hY5 full 
length wild type sequence were used as templates. For generating the PCR products 
for the mutant pools 4, 5 and 6 the degenerate nucleotides for each region were 
introduced by overlap extension PCR. The long fragment was amplified according to 
the Phusion protocol using 1 ng of template 1 (see Appendix II, Table 0.7). For the 
PCR of the short fragment 1 ng of template 2 was used.  
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The PCR for plasmid DNA template 1 was run at the following conditions: 98°C for 
30 s, followed by 25 cycles of 98°C for 10 s, 52°C for 30 s, 72°C for 30 s, followed by 
a final extension of 72°C for 10 min and 4°C hold.  
The PCR products were purified and quantified using the nanodrop. The final overlap 
extension PCR reaction was carried out as previously described (2.8.1). The two 
fragments were annealed at 55°C and after 5 cycles the forward and reverse primers 
were added to the PCR reaction for another 25 cycles.  
The PCR conditions were as follows 98°C for 30 s, followed by 4 cycles of 98°C for 
10 s, 52°C for 30 s, 72°C for 2 min without final extension and 4°C hold.  
After 5 cycles the 0.5 mM forward primer and 0.5 mM reverse primers (see Appendix 
II, Table 0.8) were added to the PCR reaction. The annealing temperature was raised 
to 69°C and the PCR was run for another 25 cycles.  
The overlap extension PCR conditions were: 98°C for 30 s, followed by 25 cycles of 
98°C for 10 s, 69°C for 30 s, 72°C for 2 min, followed by a final extension of 72°C for 
10 min and 4°C hold.  
The PCR products were purified using the Zymoclean gel extraction kit, A-tailed, 
ligated into pGEMT easy vector and transformed into E. coli. The generation of the 
large plasmid mutant pools was carried out as previously described. For each mutant 
pool replicate 30 colonies were selected and plasmid DNA was sent for Sanger 
Sequencing in order to check successful mutagenesis.  
 
2.8.4 Generation of full length cDNA and plasmid libraries for the hY5 5’ 
end mutant pools 
 
The plasmid libraries for the hY5 5’ end mutant pools were prepared as previously 
described using 1 ng of template for PCR. The purified plasmid libraries were sent for 
next generation sequencing (Earlham Institute, Norwich Research Park).  
For the full length cDNA libraries 5 μg of RNA was treated with Turbo DNase (Thermo 
Fisher Scientific, AM2238) for 30 min at 37°C to eliminate all the genomic DNA. The 
DNase treated RNA was purified using the RNA clean and concentrator kit according 
to the manufacturer’s instructions. The RNA was eluted in 10 μl and the concentration 
was determined by nanodrop. The reverse transcription reaction was carried out 
using the Superscript II protocol according to the manufacturer’s instructions. For first-
strand synthesis 500 ng purified RNA was mixed with 1 μl of 10 mM dNTPs and 1 μl 
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of 2 μM hY5 RNA specific primer. The reaction was incubated at 65°C for 5 min and 
chilled on ice immediately. After denaturing the RNA, 4 μl of 5 x First Stand buffer, 2 
μl of 0.1 M DTT and 1 μl of RNaseOUT (Thermo Fisher Scientific, 10777019 ) were 
added and incubated at 42°C for 2 min. At the final step 1 μl of Superscript II reverse 
transcriptase (Thermo Fisher Scientific, 18064014 ) was added and the reaction was 
gently mixed by pipetting up and down. The reaction was briefly centrifuged and 
incubated at 42 °C for 50 min. The reaction was inactivated at 70°C for 15 min. As 
described before for the plasmid libraries two PCR reactions had to be carried out in 
order to introduce the Illumina adapter and index sequences for the following next 
generation sequencing. The cDNA was used as a template for the first PCR reaction 
and the PCR was performed using the primers shown in Appendix II, Table 0.9 
according to the Phusion protocol for 15 cycles. The resulting PCR product was 
separated on a 6% PAGE gel and purified as described above. Then, 1 ng of the 
purified PCR product was used for the second PCR to introduce the Illumina index 
sequences according to the Phusion protocol for 10 cycles. The final cDNA full length 
libraries were run on a 6% PAGE and purified. The full length hY5 cDNA libraries 
were quantified using the Typhoon Image Quant software and after verification by 
Sanger sequencing the 5’ end hY5 full length cDNA libraries were sent for next 
generation sequencing. 
 
2.8.5 Small RNA library construction of hY5 5’ mutants 
 
The small RNA libraries were generated according to our published protocol (Xu et 
al., 2015) and standard Illumina protocol with some modifications. The total RNA was 
extracted using the TriReagent protocol as described previously. For small RNA 
library construction 2 μg of total RNA was used. The small RNA libraries were 
constructed with Illumina adapters and a customized RP1 PCR primer containing the 
original Illumina RP1 index sequence plus fifteen additional nucleotides on the 3’ end 
of the oligonucleotide (see Appendix II, Table 0.10). This modified RP1 primer had to 
be used in order to enrich for YsRNAs because of their low abundance compared to 
other small RNAs. Different enrichment sequences for YsRNAs (5 nt, 10 nt and 15 
nt) were tested and 15 nt additional hY5 RNA sequence seemed to be sufficient for 
YsRNA enrichment.  
For small RNA library construction the 3’ Illumina adapter (Sigma) had to be 
phosphorylated and adenylated because the truncated T4 RNA Ligase 2 (NEB) 
specifically ligates pre-adenylated 5´ ends of DNAs or RNAs to 3´ hydroxyl groups of 
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RNAs. For phosphorylation 6 μl of 100 μM 3’ Illumina adapter was mixed with 10 μl 
of 10 x T4 polynucleotide buffer (NEB), 10 μl of 10 mM adenosine triphosphate (ATP) 
(NEB), 72 μl of water and 2 μl of 10 U/μl T4 polynucleotide kinase (NEB) and 
incubated at 37°C for 30 min. The phosphorylated product was concentrated by 
ethanol precipitation overnight at -20°C.  
After centrifugation at 20,000 x g for 10 min at 4°C the pellet was washed with 250 µl 
80% ethanol and centrifuged at 20,000 x g for 5 min. The pellet was air dried for 10 
min and resuspended in 12 µl nuclease-free water.  
For adenylation of the phosphorylated 3’ adapters the 5’ DNA adenylation kit (NEB) 
was used according to the manufacturer’s manual. The reaction was set up by adding 
4.5 μl of the phosphorylated 3’ adapter to 4 μl of 10 x 5’ DNA adenylation buffer (NEB), 
4 μl of 1 mM ATP (NEB), 4 μl of Mth RNA ligase (NEB) and 23.5 μl nuclease-free 
water. The reaction mix was incubated at 65°C for 1 h and the enzyme was 
inactivated at 85°C for 5 min. The adenylation reaction was cleaned up by phenol: 
chloroform extraction (Sigma) and following ethanol precipitation at -20°C overnight. 
After centrifugation at 20,000 x g at 4°C for 15 min, the pellet was washed twice with 
80% ethanol and air-dried for 10 min at room temperature. The pellet was 
resuspended in 12 µl nuclease-free water. The concentration of the 3’ adenylated 
adapter was determined by nanodrop and adjusted to a final concentration of 20 µM. 
The successful adenylation was checked along with non-adenylated adapters on a 
15% denaturing polyacrylamide gel electrophoresis using the mini PROTEAN III 
system and 1.0 mm gel plates (Bio-Rad).  
The first step of the cDNA library construction was the ligation of the 3’ adenylated 
adapter to the sRNA using truncated T4 RNA Ligase 2 (NEB). Therefore, 50% 
polyethylene glycol (PEG) 8000 solution (NEB) was warmed up at room temperature. 
After that, 8 µl of the RNA sample were mixed with 1 µl of 20 µM adenylated 3’ adapter 
and denatured at 70°C for 2 min. The ligation reaction was set up by adding 2 µl of 
10 x T4 RNA ligase 2 buffer, 0.75 µl RNaseOUT (Thermo Fisher Scientific), 4 µl 50% 
PEG solution (NEB), 1 µl T4 RNA ligase 2 and 3.25 µl nuclease-free water to the 
denatured RNA and adapter reaction mixture.  
The ligation reaction was incubated for 2-3 h at 26°C and was cleaned up using the 
RNA clean and concentrator-5 kit (Zymo Research). The ligation product was eluted 
in 12.1 µl nuclease-free water and put on ice. 
In order to further clean up and remove excessive 3’ end Illumina adapter the ligation 
reaction was separated on an 18% denaturing PAGE along with appropriate size 
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markers and ligation controls. The gel was run at 100 V for 2-3 h, stained with SYBR 
Gold and imaged with the Typhoon Scanner. The ligation product was gel extracted 
and eluted in 1 x NEB2 buffer overnight as described before. The gel pieces were 
centrifuged in a Costar Spin X column (Corning, CLS8160-96EA) at 2,600 rpm for 5 
min at room temperature and the DNA was concentrated by ethanol precipitation for 
1-2 h in -80°C. The samples were centrifuged for 30 min at 20,000 x g at 4°C and the 
pellet was washed once with 80 % ethanol and centrifuged for another 5 min at 20,000 
x g at 4°C. The pellet was air dried for 5–10 min at room temperature and 
resuspended in 3.5 μl water.  
After the removal of excessive 3’ Illumina adapter by gel purification the ligation 
product was ligated to the 5’ end Illumina adapter which is a RNA adapter. The 5’ end 
adapter was denatured at 70°C for 2 min. The 5’ end ligation reaction was set up by 
adding 0.5 μl of 10 x T4 RNA ligase 1 buffer (NEB), 0.5 μl of 10 mM ATP (NEB), 0.5 
μl of denatured 5’ Illumina adapter and 0.5 μl T4 RNA ligase to the first ligation 
product. The ligation reaction was incubated for 2-3 h at 26°C.  
After the ligation the di-tagged RNA was reverse transcribed using Superscript II 
(Thermo Fisher Scientific). The ligation reaction was mixed with 1 μl RTP RNA RT 
primer and denatured at 70°C for 2 min. Then 0.5 μl of 12.5 mM dNTPs, 1 μl of 0.1 M 
DTT, 1 μl of RNase Out and 1 μl of Superscript II was added to the reaction mixture 
and incubated at 50°C for 1 h.  
For PCR amplification 4 μl of cDNA was mixed with 4 μl 5 x Phusion high fidelity 
buffer, 0.5 μl of 10 mM dNTPs, 1 μl of modified RP1 primer, 1 μl of barcoded RP index 
primer, 9.3 μl water and 0.2 μl of Phusion DNA polymerase. The PCR reactions were 
run at the following conditions: 98°C for 30 s, followed by 10-21 cycles of 98°C for 10 
s, 60°C for 30 s, 72°C for 15 s, followed by a final extension of 72°C for 10 min and 
4°C hold.  
After PCR amplification with the optimal number of reaction cycles the PCR products 
were loaded on 8% non-denaturing PAGE gels along with a 20 bp size marker. 
Products between 140-150 bp were purified as described before.  
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2.8.6 Generation of individual hY5 5’ end mutants  
 
In order to validate the sequencing results after bioinformatics analysis several hY5 
mutants were cloned individually. The PCR was set up as described in 2.8.3. The 
oligonucleotides used for the generation of individual hY5 5’ end mutants can be 
found in the appendix II, Table 0.11.  
The PCR products were tailed and separated on a 1% agarose gel. The PCR 
products were purified using the Zymoclean Gel DNA Recovery Kit according to the 
manufacturer’s instructions. The PCR products were ligated into pGEMT easy vector 
as described before. The ligation products were transformed into E. coli. The plasmid 
DNA was purified using the HiSpeed Midi Prep kit (Qiagen, 12643) and eluted in 500 
μl nuclease-free water. The concentration of the plasmid DNA was determined by 
nanodrop and sent for Sanger Sequencing (Eurofins MWG Operon, Ebersberg) to 
confirm the sequence and successful mutagenesis.  
2.9 Small RNA library construction using High Definition 
adapters  
 
The total RNA of wild type and Ro60 -/- mouse embryonic stem cells was extracted 
using the TriReagent method as previously described. Twenty μg of total RNA was 
used for purification using the mirVana kit according to the manufacturer’s 
instructions. 
For small RNA library construction 1 μg of purified total RNA was used. The 
adenylation of the 3’ HD adapter was performed the same way as previously 
described for the 3’ end Illumina adapter. 
The small RNA cDNA libraries using HD adapter had to be modified and were 
constructed after the same protocol as described for the YsRNA cDNA libraries. The 
only difference was that for the wild type and Ro60 -/- mouse embryonic stem cell 
sRNA cDNA libraries the commercial RP1 index primer and different barcoded RP 
index primers were used.  
The PCR products were separated by 8% non-denaturing PAGE gels along with a 20 
bp size marker. Due to the fact of low abundant sRNAs in mouse embryonic stem 
cells and previous sequencing results both the miRNA fraction (140-150 nt) and sRNA 
fraction derived from longer RNAs (160 nt) were excised and purified as previously 
described. 
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Chapter 3 Establishing sequence and structural 
requirements for 3’ end human Y5 RNA cleavage 
 
3.1 Introduction  
 
3.1.1 Cellular stress response 
 
Cellular stress response is a vital process that allows cells to adapt and respond 
immediately to various types of physiological and environmental stress conditions. 
Such adverse stressors include UV irradiation, DNA damage, temperature shock, 
nutrient starvation, oxidative stress, toxins, drugs, viral infection or endoplasmic 
reticulum stress (Holcik and Sonenberg, 2005; Kültz, 2005; Pakos‐Zebrucka et al., 
2016).  
In order to respond to these stress conditions immediately, protect cells from further 
damage and maintain homeostasis the cells had to evolve tightly regulated cellular 
stress response mechanisms. These stress response mechanisms involve the 
activation of molecular chaperones, DNA damage repair, autophagy, cell cycle 
control, or in severe cases cell death (Leung and Sharp, 2010). Importantly, the 
reprogramming of gene expression at transcriptional and translational level during 
stress allows the cells to respond rapidly to environmental changes in order to ensure 
cell survival and prevent damage (Spriggs et al., 2010; Vihervaara et al., 2018).  
In the last decade it became increasingly clear that regulatory non coding RNAs are 
involved in cellular stress response. For instance, miRNAs as key regulators of gene 
expression have been shown to mediate stress response in animals and plants 
(Leung and Sharp, 2007; Sunkar et al., 2007).  
Work in our laboratory has shown that miR-395 in Arabidopsis thaliana (A. thaliana) 
is upregulated under sulphate starvation and expressed in a tissue- and cell type-
specific manner (Kawashima et al., 2009). In order to investigate if there are novel 
stress-induced miRNAs in animals, various cell types were exposed to different stress 
conditions, such as heat shock, cold shock, glucose starvation and mimicking viral 
infection and compared to an untreated control sample. 
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3.1.2 Previous work and background of the project 
 
In previous work conducted in our laboratory the human breast cancer cell line MCF7 
was treated with the immunostimulant poly (I:C) in order to identify novel miRNAs 
involved in viral infection. Therefore, small RNA cDNA libraries for 19-24 nt sized 
small RNAs from poly (I:C) treated and untreated MCF7 cells have been constructed 
and sent for next generation sequencing. Surprisingly, the sequencing results showed 
that only three miRNAs (miR-1246, miR-1975 and miR-1979) were differently 
expressed. Further investigation revealed that miR-1975 was derived from the 3’ end 
of hY5 RNA, whereas miR-1979 was generated from the 3’ end of the hY3 RNA 
(Nicolas et al., 2012). Meiri et al. confirmed the same finding one year later and the 
miRNAs were removed from miRBase (Meiri et al., 2010). 
Previous experiments showed that during apoptosis human Y RNAs are cleaved in a 
caspase-dependent manner, generating Y RNA fragments with sizes ranging 
between 22-36 nt from the 3’ and 5’ end (Rutjes et al., 1999a).  
Northern blot analyses in our laboratory demonstrated that during stress human Y 
RNA fragments were upregulated in several cancerous and non-cancerous cell lines 
compared to the untreated conditions. Also it was noted that human YsRNAs were 
also generated under normal conditions at a detectable level. In order to investigate 
the biogenesis of YsRNAs it was shown in further experiments that YsRNA generation 
is Dicer independent and Y RNA fragments are not in a complex with Argonaute 2. 
Therefore, YsRNA generation seems to be independent of the canonical miRNA 
pathway (Nicolas et al., 2012). However, it is still obscure how these YsRNAs are 
produced at specific cleavage sites. 
The sequence and secondary structure of Y RNAs are evolutionarily conserved 
(Mosig et al., 2007; Perreault et al., 2007). One interesting and important question is 
whether any specific sequence motif or secondary structure or both are required for 
the specific Y RNA cleavages to occur. In order to answer this question, the human 
Y5 RNA was chosen for the experiments, because the expression of hY5 RNA can 
be studied in mouse cells which only express endogenous mY1 and mY3.  
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A previous PhD student cloned the full length hY5 RNA including a 2.9 kb RNA 
polymerase III promoter upstream and a 30 bp terminator region downstream of the 
hY5 RNA into pGEMT easy vector and started to introduce mutations close to the 
Ro60 binding site. In this previously conducted work it was shown by deletion and 
substitution mutagenesis analyses on the conserved stem-loop structure of hY5 
showed that Y RNA cleavage seemed to correlate with the secondary structure. It 
was demonstrated that the stem-loop structure and Ro60 binding site were required 
for the generation of YsRNAs (Turnbull, 2014).  
Due to the limit of targeted mutagenesis analysis, a high throughput mutagenesis 
approach was designed by Turnbull (Turnbull, 2014) in order to be able to examine 
thousands of hY5 mutants within this particular region at the same time.  
Three different regions (designated as library 1, 2 and 3) near the 3’ end cleavage 
site of the hY5 gene were selected for random mutagenesis (Figure 3.1 A and B). 
The three different plasmid mutant pools were transfected into 3T3 mouse cells and 
the cells were treated with staurosporine in order to induce apoptosis and YsRNA 
cleavage products. Small RNA libraries from the resulting YsRNAs were constructed 
and sequenced through NGS (Figure 3.1) (Turnbull, 2014).  
Preliminary bioinformatics analysis resulted in a list of fifty most expressed YsRNA 
cleavage products from three mutant pools. Interestingly, the NGS results indicated 
that the Y RNA cleavage site correlated to the secondary structure of the mutated 
hY5 RNAs. It was observed that the Y RNA cleavage of the mutated hY5 RNAs from 
library 2 and 3 showed wild type sized YsRNAs, while the Y RNA cleavage site was 
2 nt upshifted in some mutants of library 1 compared to the wild type cleavage site. 
Concluding the results from the preliminary NGS analysis, it was hypothesized that 
the position of cleavage site is influenced by the secondary structure of the mutant 
hY5 RNA sequences (Turnbull, 2014).  
However, in this previous work the sequencing results were not confirmed 
experimentally and the bioinformatics analysis had to be repeated because the data 
were not normalized correctly.  
As part of my thesis I continued the project at this point in order to validate and further 
investigate sequence and structural requirements for human Y5 RNA cleavage. 
Therefore, the work undertaken in this chapter is a continuation of the 3’ end hY5 
RNA high throughput mutagenesis experiments which were performed by Carly 
Turnbull (Turnbull, 2014).   
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Figure 3.1. Overview of the design and workflow of the 3’ end high throughput 
mutagenesis on the 3’ end of the hY5 RNA.  
A. Schematic of the pGEM-hY5-WT vector containing the mutated regions of hY5 RNA 
library 1, 2 and 3.  
The mutations for library 1 (red), library 2 (green) and library 3 (blue) were introduced by 
mutagenesis PCR using primers containing random nucleotides (N).  
B. Predicted secondary structure of human Y5 RNA including the regions that were 
selected for random mutagenesis at the 3’ end. 
In each of these regions of library 1 (red), library 2 (green) and library 3 (blue) five nucleotide 
substitution mutations were introduced resulting in 1024 (45) possible combination for each 
library.  
C. Workflow of the 3’ hY5 RNA mutagenesis approach.  
The three different plasmid mutant pools were transfected into 3T3 mouse cells and the cells 
were treated with staurosporine in order to induce apoptosis and YsRNA cleavage products. 
Small RNA libraries from the resulting YsRNAs were constructed and sequenced through 
NGS.  
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In this chapter, I mainly performed the validation of the next generation sequencing 
results from the 3’ hY5 mutagenesis analysis. From bioinformatics analysis which was 
performed by Simon Moxon I obtained a list containing the most abundant and least 
abundant hY5 RNA mutants of mutant pool library 1, 2 and 3. In this thesis, I did a 
further in-depth analysis of the resulting secondary structures of the thirty most and 
least abundant hY5 RNA mutants. From this analysis I generated and cloned the ten 
most and least abundant hY5 RNA mutants of each library into an expression vector 
and tested their expression levels and YsRNA production during stress by Northern 
blot analysis.  
In order to investigate further sequence and structural elements that are involved in 
hY5 RNA cleavage from the 3’ end of hY5 RNA I additionally performed mutagenesis 
on the internal loop L2a. My aim was to explore if the length or the nucleotide 
sequence of this loop has an influence on hY5 RNA cleavage from the 3’ end.  
As a result, I could validate and establish novel sequence and structural requirements 
for human Y5 RNA cleavage from the 3’ end.  
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3.2 Results 
 
3.2.1 Bioinformatics analysis of 3’ hY5 mutagenesis libraries 
 
All the cDNA libraries for the 3’ hY5 high throughput mutagenesis were generated in 
three replicates and sent for NGS (Turnbull, 2014). The libraries were sequenced on 
the Illumina HiSeq 2000 at BaseClear (Netherlands). The bioinformatics analysis was 
carried out by Dr. Simon Moxon.  
In this section I am giving an overview of all the analyzed datasets for the 3’ end hY5 
RNA mutagenesis study: 
The sRNA cDNA libraries of mutant hY5 RNAs were prepared in order to determine 
all YsRNAs that were derived from full length hY5 RNA sequences during apoptosis. 
Apart from the sRNA libraries, libraries from mutant plasmid pools and cDNA of full-
length hY5 RNA sequences were prepared for the normalization of the sRNA data 
set. The purpose of creating libraries from each plasmid pool was to check if all the 
hY5 RNA mutant sequences are present and to determine if some hY5 RNA mutant 
sequences were cloned more efficiently than others. The libraries from the full-length 
hY5 RNA sequences were created to see if all mutant hY5 RNA sequences were 
transcribed in the cells.  
The analyses of the plasmid libraries and the full-length hY5 libraries allowed us to 
determine if the random mutagenesis was successful. With the analysis of these data 
sets we checked if the mutagenesis was random and if there was a strong selection 
for a particular hY5 RNA mutant sequence or if there was a problem that not all mutant 
hY5 RNA sequences were successfully transfected.  
Further, with the bioinformatics analysis of the plasmid bias and full length hY5 RNA 
sequencing results it was possible for us to determine if there is any common feature 
among all the hY5 RNA mutants that were successfully transfected and transcribed. 
Therefore, the full-length hY5 RNA libraries and plasmid libraries were used to look 
at biases introduced by PCR, transfection and transcription.  
3.2.1.1 Analysis of plasmid libraries  
 
The plasmid libraries for the 3’ end high throughput mutagenesis approach were 
generated in order to check if the random mutagenesis was successful or a particular 
hY5 RNA mutant sequences was over- or underrepresented. The plasmid libraries 
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 3’ END HUMAN Y5 
RNA CLEAVAGE 
 
107 
 
were performed in three biological replicates. By introducing Illumina adapter 
sequences on the 3’ and 5’ end of hY5 RNA plasmid sequences the plasmid libraries 
could be sequenced using the Illumina NGS platform.  
For the analysis of the plasmid libraries the sequencing reads were mapped to all 
possible 1024 hY5 mutant full length hY5 RNA sequences using PatMaN (Prüfer et 
al., 2008) without allowing any mismatch and a custom Perl script was used to parse 
the mapping file and count the number of unique motifs obtained. The obtained 
sequencing reads are summarized in Table 3.1. 
The bioinformatics analysis of the plasmid libraries showed that when all the reads 
were mapped to all possible 1024 (45) full length hY5 RNA sequences that for each 
library replicate we got all expected 1024 hY5 RNA mutant sequences and the 
abundance of each sequence motif was more or less equally distributed. From the 
bioinformatics analysis we could see that there was no particular hY5 RNA mutant 
sequence that was overrepresented. The results from the bioinformatics analysis 
confirmed that the random mutagenesis approach that was performed on the 3’ end 
of hY5 RNA was successful. All 1024 different hY5 Y RNA mutant sequences were 
cloned successfully and there was no significant bias against any particular sequence 
motif.  
3.2.1.2 Full length cDNA libraries  
 
The full length cDNA libraries were prepared in order to investigate if all the hY5 RNA 
mutants were successfully transfected and transcribed or if some hY5 RNA mutant 
sequences were missing. The full length cDNA libraries were generated in three 
biological replicates. The Illumina adapter sequences were introduced by PCR. Using 
different Illumina barcode index sequences the full length cDNA libraries were 
sequenced on the Illumina HiSeq 2500 sequencing platform. After adapter removal 
the obtained sequencing reads of the full-length cDNA libraries were mapped to all 
possible 1024 hY5 mutant full length hY5 RNA sequences using PatMaN without 
allowing any mismatch and again analysed using a custom Perl script. The obtained 
sequencing reads are summarized in Table 3.2. 
   
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 3’ END HUMAN Y5 
RNA CLEAVAGE 
 
108 
 
Table 3.1. Overview of sequenced 3’ end hY5 plasmid bias libraries.  
The table summarizes the redundant read numbers for biological replicate of plasmid bias 
(PB) library 1, 2 and 3 and unique sequencing reads mapping to each possible full length hY5 
RNA mutant sequence. The first column shows the three biological replicates of each plasmid 
bias library 1, 2 and 3 that were generated and sent for NGS. The second column shows the 
number of total sequencing reads for each plasmid bias library replicate after mapping the 
sequencing reads to all possible 1024 hY5 mutant full length sequences.  
 
Total reads Unique hY5 RNA sequence motifs 
PB 1-1 592365 1024 
PB 1-2 572583 1024 
PB 1-3 480579 1024 
PB 2-1 482195 1024 
PB 2-2 425736 1024 
PB 2-3 488713 1024 
PB 3-1 304449 1024 
PB 3-2 336302 1024 
PB 3-3 698035 1024 
 
Table 3.2. Sequencing information of 3’ end hY5 full length cDNA libraries.  
The table shows the redundant read numbers for biological replicate of full length (FL) cDNA 
library 1, 2 and 3 and unique sequencing reads mapping to each possible full length hY5 RNA 
mutant sequence. The first column shows the three biological replicates of each full length 
library 1, 2 and 3 that were generated and sent for NGS. In the second column the number of 
total sequencing reads for each full length library replicate after mapping the total reads to all 
possible 1024 hY5 mutant full length sequences is listed.  In the full length cDNA library 3 
replicates not all 1024 unique mutant sequences were present and the number of mutant 
sequences missing is shown in blue. 
 
Total reads Sequence motifs 
FL 1-1 1414197 1024 
FL 1-2 1388192 1024 
FL 1-3 1780207 1024 
FL 2-1 1284671 1024 
FL 2-2 1023731 1024 
FL 2-3 748520 1024 
FL 3-1 1099655 984 (40 missing) 
FL 3-2 775323 906 (118 missing) 
FL 3-3 872712 978 (46 missing) 
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The bioinformatics analysis of the libraries for mutant pools 1 and 2 showed that all 
the hY5 RNA mutant sequences were transcribed successfully and that the generated 
transcripts were stable. 
Intriguingly, in the full-length cDNA libraries of mutant pool 3 hY5 RNAs many motifs 
were not represented across the three replicates. In replicate FL 3-1 40 sequence 
motifs were missing whereas in FL 3-2 and FL 3-3 118 and 46 sequence motifs were 
absent. It has to be noted, that the mutated region of mutant pool 3 was very close to 
the Ro60 binding site (Figure 3.2, A, shown in blue).  
We know from the literature that the bulged helix of the Ro60 binding site is highly 
conserved and Ro60 was shown to interact with the major groove of Y RNAs. In 
ribonuclease protection experiments on isolated RoRNPs from Hela cells it was 
demonstrated that the Ro60 protein binding site contains a single bulged cytidine 
within a helix (Wolin and Steitz, 1983). Further chemical probing experiments and 
mutagenesis analysis of hY1 RNA revealed that a bulged cytidine residue is important 
for Ro60 binding and interaction. Deletion of the cytosine bulge resulted in the 
inhibition of Ro60 binding. Interestingly, the mutation of the cytosine bulge to 
adenosine still allowed Ro60 binding but around five times less efficiently (Pruijn et 
al., 1991).  
A few years later Green et al. investigated the features of Y RNA sequence and 
structure that are necessary for protein recognition and they found that specific base 
pairs in the conserved bulged helix are critical for Ro60 protein recognition. Chemical 
probing and mutagenesis experiments of xY3 RNA in X. laevis demonstrated that a 
single bulged nucleotide and a bulge of 3 nt on the opposite strand of the helix are 
essential for Ro60 binding. Ro60 was shown to bind to the lower stem region of the 
conserved stem of Y RNAs and base pairing between C9 and G90 as well as a bulge 
at position 8 was essential for Ro60 recognition (Green et al., 1998).  
After the observation that some of the library 3 mutant motifs were absent, I performed 
sequence logo analysis of the missing motifs and compared it to the sequence logos 
of the fifty most abundant library 3 sequence motifs (Figure 3.2, B). For sequence 
logo analysis all the three replicates were combined and the programme WebLogo 
Version 2.8.2 (Crooks et al., 2004) was used for sequence logo generation.  
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From the sequence logo analysis I could observe that the fifth position of the pool 3 
mutated region shows an exclusive preference for guanosine (Figure 3.2, B). This 
suggested that a G-C base pair between the positions 8 and 68 is necessary in order 
to retain the cytidine bulge and ensure Ro60 binding as it was already reported in the 
literature.  
In position four of the sequence logo uridine seems to be preferred compared to 
guanosine, adenine and cytidine. An explanation for this G-U wobble base pair could 
be that this position requires some flexibility in order that a single nucleotide bulge in 
the major groove of the helix can be formed and Ro60 binding can occur.  
The secondary structure analysis of the missing sequences revealed that the mutant 
pool 3 sequence motifs that were missing in the libraries change the secondary 
structure of the mutant hY5 RNA sequence in a way that they lack a single cytidine 
bulge and the bulge increased to an internal loop (Figure 3.2, D). Importantly, in those 
mutants the G-C base pair at position 8 was absent. Therefore, the Ro60 binding site 
in all missing full length hY5 mutant sequence motifs was disrupted and the stability 
of the hY5 mutant RNA was clearly affected (Figure 3.2, D) in comparison to a highly 
abundant pool 3 mutant (Figure 3.2, C).  
  
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 3’ END HUMAN Y5 
RNA CLEAVAGE 
 
111 
 
A      B 
 
C      D 
 
Figure 3.2. Requirement of a single cytosine bulge and a G-C base pair between 
the positions 8 and 68 for Ro60 binding and hY5 RNA stability.  
A. Predicted secondary structure of human Y5 RNA.  
The mutated region of library 3 is shown in dark blue. The Ro60 binding site is indicated in 
light blue.  
B. Sequence logo analysis of most abundant and absent hY5 mutant pool 3 sequence 
motifs. 
The position 5 of abundant mutant pool 3 sequence motifs has a strong G preference.  
C. Predicted secondary structure of a highly abundant mutant pool 3 sequence motif.  
The mutated region is shown in blue. In this highly abundant pool 3 mutant the secondary 
structure is similar to the wild type hY5 RNA with an intact cytidine bulge and Ro60 binding 
site.  
D. Predicted secondary structure of a highly abundant mutant pool 3 sequence motif. 
The mutated region is shown in blue. The sequence motifs missing in the full length mutant 
pool 3 libraries result in a change of secondary structure. The cytidine bulge and G-C base 
pair are not present anymore which affects the Ro60 binding site and stability of missing 
mutant pool 3 full length hY5 RNAs.  
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3.2.1.3 Small RNA cDNA libraries 
  
During apoptosis full length Y RNAs get cleaved at the 3’ end and 5’ end of Y RNAs 
resulting in 3’ end and 5’ end derived YsRNAs. The YsRNA cDNA libraries were 
generated in order to investigate which 3’ end hY5 RNA derived Y RNA fragments 
are more abundant than others and to examine which hY5 RNA full length mutant 
sequences are cleaved more or less efficiently due to different sequence motifs. The 
YsRNA cDNA libraries were prepared in three biological replicates. On the 3’ end and 
5’ end of the YsRNAs two adapter sequences were ligated and multiplexing was 
performed using different Illumina barcode sequences. The libraries were sequenced 
on an Illumina Hiseq2500 platform.  
The first step in the bioinformatics analysis of the YsRNA cDNA libraries involved the 
removal of the adapter sequence from the 3’ end of the sequencing read. Next, the 
sequencing reads were mapped to the mouse reference genome. The reads mapping 
to the mouse genome were discarded because we were just interested in the reads 
mapping to the hY5 mutant sequences. In order to be able to map the obtained reads 
to the hY5 mutant sequences for each library a reference set containing all possible 
hY5 mutant sequences was generated using a Perl script. PatMaN was used to map 
the remaining reads of each library separately to the hY5 mutant sequences while no 
mismatch was allowed.  
For library 1 sRNA libraries we obtained between 2 and 3 million reads, for library 2 
libraries between 2.7 and 6 million, whereas for library 3 libraries we got between 1.1 
and 3.8 million total reads.  After adapter removal between 57% in and 75% of the 
reads mapped to the mouse genome (GRCm38/mm10, USCS genome browser). 
From the remaining reads between 2 % and 13% mapped to the hY5 mutant 
sequences, whereas  for library 3 sRNA library most of the sequencing reads mapped 
to hY5 RNA (shown in Appendix III, Table 0.13).  
From the size class distribution of the YsRNA libraries (Figure 3.3, A) I could see that 
the size of YsRNAs derived from hY5 library mutant pool 2 and 3 (shown in green 
and blue) is mainly 32-33 nt whereas hY5 mutant pool 1 Y RNAs (shown in red) 
generate longer YsRNAs with a length of 34-35 nt. The start position of the 
sequencing reads of hY5 mutant pool 2 and 3 indicates that the cleavage occurs 
between T49 and C50 or C50 and C51. This finding is consistent with previous 
sequencing results obtained from MCF7 cells treated with poly (I:C) in which most of 
the 3’ end derived hY5 RNA cleavage products were 32 nt.  
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3.2.2 Some library 1 hY5 RNA mutants generate longer YsRNAs 
compared to hY5 mutant pool 2 and 3  
 
For all YsRNA reads from each library replicate a size class distribution was 
generated. Interestingly, the size class distribution of all YsRNA sequencing reads 
revealed that some library 1 mutant YsRNA reads were 1-2 nt longer compared to 
hY5 mutant pool 2 and 3 YsRNA reads (Figure 3.3 A, shown in red). Mutant pool 1 
YsRNA reads were mainly 34/35 nt whereas mutant pool 2 and 3 YsRNAs were 
mainly between 32/33 nts.  
In order to investigate and validate these sequencing results the YsRNA reads were 
ranked by abundance. Then I looked at the respective predicted hY5 mutant RNA 
secondary structures if the introduced mutations affected RNA folding. I performed 
the RNA secondary structure analysis with RNAfold (Gruber et al., 2008) and for 
comparison I analyzed the 30 most abundant and 30 least abundant YsRNAs derived 
from each hY5 RNA mutant library pool.   
From the RNA secondary structure analysis (Figure 3.3, F and G) I could show that 
the overall structure of the library 1 hY5 RNA mutants with the most abundant 
YsRNAs is similar to the wild type hY5 RNA (Figure 3.3, D, E).  
However, the mutations introduced in the library 1 mutants that produced longer 
fragments changed the secondary structure in a way that the internal loop gets shorter 
and the Y RNA cleavage occurs 2-3 nt more upstream compared to the wild type hY5 
RNA, but still two nucleotides above the conserved stem (Figure 3.3, F). Intriguingly, 
all the most abundant hY5 library 1 mutants have a stem S2 region (Figure 3.3, D) 
that consists at least of five Watson-Crick base pairs.  
Interestingly, for the library 1 hY5 RNA mutant sequences with the least abundant 
YsRNAs it was shown from bioinformatics analysis that these mutants did not 
generate any YsRNAs (Figure 3.3, B). The secondary structure analysis of these 
mutants (Figure 3.3, G) revealed that their secondary structures folded in a different 
way than the wild type hY5 RNA.  
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F 
 
G 
 
L1 1 ACGUC L1 2 ACCGC L1 3 CACAC L1 4 AUGGC L1 5 ACUGC 
L1 6 GUCGC L1 7 UCAAA L1 8 UUGAA L1 9 UCGCG L1 10 UCAAG
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Figure 3.3. Some library 1 hY5 RNA mutants generate longer YsRNAs compared to 
mutant pool 2 and 3.  
A. Size class distribution of YsRNAs from each hY5 library mutant pool replicate.  
The graph shows the percentage of total reads for each sRNA cDNA library replicate of mutant 
pool 1, 2 and 3 at each size ranging from 25-34 nts. Mutant pool 2 and 3 YsRNAs (shown in 
green and blue) are mainly 32/33 nt. Mutant pool 1 YsRNA reads (shown in red) are longer 
with a length of 34/35 nt compared to mutant pool 2 and 3. 
B. Abundance of library 1 hY5 RNA mutant sequences with the five most abundant 
YsRNAs. 
The table shows the abundance of the L1 hY5 RNA mutant sequences with the five most 
abundant YsRNAs after bioinformatics analysis. All the L1 YsRNA library reads of each 
replicate were normalized and ranked by abundance. The first column shows the five 
nucleotide sequence motif of the L1 hY5 RNA mutant sequences that gave the most abundant 
YsRNA reads. In the second column the normalized abundance of each hY5 L1 sequence 
motif is shown. 
C. Abundance of library 1 hY5 mutant sequences with the five least abundant YsRNAs 
The table shows the abundance of the L1 hY5 RNA sequence motifs with the five least 
abundant YsRNAs after bioinformatics analysis. All the L1 YsRNA library reads of each 
replicate were normalized and ranked by abundance. The first column shows the five 
nucleotide sequence motif of the L1 hY5 RNA mutant sequences that resulted in the least 
abundant YsRNA reads. In the second column the normalized abundance of each hY5 L1 
sequence motif is shown. 
D. Predicted secondary structure of the wild type hY5 RNA.  
The mutated region of L1 is shown in red. The hY5 RNA cleavage site is indicated with a red 
arrow.  
E. Predicted secondary structure features of hY5 wild type RNA.  
The features and structural elements of the predicted hY5 RNA secondary structure were 
adapted and modified after van Gelder et al., 1994 and Green et al., 1996. The examined 
secondary structure features were the stem S3, the internal loop L2a and the stem S2.  
F. Predicted secondary structures of the library 1 hY5 RNA mutants with the five most 
abundant YsRNAs. 
The mutation site of L1 hY5 mutants is shown in red. The hY5 L1 mutants that resulted in the 
five most abundant YsRNAs altered the secondary structure in a way that the cleavage site 
was 2 nt upshifted compared to the wild type hY5 RNA. Further, the cleavage occurred in both 
the wild type and mutant hY5 RNAs in the loop 2-3 nt away from the stem. The red arrows 
show the Y RNA cleavage site.  
G. Predicted secondary structures of the library 1 hY5 RNA mutants with the five least 
abundant L1 hY5 RNA mutants.  
The mutation site of library 1 hY5 mutants is shown in red. The library 1 hY5 RNA mutants 
with the five least abundant YsRNAs generated 1 altered the secondary structure of the hY5 
RNA in a way that much less or no Y RNAs were cleaved.  
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I analyzed the secondary structures of the library 1 hY5 RNA mutant sequences with 
the most abundant and least abundant YsRNAs in more detail (Figure 3.4).  
When the secondary structures of the five most abundant and five least abundant 
library 1 hY5 mutants were analysed in more detail (see Figure 3.4, B and C)  it was 
noted that in the library 1 hY5 mutants that generated the most abundant YsRNAs 
the stem S2 mainly consisted of 6 nt and had a high G-C content (Figure 3.4, B). 
However, the low abundant hY5 mutants folded in a way that the stem S2 was mostly 
only 3 nt or as seen in L1-10 longer but less G-C content and more A-U and G-U 
wobble base pairs (Figure 3.4, C).  
This analysis suggested that the secondary structure features correlate with hY5 RNA 
cleavage. From the secondary structure analysis of the library 1 hY5 RNA mutants 
with the most abundant and least abundant YsRNAs it seemed that the internal loop 
and the stem S2 consisting of 5-6 nt and high G-C content might contribute to Y RNA 
cleavage from the 3’ end. The internal loop of the most abundant hY5 library 1 
mutants was mainly between 7-9 nt long and was pyrimidine rich, whereas the hY5 
library 1 mutant that produced low amount of YsRNAs only had an internal loop of 3 
nt. Notably, in the hY5 library 1 mutants that produced the most abundant hY5 
YsRNAs the introduced mutations resulted in the change of the secondary structure 
in a way that the internal loop L2a got shortened by 1-2 nt compared to the wild type 
hY5 RNA. The stem S2 has less G-C base pairs and more A-U and G-U wobble base 
pairs which indicated that this region might be less stable and more flexible (Figure 
3.4, B). These structural elements might be recognized by proteins/ribonuclease (s) 
that are involved in Y RNA cleavage from the 3’ end of hY5 RNA.  
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A 
 
 
 
 
B   
 
RNA motif 
 
Stem S3 Size of internal loop L2a Stem S2 
WT CCACA 7 nt 
1x G-C 
5x A-U 
1x G-C 
9 nt 
4x U 
2x G 
3x C 
 
 
6 nt 
4x G-C 
2x A-U 
L1-1 ACGUG 7 nt 
1x G-C 
5x A-U 
1x G-U 
7 nt 
4x U 
1x G 
2x C 
6 nt 
4x G-C 
1x A-U 
1x U-G 
L1-2 ACCGC 7 nt 
1x G-C 
5x A-U 
1x G-U 
7 nt 
4x U 
1x G 
2x C 
12 nt 
8x G-C 
2x A-U 
2x G-U 
L1-3 CACAC 7nt 
1x G-C 
5x A-U 
1x G-U 
8 nt 
4x U 
1x G 
3x C 
6 nt 
4x G-C 
2x A-U 
L1-4 AUGGC 7 nt 
1x G-C 
5x A-U 
1x G-U 
7 nt 
4x U 
2x G 
1x C 
12 nt 
7x G-C 
2x A-U 
3x G-U 
 
 
L1-5 ACGGC 
 
7 nt 
1x G-C 
5x A-U 
1x GU 
 
7 nt 
4x U 
2x G 
1x C 
 
12 nt 
8x G-C 
2x A-U 
1x G-U 
1x U-bulge 
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C 
 
Figure 3.4. Secondary structure features of library 1 hY5 RNA mutants correlate 
with hY5 RNA cleavage.  
A. Predicted secondary structure of wild type hY5 RNA.  
The feature and structural elements of the predicted hY5 RNA secondary. The human Y5 RNA 
has a characteristic stem loop structure. The examined secondary structure features were the 
stem S3 (shown in orange), the internal loop L2a (shown in blue) and the stem S2 (shown in 
green). The 3’ end hY5 RNA cleavage site is indicated with a red arrow. 
B. Secondary structure features of library 1 hY5 RNA mutants with the most abundant 
YsRNAs.  
The table gives an overview of the nucleotide and base pair composition of stem S3 (orange), 
internal loop L2a (blue) and stem S3 (green) for the library 1 hY5 RNA mutants with the five 
most abundant YsRNA reads. 
C. Secondary structure features of library 1 hY5 RNA mutants with the least abundant 
YsRNAs. 
The table gives an overview of the nucleotide and base pair composition of stem S3 (orange), 
internal loop L2a (blue) and stem S3 (green) for the library 1 hY5 RNA mutant sequences with 
the five least abundant YsRNA reads.   
RNA motif Stem S3 Size of internal loop L2a Stem S2 
    
L1-6 GUCGC 10 nt 
1x G-C 
2x G-U 
7x A-U 
3 nt 
2x U 
1x C 
3 nt 
3x G-C 
L1-7 UCAAA 10 nt 
1x G-C 
2x G-U 
7x A-U 
3 nt 
2x U 
1x C 
3 nt 
3x G-C 
L1-8 UUGAA 10 nt 
1x G-C 
2x G-U 
7x A-U 
3 nt 
2x U 
1x C 
3 nt 
3x G-C 
L1-9 UCGCG 
 
10 nt 
1x G-C 
2x G-U 
7x A-U 
3 nt 
2x U 
1x C 
3 nt 
3x G-C 
L1-10 UCAAG 7 nt 
1x G-C 
1x G-U 
4x A-U 
8 nt 
4x U 
1x G 
1x C 
6 nt 
2x G-C 
1x A-U 
1x A-G 
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Interestingly, the sequencing data showed that the hY5 wild type motif (CCACA) was 
not the most abundant sequence motif among the longer 34-35 nt YsRNA reads, but 
was one of the most abundant sequence motifs among the shorter 32 nt YsRNA 
reads. This also indicated that the secondary structure seems to be involved in 3’ end 
hY5 RNA cleavage.  
Therefore, the results from the bioinformatics and secondary structure analysis 
further strengthened the hypothesis that the hY5 RNA cleavage at the 3’ end 
correlates with the secondary structure, rather than the sequence.  
After bioinformatics analysis the resulting YsRNA reads were normalized for all library 
replicates and sorted by their abundance. Therefore, I got a list of the most abundant 
and least abundant hY5 RNA sequence motifs that resulted in the most and least 
abundant mutant YsRNAs for hY5 RNA library 1. From this list, I selected the five 
most abundant and five least abundant mutant motifs of each library and cloned them 
as individual hY5 RNA mutants including the polymerase III promotor and terminator 
sequence into pGEMT easy vector. I transfected each individual mutant plasmid DNA 
and expressed the constructs in 3T3 mouse fibroblast cells. After 24 h I treated the 
cells with staurosporine in order to induce apoptosis and generate YsRNAs. After 8 h 
of treatment I extracted RNA and performed Northern blot analyses.  
The aim of the Northern blot experiments was to compare and analyse the 
accumulation level of the individual YsRNAs derived from the mutant hY5 RNA 
sequences to the accumulation of YsRNAs derived from the wild type hY5 RNA 
(Figure 3.5). Intriguingly, the Northern blot analyses of the library 1 hY5 RNA that 
resulted in the five most abundant library 1 mutant YsRNAs (Figure 3.5, A) confirmed 
that the generated YsRNAs were longer compared to the wild type derived YsRNAs.  
When the 3’ end derived YsRNAs were quantified from the Northern blots by 
measuring the optical density and normalized to the loading control U6 and the wild 
type derived YsRNAs, I could observe that the wild type hY5 RNA generated the 
highest amount of YsRNAs compared to the other library 1 hY5 RNA mutant 
sequences that showed the most abundant YsRNAs in the bioinformatics analysis. 
However, the other L1 hY5 RNA mutants also produced a good amount of YsRNAs. 
From the relative quantification it can be concluded that all the library 1 hY5 mutant 
sequences with the most abundant YsRNAs were cleaved efficiently and resulted in 
a high amount of YsRNAs (Figure 3.3, B).  
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Interestingly, when I compared the ratios of YsRNAs were compared to the full length 
hY5 mutant RNA levels the library 1 hY5 RNA mutant L1-1 had a better ratio 
YsRNA:full length ratio than the wild type hY5 RNA. This would mean, that this library 
1 hY5 RNA mutant might be processed more efficiently than the wild type hY5 RNA 
(Figure 3.3,C).  
The library 1 hY5 RNA with the five least abundant YsRNA reads also showed in the 
relative quantification and ratio of full length hY5 mutant RNA sequence level to the 
YsRNA levels that these library 1 hY5 RNA mutants are cleaved at a much lower 
extent or not at all and cannot be efficiently processed to YsRNAs like the wild type 
hY5 RNA (Figure 3.3, E and F). These results further confirmed the sequencing 
results and bioinformatics analysis.  
Secondary structure prediction (Figure 3.3, F and G) and Northern blot analysis of 
the library hY5 RNA mutants with the five most abundant and least abundant YsRNAs 
clearly showed that the hY5 RNA cleavage mainly occurs between the second and 
third nucleotide above the conserved stem. Therefore, these results confirm the 
results of the next generation sequencing and proved that the hY5 RNA cleavage 
from the 3’ end correlates with the secondary structure.  
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Figure 3.5. Most abundant library 1 hY5 RNA mutants generate longer YsRNAs. 
A. Northern blot analysis of library 1 mutants with the five most abundant YsRNAs. 
Total RNA extracted from human MCF7 cells treated with poly (I:C) and a synthetic 3’ end 
derived hY5 RNA fragment with a length of 31 nt were used as size markers. The library 1 
hY5 RNA mutants with the five most abundant YsRNAs were transfected into mouse cells and 
treated with staurosporine. The total RNA was extracted and Northern blot was performed. 
The Northern blot was probed with the 3’ and 5’ YsRNA probe. The blot was re-probed with 
U6 to demonstrate equal loading. The YsRNAs generated from the 3’ end of the mutant hY5 
RNAs were longer than the ones generated from wild type YsRNAs whereas the 5’ end derived 
YsRNAs wild type had identical sizes for mutants and wild type.  
B. Relative quantification of the most abundant 3’ end derived mutant pool 1 YsRNAs.  
The Northern blot of the most abundant mutant pool 1 YsRNAs was quantified using the 
ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1.  
C. Calculated ratio between the expression level of full length hY5 mutant pool 1 hY5 
RNAs compared to the expression level of most abundant mutant pool 1 YsRNAs. 
The ratio of the normalized optical density of full length L1 hY5 RNA mutants and the derived 
YsRNAs was calculated and plotted on the graph.  
D. Northern blot analysis of library 1 mutants with the five least abundant YsRNAs. 
As a size marker for full length Y RNA and wild type sized Y RNA fragments, RNA extracted 
from human MCF7 cells treated with poly (I:C) and a synthetic 3’ end derived hY5 RNA 
fragment with a length of 31 nt were used. The Northern blot was probed with the 3’ end and 
5’ end YsRNA probe. The YsRNAs generated from the 3’ end of the five least abundant library 
1 mutants could not be detected by Northern blot. When the Northern blot was probed with 
the 5’ end YsRNA probe a small amount of YsRNAs was observed. The blot was re-probed 
with U6 for equal loading.  
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E. Relative quantification of least abundant 3’ end derived mutant pool 1 YsRNAs.  
The Northern blot of the least abundant 3’ end derived mutant pool 1 YsRNAs was quantified 
using the ImageQuant software. The optical density of each mutant was normalized to the 
loading control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical 
density of the wild type derived YsRNAs was set at 1.  
F. Calculated ratio between the expression level of full length hY5 mutant pool 1 hY5 
RNAs compared to the expression level of least abundant mutant pool 1 YsRNAs.  
The ratio of the normalized optical density of full length L1 hY5 RNA mutants and the derived 
YsRNAs was calculated and plotted on the graph.  
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Interestingly, I could show by further secondary structure analysis of library 1 mutants 
that three other library 1 mutants had the same secondary structure than the wild type 
(Figure 3.6). When I looked at the sequencing reads derived from these library 1 
mutants I could observe that they mainly produce YsRNAs of 32 nt like the wild type 
sequence (shown in red in Figure 3.6, A).  
Among them, the hY5 library 1 mutants L1-CUACA and L1-UCACA showed wild type-
sized YsRNAs after bioinformatics analysis and secondary structure folding (Figure 
3.6, B and C). I cloned these mutants individually into pGEMT easy vector, 
transfected into mouse cells and treated with staurosporine to induce apoptosis and 
YsRNAs. After RNA extraction I performed Northern blot analysis and compared them 
to the two most abundant library 1 hY5 mutants L1-ACGUC and L1-ACCGC that 
generated longer YsRNAs. Remarkably, the Northern blot analysis clearly showed 
that the hY5 library 1 mutants L1-CUACA and L1-UCACA that folded the same way 
than wild type (Figure 3.6, B) generated wild type sized YsRNAs (Figure 3.6, D).  
On the other hand the hY5 library 1 mutants L1-1 ACGUC and L1-2 ACCGC produced 
1-2 nt longer YsRNAs (Figure 3.3, F, Figure 3.6, C) as previously shown as the 
mutations introduced in these hY5 RNA mutants changed the secondary structure in 
a way that the cleavage occurs more upstream (Figure 3.6, D). 
Interestingly, the library 1 hY5 RNA mutants L1-CUACA and L1-UCACA that had the 
same secondary structure than the wild type hY5 RNA showed a similar amount of 
YsRNAs in the relative quantification by optical densitometry. Intriguingly, the library 
1 mutant L1-CUACA is processed to YsRNAs as efficient as the wild type hY5 RNA 
when the ratio of full length hY5 mutant RNA levels were compared to the YsRNA 
levels (Figure 3.6, E and F).  
Surprisingly, in the L1 hY5 RNA mutant L1-ACCGC that generates longer YsRNAs 
than the wild type hY5 RNA the amount of YsRNAs generated is at the same level 
compared to the wild type hY5 RNA and is almost as efficiently processed to YsRNAs 
(Figure 3.6, E and F).  
In conclusion, the random mutagenesis analysis suggests that the secondary 
structure might be more important than the nucleotide sequence to determine where 
the Y RNA cleavage occurs. Moreover, the Northern blot experiments confirmed that 
some of the mutations in library 1 alter the secondary structure in a way that the 
internal loop gets shorter and the Y RNA cleavage happens further upstream but still 
two nucleotides above the stem. 
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Figure 3.6. Library 1 hY5 mutants with exactly the same secondary structure as 
wild type produce wild type sized YsRNAs compared to the most abundant hY5 
library 1 mutants that produce longer YsRNAs. 
A. Abundances of wild type hY5 derived YsRNA reads and two hY5 library 1 mutants 
with the same secondary structure as wild type hY5 RNA and 32 nt YsRNA reads and 
two most abundant hY5 library 1 mutants that generate the most 34 nt YsRNA reads.  
The table shows the normalized abundances of wild type hY5 RNA and the YsRNA reads of 
the mutants L1-CUACA, L1-UCACA, L1-ACGUC and L1-ACCGC normalized across three 
replicates with sizes of 32 and 34 nts.  
B. Predicted secondary structures of wild type hY5 RNA and two hY5 library 1 mutants 
with the same secondary structure as the wild type hY5 RNA. 
The mutants L1-CUACA and L1-UCACA  have exactly the same secondary structure than the 
wild type hY5 RNA. The mutated region is indicated in red. The red arrows show the Y RNA 
cleavage site resulting in YsRNAs with 32 nts. The arrow in green indicates the Y RNA 
cleavage site that leads to YsRNAs with a size of 34 nts. 
C. Predicted secondary structures of wild type hY5 RNA and two hY5 library 1 mutants 
that generated longer YsRNAs.  
In the hY5 library 1 mutants  L1-ACGUC and L1-ACCGC the secondary structure is changed 
in a way that the Y RNA cleavage occurs more upstream. The mutated region is indicated in 
red. The red arrows show the Y RNA cleavage site resulting in YsRNAs with 32 nts. The arrow 
in green indicates the Y RNA cleavage site that leads to YsRNAs with a size of 34 nts.  
D. Library 1 hY5 RNA mutants with exactly the same secondary structure as wild type 
produce wild type sized YsRNAs compared to the most abundant hY5 library 1 mutants 
that produce longer YsRNAs.  
For Northern blot analysis total RNA extracted from human MCF7 cells treated with poly (I:C) 
was used as a size marker. Two library 1 mutants that folded the same way than the wild type 
hY5 RNA and the two most abundant library 1 mutants that generated longer YsRNAs were 
transfected into mouse cells and treated with staurosporine. The total RNA was extracted and 
Northern blot was performed. The Northern blot was probed with the 3’ and 5’ YsRNA probe. 
The blot was re-probed with U6 to demonstrate equal loading. The YsRNAs generated from 
the 3’ end of the two most abundant mutant hY5 RNAs (L1-ACGUC, L1-ACCGC) were longer 
than the ones generated from wild type YsRNAs and the two tested hY5 library 1 mutants (L1-
CUACA, L1-UCACA) with the same secondary structure than the wild type. The 5’ end derived 
YsRNAs had identical sizes for mutants and wild type.  
E. Relative quantification of  3’ end derived mutant pool 1 YsRNAs.  
The Northern blot of 3’ end derived mutant pool 1 YsRNAs was quantified using the 
ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1.  
F. Calculated ratio between the expression level of full length hY5 mutant pool 1 hY5 
RNAs compared to the expression level of most abundant mutant pool 1 YsRNAs. 
The ratio of the normalized optical density of full length L1 hY5 RNA mutants and the derived 
YsRNAs was calculated and plotted on the graph.  
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3.2.3 Library 2 hY5 RNA mutants generate YsRNAs at the same size as 
wild type 
 
After bioinformatics analysis the YsRNAs derived from library 2 were ranked by 
abundance (Figure 3.7, A). The library 2 hY5 RNA mutants with the top five most 
abundant and five least abundant YsRNAs from each mutant pool were chosen for 
experimental validation and cloned individually into the expression vector. I confirmed 
the sequences of the constructs by Sanger sequencing. I transfected the individual 
hY5 mutants into 3T3 cells and I tested the accumulation level of YsRNAs after 
staurosporine treatment by Northern blot (Figure 3.7, E).  
I predicted the secondary structures of 30 library 2 hY5 RNA mutants with the most 
abundant and least abundant YsRNAs using RNAfold. For library 2 mutants it can be 
seen that that all the secondary structures look similar (Figure 3.7, C and D) to the 
wild type hY5 RNA (Figure 3.7, B) and that the cleavage occurred at the wild type 
hY5 RNA cleavage site (Figure 3.7, E). 
The library 2 hY5 RNA mutants that resulted in the top five most abundant and five 
least abundant YsRNAs (Figure 3.7, A) were transfected into mouse cells and 
experimental validation was performed by testing the expression level and hY5 RNA 
cleavage pattern by Northern blot (Figure 3.7, E and G).  
The Northern blot analysis of the library 2 hY5 RNA mutants that generate the five 
most abundant YsRNAs (Figure 3.7, E) confirmed that the hY5 RNA cleavage mainly 
occurred between positions C50 and C51 as seen for the wild type hY5 RNA. The 
Northern blots and relative quantification also showed that the YsRNAs derived from 
the 3’ end of the five least abundant mutants were generated at a lower amount as 
seen  in the next generation sequencing (Figure 3.7, G and H). The relative 
quantification of the most abundant library 2 hY5 RNA mutant derived YsRNAs to wild 
type derived YsRNAs by densitometry showed that the YsRNA levels of the most 
abundant library 2 hY5 RNA mutant sequences were similar to the amount of wild 
type hY5 derived YsRNAs (Figure 3.7, F). Thus, the region that was mutated in library 
2 hY5 RNA mutants might be more flexible and not be crucial for efficient Y RNA 
processing.  
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 ive most abundant motifs   ive least abundant motifs 
   
 utant Abundance   utant Abundance 
L2 1 CCGUU 4027  L2 6 GUCCG 156 
L2 2 AGGUG 2865  L2 7 UCAAA 11 
L2 3 CCGUC 2236  L2 8 UUGAA 2 
L2 4 CUGUC 1908  L2 9 UCGCG 1 
L2 5 CUGUG 1902  L2 10 UCAAG 1 
 
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 3’ END HUMAN Y5 RNA CLEAVAGE 
 
132 
 
C 
D 
 
L2 6 GUCCG L2 7 UCAAA L2 8 UUGAA L2 9 UCGCG L2 10 UCAAG 
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 3’ END HUMAN Y5 
RNA CLEAVAGE 
 
133 
 
E 
 
F 
 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
hY5 L2-1 L2-2 L2-3 L2-4 L2-5
re
la
ti
v
e
 q
u
a
n
ti
fi
c
a
ti
o
n
 o
f 
3
' 
e
n
d
 d
e
ri
v
e
d
 Y
s
R
N
A
s
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 3’ END HUMAN Y5 
RNA CLEAVAGE 
 
134 
 
 
G 
 
H 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
hY5 L2-6 L2-7 L2-8 L2-9 L2-10
re
la
ti
v
e
 q
u
a
n
ti
fi
c
a
ti
o
n
 o
f 
3
' 
e
n
d
 d
e
ri
v
e
d
 Y
s
R
N
A
s
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 3’ END HUMAN Y5 
RNA CLEAVAGE 
 
135 
 
Figure 3.7. Library 2 hY5 RNA mutants produce YsRNAs at the same size as 
wild type.  
A. Abundances of library 2 hY5 RNA mutants with the five most abundant and five least 
abundant YsRNA reads. 
The table shows the abundance of L2 hY5 RNA mutant sequences with the five most abundant 
and five least abundant YsRNAs after bioinformatics analysis. All L2 YsRNA library reads of 
each replicate were normalized and ranked by abundance. The first column shows the five 
nucleotide sequence motif of L2 hY5 RNA mutant sequences that gave the most 
abundant/least abundant YsRNA reads. In the second column the normalized abundance of 
each L2 hY5 RNA sequence motif is shown. 
B. Predicted secondary structure of the wild type hY5 RNA.  
The secondary structure was predicted  using RNAfold and visualized using Varna. The region 
mutated in L2 mutants is highlighted in green.  
C. Predicted secondary structures of library 2 hY5 RNA mutants with the five most 
abundant YsRNAs.  
The secondary structures were predicted using RNAfold. The library 2 hY5 RNA mutants with 
the five most abundant YsRNAs fold similar to the wild type hY5 RNA. The red arrows show 
the Y RNA cleavage site.  
D. Predicted secondary structures of library 2 hY5 RNA mutants with the five least 
abundant YsRNAs.  
Predicted secondary structures of library 2 hY5 RNA mutants with the five least abundant 
YsRNAs RNAfold. The secondary structures of library 2 hY5 RNA mutants with the five least 
abundant YsRNAs are similar to the wild type hY5 RNA structure.  
E. Northern blot analysis of library 2 hY5 RNA mutants with the five most abundant 
YsRNAs.  
Total RNA extracted from human MCF7 cells treated with poly (I:C) and a synthetic 3’ end 
derived hY5 fragment of 31 nt were used as size markers for full length hY5 RNA and wild 
type-sized YsRNAs. The total RNAs extracted from the five most abundant library 2 hY5 
mutants that were transfected into mouse cells and treated with staurosporine were analysed 
by Northern blotting. The Northern blot was probed with the 3’ and 5’ YsRNA probe. The blot 
was re-probed with U6 as a loading control. The YsRNAs produced from the five most 
abundant hY5 library 2 mutants were at the same size as wild type hY5 YsRNAs both from 
the 3’ end and the 5’ end of the hY5 RNA. 
F. Relative quantification of the most abundant 3’ end derived mutant pool 2 YsRNAs.  
The Northern blot of the most abundant mutant pool 2 YsRNAs was quantified using the 
ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1.  
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G. Northern blot analysis of library 2 hY5 RNA mutants with the five least abundant 
YsRNAs.  
As a size marker for full length Y RNA and wild type sized Y RNA fragments RNA from human 
MCF7 cells treated with poly (I:C) and a synthetic 3’ end derived hY5 RNA fragment with a 
length of 31 nt were used. After transfection of the least abundant hY5 library 2 mutant 
plasmids into mouse cells and treatment with staurosporine the RNA was subjected to 
Northern blot analysis. The Northern blot was probed with the 3’ and 5’ YsRNA probe. For 
equal loading the Northern blot was re-probed with U6. The five least abundant hY5 library 2 
mutants generated wild type-sized YsRNA but at a lower level than wild type hY5 RNA.  
H. Relative quantification of the least abundant 3’ end derived mutant pool 2 YsRNAs.  
The Northern blot of the least abundant mutant pool 2 YsRNAs was quantified using the 
ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1.  
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3.2.4 Library 3 hY5 RNA mutants generate YsRNAs at the same size as 
wild type hY5 RNA 
 
After bioinformatics analysis and secondary structure prediction of library 3 hY5 RNA 
mutants with the 30 most abundant and least abundant library 3 hY5 RNA YsRNAs I 
could observe that the secondary structures of library 3 mutants folded in a similar 
way as the wild type hY5 RNA (Figure 3.8, C and D).  
The library 3 hY5 RNA mutants with the five most abundant and five least abundant 
YsRNA reads (Figure 3.8, A) were cloned individually as previously described, 
transfected into mouse cells and experimental validation was performed by testing 
the expression level and hY5 RNA cleavage pattern by Northern blot (Figure 3.8, E 
and G).  
The Northern blot analysis and relative quantification of the five most abundant 
(Figure 3.8, E and F) and five least abundant hY5 library 3 mutants (Figure 3.8, G 
and H) demonstrated that the hY5 RNA cleavage mainly occurred at the position C50 
and C51 and therefore mutant pool 3 hY5 RNAs generate wild type-sized YsRNAs.  
The relative quantification of the Northern blots with the most abundant and least 
abundant 3’ end derived mutant pool 3 YsRNAs compared to the wild type hY5 RNA 
derived YsRNAs showed that the levels of YsRNAs generated by the library 3 hY5 
RNA mutants were similar to the wild type hY5 RNA (Figure 3.8, F and H). This 
indicated that the mutations introduced in this region might not be that important for 
YsRNA generation and is more flexible compared to the mutated region of hY5 library 
1. However, when the Ro60 binding site is mutated no Y RNA can occur because the 
hY5 mutant sequences are not stable anymore and undergo degradation (Figure 
3.2).  
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Figure 3.8.  Library 3 hY5 RNA mutants generate YsRNAs at the same size as wild type 
hY5 RNA.  
A. Abundances of library 3 hY5 RNA mutants with the five most abundant and five least 
abundant YsRNA reads. 
The table shows the abundance of library 3 hY5 RNA mutant sequences with the five most 
abundant and five least abundant YsRNAs after bioinformatics analysis. All L3 YsRNA library 
reads of each replicate were normalized and ranked by abundance. The first column shows 
the five nucleotide sequence motif of L3 hY5 RNA mutant sequences that gave the most 
abundant/least abundant YsRNA reads. In the second column the normalized abundance of 
each L2 hY5 RNA sequence motif is shown. 
B. Predicted secondary structure of the wild type hY5 RNA.  
The secondary structure was predicted  using RNAfold and visualized using Varna. The region 
mutated in L3 hY5 RNA mutants is highlighted in dark blue.  
C. Predicted secondary structures of library 3 hY5 RNA mutants with the five most 
abundant YsRNAs.  
The secondary structures were predicted using RNAfold. The secondary structures of L3 hY5 
RNA mutants with the most abundant YsRNAs fold similar to the wild type hY5 RNA. The red 
arrows show the Y RNA cleavage site. The Y RNA cleavage occurred between C50 and 
C51.The red arrows show the Y RNA cleavage site. 
D. Predicted secondary structures of library 2 hY5 RNA mutants with the five least 
abundant YsRNAs.  
Predicted secondary structures of L3 hY5 RNA mutants with the five least abundant YsRNAs 
using RNAfold. The secondary structures of the L3 hY5 RNA mutant sequences that have the 
least abundant YsRNA reads fold in a similar way than the wild type hY5 RNA sequence.  
E. Northern blot analysis of library 3 hY5 RNA mutants with the five most abundant 
YsRNAs.  
Total RNA extracted from human MCF7 cells treated with poly (I:C) and a synthetic 3’ end 
derived hY5 fragment of 31 nt were used as size markers for full length hY5 RNA and wild 
type-sized YsRNAs. The five most abundant library 3 mutants were transfected into mouse 
cells and YsRNA production was induced by staurosporine. The total RNA was extracted and 
analysed by Northern blotting. The Northern blot was probed with the 3’ end and 5’ end hY5 
RNA probe. The blot was re-probed with U6 to demonstrate equal loading. The five most 
abundant hY5 library 3 mutants produced wild type-sized YsRNAs from the 3’ and 5’ end of 
the hY5 RNA.  
F. Relative quantification of the most abundant 3’ end derived mutant pool 3 YsRNAs.  
The Northern blot of the most abundant mutant pool 3 YsRNAs was quantified using the 
ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1.  
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G. Northern blot analysis of library 3 hY5 RNA mutants with the five least abundant 
YsRNAs.  
As a size marker for full length Y RNA and wild type sized Y RNA fragments RNA from human 
MCF7 cells treated with poly (I:C) and a synthetic 3’ end derived hY5 RNA fragment with a 
length of 31 nt were used. The hY5 library 3 mutant sequences that generated the five least 
abundant YsRNA reads were transfected into mouse cells and the expression level and 
YsRNA production was measured by Northern blot. The Northern blot was probed with the 3’ 
and 5’ end hY5 RNA probe. For equal loading the Northern blot was re-probed with U6. The 
hY5 RNA library 3 mutants with the five least abundant YsRNA reads produced less YsRNAs 
compared to the wild type.  
H. Relative quantification of the least abundant 3’ end derived mutant pool 3 YsRNAs.  
The Northern blot of the least abundant mutant pool 3 YsRNAs was quantified using the 
ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1.  
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3.2.5 A bulge of one nucleotide is required for human Y5 RNA cleavage 
 
The aim of this part of the work was to explore if the length of the loop L2a (Figure 
3.9, A, shown in red) is important for human Y5 RNA cleavage. Therefore, I designed 
and generated nine hY5 RNA mutants in order to sequentially delete the loop from 
the 5’ end of the hY5 RNA. These hY5 RNA mutants were termed L2a loop mutants. 
Secondary structure analysis of L2a loop mutants showed that all the deletion 
mutants except L2a Δ 8nt and L2a Δ 9nt fold similar to the wild type hY5 RNA (Figure 
3.9, B). I transfected all the L2a loop deletion mutants into mouse cells and treated 
the cells with staurosporine to induce YsRNA generation. The RNAs were subjected 
to Northern blot analysis and the accumulation of YsRNA in cells transfected with the 
deletion mutants was compared to the wild type hY5 RNA (Figure 3.9, C, D and E).  
Northern blot analysis and relative quantification showed that sequential deletion of 
the loop L2a only had a small effect on YsRNA production from either the 3’ or the 5’ 
end of the hY5 RNA compared to the wild type hY5 derived YsRNAs (Figure 3.9, C 
and D). The mutants L2a loop Δ 1 nt to L2a loop Δ 8 nt showed decreased levels of 
YsRNAs compared to the wild type hY5 RNA. The mutant L2a loop Δ 9nt did not 
produce YsRNAs either from the 3’ nor the 5’ end of hY5. Also, it has to be noted that 
the full length L2a loop Δ 9 nt RNA could not be detected because the mutant RNA 
might not be stable (Figure 3.9, C and D). Interestingly, the relative quantification of 
L2a loop derived YsRNAs showed that the mutant L2a loop Δ 4 nt, L2a loop Δ 5 nt 
and L2a loop Δ 6 nt generated more YsRNAs as the wild type hY5 RNA (Figure 3.9, 
C). This could be explained due to the fact that these mutants fold similar to the wild 
type hY5 RNA (Figure 3.9, B) and it could be that they are more accessible to RNases 
to process these hY5 RNA L2a loop mutants.  
From the Northern blot results and relative quantification of  L2a loop mutant derived 
YsRNAs compared to wild type hY5 RNA (Figure 3.9, C and D) it can be concluded 
that a bulge of one nucleotide might be sufficient for hY5 RNA cleavage. Intriguingly, 
the calculated ratio between full length hY5 RNA mutant levels compared to the 
YsRNA levels of the L2a loop mutants clearly showed that the mutants L2a loop Δ 4 
nt, L2a loop Δ 5 nt and L2a loop Δ 6 nt were processed more efficiently than wild type 
hY5 RNA, but all the L2a loop mutants got processed except the L2a loop Δ 9 nt in 
which the loop was completely removed. Therefore, a bulge of at least one nucleotide 
is crucial for Y RNA cleavage.  
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Figure 3.9. A bulge of one nucleotide is required for hY5 RNA cleavage.  
A. Secondary structure of hY5 RNA.  
The secondary structure of hY5 RNA was predicted with RNAfold and visualized using Varna. 
In this experiment the internal loop L2a indicated in red was mutated.  
B. Predicted secondary structures of L2a loop deletion mutants.  
The secondary structures of the L2a loop mutants Δ1-9 were predicted using RNAfold. The 
secondary structures were visualized using Varna.  
C. Northern blot analysis of L2a loop deletion mutants.  
As a size marker total RNA extracted from human MCF7 cells treated with poly (I:C) and a 
synthetic 3’ end derived Y RNA fragment of 31 nt were used. The L2a loop deletion mutants 
and the wild type hY5 RNA plasmid were transfected into mouse cells and treated with 
staurosporine to induce YsRNA production. The total RNA was extracted and subjected to 
Northern blot. The Northern blot was probed with the probe complementary to the 3’ and 5’ 
end of the hY5 RNA. U6 was used in order to check for equal loading. The amount of YsRNAs 
derived from the 3’ and 5’ end of L2a loop Δ 1 nt to L2a loop Δ 8 nt mutants was less compared 
to the wild type hY5 RNA. For the mutant L2a loop Δ 9 nt no full length hY5 could not be 
detected.  
D. Relative quantification of YsRNAs derived from the 3’ end of L2a loop hY5 RNA 
mutants.  
The Northern blot of 3’ end derived L2a loop hY5 RNA YsRNAs mutants was quantified using 
the ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1.  
E. Calculated ratio between the expression level of full length hY5 RNA mutants 
compared to the expression level of 3’ end derived L2a loop hY5 RNA mutants.  
The ratio of the normalized optical density of full length L2a loop hY5 RNA mutants and the 
derived YsRNAs was calculated and plotted on the graph.  
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3.2.6 The sequence of the L2a loop does not seem to be important for 
human hY5 RNA cleavage 
 
The aim of this experiment was to investigate if the sequence at the hY5 RNA 
cleavage is important for cleavage. It was previously shown in sequencing 
experiments of MCF7 cells treated with poly (I:C) that the hY5 RNA cleavage from 
the 3’ end mainly occurs between C50 and C51 generating YsRNAs with a length of 
32-34 nt.  
3.2.6.1 Mutagenesis of cytosines at the positions 50, 51 and 52 of hY5 RNA 
 
I designed and generated several hY5 RNA mutants in which the cytosines at 
positions 50, 51 and 52 were substituted or deleted in order to test if cytosines at 
these positions are critical for Y RNA cleavage.  
Another hypothesis to be examined was that the cytosines could be methylated at the 
cleavage sites and a demethylase could be in involved in Y RNA cleavage as it was 
previously shown for vault RNAs. In this study it was demonstrated that the RNA 
methyltransferase NSun2 is involved in the m5C methylation of vault RNAs. In NSun2 
deficient cells the processing of vault RNAs into svRNAs was inhibited suggesting 
that the methylation of vtRNAs at the cytosines is important for the generation of 
svRNAs (Hussain et al., 2013).  
Most of the generated hY5 substitution mutants except M9 and M14 folded in a similar 
way than the wild type hY5 RNA (Figure 3.10, A). The secondary structure analysis 
(Figure 3.10, B), Northern blot analysis and relative quantification (Figure 3.10, C, D 
and E) showed that the nucleotide sequence at positions 50, 51 and 52 did not seem 
to have any effect on hY5 RNA cleavage. All the mutants except the mutant M9 
ΔLoopL2a were cleaved and generated YsRNAs (Figure 3.10, C). Only the mutants 
M5 and M7 were less efficiently processed to YsRNAs compared to the wild type hY5 
(Figure 3.10, C and D). This could be explained that the introduced hY5 RNA 
substitution mutations changed the secondary structure of these mutants in such a 
way that the RNases that are involved in Y RNA cleavage are recruited less efficiently 
and cannot get access or the mutants M5 and M7 are less stable at the full length 
transcript level than the other hY5 RNA substitution mutants. This might be the case 
because the Northern blot already indicated that the full length levels of mutants M5 
and M7 are much less compared to the wild type hY5 RNA full length transcript 
(Figure 3.9, B).  
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Therefore, the results indicated that the cytosine residues at the positions 50, 51 and 
52 are not necessary for hY5 RNA cleavage from the 3’ end. However, it has to be 
noted that the hY5 mutants M5 and M7 in which the C50 and C51 were mutated to 
G50 and A51 resulted in less full-length hY5 transcript levels and processed less 
efficiently compared to the other hY5 RNA mutants (Figure 3.10, B, C and D). 
The secondary structure predictions I could show that when cytosines at positions 50, 
51 or 52 are substituted or deleted the hY5 RNA mutants still maintain the L2a loop 
like the wild type hY5 RNA (Figure 3.10, A and B).  
However, in the M9 ΔLoopL2a mutant that was generated by making it 
complementary to the sequence of loop L2b no full-length hY5 RNA transcript could 
be detected by Northern blot and relative quantification (Figure 3.10, B, C and D). 
The mutation in the M9 mutant changed the secondary structure in such a manner 
that it became a long double stranded RNA that could be further targeted for 
degradation.  
The mutants that involved point mutations of C51 to either G, T or A (M1, M3, M7) did 
not have any effect on the hY5 RNA full length or processing from the 3’ or 5’ end of 
the hY5 RNA. Except the mutant M7 had slightly decreased full length hY5 mutant 
transcript levels and M7 hY5 mutant Y RNA sequences were less efficiently cleaved 
(Figure 3.10, C and D).  
When C50 was mutated to A, T or G (M5, M6, M8) no effect on full-length hY5 
transcript level or Y RNA processing was seen in the mutants M6 and M8 compared 
to the wild type. The mutant M5 showed less full length hY5 RNA mutant transcript 
levels and only a small amount of YsRNAs was generated (Figure 3.10, C and D). 
In the mutants M11 and M12 the positions C50 and C51 of the hY5 RNA gene were 
mutated to G50 and G51 or G50 and T51. The Northern blot analysis also showed 
that the nucleotide sequence did not affect Y RNA cleavage from either the 3’ end or 
the 5’ end.  
Interestingly, YsRNAs were still generated at the same amount compared to the wild 
type when two cytosines at position C50 and C51 close to the 3’ end hY5 cleavage 
site in the mutant M13 were deleted. The predicted secondary structure of M13 folds 
very similarly to the hY5 wild type structure and contains 8 nt in the L2a loop whereas 
the wild type consists of 9 nt (Figure 3.10, A and B).  
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However, the deletion of three cytosines at the positions C50, C51 and C52 in the 
mutant M14 altered the secondary structure in a way that the single stranded L2a 
loop gets shortened from 9 nt to 3 nt which resulted in a lower accumulation of 
YsRNAs compared to the wild type (Figure 3.10, B, C and D). These results coincide 
with the previous Northern blot analyses of the L2a loop deletion mutants. Shortening 
of the L2a loop resulted in a decrease of YsRNA generation compared to the wild 
type and Y RNA cleavage still occurred when there was at least a bulge of 1 nt.  
In conclusion, the mutagenesis of the cytosines indicated that these nucleotides at 
the position 50, 51 and 52 are not essential for hY5 RNA cleavage. Additionally, this 
might also suggest that m5C methylation by the RNA methyltransferase NSun2 that 
was shown to be involved in vault RNA processing might not play a role in YsRNA 
generation.  
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Figure 3.10. The cytosines at the positions 50, 51 and 52 are not essential for hY5 RNA 
cleavage.  
A. Predicted secondary structures of L2a loop mutants. 
The secondary structures of the L2a loop mutants were predicted using RNAfold and 
visualized using Varna. The mutated nucleotides are indicted with a red circle.  
B.  Northern blot analysis of L2a loop mutants.  
The L2a loop mutant sequences were transfected into mouse cells and treated with 
staurosporine to induce Y RNA cleavage. Total RNA was extracted and subjected to Northern 
blot analysis to investigate the amount of YsRNAs that were derived from L2a loop mutants. 
The Northern blot was probed with the 3’ end hY5 probe, 5’ end hY5 probe and U6 as a loading 
control. As a positive control and size marker RNA extracted from MCF7 treated with poly (I:C) 
and a synthetic 3’ hY5 derived fragment were included.  
C. Relative quantification of YsRNAs derived from the 3’ end of L2a loop hY5 RNA 
mutants.  
The Northern blot of 3’ end derived L2a loop hY5 RNA YsRNAs mutants was quantified using 
the ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1. 
D. Calculated ratio between the expression level of full length hY5 RNA mutants 
compared to the expression level of 3’ end derived L2a loop hY5 RNA mutants.  
The ratio of the normalized optical density of full length L2a loop hY5 RNA mutants and the 
derived YsRNAs was calculated and plotted on the graph.  
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3.2.6.2 Mutagenesis of uridine at position 49 of hY5 RNA 
 
Recently, Donovan et al. reported that the ribonuclease RNase L is responsible for 
tRNA cleavage and Y RNA cleavage from the 5’ end of hY5 RNAs. Since RNase L is 
known to cleave single-stranded RNAs after the UN^N in a sequence-specific manner 
it was investigated if hY5 RNA still generate YsRNAs when the uridine at position 49 
is mutated to adenine, guanine or cytosine. Additionally, this UN^N motif was in 
proximity to the hY5 RNA cleavage position at C50 and C51 raising the question if 
RNase L is responsible for Y RNA cleavage from the 3’ end. I generated hY5 RNA 
substitution mutants in which the uridine at position 49 was mutated to A, G and C 
and transfected them into 3T3 mouse cells. In a parallel experimental set up I 
transfected these hY5 mutants into wild type and RNase L -/- mouse embryonic 
fibroblast cells. The YsRNA production was tested by Northern blot analysis. 
Additionally, I analysed the secondary structures of these mutants using RNAfold.  
The secondary structure analysis (Figure 3.11, A) revealed that the introduced 
mutations that position 49 did not change the secondary structure and all hY5 RNA 
mutants folded in the same way than wild type hY5 RNA.  
Intriguingly, the Northern blot analysis of hY5 RNA mutants transfected into 3T3 
mouse cells (Figure 3.11, B) showed that mutating the uridine at position 49 of the 
hY5 RNA to guanine, cytosine and adenine had no effect on 3’ and 5’ end Y RNA 
cleavage. This suggested that RNase L might not be critical for Y RNA cleavage from 
the 3’ end and the UN^N sequence motif does not seem to be important.  
From the Northern blot analysis of hY5 substitution mutants it can be concluded that 
uridine at position 49 can be replaced by adenine, guanine and cytosine without any 
effect on Y RNA expression and Y RNA cleavage from the 3’ and 5’ end. It was clearly 
shown that the hY5 substitution mutants were cleaved into Y RNA fragments from the 
3’ and 5’ end.  
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Figure 3.11. Substitution mutations of hY5 RNA at position 49 did not have any 
effect on hY5 RNA cleavage.  
A. Predicted secondary structures of hY5 RNA substitution mutants at position 49.  
The secondary structures were predicted with RNAfold and visualized using Varna. The 
mutated nucleotide is indicated with a turquoise circle.  
B. Northern blot analysis of hY5 substitution mutants at position 49 in 3T3 mouse cells.  
The hY5 mutants were transfected into 3T3 mouse cells, treated with staurosporine, total RNA 
was extracted after 8 h and subjected to Northern blot analysis. The Northern blot membrane 
was hybridized with the 3’ end hY5 probe, 5’ end hY5 probe and U6 as a loading control. As 
a size marker total RNA extracted from human MCF7 cells treated with poly (I:C) was used.  
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3.3 Discussion  
 
From previous deletion and substitution mutagenesis analysis on the human Y5 RNA 
conducted by Carly Turnbull, a previous PhD student it was hypothesized that Y RNA 
cleavage correlates with secondary structure and is rather sequence independent 
(Turnbull, 2014). In several mutagenesis experiments it was observed that the stem-
loop structure and Ro60 binding site were required for the generation of YsRNAs 
(Turnbull, 2014).  
However, in order to establish sequence and structural requirements for human Y5 
RNA cleavage and to identify proteins involved in Y RNA cleavage, the approach in 
generating individual hY5 mutants and testing their expression level by Northern blot 
analysis was quite time consuming, low throughput and only a few hY5 mutants could 
be tested at a time.  
In recent years next generation sequencing of small RNA libraries has become an 
important tool for profiling and discovery of novel sRNAs in different biological 
systems. In our laboratory a high throughput mutagenesis approach on the human 
Y5 RNA has been designed to apply the NGS technology that enabled to examine 
thousands of different hY5 RNA mutants within a particular region of the hY5 RNA at 
the same time. Using a high throughput mutagenesis approach on the hY5 RNA 
instead of testing individual hY5 RNA mutants has the advantage to look at thousands 
of different mutants at the same time. This approach would help to identify a particular 
region or structural element of the hY5 RNA and proteins involved and responsible 
for Y RNA cleavage.  
After NGS of the 3’ hY5 high throughput mutagenesis libraries and bioinformatics 
analysis the hypothesis was confirmed that the Y RNA cleavage site correlated with 
the secondary structure of the mutated hY5 RNAs. The size class distribution showed 
that hY5 library 2 and 3 mutants mainly generated wild type-sized YsRNAs. 
Interestingly, hY5 library 1 mutants produced YsRNA reads that were 1-2 nt longer 
compared to mutant pool 2 and 3.  
I generated and cloned the hY5 RNA mutant sequences with the five most abundant 
and five least abundant YsRNAs of each library individually and tested and compared 
their expression levels as well as YsRNA generation to the wild type hY5 RNA by 
Northern blot analysis and relative quantification.  
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I could confirm that the library 2 and 3 hY5 RNA mutant sequences generated wild 
type-sized YsRNAs whereas library 1 hY5 RNA mutants generated longer YsRNAs 
compared to the wild type.  
I performed secondary structure prediction of 30 library 1 hY5 RNA mutants with the 
most abundant YsRNAs and I could clearly show that the mutations introduced in 
region 1 resulted in a change of the secondary structure. 
In further detailed analysis of the secondary structural features of library 1 hY5 RNA 
mutants with the five most abundant and least abundant YsRNA reads I observed 
that the secondary structure of the hY5 library 1 mutants that generated the most 
abundant YsRNAs all consisted of a pyrimidine-rich internal loop that was shortened 
by 1-2 nt compared to the wild type hY5 RNA. Interestingly, in all of those mutants 
the internal loop was followed by a stem which was 5-6 nt long and had a high G-C 
content. In contrast, most of the hY5 library 1 mutants that only generated a low 
number of YsRNAs only contained a stem of 3 nt. This might suggest that a stem 
consisting of 5-6 nt and an internal loop might be required as structural features for 
proteins/ ribonuclease(s) to recognize hY5 RNA and generate YsRNAs from the 3’ 
end of hY5 RNAs.  
From the secondary structure analysis of the hY5 library 1 mutants I concluded that 
by the introduced mutations in library 1 the internal L2a loop got shortened by 1-2 nt 
compared to the internal loop of the wild type hY5 RNA. Thus, in library 1 hY5 RNA 
mutants the Y RNA cleavage occurs 2-3 nt more upstream compared to the wild type 
hY5 RNA but still two nucleotides above the stem. This would suggest that 
protein(s)/ribonuclease(s) involved in hY5 RNA cleavage from the 3’ end might 
recognize the stem and cleave hY5 RNAs between the 2nd/3rd nt above the stem.  
The results from the next generation sequencing, secondary structure prediction, 
Northern blot analyses confirmed that for hY5 RNA mutants in library 2 and 3 the Y 
RNA cleavage mainly occurred at the position C50/C51.  
By Northern blot analyses of the library 1 hY5 RNA mutants I demonstrated that Y 
RNA cleavage occurs between 2nd/ 3rd nt above the stem of 5-6 nucleotides and 
showed that the Y RNA cleavage correlates with the secondary structure.  
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In addition, by relative quantification of Northern blots comparing full length library 1 
hY5 RNA mutant levels to YsRNAs compared to the wild type hY5 RNA I could show 
that library 1 hY5 RNA mutants with the most abundant YsRNAs were as efficiently 
processed as wild type hY5 RNA. This further suggested that 3’ end hY5 RNA 
cleavage correlates with secondary structure.  
Interestingly, hY5 library 1 mutations that resulted in the same secondary structure 
as the wild type hY5 sequence showed wild type sized YsRNAs whereas hY5 library 
1 mutations that have different secondary structure from the wild type hY5 RNA 
generated longer hY5 RNA fragments. Thus, it further nicely confirmed the hypothesis 
that hY5 RNA cleavage from the 3’ end correlated with the secondary structure.  
The secondary structure predictions suggested that the nucleotide sequence 
introduced in mutant pool 1, 2 and 3 did not have any effect on Y RNA cleavage as 
long as the secondary structure contained a five nucleotide stem region preceded by 
an internal loop. These results indicate that proteins involved in Y RNA cleavage 
might recognize the stem and cleave the hY5 RNA two to three nucleotides in the L2a 
loop.  
In this part of the work I clearly demonstrated that the secondary structure of the hY5 
RNA correlates with 3’ end hY5 RNA cleavage and I was able to identify and establish 
secondary structure features and elements.  
The next steps would involve the investigation of the proteins/endoribonuclease(s) 
involved in 3’ end hY5 RNA cleavage that recognize the stem region and cleave in a 
single-stranded loop region using RNA immunoprecipitation experiments combined 
with mass spectrometry. One approach to look into Y RNA interaction partners of Y 
RNAs and potential ribonucleases in Y RNA cleavage would be to transfect 
biotinylated Y RNAs and carry out staurosporine treatment. The next step would 
involve immunoprecipitation experiments using streptavidin beads of untreated and 
treated samples followed by mass spectrometry.  
Further experiments would involve investigations into the function of 3’ end derived 
hY5 RNA fragments because until now in the literature no function of 3’ end derived 
hY5 fragments has been described. In contrast, only the 5’ end derived hY5 RNA 
fragment was reported to trigger apoptosis (Chakrabortty et al., 2015).  
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Additionally, 5’ end derived Y RNA fragments have been shown to be highly enriched 
in extracellular vesicles of several cancers (Dhahbi et al., 2013) and diseases 
(Cambier et al., 2017) and have been observed to be involved in immunity (Hizir et 
al., 2017).  
In order to further investigate the sequence and structural requirements for 3’ end 
hY5 RNA cleavage I carried out additional mutagenesis experiments to explore if 
there was a minimal nucleotide requirement for Y RNA cleavage to occur.  
The loop 2a was shortened by deletion mutagenesis and hY5 RNA mutants were 
subjected to Northern blot analyses. The obtained sRNA Northern blot results and 
their relative quantifications by densitometry suggested that the removal of 8 nt from 
the L2a loop in general only resulted in a small decrease of YsRNA production from 
the 3’ and the 5’ end of the hY5 RNA. However, the removal of 9 nt had a dramatic 
effect on YsRNA generation from the 3’ and 5’ end of the human Y5 RNA and not 
even the full length hY5 RNA was stable anymore. This phenomenon might be due 
to the fact that the Loop L2a Δ9 nt mutant folds similar to long double stranded RNA 
such as viral double stranded RNA that might be processed by RNase L for 
degradation.  
From the L2a loop deletion mutagenesis I concluded that a bulge of one nucleotide 
is required for Y RNA cleavage or to have a stable Y RNA that can be processed.  
In parallel to the L2a loop deletion experiments I studied in further experiments, if the 
nucleotide sequence at the positions 50, 51 and 52 of the L2a loop which are in 
proximity to the 3’ end hY5 RNA cleavage site were important for 3’ end hY5 RNA 
cleavage. It was shown in previous experiments that the hY5 RNA cleavage from the 
3’ end mainly occurs between C50 and C51 producing YsRNAs of 33-34 nt.  
In the Northern blot analysis and relative quantification of 3’ end derived YsRNAs I 
observed that the nucleotide sequence at the positions 50, 51 and 52 did not seem 
to have any effect on hY5 RNA cleavage. Therefore, this suggested that cytosine 
residues at the positions 50, 51 and 52 are not necessary for hY5 RNA cleavage from 
the 3’ end. Thus, we could conclude that m5C methylation of cytosines that is 
mediated by the RNA methyltransferase NSun2 and generation of vault RNA derived 
small RNAs might not be involved in YsRNA generation. 
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Intriguingly, when all three cytosines at the positions C50, C51 and C52 were deleted 
a small decrease of YsRNA accumulation compared to wild type was observed, but 
Y RNA cleavage from the 3’ and 5’ end of hY5 RNAs still occurred. This result was 
consistent with the previous Northern blot analyses obtained from the loop L2a 
deletion mutagenesis experiments that revealed that a bulge of 1 nt was sufficient for 
Y RNA cleavage to occur.  
Interestingly, when the loop L2a was completely deleted in the mutant M9 by 
generating a sequence complementary to the sequence of the loop L2b no full length 
hY5 RNA transcript could be detected by Northern blot. The predicted secondary 
structures of this mutant indicate that the structure was altered dramatically compared 
to the wild type hY5 RNA and it formed a long double stranded RNA region that might 
be targeted for degradation resulting in the loss of Y RNA stability.  
As in 2017 Donovan et al. claimed that RNase L is responsible for Y RNA cleavage 
from the 5’ end (Donovan et al., 2017) I investigated if this ribonuclease is also 
involved in the generation of Y RNA fragments from the 3’ end. RNase L is known to 
cleave single-stranded RNAs in a sequence-specific manner after UN^N sequence 
motif. The very same motif was found close to the 3’ end Y RNA cleavage site. 
In order to prove that RNase L is critical for the 3’ end hY5 RNA cleavage I mutated 
the uridine at position 49 to adenine, guanine and cytosine and tested the generated 
hY5 substitutions mutants by Northern blot. The obtained Northern blot experiments 
clearly showed that YsRNA fragments were generated from both the 3’ and 5’ end of 
hY5 RNA substitution mutants. These experiments suggested that uridine at position 
49 is not essential for Y RNA cleavage from the 3’ end of hY5 RNA. Thus, RNase L 
might not be responsible for Y RNA cleavage from the 3’ end of hY5 RNAs and other 
proteins/ribonucleases are involved in Y RNA cleavage from the 3’ end of hY5 RNA.  
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Chapter 4 Establishing sequence and structural 
requirements for 5’ end human Y5 RNA cleavage 
 
4.1 Introduction  
 
4.1.1 Extracellular vesicles 
 
Extracellular vesicles (EVs) are a heterogeneous population of membrane-enclosed 
vesicles comprised of a phospholipid bilayer. They are characterized to release 
cargoes such as nucleic acids, lipids or proteins from the plasma membrane of donor 
cells to neighbouring or distinct recipient cells. EVs have been identified in both 
eukaryotes and prokaryotes and the secretion of EVs is evolutionarily conserved 
(Gould and Raposo, 2013). EVs are derived from many different cell types and have 
been isolated from body fluids such as urine, blood, saliva, semen or breast milk 
(Colombo et al., 2014).  
According to their size, origin, morphology, purification, function and cargo EVs can 
be roughly classified into exosomes, microvesicles and apoptotic bodies. However 
the classification of EVs is still controversial in the field and there are still limitations 
in the purification of EVs (Gould and Raposo, 2013).  
Exosomes (30-100 nm in diameter) are formed during endosomal pathways within 
large endosomal compartments called multivesicular endosomes or multivesicular 
bodies (MVBs). They are released into the extracellular space by fusion of MVBs with 
the plasma membrane (Johnstone et al., 1987). Microvesicles are larger than 
exosomes (100-1000 nm) and are released by budding or fission of the plasma 
membrane. Apoptotic bodies are generated during apoptosis and vary in size 
between 1000 nm and 5000 nm (Gould and Raposo, 2013; Colombo et al., 2014).  
EVs are key mediators of intercellular communication and are involved in multiple 
physiological and pathological conditions. EVs play an important role in development, 
cell homeostasis, neuronal signalling and immunity (Yanez-Mo et al., 2015; Maas et 
al., 2017).  
However, EVs have also been associated with inflammatory diseases (Buzas et al., 
2014), neurodegenerative diseases (Coleman and Hill, 2015) and cancer (Minciacchi 
et al., 2015).  
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In the last years it was shown that cancer-cell derived EVs have been implicated in 
the tumour microenvironment and promote tumour progression, angiogenesis, cell 
invasion and metastasis (Tkach and Théry, 2016).  
The recent development of next generation sequencing technologies in the last 
decade allowed the identification of a wide range of low abundant RNA species in 
EVs isolated from different types of body fluids. A breakthrough in the field of EVs 
was the discovery that exosome-derived mRNAs and miRNAs could be transferred 
between cells and the released mRNAs were translated into proteins in the recipient 
cells (Ratajczak et al., 2006; Valadi et al., 2007).  
Due to the association of EVs with many different diseases including cancer, EV 
associated miRNAs have emerged as novel diagnostic biomarkers (Kinoshita et al., 
2016) with a huge potential for therapeutic approaches (Fais et al., 2016). 
Surprisingly, high throughput RNA sequencing of small RNAs derived from immune 
cell EVs revealed that miRNAs represented only a small fraction of the RNA repertoire 
in the EVs compared to cellular RNA. Unexpectedly, the EVs contained several other 
classes of regulatory non-coding RNAs, such as small nucleolar RNAs, small nuclear 
RNAs, transfer RNAs, ribosomal RNAs, long non-coding RNAs, circular RNAs, vault 
RNAs as well as Y RNAs (Nolte-'t Hoen et al., 2012; Kim Kyoung et al., 2017). Among 
them, vault RNAs and Y RNAs were found highly enriched in the immune cell derived 
EVs. In addition, Nolte-t’ Hoen et al. also identified small RNA fragments derived from 
longer transcripts, such as Y RNA fragments, tRNA fragments or a vault RNA derived 
sRNA fragment enriched in immune cell EVs. Among them, Y RNA fragments were 
the most abundant small RNA fragments in EVs suggesting a functional role of these 
small RNAs derived from longer transcripts.  
4.1.2  unctions of 5’ end derived Y RNAs in extracellular vesicles 
 
Vojtech et al. showed by next generation sequencing of exosomes derived from 
semen that 5’ end derived Y RNA fragments were highly enriched (Vojtech et al., 
2014). Interestingly, in human serum and plasma of healthy donors, Y RNA fragments 
derived from the 5’ end of specific Y RNA genes and Y RNA pseudogenes with sizes 
of 27 nt and 30-33 nt were identified. Surprisingly, in the plasma these 5’ end derived 
Y RNA fragments were not incorporated within EVs but circulated in the blood as part 
of a large complex with a mass of 100-130 kDa.  
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In the same study it was shown that 5’ end derived Y RNA fragments were more 
abundant in human serum compared to mouse serum while the opposite was 
observed for 5’ end tRNA halves. It needs to be further investigated why the 
composition of circulating sRNAs was different between human and mouse sera 
(Dhahbi et al., 2013). Specific tRNA halves and Y RNA fragments were found to be 
associated with breast cancer and differentially expressed compared to healthy 
individuals (Dhahbi et al., 2014). 
Dhahbi et al. observed that in human serum 5’ end derived Y RNA fragments are 
about twenty times more abundant compared to 3’ end derived Y RNA fragments 
(Dhahbi et al., 2013). Interestingly, RNA sequencing of five breast cancer patients 
compared to control samples revealed that mostly 3’ end derived Y RNA fragments 
were upregulated in five diagnosed breast cancer patients whereas 5’ end derived Y 
RNA fragments showed downregulation compared to healthy patient samples 
(Dhahbi et al., 2014). However, any function or mechanism or biogenesis pathway 
remained obscure. 
A recent study investigated the processing and transfer of hY5 RNA fragments within 
EVs derived from primary and cancer cell lines. It was shown that hY5 RNAs were 
highly abundant and enriched in EVs. Shorter fragments (23, 29 and 31 nt) derived 
from the 5’ and 3’ end of hY5 were also detected in EVs (Chakrabortty et al., 2015). 
In the same study hY5 RNA fragmentation occurred in the EVs instead of inside the 
cells.  
Notably, the 5’ end derived hY5 RNA fragments contained a conserved 8 nt RNA 
sequence motif (5’-GUUGUGGG-3’) that was previously reported to be also involved 
in the initiation of chromosomal replication (Gardiner et al., 2009). The same motif 
was shown to be important for the processing of full-length hY5 RNAs into smaller 
functional Y RNA fragments (Chakrabortty et al., 2015). Interestingly, the exposure of 
human healthy cells with EVs derived from cancer cells resulted in rapid cell death. 
However, cancer cells did not show any phenotype when they were treated with EVs 
from normal or cancer cells.  
Intriguingly, it was shown that only a synthetic version of the 23 nt- and 31 nt 5’ end 
derived hY5 fragment and not the 3’ end derived hY5 fragment nor a double stranded 
version of 3’ and 5’ hY5 fragment triggered cell death in primary cells in a dose-
dependent manner through an apoptotic pathway.  
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Further, it was observed that the conserved 8 nt motif in the 5’ end derived Y RNA 
fragments was required for the induction of cell death (Chakrabortty et al., 2015).  
The study conducted by Chakrabortty et al. indicated that there seems to be a 
correlation between 5’ end derived Y RNA fragments and cancer, since 5’ end derived 
hY5 RNA fragments only derived from cancer cell EVs trigger rapid cell death in 
normal cells. It was hypothesized that the 5’ end derived hY5 RNA fragment induced 
cell death might help tumours to invade tissues and to establish a microenvironment 
(Chakrabortty et al., 2015). 
In 2012 the Dalmay laboratory already showed that Y RNAs are also generated from 
the 5’ end of human Y RNAs in several cancerous and non-cancerous cell lines as 
previously described (Nicolas et al., 2012). However, because of the higher 
abundance of 3’ end derived hY5 fragments compared to 5’ end derived hY5 RNA 
fragments the research focus of our laboratory was mainly on the 3’ end derived hY5 
RNA fragments.  
Due to the fact that Chakrabortty et al., gave some evidence that 5’ end derived hY5 
RNA fragments are functional and require a conserved 8 nt motif in order to induce 
cell death, in this part of the work I aimed to investigate if there was any sequence 
and/or secondary structure requirement for hY5 RNA cleavage from the 5’ end. In 
order to pursue this, I designed and performed a high throughput mutagenesis 
approach on the 5’ end of the human Y5 RNA.  
4.2 Results 
 
4.2.1 Generation of 5’ end hY5 mutant plasmid pools  
 
I designed the 5’ end hY5 high throughput mutagenesis approach in a similar way to 
the 3’ end hY5 mutagenesis study. Previous next generation sequencing performed 
in our laboratory showed that MCF7 cells treated with poly (I:C) generated hY5 RNA 
fragments from the 3’ and 5’ end. The main cleavage product from the 5’ end of the 
hY5 RNA was 32 nt.  
Thus, I selected three different five nucleotide regions immediately upstream of the 
determined cleavage site for random mutagenesis (Figure 4.1, A and B). The five 
nucleotide substitution mutations were introduced using primers containing 
degenerate nucleotides at each of the five positions.  
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The PCR products including the promoter region and 30 bp downstream terminator 
region were amplified from the hY5 wild type expression construct by overlap 
extension PCR (Figure 4.1, B) in three replicates for each mutant pool. 
In order to check if the five nucleotide substitution mutations were introduced correctly 
and to see if the degenerate nucleotides at each of the five positions are equally 
distributed, I sent the generated PCR products of each library replicate for Sanger 
sequencing and analyzed the sequences and chromatograms.  
I cloned the A-tailed PCR products into pGEMT easy vector, transformed them into 
E. coli. Apart from the PCR products I also sent ten plasmid DNA clones of each 
library replicate for Sanger Sequencing and checked if the sequence and introduced 
mutations were correct.  
However, the analysis of the Sanger sequencing results of the mutant pool PCR 
products and purified plasmid DNA samples of each mutant pool replicate revealed 
that for mutant pool 4 and 5 the nucleotide composition at each of the five positions 
was significantly biased (Figure 4.1, C and D).  
After literature search and contacting gene synthesis companies I was suggested to 
use “hand-mixed” primers containing degenerate nucleotides instead of custom 
synthesized primers in order to overcome the bias. The primers would be synthesized 
in a way that each nucleotide would be added individually by hand at a percentage of 
25% at the five nucleotide mutagenesis region by hand and not randomized by the 
oligo synthesis machine.  
I repeated the PCR reactions for mutant pool 4 and 5 with newly designed “hand-
mixed” primers and sent the PCR products of all mutant pool replicates for Sanger 
sequencing in order to investigate if the bias at the mutagenized regions could be 
improved.  
The chromatograms of library 4, 5 and 6 mutant pool PCR products and Sanger 
Sequencing results of fifty isolated plasmid DNA clones of library 4, 5 and 6 using 
“hand-mixed” primers indicated that the distribution of the four possible nucleotides 
for library 4 and 5 was improved and more equally distributed (Figure 4.1, E and F) 
compared to the machine-mixed custom synthesized primers that were used for the 
PCR previously (Figure 4.1, C and D).  
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Figure 4.1. Design and generation of the 5’ end hY5 high throughput 
mutagenesis approach. 
A. Predicted human hY5 RNA secondary structure with the regions that were mutated 
for the 5’ end high throughput mutagenesis analysis.  
In each of these regions of library 4 (blue), library 5 (orange) and library 6 (purple), five 
nucleotide substitution mutations were introduced resulting in 1024 (45) possible combinations 
for each library. 
B. Schematic of the pGEM-hY5-WT vector containing the mutated regions of hY5 RNA 
library 4, 5 and 6.  
The mutations for library 4 (blue), library 5 (orange) and library 6 (purple) were introduced by 
mutagenesis PCR using primers containing random nucleotides (N).  
C. Chromatograms of generated PCR products from library 4, 5 and 6 using custom 
synthesized primers.  
For library 4 and 5 it can be seen that the degenerate random nucleotides are not equally 
distributed and that some bases are overrepresented when machine-mixed degenerate 
primers were used for PCR, whereas in library 6 the degenerate nucleotides showed more or 
less equal proportions at each position.  
D. Sanger sequencing results of hY5 library mutants generated from library 4, 5 and 6 
using custom synthesized primers.  
Ten plasmid DNA samples isolated from each library replicate of mutant pool 4, 5 and 6 were 
sent for Sanger Sequencing and analysed if the nucleotide composition at each of the five 
positions is equally distributed or biased. The graph shows the base composition on the x-axis 
as percentage of all the clones analysed. On the y-axis each position of the mutated five-
nucleotide mutagenesis region is given. 
E. Chromatograms of generated PCR products from library 4, 5 and 6 using hand-mixed 
synthesized primers.  
When hand-mixed degenerate random primers were used for PCR, the proportions of each of 
the four bases at each of the positions of the five-nucleotide region for library 4 and 5 improved 
greatly and no overrepresentation of any nucleotide could be observed anymore.  
F. Sanger sequencing results of hY5 library mutants generated from library 4, 5 and 6 
using hand-mixed synthesized primers.  
Fifty plasmid DNA samples isolated from one library replicate of mutant pool 4, 5 and 6 were 
sent for Sanger Sequencing and analysed if the nucleotide composition at each of the five 
positions is equally distributed or biased. The graph shows the base composition on the x-axis 
as percentage of all the clones analysed. On the y-axis each position of the mutated five-
nucleotide mutagenesis region is given. The Sanger Sequencing results showed that hand-
mixed random nucleotides for generating library 4, 5 and 6 mutant pool PCR products 
dramatically reduced the bias of nucleotide composition in each mutated position.  
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4.2.2 Generating 5’ end hY5 mutant plasmid pools 
 
Similar to the 3’ end hY5 high throughput mutagenesis approach I generated 5’ end 
hY5 plasmid libraries and full length hY5 cDNA libraries in order to check if all the 
1024 possible hY5 mutant sequences were cloned successfully and to allow us to 
normalize the YsRNA datasets in a certain way and to account for occurring biases 
in the datasets.  
For generation of the 5’ end hY5 mutant plasmid pools I harvested around 10000 
colonies for each library replicate in order to ensure that all the 1024 possible hY5 
mutant combinations are present. Statistical analysis that was performed for the 3’ 
end hY5 high throughput mutagenesis approach suggested that around 4850 positive 
colonies need to be harvested in order to be sure that all the 1024 possible sequences 
will be present with a probability of 99%.  
I prepared the 5’ end hY5 plasmid bias cDNA libraries as previously described and 
sent for next generation sequencing. The bioinformatics analysis of the plasmid bias 
libraries showed that all the 1024 different hY5 mutant sequences were present in the 
plasmid libraries that were generated from the 5’ end of the hY5 RNA. However, the 
plasmid bias libraries were hugely biased for the hY5 wild type sequence in hY5 
library pools 4 and 5. Among all the three replicates the hY5 wild type sequence was 
roughly six to seven times more abundant in hY5 mutant pool 4 and 5 than all the 
other 1023 hY5 mutant sequence combinations. For mutant pool 6 this prominent hY5 
wild type sequence bias was not observed and all the 1024 hY5 mutant sequence 
combinations were present and statistically equally distributed. 
Consequently, I had to modify the cloning strategy for mutant pool 4 and 5 of the 5’ 
end high throughput mutagenesis approach in order to ensure that the wild type 
sequence is not overrepresented anymore.  
The first cloning strategy was based on a plasmid containing the hY5 full length wild 
type sequence. The mutations for the 5’ end mutagenesis approach were introduced 
by overlap extension PCR (Figure 4.2, A). Due to the fact that overlap extension PCR 
(Figure 4.2, B) in general is not very efficient any small traces of the full length hY5 
wild type sequence will result in amplification of the hY5 wild type sequence.  
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Figure 4.2.  irst cloning strategy for 5’ end high throughput mutant pool 
generation.  
A. Generation of the long fragment and short fragment PCR products for 5’ end high 
throughput mutagenesis approach.  
As a template for PCR the pGEM-hY5 wild type plasmid was used and the random mutations 
were introduced by the short fragment PCR.  
B. Overlap extension PCR for generating the mutant pool 4, 5 and 6 PCR products. 
Mutant pools 4, 5 and 6 were generated by overlap extension PCR using the wild type pGEM-
hY5 plasmid as a template. The short fragment containing the random nucleotides and the 
long fragment were annealed for 5 cycles, then primers were added and amplified for another 
25 cycles.  
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After re-examining the first cloning strategy (Figure 4.2) I designed a second cloning 
approach and I used a truncated hY5 wild type sequence as a template in order to 
avoid full length wild type hY5 sequence carryover.  
Thus, I generated two different template plasmids for the long and the short fragment 
in a way that the hY5 full length sequence is disrupted. For the templates I ensured 
that I picked a single colony for further cloning and overlap extension PCR. The full 
length hY5 sequence containing the five nucleotide mutated regions for each of the 
mutant pools was generated by a primer that spanned the truncated part of the hY5 
wild type sequence and included an overhang for further overlap extension PCR of 
the long and the short fragment. 
I generated the PCR products of each mutant pool and confirmed them by Sanger 
sequencing. The PCR products were A-tailed and were cloned into pGEMT easy 
vector and transformed into bacteria.  
The chromatograms of the PCR products showed no obvious contamination and in 
addition, I sent ten purified plasmid DNA clones of each mutant pools for Sanger 
sequencing before the generation of the large mutant plasmid pools.  
The Sanger sequencing analysis confirmed that the 5’ end hY5 mutant pools were 
generated correctly without any mutations. As previously described I harvested again 
around 10,000 colonies per library replicate, purified and isolated the large scale 5’ 
end hY5 mutant plasmid pools. 
I prepared the plasmid libraries as previously described and sent them for next 
generation sequencing in order to monitor whether the hY5 wild type sequence bias 
could be improved.
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 5’ END HUMAN Y5 RNA CLEAVAGE 
 
174 
 
A 
 
 
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 5’ END HUMAN Y5 
RNA CLEAVAGE 
 
175 
 
 
B 
 
Figure 4.3. Second cloning strategy for 5’ end high throughput mutant pool 
generation. 
A. Generation of a long and short PCR fragment with truncated hY5 RNA wild type 
sequence.  
In order to prevent carryover of the full length hY5 RNA wild type sequence in the final overlap 
extension PCR two separate plasmids containing the long fragment and short fragment each 
with the truncated hY5 RNA wild type sequence were cloned into pGEMT-easy. 
B. Final overlap extension PCR to generate mutant pool 4, 5 and 6 PCR products.  
The cloning strategy for the 5’ end high throughput mutant pool generation was re-designed 
and a truncated version of the hY5 wild type sequence was used as a template instead of the 
full length hY5 RNA wild type sequences. The PCR products of the short and long fragment 
were cloned into an expression vector and a single colony was picked and checked by Sanger 
sequencing in order to ensure that the full length hY5 RNA sequence was truncated. The 
construct containing a truncated version of the hY5 wild type sequence was used to generate 
the PCR products for the long fragment and short fragment including the random nucleotides 
for mutant pool 4, 5 and 6. For the final overlap extension PCR the two fragments were 
annealed for 5 cycles and then the full length forward and reverse primers were added and 
amplified for 25 cycles to generate the mutant pool 4 (blue), mutant pool 5 (orange) and mutant 
pool 6 (purple) PCR product.  
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4.2.3 Bioinformatics analysis of the 5’ end hY5 mutagenesis libraries  
 
I constructed all cDNA libraries for the 5’ end hY5 high throughput mutagenesis in 
three replicates and sent the libraries for NGS. The libraries were sequenced on the 
Illumina HiSeq 2500 at the Earlham Institute (Norwich Research Park, UK). The 
bioinformatics analysis was carried out by Dr. Simon Moxon and Dr. Archana Singh 
(John Innes Centre, UK).  
Similar to the 3’ end hY5 mutagenesis libraries, I prepared 5’ end hY5 plasmid 
libraries and 5’ hY5 full length cDNA libraries in order to check if all the mutant hY5 
sequences were cloned, transfected and transcribed successfully.  
With the analysis of the 5’ hY5 plasmid libraries and 5’ end hY5 full length cDNA 
libraries it was possible to normalize the obtained YsRNA reads to some extent. This 
would provide additional information which 5’ end hY5 mutants are cleaved 
preferentially or not cleaved at all. Combining all the bioinformatics analyses from the 
5’ end mutagenesis libraries together I could get further insight into the sequence and 
structural requirements for human Y5 RNA cleavage from the 5’ end.  
 
4.2.3.1 Plasmid libraries  
 
I generated the plasmid libraries for the 5’ end hY5 mutant plasmid pools as 
previously described in the material and methods part. I used 5 ng of each mutant 
pool plasmid DNA as template for PCR. In order to introduce the Illumina adapter 
sequences and indices for Illumina sequencing I carried out two separate PCR 
reactions. The Illumina adapter sequences were introduced by PCR using barcoded 
index primer sequences. The PCR products were separated on an 8% native PAGE 
gel, the DNA bands excised and purified by ethanol precipitation. I diluted the purified 
PCR products to 1 ng and used this as a template in order to introduce the Illumina 
index primer sequences.  
The final PCR products were separated on a 8% native PAGE gel, excised and 
purified by ethanol precipitation (Figure 4.4, A). 
I measured the concentration of the final plasmid libraries by nanodrop and for 
quantification 1 μl of each library replicate was loaded on a 8% PAGE gel. 
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Before the samples were sent for next generation sequencing I quantified all the 
plasmid library replicates using the Typhoon Image Quant software (Figure 4.4, B) 
The bioinformatics analysis of the 5’ hY5 plasmid libraries was performed in a similar 
way to the 3’ end hY5 plasmid libraries. The sequencing reads were mapped to all 
possible 1024 mutant full length hY5 RNA sequences using PatMaN without allowing 
any mismatch and further analysed using a custom Perl script. The obtained 
sequencing reads are summarized in Figure 4.4, C.  
The bioinformatics analysis of the plasmid libraries showed that for each library 
replicate we obtained between 300000 and 500000 sequencing reads so for each 
individual hY5 sequence motifs we expected to get 300 and 500 reads when all the 
sequence motifs would be equally distributed. When all the obtained reads were 
mapped to all possible 1024 (45) full length hY5 RNA mutant sequences we found all 
1024 hY5 RNA mutant sequences represented and the abundance of each sequence 
motif was more or less equally distributed. From the bioinformatics analysis we could 
see that there was no particular hY5 RNA mutant sequence overrepresented and that 
all the individual hY5 mutant sequence motifs were equally present (Figure 4.4, C).  
Also, none of the hY5 mutant sequence showed a significant overrepresentation in 
the plasmid bias libraries and this indicates that the random mutagenesis performed 
on the 5’ end of hY5 RNA was successful.  
In conclusion, in the plasmid libraries generated from the mutant pools 4, 5 and 6 all 
1024 possible hY5 RNA mutants were present and successfully cloned.  
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Figure 4.4. Plasmid libraries of hY5 libraries 4, 5 and 6. 
A.  Generation of hY5 plasmid libraries 4, 5 and 6.  
For the generation of the plasmid libraries the PCR products were excised and separated on 
a 8% PAGE gel. The purified PCR products were used as a template to introduce the standard 
Illumina adapter sequences. The final plasmid DNA libraries were separated on a 8% PAGE 
gel electrophoresis and bands at 208 nt were excised, eluted and ethanol precipitated.  
B. Quantification of hY5 plasmid libraries 4, 5 and 6.  
For final quantification 1 μl of each library replicate was loaded on a 8% PAGE gel, stained 
with SYBR Gold and quantified using the Image Quant software in order to ensure that equal 
amounts of each plasmid library is sent for NGS.  
C. Sequencing information of the 5’ end hY5 plasmid libraries. 
 In the first column all the library replicates of plasmid mutant pool 4, 5 and 6 are listed and for 
each replicate the abbreviation PB which stands for plasmid bias library was used. The second 
column shows all the obtained sequencing reads and in the third column all the unique 
sequence motif for each replicate is listed. In the plasmid libraries generated from plasmid 
mutant pools 4, 5 and 6 all 1024 possible hY5 RNA mutants were present and successfully 
cloned. 
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4.2.3.2 Full length cDNA libraries 
 
I prepared the full length cDNA libraries as previously described. Therefore, 5 μg of 
total RNA was treated with DNase and purified RNA was reverse transcribed. The 
Illumina adapter sequences and index primer sequences were added to the hY5 
cDNA libraries by PCR (Figure 4.5, A).  
The PCR products were separated by 8% PAGE gel electrophoresis and quantified 
using the Image Quant software (Figure 4.5, B). 
The cDNA full length libraries were sent to the Earlham Institute for next generation 
sequencing (HiSeq 2500).  
The analysis of the 5’ end hY5 full length for each library replicate showed that 
between 100000 and 460000 sequence reads were obtained. After bioinformatics 
analysis I could show that all the 1024 hY5 mutant combinations were present. This 
suggested that all pool 4, 5 and 6 hY5 RNA mutants were transcribed successfully 
and therefore stable.  
However, I observed that the wild type hY5 sequence seemed to be overrepresented 
around 3-4 times compared to abundant hY5 RNA mutant transcripts. The obtained 
sequencing reads for each hY5 library replicates are summarized in (Figure 4.5, C).  
The analysis of the 5’ end hY5 plasmid bias and full length libraries demonstrated that 
the random mutagenesis on the 5’ end of the hY5 RNA was successful and all the 
hY5 RNA mutants were present. All the hY5 RNA mutant sequences were transcribed 
successfully and that the generated transcripts were stable. 
As already been seen in the bioinformatics analysis of the plasmid bias libraries there 
was no strong selection for any particular hY5 mutant sequence motif and all mutants 
were represented in the generated mutant pools 4, 5 and 6.  
Interestingly, the analysis of the full length libraries showed that the hY5 wild type 
sequence had around three to four times more transcript level compared to some 
other abundant hY5 mutant full length transcripts. The reason for this could be that 
the hY5 wild type sequence was transfected and therefore be transcribed more 
efficiently or that the wild type full length transcript was more stable compared to the 
other hY5 mutant full length transcripts.  
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Figure 4.5. Full length cDNA libraries of hY5 library mutant pool 4, 5 and 6. 
A. Generation of full length cDNA libraries of hY5 library mutant pool 4, 5 and 6.  
The full length cDNA libraries were separated by 8% PAGE gel electrophoresis and PCR 
products at the size of 200 nt were excised, eluted and precipitated.  
B, Quantification of hY5 full length cDNA libraries 4, 5 and 6.  
For final quantification 1 μl of each full length cDNA library replicate was loaded on a 8% 
PAGE gel, stained with SYBR Gold and quantified using the Image Quant software in order 
to ensure that equal amounts of each plasmid library is sent for NGS.  
C. Sequencing information of the 5’ end hY5 full length cDNA libraries. 
In the first column all the full length cDNA library replicates of mutant pool 4, 5 and 6 are listed 
and for each replicate the abbreviation FL for full length was used. The second column shows 
all the obtained sequencing reads and in the third column all the unique sequence motif for 
each replicate is listed.  
ESTABLISHING SEQUENCE AND STRUCTURAL REQUIREMENTS FOR 5’ END HUMAN Y5 
RNA CLEAVAGE 
 
182 
 
 
4.2.3.3  Small RNA cDNA libraries  
 
I transfected the mutant plasmid pools into mouse cells and after 24 h the cells were 
treated with staurosporine for 4 h to induce apoptosis and generate YsRNAs. Total 
RNA was extracted and transfection and YsRNA production from hY5 mutant pools 
was checked by Northern blot (Figure 4.6, A) before cDNA libraries were constructed 
(Figure 4.6, B and C) and sent for next generation sequencing.  
The bioinformatics analysis was carried out by Dr. Simon Moxon. For the YsRNA 
analysis first the adapter sequence was removed from the 3’ end of the sequencing 
read. Then the reads were mapped to the mouse reference genome. In order to be 
able to map the obtained reads to the hY5 mutant sequences for each library a 
reference set containing all possible hY5 mutant sequences was generated. PatMaN 
was used to map the remaining reads of each library separately to the hY5 mutant 
sequences while no mismatch was allowed. 
From the size class distribution of the YsRNA libraries (Figure 4.6, D) it can be seen 
that the size of YsRNAs derived from hY5 library mutant pool 4 and 5 is mainly 29/30 
nt whereas hY5 mutant pool 6 Y RNAs generate longer YsRNAs with a length of 
30/31 nt. Mutant pool 4 and 5 generate more 28/29 mer YsRNAs whereas mutant 
pool 6 derived YsRNAs are longer with a length around 30/31 nt. 
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Figure 4.6. Generation of 5’ end derived YsRNA cDNA libraries.  
A. Northern blot analysis of 5’ end derived YsRNAs.  
Before cDNA library construction the transfection efficiency and YsRNA generation of mutant 
pool 4, 5 and 6 was tested by Northern blot analysis. The Northern blot membranes were 
probed with 3’ and 5’ end specific hY5 DNA probes and U6 as a loading control. As a size 
marker total RNA extracted from MCF7 cells treated with poly (I:C) was used.  
B. YsRNA library construction.  
For YsRNA cDNA library preparation 2 μg of total RNA was used. The YsRNA cDNA libraries 
were constructed using Illumina adapters. The PCR products were separated on a 8% PAGE 
gel and PCR products with sizes of 150 nt were excised, eluted and ethanol precipitated. As 
a size marker a 20 bp DNA ladder was used.  
C. Quantification of YsRNA cDNA libraries.  
For quantification 1 μl of each library replicate was loaded on a 8% PAGE gel. The gel was 
stained with SYBR Gold and the bands were quantified using the Typhoon Image Quant 
software.  
D. Size class distribution of YsRNAs from each hY5 library mutant pool replicate.  
Mutant pool 4 and 5 YsRNAs (shown in blue and yellow) are mainly 30 nt whereas mutant 
pool 6 hY5 RNA mutants mainly generate YsRNAs of 30 nt and longer YsRNAs of 31 nt.  
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4.2.4 Library 4 hY5 RNA mutants generate wild type sized YsRNAs  
 
The bioinformatics analysis was carried out in a similar way to the 3’ end hY5 YsRNA 
analysis. The size class distribution of YsRNA sequencing reads demonstrated that 
hY5 library 4 mutant YsRNA reads were mainly 30 nt as seen for the wild type hY5 
RNA. Interestingly, it was noted that hY5 RNA was cleaved at different positions 
specifically at the 5’ end and generated YsRNA fragments with various sizes.  
The YsRNAs derived from each hY5 mutant pool 4 library replicates were ranked by 
abundance. In order to validate the results from the next generation sequencing I 
performed some RNA secondary structure analysis of 30 library 4 hY5 RNA mutant 
sequences with the most abundant and least abundant YsRNAs using RNAfold. In 
addition, I carried out sequence logo analysis of the thirty most abundant library 4 
hY5 mutant sequences using WebLogo3. 
From the secondary structure analysis I found that the overall structure of the most 
abundant hY5 library 4 mutants is more or less similar to the wild type hY5 RNA 
(Figure 4.7, C).  
The sequence logo analysis clearly showed that there was quite a strong selection 
for the wild type hY5 RNA sequence motif UGGGU (Figure 4.7, B).  
This indicates that the region mutated in hY5 library 4 seems to be important for Y 
RNA cleavage. Intriguingly, the mutated region of library 4 is part of the 8 nt conserved 
sequence motif (5’ GUUGUGGG 3’) that was shown to be required for DNA 
replication and was recently reported to be involved in triggering apoptosis in 5’ end 
derived hY5 fragments (Chakrabortty et al., 2015).  
The cloned some library 4 hY5 RNA mutants that generated the most YsRNAs ( 
 
 
 
 
 
Figure 4.7, A) individually into an expression vector and tested their expression 
level by Northern blot analysis.The Northern blot results of the library 4 hY5 RNA 
mutants that resulted in the five most abundant YsRNA reads (Figure 4.7, 
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D)confirmed that hY5 RNA mutant sequences produced different sized 5’ end 
derived hY5 RNA fragments and hY5 RNA cleavage mainly happened between 
position A30 and A31 ( 
 
 
 
 
 
Figure 4.7, red arrows). In the hY5 L4-6 mutant the hY5 RNA sequence UGGGU was 
mutated to CAACC. Intriguingly this mutant folded completely differently compared to 
the wild type and did not generate YsRNAs either from the 3’ end or the 5’ end of hY5 
RNA (Figure 4.7, C).  
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Figure 4.7. Library 4 hY5 RNA mutants generate wild type-sized YsRNAs. 
A. Abundances of validated mutant pool 4 hY5 sRNA mutants.   
The abundances of each hY5 library 4 mutant with the most abundant YsRNAs were 
normalized across all the three replicates.  
B. Sequence logo analysis of 30 most abundant hY5 library 4 mutants that generated 
the most YsRNAs using WebLogo 3.  
The sequence logo UGGGU seems to be strongly preferred compared to other L4 hY5 mutant 
sequences.  
C. Predicted secondary structures of the L4 hY5 RNA mutants with the most abundant 
YsRNA reads and one low abundant L4 hY5 mutant.   
The secondary structures were predicted using RNAfold and were visualized using Varna. 
The L4 hY5 RNA mutants the five most abundant and one low abundant YsRNA reads. The 
L4 hY5 RNA sequences fold similar to the wild type hY5 RNA structure. The red arrows 
indicate the observed cleavage positions.  
D. Northern blot analysis of the library 4 hY5 RNA mutants with the five most abundant 
library 4 hY5 RNA mutants and one low abundant YsRNA reads.  
Total RNA extracted from human MCF7 cells treated with poly (I:C) and a synthetic 3’ end 
derived hY5 fragment of 31 nt were used as a size marker for full length hY5 RNA and wild 
type-sized YsRNAs.  
Total RNA was extracted from the five most abundant L4 hY5 mutants and one low abundant 
library 4 hY5 mutant and analysed by Northern blotting. The Northern blot was probed with 
the 3’ and 5’ YsRNA probes. The blot was re-probed with U6 as a loading control. The YsRNAs 
produced from the five most abundant hY5 library 4 mutants were at the same size as wild 
type hY5 YsRNAs.  
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4.2.5 Library 5 hY5 RNA mutants produce wild type sized YsRNAs 
 
The bioinformatics analysis of YsRNA sequencing reads showed that hY5 library 
mutant pool 5 derived YsRNAs are mainly 30 nt reads as seen for hY5 library 4 
mutants and the wild type hY5 RNA. The library 5 mutant pool derived YsRNAs were 
ranked by abundance and I analyzed 30 library 5 hY5 RNA mutants with the most 
abundant and least abundant YsRNA using RNAfold. In addition, I carried out 
sequence logo analysis of 30 library 5 hY5 RNA mutant sequences that generated 
the most YsRNAs using WebLogo3. 
The secondary structure analysis showed that the overall structure of the most 
abundant hY5 library 5 mutants is more or less similar to the wild type hY5 RNA. 
However, for some of the L5 hY5 RNA mutants the secondary structure changed in 
way that an additional internal loop is formed further upstream close to the introduced 
mutations of L5 as could be observed for L5-2 UAUGG and L5-4 UAUGA mutants 
(Figure 4.8, C). 
The sequence logo analysis showed that there is a preference for the RNA sequence 
UAU at the first three positions of library 5 mutated region (Figure 4.8, B)  
At position 5 of library 4 The sequence logo of library 4 which was shown in Figure 
4.7 revealed that uridine at the 5th position of the sequence logo is preferred.  
Also, I did a multiple sequence alignment of all human Y RNAs and I could clearly 
show that the motif UUAU is conserved among hY5, hY4 and hY1 but not hY3, 
whereas the U at the third position is highly conserved among all human Y RNAs.  
I cloned the hY5 mutant pool 5 library mutants that generated the five most abundant 
YsRNAs (Figure 4.8, A) individually into pGEMT easy vector and tested their 
expression level by Northern blot analysis.  
The Northern blot analysis of mutant pool 5 hY5 RNA mutants revealed that all the 
tested hY5 RNA mutants generated wildtype-sized YsRNAs (Figure 4.8, C).  
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Figure 4.8. hY5 library 5 mutant Y RNAs produce wild type sized YsRNAs. 
A.  Abundances of validated mutant pool 5 hY5 sRNA mutants. 
The abundances of each hY5 library 5 mutant with the most abundant YsRNAs were 
normalized across all the three replicates.  
B. Sequence logo analysis of library 5 hY5 RNA mutants with the 30 most abundant 
YsRNA reads. 
The sequence logo analysis was carried out using Weblogo3. The sequence logo analysis 
shows sequence preference for the motif UAUCG for 30 mer YsRNAs.  
C. Predicted secondary structures of L5 hY5 RNA mutants with the four most abundant 
YsRNAs.  
The secondary structures were predicted using RNAfold and visualized using Varna. 
The L5 hY5 RNA sequences that resulted in the four most abundant YsRNAs fold more or 
less similar to the wild type hY5 RNA structure, but some L5 hY5 RNA mutants have an 
additional internal loop.  
D. Northern blot analysis of L5 hY5 RNA mutants with the five most abundant library 5 
hY5 RNA mutants.  
Total RNA extracted from human MCF7 cells treated with poly (I:C) and a synthetic 3’ end 
derived hY5 fragment of 31 nt were used as a size marker for full length hY5 RNA and wild 
type-sized YsRNAs. Total RNA was extracted from the L5 hY5 RNA mutant sequences that 
resulted in the five most abundant YsRNAs and compared to the wild type hY5 RNA derived 
YsRNAs by Northern blotting. The Northern blot was probed with the 3’ and 5’ YsRNA probes. 
As a loading control the Northern blot membrane was re-probed with U6. The five most 
abundant hY5 library mutants that were analysed produced wild type-sized hY5 YsRNAs both 
from the 3’ end and the 5’ end of the hY5 RNA. 
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4.2.6 Library 6 hY5 RNA mutants generate YsRNAs at the same size as 
wild type 
 
The size class distribution of YsRNAs from library 6 revealed that the length of hY5 
mutant pool 6 YsRNAs is mainly 30 nt (Figure 4.6, D). Interestingly, hY5 library 6 
mutants also generated longer YsRNA fragments of 31 nt that could not be detected 
in hY5 mutant pool 4 and 5.  
Due to the fact that hY5 library 6 mutants mainly produced YsRNAs with 30/31 nt and 
not YsRNAs with a length of 32 nt as we expected, the sequence information of the 
fourth and fifth nucleotide for the 30 mer YsRNAs and the fifth nucleotide for the 31 
mer YsRNAs of the mutated five nucleotide hY5 library 6 motif got lost. Even with the 
bioinformatics analysis of the hY5 library 6 full length libraries we could not be sure 
from which mutant motif the YsRNAs of 30/31 nt were derived.  
The YsRNAs from library 6 were ranked by abundance (Figure 4.9, A) and I folded 
30 library 6 hY5 RNA mutant sequences with the most abundant YsRNA reads using 
RNAfold. I also performed sequence logo analysis of all these L6 hY5 RNA mutant 
sequences using WebLogo3. 
The predicted secondary structures of hY5 library 6 mutants folded in a different way 
than the wild type hY5 RNA (Figure 4.9, C). The sequence logo analysis showed that 
for 32/33mer library 6 mutant YsRNAs there seems to be a preference for guanosine 
at each position of the mutated region (Figure 4.9, B).  
The Northern blot analysis demonstrated that the pool 6 mutants produced YsRNAs 
with 30 nt and 31 nt from the 5’ end (Figure 4.9, D).  
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Figure 4.9. Library 6 mutant Y RNAs produce wild type sized YsRNAs. 
A. Abundances of validated mutant pool 6 hY5 RNA mutants.  
The abundances of L6 hY5 RNA mutants that resulted in the most abundant YsRNAs were 
normalized for each library replicate and the abundance of L6 hY5 RNA mutants with the four 
most abundant 32 mer YsRNAs are listed.  
B. Sequence logo analysis of 30 L6 hY5 RNA mutant sequence that generated the most 
YsRNAs. 
The sequence logo analysis was performed using WebLogo 3. For L6 hY5 RNA mutants no 
sequence motif preference could be observed.   
C. Predicted secondary structures of L6 hY5 RNA mutants with most abundant 
YsRNAs. 
The secondary structure analysis was performed using RNAfold and the structures were 
visualized by Varna. The L6 hY5 RNA mutants with the most abundant fold in a different way 
than the wild type hY5 RNA.  
D. Northern blot analysis of the five most abundant library 6 hY5 RNA mutants.  
Total RNA extracted from human MCF7 cells treated with poly (I:C) and a synthetic 3’ end 
derived hY5 fragment of 31 nt were used as size markers for full length hY5 RNA and wild 
type-sized YsRNAs. Total RNA was extracted from the five most abundant L6 hY5 mutants 
and compared to the wild type hY5 RNA by Northern blotting. The Northern blot was probed 
with the 3’ and 5’ YsRNA probes. As a loading control the Northern blot membrane was probed 
with U6. The five most abundant hY5 library mutants that were analysed produced wild type-
sized hY5 YsRNAs both from the 3’ end and the 5’ end of the hY5 RNA.  
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4.2.7 Is the loop L2b important for human Y5 RNA cleavage?  
 
Bioinformatics analysis and sequence logo analysis of the mutant pool 4 and 5 
YsRNAs indicated that the region around the loop L2b (Figure 4.10, A) might be 
important for human Y5 RNA cleavage from the 3’ and 5’ end.   
Interestingly, the upper stem domain of Y RNA is characterized by a highly conserved 
A/GUG-CAC-U nucleotide sequence motif that was previously reported to be required 
for chromosomal DNA replication initiation (Christov et al., 2006; Gardiner et al., 2009; 
Wang et al., 2014). Interestingly, in nematode sbRNAs the penta-nucleotide motif 
UUAUC motif was identified which is part of the internal loop L2b. Thus, this region 
of hY5 RNA might be essential for the initiation of DNA replication as it was already 
observed in nematode sbRNAs and Dm1 in Drosophila melanogaster. The region 
which was shown to be essential of DNA replication initiation is shown in light green 
and is close to the internal loop L2b.  
4.2.7.1 The uridine at position 22 essential for Y RNA cleavage from the 5’ 
end 
In this part of the work I investigated if the wild type RNA sequence UGGGU is 
necessary for 3’ and 5’ end hY5 RNA cleavage. The sequence logo analysis of mutant 
pool 4 YsRNAs showed a strong preference for U at the last position (Figure 4.7, B).  
Interestingly, in the multiple sequence alignment of all human Y RNAs I observed that 
uridine at the first position, guanine at the second position and uridine at the fifth 
position are conserved in all the human Y RNAs (Figure 4.10, B). 
In order to check if the uridine at the fifth position of the RNA sequence logo is 
essential, I replaced the U by A, C and G. I generated the hY5 RNA mutants UGGGC 
and UGGGA and UGGGG and looked at the YsRNA accumulation by Northern blot 
analysis. Interestingly, the mutant UGGGC folded exactly in the same manner as the 
wild type sequence (Figure 4.10, C). However, when the YsRNAs that were derived 
from the hY5 RNA mutant UGGGC were compared with the wild type hY5 derived 
YsRNAs by Northern blotting I could show that Y RNA cleavage was clearly affected 
and impaired at the 5’ end of the hY5 RNA.  
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From the 3’ end of hY5 RNAs Y RNA cleavage still occurred in the mutants but Y 
RNA cleavage was decreased in the substitution mutants compared to the wild type 
hY5 RNA. 
From these results it can be concluded that the uridine at position 22 of the conserved 
Y RNA sequence motif UGGGU is essential for 5’ end hY5 RNA cleavage and might 
be involved in 3’ end hY5 RNA cleavage. 
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Figure 4.10. The uridine at position 22 is essential for 5’ end hY5 RNA cleavage 
and might be involved in 3’ end hY5 RNA cleavage.  
A. Predicted secondary structure of human Y5 RNA including characteristic secondary 
structure features.  
The human Y5 RNA has a characteristic stem loop structure. The Ro60 protein binds to a C-
bulge within the highly conserved stem S1, whereas the La protein interacts with the uridine-
stretch at the 3’ end. The secondary structure of hY5 contains stem regions (S1, S2 and S3) 
as well as several internal loop regions or smaller bulges (L1, L2a, L2b, L3).  
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B.  ultiple sequence alignment of the 5’ end of all human Y RNAs using the ClustalW 
algorithm.  
The multiple sequence alignment shows that the pool 4 mutated region TGGGT is conserved 
at the first, second and last position.  
C. Secondary structures of hY5 RNA with the wild type sequence motif UGGGU and 
substitutions hY5 RNA mutants.   
In hY5 RNA mutant pool 4 sequences the uridine residue at position 22 was substituted by 
adenine, cytosine and guanosine. The secondary structures were folded using RNAfold and 
visualized by Varna.  
D. Northern blot analysis of mutant pool 4 YsRNAs derived from hY5 substitution 
mutants UGGGA, UGGGC and UGGGG compared to the wild type YsRNA accumulation.  
Mouse 3T3 cells were transfected with plasmid DNA constructs encoding mutant pool 4 hY5 
RNA sequences with the sequence motifs UGGGA, UGGGC and UGGGG and the wild type 
hY5 RNA sequence motif UGGGU. Total RNA was extracted and the expression of mutant 
pool 4 derived YsRNAs compared to wild type hY5 RNA derived YsRNAs by Northern blotting. 
As a size marker a synthetic 5’ end derived hY5 fragment and RNA extracted from MCF7 cells 
treated with poly (I:C) were loaded. The Northern blot membrane was hybridized using the 5’ 
and 3’ end hY5 RNA probes. U6 was used as a loading control.  
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4.2.7.2 Role of UUAU motif at position 22-25 for 3’ and 5’ end hY5 RNA 
cleavage  
 
Intriguingly, further secondary structure and northern blot analysis of library 1 hY5 
RNA mutants (described in the previous chapter 3.2.2) also revealed that the loop 
L2b at the position 22-26 of hY5 RNA (shown in turquoise in Figure 4.11, A) might 
contribute to YsRNA generation from the 3’ and 5’ end.  
For this analysis, I compared the abundance of YsRNAs derived from mutant pool 1 
to the abundance of mutant pool 1 hY5 full length sequences. The YsRNAs with the 
highest number of abundance were ranked as number one (Figure 4.11, B).  
First, I predicted the secondary structures of the 30 most abundant L1 hY5 mutants 
that produced a significant number of YsRNAs compared to full length transcripts 
using RNAfold (Figure 4.11, C and D).  
I could show that the secondary structures folded in a similar way as the wild type 
hY5 RNA (Figure 4.11, C and D). I performed a detailed secondary structure analysis  
and is summarized in Figure 4.11, E. 
From the secondary structure analysis (Figure 4.11, E) it can be seen that the L1 hY5 
mutants that generated a small amount of YsRNAs compared to the full-length 
transcript showed a different secondary structure than the wild type hY5 RNA.  
The hY5 RNA library 1 mutants that showed a high accumulation of YsRNAs 
compared to the full length hY5 RNA all of these mutants had an internal loop L2b 
consisting of 4 nt with the sequence UUAU whereas hY5 library 1 mutants that 
produced a low amount of YsRNAs compared to the full length hY5 RNA all had a 
shortened internal loop L2b of 3 nt. Additionally, it was noted that in mutants that 
showed a high accumulation of YsRNAs the internal loop L2a where the 3’ hY5 RNA 
cleavage occurs was 9 nt. In the hY5 RNA library 1 mutants with low amount of 
YsRNAs this internal loop L2a was enlarged by 1 nt to 10 nt in total. Also, the stem 
regions S2 and S3 seemed to be less stable than in the hY5 RNA mutants that 
generated a lot of YsRNAs.  
Notably, the main difference between the mutants that had a high accumulation of 
YsRNAs and the mutants that produced a low amount of YsRNAs was that the 
internal loop L2b in the less efficient L1 hY5 RNA mutants got shortened from four 
nucleotides to three nucleotides.  
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The sequence logo analysis that was performed for mutant pool 4 and 5 and the 
change of secondary structure introduced by L1 hY5 RNA mutations was the rationale 
for further investigation into the importance of the internal L2b loop. 
In order to validate the results from the secondary structure analysis I cloned three 
L1 hY5 mutants that produced a good amount of YsRNAs and three L1 hY5 mutants 
that produced only a small amount of YsRNAs compared to the full length hY5 mutant 
transcript (Figure 4.11, A) individually and I transfected the constructs into mouse 
cells. The cells were treated to induce Y RNA cleavage. I tested the YsRNA 
accumulation by Northern blot.  
The Northern blot analysis and relative quantification of the Northern blots by 
densitometry confirmed the bioinformatics analysis and showed the difference in 
YsRNA accumulation between the hY5 mutant sequences that produced a good 
amount of YsRNAs and the mutants that produced little or no YsRNAs compared to 
the full length hY5 RNA (Figure 4.11, F, G, H and I). When the ratio between the 
produced mutant YsRNA levels and the full length hY5 RNA mutant transcript levels 
calculated was compared I could show that the library 1 hY5 RNA mutants with the 
internal loop L2a intact are more efficiently processed than the library 1 hY5 RNA 
mutants in which the internal loop L2a got shortened by the introduced mutations. 
Also, for the 5’ end derived YsRNAs I observed a decrease of YsRNA accumulation 
when the internal loop L2a got shortened (Figure 4.11, I).  
In conclusion, both the 3’ and 5’ end hY5 RNA cleavage seemed to be impaired in 
the hY5 mutants with a shorter internal loop L2b (Figure 4.11, G and I). These results 
together with the secondary structure predictions of these mutants suggested that the 
internal loop L2b might contribute to 3’ and 5’ hY5 RNA cleavage.  
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Figure 4.11. The internal loop L2b seems to be important for human Y5 RNA 
cleavage from both the 3’ and 5’ end of human Y5 RNA.  
A. Predicted secondary structure of human Y5 RNA including the mutated region of 
loop L2b. 
The secondary structure of human Y5 RNA was predicted using RNAfold and visualized using 
Varna. The internal loop L2b is shown in turquoise.  
B. Abundances and ranks for L1 mutant hY5 RNA full length transcripts that have a 
high or low accumulation of YsRNAs.  
The abundances were normalized across all three replicates.  
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C. Predicted secondary structures of mutant pool 1 hY5 RNA mutants that show high 
accumulation of YsRNAs compared to the full length transcript level. 
The secondary structures were predicted with RNAfold under default parameters und were 
visualized using Varna.  
D. Predicted secondary structures of mutant pool 1 hY5 RNA mutants that have a low 
accumulation of YsRNAs compared to the full length transcript level. 
The secondary structures were predicted with RNAfold under default parameters und were 
visualized using Varna.  
E. Analysis of secondary structure features of library 1 hY5 RNA mutants.  
The table gives an overview of the nucleotide and base pair composition of stem S3, internal 
loop L2a and stem S3 for the tested library 1 hY5 RNA mutants.   
F. Northern blot of library 1 hY5 RNA mutants that generate a high/low amount of 
YsRNAs compared to the full length hY5 RNA level.  
Three hY5 RNA mutants that generate a high number of YsRNAs compared to the full length 
hY5 level were compared to the hY5 RNA mutants that generated little/no YsRNAs. Mouse 
3T3 cells were transfected with library 1 hY5 RNA mutant plasmid DNAs and treated with 
staurosporine to induce Y RNA cleavage. Total RNA was extracted and the Northern blot 
membrane was probed with the 3’ and 5’ end probe. Total RNA extracted from MCF7 cells 
treated with poly (I:C) for 8 h was used as a size marker. The membrane was stripped and re-
probed with U6 in order to ensure equal loading.  
G. Relative quantification of 3’ end derived mutant pool 1 YsRNAs.  
The Northern blot of 3’ end derived mutant pool 1 YsRNAs was quantified using the 
ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1.  
H. Calculated ratio between the expression level of full length library 1 hY5 RNA mutant 
sequences compared to the expression level of mutant pool 1 YsRNAs. 
The ratio of the normalized optical density of full length L1 hY5 RNA mutants and the 3’ end 
derived YsRNAs was calculated and plotted on the graph.  
I. Relative quantification of 3’ end derived mutant pool 1 YsRNAs.  
The Northern blot of 5’ end derived mutant pool 1 YsRNAs was quantified using the 
ImageQuant software. The optical density of each mutant was normalized to the loading 
control U6 and the wild type hY5 RNA derived YsRNAs. The normalized optical density of the 
wild type derived YsRNAs was set at 1.  
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In further experiments I tested if the nucleotide sequence or the structure of the 
internal loop L2b is important for hY5 RNA cleavage. First, all possible hY5 RNA 
mutant combinations with the mutated RNA sequence motif UUAU were generated 
in-silico resulting in 256 possible sequence combinations (data not shown).  
Twenty two hY5 RNA mutants out of the 256 hY5 RNA mutants folded the same as 
wild type hY5 RNA (Figure 4.12, A)  
I cloned four hY5 RNA mutants out of the 22 hY5 RNA mutants that folded the same 
as wild type hY5 RNA individually and tested YsRNA accumulation by Northern blot. 
Interestingly, all four hY5 RNA mutants (AAAU, UUUU, CGUU, CCCC) with mutated 
internal L2b loop but same secondary structure than wild type showed decreased 
levels of YsRNAs from both the 5’ and 3’ end. Thus, these results gave some 
indication that the secondary structure of the internal loop L2b might not be critical for 
hY5 RNA cleavage and that the nucleotide sequence of this internal loop might affect 
both the 3’ and 5’ end hY5 RNA cleavage.  
In order to further test if the internal loop L2b is critical for hY5 RNA cleavage I 
generated three additional hY5 RNA mutants with different secondary structure than 
wild type hY5 RNA. In these hY5 RNA mutants I mutated the sequence motif UUAU 
to AAAA, AUAU and CACC. I tested the generated hY5 RNA Loop L2b mutants 
experimentally by Northern blot (Figure 4.12, C).   
Intriguingly, the Northern blot analysis showed that the mutations introduced in the 
hY5 RNA sequences resulted in lower accumulation of YsRNAs from both the 3’ and 
5’ end compared to the wild type hY5 RNA (Figure 4.12, C)  
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Figure 4.12. The wild type sequence motif UUAU of the internal loop L2b is 
important for 3’ and 5’ end hY5 RNA cleavage.  
A. Predicted secondary structures of hY5 RNA mutants with mutations in the internal 
loop L2b that fold the same way as wild type hY5 RNA. 
The mutated region is shown in turquoise. The hY5 RNA mutants have exactly the same 
secondary structure as wild type hY5 RNA. 
B. Predicted secondary structures of hY5 RNA mutants with mutations in the internal 
loop L2b that have a different secondary structure to the wild type hY5 RNA.  
The RNA secondary structures were predicted using RNAfold. The mutated region is shown 
in turquoise. The hY5 RNA mutants have different secondary structure as wild type hY5 RNA. 
C. Northern blot of YsRNAs derived from hY5 RNA mutants in which the sequence of 
the internal loop was mutated.  
The Northern blot membrane was hybridized with the 3’ and 5’ end hY5 probe. As a size 
marker a synthetic version of the 5’ end derived hY5 fragment was used. For equal loading 
the membrane was re-probed with U6.  
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4.3 Discussion  
 
With the recent advances of next generation sequencing technologies novel classes 
of small RNAs derived from longer transcripts have been identified. Among them, 5’ 
end derived Y RNA fragments have been found highly enriched in extracellular 
vesicles released from various body fluids and have been shown to be associated 
with multiple types of cancer (Dhahbi et al., 2013; Dhahbi et al., 2014; Victoria 
Martinez et al., 2015; Tolkach et al., 2017; Tolkach et al., 2018).  
Recently, Chakrabortty et al. demonstrated that 5’ end derived hY5 fragments are 
functional and trigger apoptosis when primary cells were treated with EVs derived 
from cancer cells. Interestingly, these functional 5’ end derived hY5 RNA fragments 
contain a conserved 8 nt motif in the upper stem of Y RNAs (5’-GUUGUGGG-3’) that 
is also required for the initiation of chromosomal DNA replication (Gardiner et al., 
2009). 
A few years later further mutagenesis experiments on the conserved functional upper 
stem region of human Y1 were performed by Wang et al. in order to investigate which 
nucleotides or structural requirements contribute to the function of Y RNAs in 
chromosomal DNA replication (Wang et al., 2014). They applied biophysical methods 
such as solution state nuclear magnetic resonance (NMR) and far-UV circular 
dichroism (CD) spectrometry on mutated upper stem versions of hY1 RNA and 
compared the spectra to the wild type hY1 conserved stem. Sequence alignment and 
sequence logo analysis of vertebrate Y RNAs showed that the GUG-CAC nucleotide 
motif is evolutionarily conserved among all vertebrates. This indicates that this region 
might contribute to functionality due to selection pressure during evolution (Wang et 
al., 2014). When GUG was mutated to ACA the initiation of DNA replication was 
abolished. NMR spectroscopy and previous structure probing experiments revealed 
that the base pairs G17-C91 and C19-C87 are required for initiation of DNA 
replication. The G-C base pairs function as clamps in order to stabilize the unstable 
base pairs in the upper stem domain of hY1 RNA in an A-form helix. Mutations that 
lead to the destabilization of the A-form helical structure result in the impairment of 
DNA replication initiation (Wang et al., 2014).  
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Therefore, mutagenesis and biophysical analysis of the upper stem domain of hY1 Y 
RNA demonstrated that the highly evolutionarily conserved nucleotides and the 
stability of secondary structure in this region contributed to the function of hY1 in the 
initiation of DNA replication.  
Interestingly, nematode sbRNAs and vertebrate Y RNAs have similar sequence and 
secondary structure features. Among them, the GUG-CAC motif and a further 
downstream penta-nucleotide motif UUAUC which were shown to be required for the 
initiation of DNA replication (Gardiner et al., 2009; Kowalski et al., 2015).  
All the literature and findings that the 5’ end derived hY5 RNA fragments are 
functional in combination with our results from the 3’ hY5 RNA mutagenesis 
experiments gave us the motivation to further investigate the sequence and structural 
requirements for the 5’ end hY5 RNA cleavage.  
In this chapter, I mutated three different regions along the hY5 RNA close to the 5’ 
end cleavage site in a high throughput mutagenesis approach using degenerate 
nucleotides similar to the 3’ end hY5 mutagenesis approach.  
The generated cDNA libraries were sent for NGS and bioinformatics analysis 
revealed that mutant pools 4, 5 and 6 mainly generated YsRNAs with 30 nt indicating 
that the hY5 RNA cleavage from the 5’ end in general occurs between A30 and A31 
at the position UA^A. However, the size class distribution of the YsRNA libraries also 
showed different sized YsRNAs with 26, 29, 30, 31, 32 or 33 nt. This heterogeneity 
of 5’ end derived sRNAs could be explained that either the RNase involved in not very 
specific or that different ribonucleases are involved in Y RNA cleavage from the 5’ 
end. Thus, it could be the case that different sizes 5’ end derived YsRNAs could have 
different functions such as in extracellular vesicles or body fluids.  
Intriguingly, Donovan et al. suggested that RNase L is responsible for Y RNA and 
tRNA cleavage during poly (I:C) treatment (Donovan et al., 2017). RNase L is a metal 
ion independent endoribonuclease that gets activated during viral response and 
cleaves single-stranded RNAs leaving a 2’, 3’-cyclic phosphate. Donovan et al. 
generated small RNA cDNA libraries of stress induced RNAs containing a 2’, 3’-cyclic 
phosphate using RtcB ligase instead of the commercial T4 RNA ligase 2 in order to 
capture RNAs with 2’, 3’-cyclic phosphates on the 3’ end of RNA fragments. Their 
sequencing results showed that the cleaved RNA fragments during poly (I:C) 
treatment all had a consensus motif UN^N at the cleavage site compared to the 
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untreated control samples indicating that RNase L is responsible for Y RNA cleavage. 
Using the RtcB ligase cDNA library preparation method for hY5 RNA the main 
cleavage sites were at position 26 (UU^G), 29 (UU^A) and 30 (UA^A) which is 
controversial because RNase L is known to cleave single-stranded RNA and hY5 
RNA is double-stranded in all the cleavage sites. This would imply that the double-
stranded regions would need to get unwound and refolded in a way that the RNA gets 
single-stranded.  
These results made it even more important to determine whether it is the nucleotide 
sequence or the secondary structure or both which are required for human Y5 RNA 
cleavage to occur.  
In this chapter I could clearly show by sequence logo analysis and individual 
substitution mutations of library 4 YsRNA mutants that at position 22 a uridine residue 
is critical for hY5 RNA cleavage from the 5’ end.  
The Northern blot analysis clearly demonstrated that when the uridine at the fifth 
position was mutated to adenine, cytidine, or guanine YsRNA generation from the 5’ 
end of hY5 RNA was abolished and no YsRNAs could not be detected. Interestingly, 
hY5 RNA was still cleaved from the 3’ end of hY5 RNAs in the substitutions hY5 RNA 
mutants but the YsRNA accumulation was decreased compared to the accumulation 
of YsRNAs derived from the wild type hY5 RNA. Additionally, in the multiple sequence 
alignment of all human Y RNAs I observed that this uridine residue is highly 
conserved among all the human Y RNAs.  
Intriguingly, part of the RNA motif UGGGU that was selected for library 4 hY5 RNA 
mutagenesis shares the nucleotides UGGG at the position 18-21 with the consensus 
sequence GUAGUGGG that was previously shown to be essential for DNA replication 
initiation (Christov et al., 2006). Also, Chakrabortty et al., reported that the sequence 
GUUGUGGG as part of the 5’ end derived hY5 RNA fragment is required for 
triggering apoptosis. Additionally, the results of the hY5 library 4 mutagenesis 
analysis confirmed that uridine at position 22 was critical for 5’ end hY5 RNA cleavage 
and contributes to 3’ end hY5 RNA cleavage. These results gave further insights that 
the region 5’-GUUGUGGG-3’ including the uridine at position 22 might be important 
for functionality. 
Remarkably, from all the bioinformatics, secondary structure and sequence logo 
analysis of hY5 library 4 and 5 hY5 RNA mutants I concluded that the internal loop 
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L2b at the positions 22-25 might also be involved in Y RNA cleavage from both the 3’ 
and 5’ end of hY5 RNAs.  
Intriguingly, this internal loop got my interest already during the 3’ end mutagenesis 
analysis of hY5 L1 mutants. Secondary structure prediction of hY5 L1 mutants that 
generated a good amount of YsRNAs compared to the full length hY5 RNA and hY5 
L1 mutants that produced little/low amount of YsRNAs showed clear differences in 
the size of the internal loop L2b.  
Individual hY5 L1 mutants that produced a good amount of YsRNAs and those that 
generated little amount of YsRNAs were taken for further validation.  
The Northern blot analysis demonstrated that the hY5 L1 mutants with an internal 
loop with the sequence UUAU showed a high YsRNA accumulation compared to the 
hY5 L1 mutants that had a shorter internal L2b loop. From these results it could be 
suggested that the internal loop with the sequence UUAU affected hY5 RNA cleavage 
from both the 3’ and 5’ end.  
The sequence logo analysis of the most abundant mutant pool 5 YsRNAs indicated 
that the sequence UAU is preferred. In order to validate if it is the nucleotide sequence 
UUAU or the secondary structure or both that are required for hY5 RNA cleavage to 
occur I tested several substitution mutants for YsRNA accumulation.  
Secondary structure analysis of all the possible nucleotide combinations of the RNA 
motif UUAU was performed and I observed that 22 hY5 RNA mutants had the same 
secondary structure than the wild type hY5 RNA.  
Northern blot analysis of 4 out of 22 hY5 RNA mutants with the same secondary 
structure but different primary sequence than wild type demonstrated that in all the 
hY5 RNA mutants YsRNA generation from both the 3’ and 5’ end of hY5 RNAs was 
impaired.  
From these results it was suggested that both the sequence UUAU and the secondary 
structure of the internal loop L2b (single-stranded RNA) might contribute to hY5 RNA 
cleavage from both the 3’ and 5’ end.  
Notably, in order to make this conclusion all the other 18 hY5 RNA mutants that folded 
the same way than wild type hY5 RNA should be tested and further investigation of 
mutant pool 5 hY5 RNA mutants is needed to pinpoint the exact sequence and 
structural requirement of this internal loop for Y RNA cleavage. In future experiments 
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it might be worthwhile to check if the 5’ end hY5 fragment with mutations in this 
internal loop is still functional and triggers apoptosis.  
The multiple sequence alignment of all human Y RNAs also revealed that the RNA 
motif UUAU is highly conserved between hY5, hY4 and hY1, whereas hY3 had one 
mismatch. This observed nucleotide conservation indicates that due to the selection 
pressure during evolution, this part of the sequence might have been important for 
the function of Y RNAs. Interestingly, the penta-nucleotide sequence motif UUAUC is 
highly conserved among nematode sbRNAs and are functional in the initiation of DNA 
replication. Also, it was shown in phylogenetic analysis that nematode sbRNAs are 
evolutionarily more related to Y5 than to the other major Y RNA clades (Kowalski et 
al., 2015; Duarte Junior et al., 2019).  
Unexpectedly, the analysis of mutant pool 6 YsRNAs allowed us to determine the 
cleavage site from the 5’ end which is mainly between position A30 and A31 
generating YsRNAs of 30 nt and not 32 nt as previously anticipated. For this reason 
the analysis of the mutant pool 6 YsRNA libraries with sizes under 32 nt was difficult 
as it was impossible to figure out from which full length hY5 RNA mutant the sRNA 
was derived. The sequence logo analysis of the most abundant mutant pool 6 
YsRNAs showed some preference for guanidine at all the positions. The predicted 
secondary structures of mutant pool 6 hY5 RNAs folded in a different way than the 
wild type hY5 RNA indicating that this part of the mutated region is not structure 
dependent and confers some structural flexibility and accessibility for RNA binding 
proteins and endoribonucleases responsible for hY5 RNA cleavage.  
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Chapter 5 Investigation of proteins involved in Y 
RNA cleavage 
 
5.1 Introduction  
 
5.1.1  Role of RNA binding proteins in cellular stress conditions 
 
RNA binding proteins (RBPs) are key players of post-transcriptional gene regulation. 
They are involved in every step of RNA metabolism from transcription to processing, 
cellular localization, stability, transport, translation and the degradation of mRNAs 
(Glisovic et al., 2008; Lukong et al., 2008).  
During the last decade over 1500 human RBPs have been identified and various RNA 
binding domains have been characterized. These domains include the most 
prominent RNA recognition motif (RRM), the hnRNP K homology (KH) domain, DEAD 
box helicase domain, double stranded RNA binding motif, Zinc finger, Pumilio domain 
or the Piwi/Argonaute/Zwille (PAZ) domain (Gerstberger et al., 2014).  
Most of the RBPs have a modular architecture and interact with RNA via one or 
multiple RNA binding domains in a sequence and or structure dependent manner 
(Lunde et al., 2007; Dominguez et al., 2018). RBPs often form large dynamic 
ribonucleoprotein complexes (RNPs) with coding, non-coding or untranslated RNA 
(Lukong et al., 2008). The dynamic assembly and disassembly of RNPs allows the 
spatial and temporal regulation of gene expression at post-transcriptional level. RNPs 
mediate fine-tuning of the complex transcriptomic and proteomic landscape. The 
composition of the RNPs controls the way how cells respond and adapt to stress 
conditions rapidly (Beckmann et al., 2016).  
The dysregulation and aberrant function of RNPs has been shown to be often 
associated with various different human diseases, including genetic diseases 
(Castello et al., 2013), neurodegenerative disorders (Cookson, 2017), neuromuscular 
diseases (Kolb et al., 2007), autoimmune disorders (Turner and DÍaz-Muñoz, 2018) 
or cancer (Pereira et al., 2017). 
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5.1.2 Y RNAs as part of RoRNPs  
 
Y RNAs were initially discovered as components of the Ro60 and La 
ribonucleoprotein complexes in sera of patients with the autoimmune disorders 
systemic lupus erythematosus and Sjögren’s syndrome (Lerner et al., 1981a; Wolin 
and Steitz, 1984). RoRNPs are involved in diverse cellular processes such as quality 
control pathways of various non-coding RNAs and stress response mechanisms 
including cell survival induced by UV irradiation or the regulation of RNA metabolism 
during different environmental stress conditions (Sim and Wolin, 2011).  
Several studies reported that Ro60 contributes to Y RNA stability in animals and 
bacteria. Intriguingly, the levels of Y RNA transcripts were dramatically reduced in 
Ro60 -/- cells (Labbé et al., 1999) and Ro60 -/- mice were more sensitive to develop 
lupus like syndromes (Xue et al., 2003).  
However, the precise biochemical function of RoRNPs and the role of Y RNAs during 
stress conditions remains poorly characterized.  
 
5.1.3 Role of ribonucleases during stress  
 
Ribonucleases (RNases) are enzymes that catalyse the cleavage of RNA at 
phosphodiester bonds. RNases have an essential role in the regulation of gene 
expression, RNA processing and turnover. During stress response RNases target 
mRNAs and non-coding RNAs specifically for degradation in order to respond rapidly 
to the change of environmental conditions. Several studies showed that during stress 
longer non-coding RNAs were processed into smaller RNA fragments by 
endonucleolytic cleavage and some of these fragments were proven to be functional 
(Thompson and Parker, 2009; Rother and Meister, 2011).  
Rutjes et al, described that during apoptosis Y RNAs are rapidly and specifically 
cleaved in a caspase-dependent manner generating shorter YsRNA fragments 
between 22-25 nt and a larger fragment of 31 nt (Rutjes et al., 1999a). In this study it 
was suggested that the nucleases that cleave Y RNAs are caspase-dependent 
nucleases since Y RNA cleavage was similar to the cleavage of the U1-70K which 
was shown to be caspase-3-dependent (Casciola-Rosen et al., 1994; Rutjes et al., 
1999a).  
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Recently, it was reported that RNase L is involved in tRNA and Y RNA cleavage 
during stress conditions. RNase L is an endoribonuclease that is activated in cells 
upon viral infection as part of the interferon induced viral response pathway. RNase 
L is only known to cleave single stranded RNAs and not double stranded RNA species 
and leaves a 3’-5’ cyclic phosphate at the cleavage position.  
 
5.1.4 Previous work and aims of this chapter 
 
RNA interference experiments and further biochemical cleavage assays performed 
by a previous PhD student in our laboratory revealed that Ro60 is required for Y RNA 
cleavage during stress (Hall, 2013).  
In order to further validate this finding and to investigate if there are other small RNAs 
dependent on Ro60, I constructed cDNA libraries of wild type and Ro60 -/- mouse 
embryonic stem cells (mES) untreated and treated with poly (I:C). I prepared the small 
RNA cDNA using High Definition (HD) adapters. The cDNA libraries that were 
constructed in previous work were all hugely biased for one sequence when the 
commercial Illumina adapter sequences were used for sRNA cDNA library 
construction.   
The use of HD adapters has the advantage to reduce the ligation bias and to clone 
more different sequences compared to Illumina adapters especially when the small 
RNA repertoire is not large and diverse like the amount of small RNAs of mouse 
embryonic stem cells. It is was shown that in mouse embryonic stem cells there is 
only  (Houbaviy et al., 2003).  
The second aim of this chapter was to investigate if RNase L is involved in YsRNA 
generation. Recently, a study reported that RNase L is responsible for Y RNA 
cleavage in human cells (Donovan et al., 2017). In addition, work by a previous PhD 
student in our laboratory showed that RNase L might contribute to Y RNA cleavage 
in mouse cells upon poly (I:C) treatment (Hall, 2013). However, these results revealed 
that RNase L was only involved in Y RNA cleavage in mouse cells but not in human 
cells. In this chapter further experiments have been conducted in mouse cells and 
human cells to review if RNase L is required for Y RNA cleavage during stress.  
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5.2 Results 
 
5.2.1 Ro60 is required for Y RNA cleavage  
 
In order to further investigate if Ro60 is required for YsRNA generation, I generated 
cDNA libraries of small RNAs from wild type and Ro60 -/- mouse embryonic stem cells 
(mES) 8 hours after treated with poly (I:C) or mock treatment. The wild type and Ro60 
-/- mES cell line were kindly gifted by Prof. Sandra Wolin. I confirmed the genotype of 
the wild type and Ro60 -/- mES cell line by a Western blot.  
The Western blot showed that in the Ro60 -/- mES cell line no Ro60 could be detected 
whereas in the wild type mES cells Ro60 was expressed (Figure 5.1, A).  
In order to establish whether Ro60 is involved in YsRNA generation as previously 
shown in our laboratory I performed a Northern blot  of the extracted total RNAs from 
wild type and Ro60 -/- mES cells (Figure 5.1, B).  
The Northern blot confirmed that Ro60 -/- mES cells did not generate any YsRNAs 
from the 3’ and 5’ end of mY1 when the cells were treated with poly (I:C). The wild 
type mES cells on the other hand showed mY1 cleavage products from both the 3’ 
and 5’ end of mY1 upon poly (I:C) treatment (Figure 5.1, B). These results showed 
that Ro60 is involved in the generation of Y RNA fragments in mES cells during poly 
(I:C) treatment.  
By Adam Hall it was shown that Ro60 is also required for YsRNA generation from the 
3’ end of human Y5 RNA. Surprisingly, it was observed that the level of full length 
hY5 transcripts in the Ro60 -/- mES cells was not affected by the knockout of Ro60, 
whereas for mouse Y RNAs a dramatic decrease of full length Y RNAs could be seen 
(Hall, 2013).  
In order to confirm this finding mES wild type and Ro60 -/- mES cells were transfected 
with the hY5 wild type plasmid and treated with poly (I:C). Northern blot analysis was 
performed and YsRNA generation was examined.  
The Northern blot experiment confirmed that Ro60 is critical for hY5 RNA cleavage 
from the 3’ end as no YsRNA production could be observed in Ro60 -/- mES cells 
treated with poly (I:C). Additionally, it could be clearly seen that the full length hY5 
RNA transcript level was not decreased in mES Ro60 -/- cells but the mY1 full length 
transcript was significantly reduced in the Ro60 -/- mES cells (Figure 5.1, C).  
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Figure 5.1. Ro60 contributes to Y RNA cleavage in mES cells. 
A. Western blot of wild type and Ro60 -/- mES cell line.  
For the detection of Ro60 an antibody against mouse Ro60 was used. As a loading control 
the membrane was incubated with an antibody against mouse β-actin.  
B. Northern blot of mES wild type and mES Ro60 -/- cells treated and untreated with 
poly (I:C).  
Total RNA of wild type and Ro60 -/- mES cells was extracted 8 hours after treated with poly 
(I:C) or mock treatment and subjected to Northern blot analysis. The membrane was probed 
with oligonucleotides complementary to the 3’ or 5’ end of mY1. U6 was used as a loading 
control.  
C. Northern blot analysis of of mES wild type and mES Ro60 -/- cells transfected with 
hY5 RNA treated and untreated with poly (I:C).  
Total RNA of wild type and Ro60 -/- mES transfected with the hY5 RNA gene and mock treated 
or treated with poly (I:C) was subjected to Northern blot analysis. The membrane was probed 
with oligonucleotides complementary to the 3’ end of hY5 RNA and 3’ end of mY1 RNA. As a 
loading control U6 was used.  
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As Ro60 was shown by Northern blot analysis that it is essential for YsRNA 
generation in human and mouse cells I further investigated by next generation 
sequencing of sRNA cDNA libraries of mES wild type and Ro60-/- cells treated and 
untreated with poly (I:C) if Ro60 is only responsible for YsRNA production or if the 
production of other sRNAs derived from longer transcripts is dependent on Ro60.  
The sRNA cDNA libraries prepared by the previous PhD student Adam Hall were 
hugely biased for one particular sequence and it is reported that mouse embryonic 
stem cells have a less diverse sRNA repertoire, in this thesis I successfully modified 
and adapted the small RNA library construction method in order to allow efficient 
cloning of sRNAs.  
Several recent studies reported that RNA ligases show some sequence preference 
in ligation of small RNAs to the adapter and that some sequences get ligated more 
efficiently than others (Hafner et al., 2011; Jayaprakash et al., 2011; Sorefan et al., 
2012).  
In 2012, our laboratory developed High definition (HD) adapters for the Illumina 
sequencing platform to reduce ligation bias. The HD adapters contain four degenerate 
nucleotides at each of the ligation ends of the commercial Illumina adapters (Figure 
5.2, A and B).  
Sorefan et al reported that sRNA libraries generated with HD adapters recover more 
different sRNA sequences and the obtained sequencing data correlated more 
quantitatively with the real expression level of sRNAs in the cell.  
During recent years an improved method for sRNA library construction using HD 
adapters was developed and many libraries from several different species have been 
successfully generated. However, because of the low amount of sRNAs and less 
sRNA diversity, the protocol had to be modified and an additional gel purification step 
after the first ligation had to be included.  
Two µg of purified total RNA was used for small RNA library preparation and the 
libraries were generated in three replicates. The RNA was ligated to the 3’ end HD 
adapter and the ligation product was separated on an 18% urea polyacrylamide gel 
and purified before the 5’ end HD adapter ligation, as described in detail in the 
materials and methods section.  
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In order to be able to sequence low abundance longer small RNAs with a size of 32-
35 nt such as YsRNA derived fragments and to allow the differential expression 
analysis between Ro60 wild type and Ro60 -/- mouse embryonic stem cells upon poly 
(I:C) treatment, two cDNA library bands were purified (Figure 5.2, C).  
A smaller cDNA library band was purified at the size of 145 nt, which included all 
small RNAs with sizes of 19-21 nt such as miRNAs. A longer cDNA band was also 
cut out between 150-160 nt as this contained all sRNAs between 32-35 nt.  
For the final quantification the cDNA libraries were run on an 8% polyacrylamide gel 
(Figure 5.2, D) and all cDNA library bands were quantified using the Image Quant 
software and sent for next generation sequencing.  
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Figure 5.2. Generation of small RNA cDNA libraries of wild type and Ro60 -/- 
mES cells treated with poly (I:C) or mock treated using High definition adapter 
sequences.  
A. Original Illumina adapter previously used in sRNA library construction.  
During previous sRNA cDNA library construction the 5’ end and 3’ end of a small RNA was 
ligated to the original Illumina adapter sequences.  
B. High definition (HD) adapter used in sRNA library preparation.  
HD adapters include four degenerate nucleotides which were added to the 5’ and 3’ ends of 
the commercial Illumina adapters in order to reduce ligation bias.  
C. Small RNA cDNA library construction.  
Total RNA of wild type and Ro60 -/- mES cells was extracted after with poly (I:C) or mock 
treatment. The sRNA cDNA construction method using HD adapter was modified. Two μg of 
total RNA was used and the product after the first ligation had to be purified by gel extraction. 
The final PCR products were separated on a 8% PAGE and two PCR products including the 
miRNA band (150 nt) and a band containing 30 mer sRNAs (160 nt) were excised (shown in 
boxes and arrows), eluted and ethanol precipitated. A 20 bp DNA ladder was loaded as a size 
marker. 
D. Quantification of YsRNA cDNA libraries.  
One μl of each library replicate was loaded on an 8 % PAGE, alongside of a 20 bp DNA ladder 
and stained with SYBR Gold. The final quantification was carried out using the Image Quant 
software.  
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The bioinformatics analysis was carried out by Simon Moxon. After adapter removal, 
8-13 million reads per library replicate mapping to the mouse genome (GRCm38.91) 
were obtained and between 70-85 % of the reads mapped to the mouse genome (see 
Appendix IV, Table 0.14).  
Principal component analysis (PCA) was performed in order to check if the replicates 
are similar to each other, to evaluate the variation and to evaluate how well the 
different conditions and sRNA cDNA library replicates cluster and to visualize the 
variance between them (Figure 5.3, A). From the PCA plot it can be seen that one 
replicate of the poly (I:C) treated Ro60 -/- sample shown in green and a poly (I:C) 
treated wild type sample shown in purple are outliers. In general, the PCA plot showed 
that the replicates of all the different conditions cluster together and the different 
conditions separate nicely. For the bioinformatics analysis all the library replicates 
were kept. 
From the size class distribution of the wild type and Ro60 -/- mES cells treated or not 
treated with poly (I:C) it can be seen (Figure 5.3, B) that the most abundant reads 
are 22 nt, which includes miRNAs. Interestingly, the size classes from 16-30 nt do not 
seem to be affected by the poly (I:C) treatment whereas longer sRNAs with sizes of 
30-34 nt are more abundant in the poly (I:C) treated samples compared to the mock 
treated control.  
The differential gene expression analysis using DEseq2 clearly showed by 
considering the p-value that sRNAs derived from mY1 and mY3 are significantly 
upregulated after poly (I:C) treatment (see differential expression analysis in appendix 
IV, Table 0.15). However, knockout of Ro60 resulted in a dramatic decrease of 
YsRNA accumulation.  
For further visualization of the genomic location of the sRNAs derived from mY1 and 
mY3 coverage plots were generated and the genomic loci were further investigated.  
A coverage plot describes the abundance of each nucleotide in all sequencing reads 
for a particular sequence mapped to a specific position within a reference genome. 
For the coverage plots of mY1 and mY3 all the reads were plotted against each 
position of the full length mY1/mY3 sequence.  
The coverage plots for mY1 and mY3 (Figure 5.3, A and B) clearly showed that the 
sRNAs derived from mY1 and mY3 were dramatically downregulated in the Ro60 -/- 
mES cells compared to the wild type mES and that the sRNAs were mainly generated 
from the 3’ end of mY1 and mY3.  
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Interestingly, for mY3 RNA it could be observed that not only 3’ and 5’ end derived 
sRNAs were detected but also the middle part of mY3 RNA.  
Upon treatment with poly (I:C) the sRNAs derived from mY1 and mY3 were 
significantly upregulated only in wild type mES cells, whereas the Ro60 -/- mES cells 
were more or less unaffected. The coverage plots clearly showed that Ro60 is 
required for YsRNA generation in wild type mES cells after poly (I:C) treatment. 
Previously, it was shown in the literature that the knockout of Ro60 had a dramatic 
effect on Y RNA transcript levels. It was clearly demonstrated that Ro60 stabilizes Y 
RNAs and that mice lacking Ro60 had drastically reduced levels of Y RNA transcripts 
which was reported to be around twenty times less in Ro60 -/- mES cells (Labbé et 
al., 1999; Chen et al., 2000). Thus, the absence of YsRNAs might be because the 
levels of Y RNA full length transcript are significantly reduced.  
In order to check if the lack of YsRNAs was caused by the reduced levels of full length 
Y RNAs in the Ro60 -/- mES cells twenty times less total RNA of the wild type mES 
cells compared to the total RNA extracted from Ro60 -/- mES cells was separated on 
a urea polyacrylamide gel and subjected to northern blot analysis (Figure 5.3, C). 
The Northern blot showed that no YsRNAs could be detected in the Ro60 -/- cells 
treated with poly (I:C) even when twenty times more total RNA extracted from the 
Ro60 -/- samples were loaded. Therefore, it can be concluded that Ro60 is essential 
for YsRNA cleavage in mouse cells.  
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Figure 5.3. Ro60 is required for Y RNA cleavage. 
A. Principal component analysis of wild type and Ro60 -/- mES treated or not treated 
with poly (I:C) sRNA cDNA libraries.  
The replicates do not cluster too tight whereas the different conditions separate nicely between 
the wild type and Ro60 -/- mES cells either treated or not treated with poly (I:C).  
B. Size class distribution of wild type and Ro60 -/- mES cells either untreated or treated 
with poly (I:C) sRNA cDNA libraries. 
The most abundant small RNAs are at 22 nt which includes the miRNAs. For the longer 
fragments the most abundant sRNA peak was at 32 nt. It was observed that upon poly (I:C) 
treatment only the sRNAs longer than 30 nt were upregulated compared to the non-treated 
control samples. 
C. Coverage plot and genomic location of mY1.  
Upon poly (I:C) treatment the 3’ end derived mY1 sRNAs were significantly upregulated in wild 
type mES (shown in blue) compared to the non-treated control sample (shown in green). The 
knockout of Ro60 resulted in a dramatic decrease of mY1 derived sRNAs (black line shows 
non-treated Ro60-/- and red line shows poly (I:C) treated Ro60-/- cells.  
D. Coverage plot and genomic location of mY3.  
The sRNAs derived from the 3’ end of mY3 showed an upregulation (blue) after poly (I:C) 
treatment compared to the untreated sample (green). Apart from the 3’ end derived mY3 sRNA 
also a fragment spanning the middle part of the mY3 RNA (30-60 nt) was observed. After 
knockout of Ro60 no sRNAs derived from mY3 could be not be detected by sequencing neither 
in the Ro60 -/- nor the Ro60 -/- poly (I:C) treated sample (black and red, respectively).  
E. Northern blot analysis of mES wild type and mES Ro60 -/- cells treated and untreated 
with poly (I:C).  
For Northern blot analysis 1 μg of total RNA extracted from mES wild type cells and 20 μg 
isolated from Ro60 -/- mES cells treated with poly (I:C) and mock treated were loaded. The 
membrane was probed with oligonucleotides complementary to the 3’ or 5’ end of mY1 RNA. 
U6 was used as a loading control. 
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5.2.2 Are there other Ro60 dependent small RNAs? 
 
As Ro60 is required for YsRNA generation we wanted to further investigate if there 
are other small RNAs in the 30-40 nt size range apart from mY1 and mY3 sRNAs that 
are dependent on Ro60.  
The bioinformatics analysis was performed by Simon Moxon. All the obtained reads 
were mapped to the mouse genome using PatMaN and a set of regions that give rise 
to small RNAs was defined based on mapping proximity (reads mapping within 200 
bp of each other were clustered into a locus) which resulted in around 93000 different 
regions. All individual samples were mapped using Bowtie with the –best/-strata –m1 
options (Langmead, 2010). Reads that mapped to more than one genomic position 
were randomly assigned to one locus. The software BEDTools was applied to count 
the sRNA coverage in each bam file to each locus (Quinlan, 2014). Then the read 
numbers were normalized and differential expression analysis was carried out by 
DEseq2 version 1.8.2 using default parameters (Love et al., 2014). An adjusted p-
value < 0.01 was initially applied as a threshold for significant differential gene 
expression.  
In order to explore if there are other Ro60 dependent small RNAs the sRNA I 
compared the expression levels between wild type and Ro60 -/- mES samples either 
treated with poly (I:C) or untreated samples. As there were no sRNAs significantly 
differentially expressed with a p-value adjusted < 0.01 apart from mY1, mY3 a p-value 
< 0.05 was considered. I loaded the annotation files of the samples into IGV in order 
to visualize the genomic locations where the sRNAs were derived from. I pasted the 
loci of the most significantly differentially expressed sRNAs (lowest p values) from the 
DEseq2 analysis (Appendix IV, table 0.16) into IGV individually and I assessed the 
genomic location by coverage plots whether the sRNAs were derived from intronic, 
exonic or non-annotated regions. 
Then I tested the expression levels of a few promising potential Ro60 dependent 
sRNAs by Northern blot analysis in order to evaluate if the sequencing results could 
be validated.  
The expression levels of a few promising sRNAs, including a sRNA derived from 
snoRNA 118, miR 296, miR 146a and miR 708 were examined by Northern blot.  
From the analysis of the coverage blots and Northern blot analysis I observed that 
the sRNAs derived from mY1 and mY3 were most significantly differentially 
expressed (Appendix IV, table 0.15).  
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The snoRNA 118 was the most promising candidate to be a Ro60 dependent small 
RNA among the tested sRNAs but there was just a small decrease in sRNA 
accumulation in Ro60 -/- cells treated with poly (I:C) compared to the wild type cells 
treated with poly (I:C) and the differential expression levels were not significant 
(Figure 5.4, A and B).  
The coverage plots of the chosen and most promising miRNAs including miRNA 
146a, 296 and miR 708 were generated (Figure 5.4, C, D and E) and the miRNA 
expression levels in mES wild type and Ro60 -/- cells mock treated or not treated with 
poly (I:C) tested by Northern blot analysis.  
The Northern blot analysis of miRNA 146a, miR 296 and miR 708 indicated that Ro60 
does not affect miRNA accumulation of these miRNAs (Figure 5.4, E).  
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Figure 5.4. Ro60 seems not be involved in other Ro60 dependent sRNA 
generation mechanisms.   
A. Coverage blot of the sRNA derived from snoRNA 118.  
The snoRNA 118 derived sRNAs are upregulated upon poly (I:C) treatment compared to the 
untreated control. The Ro60 knockout resulted in a slight decrease of sRNA derived from 
snoRNA 118 compared to the wild type.  
B. Northern blot analysis of the sRNA derived from snoRNA 118.  
Total RNA extracted from wild type and Ro60 -/- cells mock treated and treated with poly (I:C) 
was separated on a denaturing urea polyacrylamide gel and transferred to a membrane. The 
membrane was probed with a probe complementary to the sRNA derived from snoRNA 118. 
The membrane was stripped and re-probed with U6 as a loading control.  
C.  Coverage plot of miR 146a.  
The miR 146a showed an upregulation after poly (I:C) treatment. When Ro60 was knocked 
out miR 146a was down regulated. However, no difference between untreated and poly (I:C) 
treated wild type mES could be observed.  
D. Coverage plot of miR 296.  
For miR 296 no significant difference between wild type and Ro60 -/- mES either treated or not 
treated with poly (I:C) was seen. 
E. Coverage plot  of miR 708.  
The expression levels of miR 708 in wild type and Ro60 -/- mES cells treated with poly (I:C) or 
untreated were similar.  
F. Northern blot analysis of expression levels of miR146a, miR296 and miR708. 
Total RNA was extracted of wild type and Ro60 -/- mES cells untreated and treated with poly 
(I:C). Northern blot analysis was performed and the membrane was probed with 
oligonucleotides complementary to the miRNA sequences tested. The membrane was 
stripped and re-probed with miR 146a, miR 296 and miR 708. As a loading control the 
membrane was re-probed with U6.  
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5.2.3 Is RNase L involved in Y RNA cleavage? 
 
RNase L is a metal ion independent ribonuclease that is involved in the interferon 
induced antiviral response. The ribonuclease inhibits viral replication and cell 
proliferation and it is reported that it promotes apoptosis. RNase L is activated 
downstream of the 2’ 5’ oligoadenylate pathway (OAS) and double stranded RNA is 
the trigger for intracellular RNA cleavage. Only single stranded and not double 
stranded RNA is cleaved by RNase L and there is sequence specificity towards the 
consensus sequence UN^N.  
In a recent study it was shown by Donovan et al. that RNase L is directly involved in 
the stress-induced Y RNA and tRNA cleavage (Donovan et al., 2017). Intriguingly, 
work by Adam Hall in our laboratory showed that RNase L contributed to Y RNA 
cleavage in mouse cells using wild type and RNase L -/- mouse fibroblast cells (mEFs) 
but could not be confirmed in human MCF7 cells when RNase L was silenced by a 
siRNA as there was no RNase L knockout available in human cells at this stage (Hall, 
2013).  
In this chapter I investigated if RNase L is involved in the generation of YsRNAs from 
the 3’ and 5’ end of human and mouse Y RNAs upon poly (I:C) treatment.  
After I confirmed the genotype of wild type and RNase L -/- mEF cells the (Figure 5.4, 
A) the cells were either mock treated or treated with poly (I:C) in order to test if RNase 
L contributes to Y RNA cleavage in mEF cells. The extracted total RNA was subjected 
to Northern blot analysis and the membrane was probed with oligonucleotides 
complementary to the 3’ and 5’ end of mY1.  
The Northern blot analysis showed that poly (I:C) treatment induced the generation 
of YsRNAs from the 3’ and 5’ end of mY1 RNA in mEF cells (Figure 5.5, B).  
However, the knockout of RNase L in mEF cells clearly affected the accumulation of 
3’ and 5’ end derived mY1 sRNAs and resulted in a significant decrease of mY1 sRNA 
levels in RNase L -/- cells. These results indicate that RNase L is involved in Y RNA 
cleavage upon poly (I:C) treatment in mEF cells.  
In order to investigate if RNase L contributes to YsRNA generation in human cells, 
A549 lung cancer cells and A549 CRISPR RNase L -/- cells were either treated or not 
treated with poly (I:C). The extracted RNA was subjected to Northern blot analysis 
and Y RNA cleavage assessed (Figure 5.4, C).  
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The Northern blot of wild type and RNase L -/- A549 lung cancer cells demonstrated 
that the knockout of RNase L did not affect the YsRNA generation in such an extent 
as in the embryonic mouse fibroblast cells that were tested (Figure 5.4, C and D). 
After RNase L knockout I observed a downregulation of 3’ and 5’ hY1 and hY5 
sRNAs but YsRNA production still occured (Figure 5.5, C).  
In order to test that RNase L was completely knocked out in the cells we received I 
probed the Northern blot with an oligonucleotide complementary against tRNA-His 
and tRNA-Pro. The Northern blot showed that tRNA cleavage was completely 
abolished in the RNase L-/- A549 lung cancer cells upon poly (I:C) treatment, 
confirming that RNase L deletion is complete in these cells (Figure 5.5, C).   
In order to further investigate if RNase L is required for 3’ end hY5 RNA cleavage  I 
generated hY5 substitution mutants in which the uridine of the UN^N sequence motif 
was replaced by adenine, guanine or cytosine. These hY5 RNA substitutions mutants 
were transfected into wild type and RNase L -/- mEF cells.  
The Northern blot analysis clearly showed that the mutations introduced at position 
49 did not affect the YsRNA production from the 3’ or 5’ end of hY5 RNAs 
Remarkably, it was demonstrated that the hY5 substitution mutants are expressed in 
RNase L -/- cells and cleaved into YsRNA fragments (Figure 5.4, D). 
The Northern blot results revealed that in the hY5 substitution mutants in which the 
uridine in the UN^N sequence motif was replaced the hY5 RNAs still generated 
YsRNAs from the 3’ and 5’ end of hY5 RNAs. When these mutants were tested in 
3T3 mouse cells) hY5 RNA cleavage could be observed from 3’ and 5’ end (Figure 
3.11).   
Thus, from these results it can be suggested that RNase L is not involved in hY5 RNA 
cleavage from the 3’ end of hY5 RNAs.  
However, I observed a different effect of RNase L for mouse Y1 and Y3 RNAs. In the 
Northern blot results I could clearly see that in RNase L -/- mEF cells the accumulation 
of YsRNAs was less compared to the wild type mEF cells. This suggested that RNase 
L might be involved in Y RNA cleavage from the 3’ and 5’ end of mouse Y RNAs but 
not human Y5 RNA. 
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Figure 5.5. RNase L contributes to Y RNA cleavage in mEF cells and human A549  lung 
cancer cells upon poly (I:C) treatment but is not involved in 3’ end hY5 RNA cleavage. 
A.  Confirmation of the RNase L -/- knockout mEF cell line by PCR genotyping.  
Genomic DNA of wild type and RNase L -/- mEF cells was extracted and PCR was performed 
using primers flanking the insertion site of the neomycin resistance gene. The PCR products 
were separated on a 1% agarose gel. The size of the PCR product for the wild type is at 900 
bp, whereas for the RNase L -/- cells it is 2.1 kb because of the neomycin gene insertion.  
B. Northern blot analysis of mEF wild type and RNase L-/- cells either treated with 
poly (I:C) or untreated.  
Total RNA of wild type and RNase L -/- mEF cells either treated with poly (I:C) or not treated 
was extracted and Northern blot analysis was performed. As a positive control total RNA 
extracted from MCF7 cells treated with poly (I:C) was loaded. The membrane was hybridized 
with oligonucleotides against the 3’ and 5’ end of mY1. As a loading control U6 was used.  
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C. Northern blot analysis of wild type and RNase L -/- human A549 lung cancer cells 
treated with poly (I:C) or untreated.  
For Northern blot analysis total RNA extracted from of wild type and RNase L -/- human A549 
lung cancer cells either treated with poly (I:C) or not treated was extracted and separated on 
a denaturing urea polyacrylamide gel and transferred to a membrane. As a positive control 
total RNA extracted from MCF7 cells treated with poly (I:C) was used. The membrane was 
hybridized with oligonucleotides against the 3’ and 5’ end of mY1. As a loading control the 
membrane was re-probed with U6.  
D. Northern blot analysis of hY5 mutants at position 49 in mEF wild type and RNase L -
/- cells.  
Total RNA extracted from human MCF7 cells treated with poly (I:C) was used as a size marker. 
The hY5 substitution mutants in which the position U49 was mutated were transfected into 
wild type and RNase L -/- and treated with staurosporine for 8h. The total RNA was extracted 
and Northern blot was performed. The Northern blot membrane was probed with the 3’ and 5’ 
YsRNA probe as well as a probe against 3’ mY1 sRNA. In order to confirm the RNase L -/- cell 
line the membrane was hybridized with a probe against tRNA-His. The blot was re-probed 
with U6 to demonstrate equal loading. The YsRNAs generated from the 3’ end of the mutant 
hY5 RNAs were longer than the ones generated from wild type YsRNAs whereas the 5’ end 
derived YsRNAs wild type had identical sizes for mutants and wild type.  
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5.3 Discussion 
 
During stress Y RNAs are specifically cleaved from the 3’ and 5’ end. However, the 
biogenesis and biological significance of Y RNA processing remain obscure. In the 
last decades it became apparent that several classes of longer non coding RNAs 
including tRNAs (Lee and Collins, 2005; Thompson et al., 2008; Yamasaki et al., 
2009), snoRNAs (Taft et al., 2009), snRNAs (Burroughs et al., 2011), vault RNAs 
(Persson et al., 2009) or rRNAs (Li et al., 2012) generate shorter sRNA fragments 
upon cellular stress conditions. The fact that longer non-coding RNA transcripts give 
rise to smaller RNA fragments showed that not only the full-length non-coding RNA 
transcripts but also the small RNAs derived from these transcripts can be functional.  
There are several mechanisms how these sRNAs could be produced. The sRNAs 
can be specifically transcribed from the genomic region encoding the longer non-
coding RNA transcript. Another sRNA biogenesis pathway could be that the longer 
non-coding RNA transcripts function as precursors that are processed by post-
transcriptional endonucleolytic cleavage events.  
The experiments conducted by the PhD student Adam Hall in our laboratory already 
indicated that Ro60 is required for Ro60. In knockdown and in vitro cleavage assays 
he observed that Ro60 is essential for Y RNA cleavage in human MCF7 cells (Hall, 
2013).  
Intriguingly, when I performed Northern blot analysis on wild type and Ro60 -/- mES 
cells either treated with poly (I:C) or mock treated I confirmed that no YsRNAs derived 
from mY1 and mY3 could be detected when Ro60 was knocked out.  
In order to take these results further and to investigate if there are other sRNAs 
dependent on Ro60, I designed and generated sRNA cDNA libraries of wild type and 
Ro60 -/- mES either treated with poly (I:C) or not treated in this chapter.  
For sRNA cDNA library construction I used HD adapters and successfully modified 
the sRNA cDNA library construction protocol. These adapters were developed in our 
laboratory in order to reduce the ligation bias and the sRNA library construction 
method has been improved (Xu et al., 2015). As mES cells contain less diverse 
sRNAs (Houbaviy et al., 2003) compared to other differentiated cell lines, using HD 
adapters during sRNA library construction might capture more diverse sRNAs 
compared to the Illumina adapters that were previously used. The cDNA sRNA 
libraries of wild type and Ro60 -/- mES treated with poly (I:C) and untreated control 
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constructed by Adam Hall in the past using the commercial Illumina adapters were 
hugely biased for one particular sequence (Hall, 2013).  
In this chapter I successfully generated sRNA cDNA libraries of wild type and Ro60 -
/- mES cells either treated with poly (I:C) or not treated using HD adapters and a good 
read coverage and percentages of reads mapping to the mouse genome were 
obtained. 
The bioinformatics analysis and coverage plots clearly showed that Ro60 is essential 
for the generation of sRNAs from mY1 and mY3 RNAs. When wild type cells and 
Ro60 -/- cells were treated with poly (I:C) I could observe a dramatic downregulation 
of sRNAs derived from mY1 and mY3 in the Ro60 -/- cells. The same phenomenon I 
found in the Northern blot analysis when wild type and Ro60 -/- mES cells treated with 
poly (I:C) and untreated control samples were compared to each other. Intriguingly, 
no sRNAs generated from mY1 and mY3 could be detected by Northern blot. 
Remarkably, the knockout of Ro60 also had a dramatic effect on the full-length Y RNA 
levels of mY1 and mY3 in the Ro60 -/- cells.  
Intriguingly, mY3 RNA also showed a sRNA fragment derived from the middle part of 
the mY3 RNA. This phenomenon could not be observed for the other Y RNAs in the 
past and it was assumed previously that the middle part of Y RNAs could not be 
detected due to degradation mechanisms. However, for mY3 RNA it seemed that it 
might have a different biogenesis mechanism and this sRNA fragment might be 
functional. 
In conclusion, the bioinformatics analysis and Northern blot analysis confirmed that 
Ro60 is essential for Y RNA cleavage in mES cells upon poly (I:C) treatment. 
However, the role and exact mechanism on how Ro60 is involved in YsRNA cleavage 
remains obscure. As Ro60 is involved in the quality control of some other small non-
coding RNAs, one possibility is that Ro60 might protect Y RNAs from degradation by 
other ribonucleases. When Ro60 is knocked out these RNases gain access and Y 
RNAs undergo degradation (see Figure 5.6).  This hypothesis could also explain less 
accumulation of full length Y RNAs and loss of stability in Ro60 -/- cells compared to 
the wild type. 
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Figure 5.6. Model of the role of Ro60 in YsRNA generation and protection of Y 
RNAs from degradation.  
As it was shown that Ro60 is essential for Y RNA cleavage from the 3’ end (shown in red) and 
5’ end (shown in blue) it was hypothesized that Ro60 is involved in the recruitment of other 
ribonucleases such as RNase L. From the 3’ and 5’ hY5 RNA mutagenesis analysis it was 
suggested that two different RNases might be involved in 3’ and 5’ end Y RNA cleavage. In 
this this thesis it was shown that RNase L (green) contributes to Y RNA cleavage but is not 
essential for Y RNA cleavage.  
Therefore, Ro60 might recruit other ribonucleases/proteins involved in Y RNA cleavage 
(shown in blue). Interestingly, Ro60 is involved in quality control of some other small non 
coding RNAs and therefore Ro60 might also protect Y RNAs from degradation by preventing 
the access of RNases and degradation complexes (shown in orange). Thus, when Ro60 is 
knocked out (indicated by the red cross) full length Y RNAs undergo degradation and full 
length Y RNA are less stable. 
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In order to test if there are other Ro60 dependent sRNAs, we initially identified loci 
that produced higher read numbers of small RNAs in the wild type cells after poly (I:C) 
treatment. Then we looked at these loci and identified the ones that did not produce 
more small RNA reads in the Ro60 -/- cells after the treatment. Most of the sRNAs 
with the lowest p-values were further analysed regarding their genomic location and 
gene structure using the Integrative Genome Browser. After this preliminary analysis 
I further tested a few candidates by northern blot in order to check if the sequencing 
results can be validated. 
The differential gene expression analysis of the wild type and Ro60 -/- mES treated 
with poly (I:C) and not treated showed that the sRNAs derived from mY1 and mY3 
had the lowest p-values and were the most differentially expressed sRNAs.  
From the analysis of the coverage plots, a sRNA derived from snoRNA 118, miR 
376b, miR 296, miR 146a and miR 708 were tested by Northern blot.  
However, the tested miRNAs did not seem to be dependent on Ro60 as there was no 
significant differential expression between wild type and Ro60 -/- mES samples 
observed in the Northern blot analysis.  
Among the sRNAs tested, the snoRNA 118 derived sRNA was the most promising 
candidate to be dependent on Ro60. Treatment of wild type and Ro60 -/- mES cells 
with poly (I:C) resulted in an increase of sRNAs derived from snoRNA 118 compared 
to the control samples. However, in Ro60 -/- mES cells the accumulation of sRNAs 
generated from snoRNA 118 was only affected at a small degree was only a small 
decrease in Ro60-/- cells treated with poly (:C) compared with the sRNAs derived from 
mY1 and mY3.  
Therefore, I concluded that Ro60 is required for Y RNA cleavage and that there 
seemed no other Ro60 dependent sRNA significantly differentially expressed in mES 
wild type and Ro60 -/- cells upon poly (I:C) treatment.  
Apart from Ro60, I further investigated in this chapter whether RNase L contributes 
to YsRNA generation. In a recent study performed by Donovan et al. it was reported 
that RNase L is responsible for Y RNA cleavage at the 5’ end and tRNA cleavage in 
human cells (Donovan et al., 2017).  
Work by Adam Hall in the past demonstrated that RNase L is involved in Y RNA 
cleavage in mouse cells (Hall, 2013). However, the involvement of RNase L could not 
be confirmed in human MCF7 cells when RNase L was silenced by a siRNA. 
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Unfortunately, a human RNase L knockout cell line has not been generated at that 
time (Hall, 2013). 
During my PhD I obtained new wild type and RNase L -/- mEF cells. After I confirmed 
the genotype I treated the cells with poly (I:C), performed Northern blot analysis 
including untreated control samples and assessed Y RNA cleavage products.  
The poly (I:C) treatment resulted in an upregulation of YsRNAs from the 3’ and 5’ end 
of mY1 RNA in mEF cells compared to the untreated control. Intriguingly, the 
knockout of RNase L in mEF cells had a clear effect on the production of YsRNAs 
from both the 3’ and 5’ end of mY1 RNA and a reduction of YsRNAs could be 
observed on the Northern blot. These results indicate that RNase L is involved in Y 
RNA cleavage upon poly (I:C) treatment in mEF cells.  
In order to check whether RNase L contributes to human Y RNA cleavage, human 
wild type and CRISPR RNase L -/- A549 cells were either treated or not treated with 
poly (I:C) and YsRNA accumulation tested by Northern blot. The Northern blot results 
demonstrated that RNase L contributes to Y RNA cleavage but YsRNA production 
still occurs in the RNase L -/- A549 cells after poly (I:C) treatment. The comparison of 
the Northern blot results obtained from mEF cells and human A549 lung cancer cells 
proposes that RNase L knockout affected the mouse cells more compared to human 
cells regarding YsRNA production.  
I tested the complete knockout of RNase L in the human CRISPR knockout A549 
cells by genotyping PCR and re-probing the Northern blot with tRNA-His and tRNA-
Pro as it was reported that RNase L is responsible for tRNA cleavage upon poly (I:C) 
treatment (Donovan et al., 2017). In the northern blot I confirmed that both tested 
tRNAs were cleaved in wild type but not in RNase L -/- mEF cells. 
The fact that the knockout of RNase L had a bigger effect on YsRNA generation in 
mice compared to human A549 lung cancer cells might be that other ribonucleases 
might be present in human cells that are involved in YsRNA production and help to 
maintain the cellular homeostasis when RNase L is knocked out.  
Previous experiments in chapter 3 already indicated that ribonuclease(s) other than 
RNase L might be involved in hY5 RNA cleavage. When the uridine at position 49 
which is part of the RNase L-specific UN^N sequence motif hY5 RNA cleavage still 
occurred from the 3’ and 5’ end. These results proposed that RNase L might not be 
involved in hY5 RNA cleavage from the 3’ end. In order to validate these findings, I 
transfected the hY5 RNA mutants in which the uridine at position 49 was substituted 
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in wild type and RNase L-/- mEF cells, treated them with staurosporine and performed 
Northern blot analysis. In the Northern blot analysis I observed that YsRNAs were still 
generated from the 3’ end of these hY5 RNA substitution mutants in RNase L -/- mEF 
cells which provided more evidence that RNase L is not required for hY5 RNA 
cleavage from the 3’ end.  
In conclusion, the obtained results suggested that apart from Ro60 and RNase L other 
protein complexes and ribonuclease(s) might be important for YsRNA generation that 
need to be investigated. One way to find the other ribonucleases critical for Y RNA 
cleavage could be to immunoprecipitate biotinylated Y RNAs in human and mice and 
perform a pulldown with streptavidin beads followed by mass spectrometry. However, 
this might be difficult because some protein interactions might be transient and might 
not be able to be capture. 
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Chapter 6 Summary and general discussion 
 
Previous hY5 RNA mutagenesis experiments performed by Carly Turnbull, a previous 
PhD student in our laboratory indicated that hY5 RNA cleavage from the 3’ end 
correlated with secondary structure (Turnbull, 2014). From these deletion and 
substitution experiments it was found that a double-stranded stem region in proximity 
to the internal loop in which the Y RNA cleavage occurs was critical for hY5 RNA 
cleavage from the 3’ end.  
In order to investigate sequence and structural requirements of 3’ end hY5 RNA 
cleavage in more detail and to look at thousands of hY5 RNA mutants at the same 
time a high throughput mutagenesis approach of hY5 RNA close to the 3’ end hY5 
RNA cleavage site was performed.  
In general, the aim of my thesis was to establish sequence and structural 
requirements of human Y5 RNA cleavage and to investigate which ribonucleases are 
involved in YsRNA generation. 
After bioinformatics analysis I validated in chapter 3 the results from the high 
throughput mutagenesis approach by further secondary structure analysis, 
generation and testing of individual hY5 RNA mutants by Northern blot analysis.  
In this chapter I could clearly show that the mutations introduced in the most abundant 
hY5 library 1 mutants changed the secondary structure in a way that these hY5 RNA 
mutants generated longer YsRNAs compared to the wild type hY5 RNA.  
Interestingly, in all of these tested mutants the hY5 RNA cleavage occurred between 
the 2nd/3rd nt above a conserved double-stranded stem which had a high G-C content. 
In conclusion, in chapter 3 I was able to finally confirm that 3’ end hY5 RNA cleavage 
correlates with secondary structure. As it is unknown which ribonuclease or proteins 
are involved in Y RNA cleavage these results suggest that components required for 
Y RNA cleavage might recognize structural features (double-stranded stem and 
internal loop) rather than the nucleotide sequence.  
The secondary structure of hY5 RNA mutants was only computationally predicted 
using RNAfold and analysed by testing the expression levels of the different hY5 RNA 
mutants in vitro by Northern blotting. With these in vitro experiments I could already 
show that Y RNA cleavage correlates with the secondary structure. However, the 
biogenesis mechanisms of how Y RNAs are cleaved are still unknown.  
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In order to look in more detail into the identified secondary structure and sequence 
motifs in the most interesting identified hY5 RNA mutants in vivo structure probing of 
the most interesting hY5 RNA mutants identified in this thesis under stress conditions, 
such as poly (I:C) or staurosporine treatment would give further insights whether 
and/or how the secondary structure changes upon stress conditions. In these 
experiments it might be possible to see how the internal loops and stem domains of 
the hY5 RNA mutants change and it might be possible to investigate if this change in 
secondary structure is dynamically or not. Thus, future experiments involving in vivo 
structure analysis of all the most promising hY5 RNA mutants by SHAPE (selective 
2′-hydroxyl acylation analysed by primer extension) would give further insights into 
the real secondary structure, interaction partners and tertiary interactions in the 
cellular environment. In SHAPE experiments the RNA is probed with electrophiles 
such as N-methylisatoic anhydride (NMIA) that react with the 2’ hydroxyl group of 
RNA. Using primer extension the nucleotide flexibility of the RNA can be determined 
at single nucleotide resolution and base-paired, single stranded RNA regions or 
pseudoknots can be distinguished (Wilkinson et al., 2006; Hajdin et al., 2013).  
Thus, for Y RNA cleavage from the 3’ end we would be able to see for instance if the 
5-6 nt-double-stem region and internal loop L2a are still present upon stress 
conditions or if the secondary structure of the hY5 RNA mutants look different in vivo 
after treatment with staurosporine. 
Furthermore, in vivo structure probing might also be interesting for the central loop 
domain with the penta-nucleotide UUAUC sequence motif. Therefore, we could 
further investigate if this motif is present single-stranded in an internal loop, or if it is 
double-stranded or whether the internal loop L2b gets shortened in some of the hY5 
RNA mutants. This might help to investigate the mechanism of how Y RNAs are 
cleaved and what are the sequence and/or structural requirements for Y RNA 
cleavage to occur.  
In additional experiments in chapter 3 I could show that a bulge of 1 nt in the internal 
loop is sufficient for hY5 RNA cleavage to occur and the nucleotides at the positions 
51, 52 and 53 seem not play a role in Y RNA cleavage.  
As Y RNAs are cleaved from both the 3’ and 5’ end of hY5 RNAs and the 5’ end 
derived hY5 RNA fragment was shown to trigger cell death in cancer cells 
(Chakrabortty et al., 2015) in chapter 4 I investigated if the 5’ end hY5 RNA cleavage 
correlates with nucleotide sequence or secondary structure elements or both 
together.  
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Thus, in chapter 4, I designed and performed a high- throughput mutagenesis 
approach similar to the 3’ end high throughput mutagenesis study. 
Interestingly, the sRNA cDNA libraries of 5’ end derived YsRNAs from library 4, 5 and 
6 resulted in different sized YsRNAs ranging from 26-33 nt. One explanation for this 
heterogeneity of different sized 5’ end derived YsRNAs could be that ribonucleases 
involved in Y RNA cleavage at the 5’ end are either not very specific or different 
ribonucleases are responsible for different sized fragments. These different sized 
fragments could also have different functions for instance in extracellular vesicles or 
body fluids. Further it seemed, that two different ribonucleases might be involved in 
3’ end and 5’ end hY5 RNA cleavage. The 3’ end hY5 RNA cleavage correlates with 
secondary structure and the cleavage occurs between the 2nd/3rd nucleotide above a 
5-6 nt double-stranded stem region, whereas the 5’ end hY5 RNA seemed to the 
rather sequence dependent but resulting in different sized 5’ end derived YsRNAs. 
Thus, this indicated that the Y RNA cleavage from the 5’ end might not be specific 
and different sized fragments might fulfil different functions.  
To sum up, in chapter 4 I was able to show that the RNA sequence motif of the internal 
loop L2b UUAU at the positions 22-25 seems to be important for both 3’ and 5’ end 
hY5 RNA cleavage. It was found that the sequence UUAU might be important, but 
this sequence also needs to be in a single stranded internal loop. The fact that this 
sequence motif affects both the 3’ and 5’ end Y RNA cleavage suggested that the 3’ 
and 5’ end cleavage occur dynamically but by different ribonucleases. It could be 
hypothesized that first one fragment gets cleaved and then other regions of the Y 
RNA get accessible and additional ribonucleases get recruited to the Y RNA and the 
Y RNA gets further processed.   
Multiple sequence alignment of all human Y RNAs showed that this motif is highly 
evolutionarily conserved suggesting that it might be important for the function of 
YsRNAs. Intriguingly, mutagenesis experiments of the uridine residue at position 22 
revealed that the uridine is critical for 5’ end hY5 RNA cleavage and also affected 
cleavage at the 3’ end, but to a smaller extent. Interestingly, the RNA motif 5’-
GUUGUGGG-3’ at the positions 14-21 which is close to the uridine residue at position 
22 was in a previous study shown to be involved in triggering cell death in cancer 
cells (Chakrabortty et al., 2015). Additionally, this conserved motif was previously 
reported to be essential for the initiation of chromosomal DNA replication (Gardiner 
et al., 2009).  
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Interestingly, both nematode sbRNAs and Y RNAs have similar secondary structures 
with a highly conserved stem-loop secondary structure. The upper stem domain 
contains a  evolutionarily conserved A/GUG-CAC-U nucleotide sequence motif which 
was reported to be crucial for the initiation of chromosomal DNA replication (Boria et 
al., 2010; Christov et al., 2006; Gardiner et al., 2009; Kowalski et al., 2015; Wang et 
al., 2014). Also, the central loop domain is conserved between both sbRNAs and Y 
RNAs which consists of a conserved polypyrimidine-rich penta-nucleotide motif of 
UUAUC at the 5’ end of the loop domain (Boria et al., 2010; Wang et al., 2014; 
Kowalski et al., 2015).  
Interestingly, the sbRNAs identified in Bombyx mori has a highly evolutionarily 
conserved sequence motif (GTGGCTTATC) with hY5 RNA and Chinese hamster 
chY5 RNA. This suggested that these sbRNAs may function as Y RNAs but further 
investigations are needed into the functions of sbRNAs in Bombyx mori (Duarte Junior 
et al., 2015; 2019).  
In chapter 4 I could clearly show that uridine at position 22 of the conserved Y RNA 
sequence motif UGGGU is essential for 5’ end hY5 RNA cleavage and might 
contribute to 3’ end hY5 RNA cleavage. Further the internal loop with the sequence 
UUAU in a single-stranded RNA loop at the positions 22-25 nts affected hY5 RNA 
cleavage from both the 3’ and 5’ end. As the UUAUC penta-nucleotide sequence 
motif of nematode sbRNAs is essential for DNA replication and the fact that Bombyx 
mori sbRNAs are closely related to Y5 RNA it can be suggested that the function of 
these Y RNAs is evolutionarily conserved and Y RNA cleavage might also play a role 
in the initiation of DNA replication and stress conditions. Further, the high sequence 
conservation of the penta-nucleotide motif UUAUC between vertebrate Y RNA and 
sbRNAs also indicates that ribonucleases involved in Y RNA cleavage could 
recognize this polypyrimidine-rich penta-nucleotide motif and/or recruit other proteins 
or ribonucleases. In addition, it would be interesting to understand the mechanisms 
of how or whether the sequence, secondary structure features and/or the protein 
interaction partners change during stress and to look at Y RNA cleavage and DNA 
replication under stress conditions, such as poly (I:C) treatment. As recently the Dm1 
and Dm2 sbRNAs were identified in Drosophila melanogaster it would be exciting to 
investigate Y RNA cleavage in insect cells in order to look if Y RNA cleavage into 
sRNA fragments is evolutionarily conserved.  
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As the penta-nucleotide motif UUAUC is also part of the 5’ end derived hY5 RNA 
derived sRNA fragments in extracellular vesicles that trigger cell death and help 
tumors to establish a microenvironment there would be the need to examine the exact 
mechanisms of how the 5’ end derived hY5 RNA fragments are generated, how they 
function and if they also have a role in the initiation of DNA replication also in 
correlation to stress and cell death. Thus, more research is needed to investigate the 
biogenesis and function of YsRNAs in extracellular vesicles and body fluids as Y 
RNAs and their fragments are highly abundant and contribute to several inflammatory 
diseases, including cancer (Chakrabortty et al., 2015; Hizir et al., 2017; Dhahbi et al., 
2013; 2014).  
In the following figure a graphical summary of establishing sequence and structural 
requirements of 3’ and 5’ end Y RNA cleavage is shown. This figure summarizes the 
main results that I obtained in chapter 3 and 4 in which I investigated sequence and 
structural requirements for human Y5 RNA from the 3’ and 5’ end of hY5 RNA.  
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Figure 6.1. Graphical summary of the sequence and structural features 
identified from the 3’ and 5’ end high throughput mutagenesis analysis. 
In chapter 3 it was shown that the 3’ end hY5 RNA cleavage correlates with secondary 
structure. It was shown that the hY5 RNA cleavage occurred between the 2nd/3rd nt above a 
conserved double-stranded stem of 5-6 nts which had a high G-C content. Also, a bulge of 1 
nt is sufficient for 3’ end hY5 RNA cleavage.  
In chapter 4 it was found that uridine at position 22 of the conserved Y RNA sequence motif 
UGGGU is essential for 5’ end hY5 RNA cleavage and might be involved in 3’ end hY5 RNA 
cleavage. Further the internal loop with the sequence UUAU and secondary structure (single 
stranded RNA) at the positions 22-25 nts affected hY5 RNA cleavage from both the 3’ and 5’ 
end. It has to be noted that the structural features identified from the 5’ end high throughput 
mutagenesis analysis have been reported to be essential for the initiation of DNA replication 
in vertebrates and nematode sbRNAs.  
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In order to elucidate which protein(s) or ribonuclease(s) are involved in Y RNA 
cleavage I investigated the role of Ro60 and RNase L on Y RNA cleavage.  
Previous experiments involving in vitro cleavage assays and knockdown experiments 
using RNAi conducted by Adam Hall showed that Ro60 is involved in YsRNA 
generation (Hall, 2013) Notably, when the Ro60 binding site was mutated, Y RNA 
cleavage was inhibited (Turnbull, 2014). 
In order to confirm that finding and to explore if there are other sRNAs dependent on 
Ro60 in chapter 5 I generated cDNA libraries of wild type and Ro60 -/- mES cells 
untreated and treated with poly (I:C). In this chapter I successfully modified the cDNA 
library construction method and used HD adapter sequences in order to allow more 
diverse sequences to be cloned during sRNA library preparation.  
Northern blot analysis and bioinformatics analysis clearly showed that YsRNA 
generation is dependent on Ro60 upon poly (I:C) treatment. Interestingly, as also 
previously shown by Adam Hall in our laboratory Ro60 did not affect the full-length 
transcript level of transfected hY5 RNA whereas the Y RNA stability of mouse Y RNAs 
was clearly decreased (Hall, 2013). From the literature it is known that in Ro60 -/- cells 
the Y RNA transcript stability is around twenty times less compared to the wild type 
(Labbé et al., 1999; Chen et al., 2000).  
Further investigations will need to explore why the transfected hY5 RNA is more 
stable compared to endogenous mouse Y RNAs.  
After differential gene expression analysis a few miRNAs that were known from the 
literature to be stress related were tested by Northern blot if they were Ro60 
dependent. However, Northern blot analysis did not show that these miRNAs were 
dependent on Ro60. 
One snoRNA derived sRNA (snoRNA 118) was the most promising candidate and 
Northern blot analysis showed a higher level in wild type mES cells treated with poly 
(I:C) and lower level in Ro60 -/- mES cells. However, the differential expression 
between wild type mES cells and Ro60 -/- cells treated and untreated with poly (I:C) 
was not significant. In future experiments more candidates could be tested by qRT-
PCR experiments and immunoprecipitation experiments performed on the most 
promising candidates in order to investigate that they are bound to Ro60 protein.  
To summarize, Ro60 is essential for Y RNA cleavage but seems not be involved in 
the generation of other Ro60 dependent sRNAs.  
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In addition, in chapter 5 I investigated if RNase L is responsible for Y RNA cleavage. 
Previous experiments performed by Adam Hall revealed that RNase L contributes to 
Y RNA cleavage in mouse cells, but not in human cells (Hall, 2013). Interestingly, in 
2015 Donovan et al. claimed that RNase L is required for Y RNA cleavage. In order 
to investigate whether RNase L is required for Y RNA cleavage YsRNA production 
upon poly (I:C) treatment was tested in a mouse and human RNase L -/- cell line.  
Northern blot analysis of wild type and RNase L -/- mEF cells treated with poly (I:C) or 
untreated indicated that RNase L is involved in Y RNA cleavage upon poly (I:C) 
treatment in mEF cells. However, in human A549 lung cancer and RNase L -/- cells it 
was observed that YsRNA were still generated in the RNase L -/- cell line.  
In conclusion, RNase L contributed to Y RNA cleavage in mouse embryonic fibroblast 
cells and human A549 lung cancer cells but is not essential for Y RNA cleavage in 
human A549 lung cancer cells. Therefore, this might suggest that different 
ribonucleases or different repertoire of proteins are involved in YsRNA production in 
mouse and human cells.  
Future experiments should aim to explore the RNase(s) and Y RNA interaction 
partners that are responsible for Y RNA cleavage in mouse and human cells. This 
could be achieved by immunoprecipitation of biotinylated human and mice Y RNAs 
followed by a pulldown using streptavidin and mass spectrometry. 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
258 
 
References 
 
Abbas, Y.M., Pichlmair, A., Górna, M.W., Superti-Furga, G., and Nagar, B. (2013). 
Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins. 
Nature 494, 60-64. 
Abbasi-Moheb, L., Mertel, S., Gonsior, M., Nouri-Vahid, L., Kahrizi, K., Cirak, S., 
Wieczorek, D., Motazacker, M.M., Esmaeeli-Nieh, S., Cremer, K., 
Weißmann, R., Tzschach, A., Garshasbi, M., Abedini, S.S., Najmabadi, H., 
Ropers, H.H., Sigrist, S.J., and Kuss, A.W. (2012). Mutations in NSUN2 
cause autosomal-recessive intellectual disability. American Journal of Human 
Genetics 90, 847-855.  
Aftab, M.N.,He, H., Skogerbo, G., Chen, R. (2008). Microarray analysis of ncRNA 
expression patterns in Caenorhabditis elegans after RNAi against snoRNA 
associated proteins. BMC Genomics 9, 278 
Alspaugh, M.A., and Tan, E.M. (1975). Antibodies to cellular antigens in Sjögren's 
syndrome. Journal of Clinical Investigation 55, 1067-1073. 
Amort, M., Nachbauer, B., Tuzlak, S., Kieser, A., Schepers, A., Villunger, A., and 
Polacek, N. (2015). Expression of the vault RNA protects cells from 
undergoing apoptosis. Nature Communications 6, 7030. 
Armour, C.D., Castle, J.C., Chen, R., Babak, T., Loerch, P., Jackson, S., Shah, 
J.K., Dey, J., Rohl, C.A., Johnson, J.M., and Raymond, C.K. (2009). Digital 
transcriptome profiling using selective hexamer priming for cDNA synthesis. 
Nature Methods 6, 647-649. 
Balakin, A.G., Smith, L., and Fournier, M.J. (1996). The RNA World of the 
Nucleolus: Two Major Families of Small RNAs Defined by Different Box 
Elements with Related Functions. Cell 86, 823-834. 
Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. 
Cell 116, 281-297. 
Bartel, D.P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 
215-233. 
Beckmann, B.M., Castello, A., and Medenbach, J. (2016). The expanding universe 
of ribonucleoproteins: of novel RNA-binding proteins and unconventional 
interactions. Pflügers Archiv - European Journal of Physiology 468, 1029-
1040. 
Belisova, A., Semrad, K., Mayer, O., Kocian, G., Waigmann, E., Schroeder, R., 
and Steiner, G. (2005). RNA chaperone activity of protein components of 
human Ro RNPs. RNA 11, 1084-1094. 
Bell S.P. and Dutta A.(2002). DNA replication in eukaryotic cells. Annual Review of 
Biochemistry 71, 333–374. 
Ben-Chetrit, E., Chan, E.K., Sullivan, K.F., and Tan, E.M. (1988). A 52-kD protein 
is a novel component of the SS-A/Ro antigenic particle. The Journal of 
Experimental Medicine 167, 1560-1571. 
Berger, W., Steiner, E., Grusch, M., Elbling, L., and Micksche, M. (2008). Vaults 
and the major vault protein: Novel roles in signal pathway regulation and 
immunity. Cellular and Molecular Life Sciences 66, 43. 
Bernstein, E., Caudy, A.A., Hammond, S.M., and Hannon, G.J. (2001). Role for a 
bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 
363-366. 
Birney, E., Stamatoyannopoulos, J.A., Dutta, A., Guigó, R., Gingeras, T.R., et al. 
(2007). Identification and analysis of functional elements in 1% of the human 
genome by the ENCODE pilot project. Nature 447, 799-816. 
REFERENCES 
 
259 
 
Boccitto, M., and Wolin, S.L. (2019). Ro60 and Y RNAs: structure, functions, and 
roles in autoimmunity, Critical Reviews in Biochemistry and Molecular Biology 
54:2, 133-152 
Bohnsack, M.T., Czaplinski, K., and Gorlich, D. (2004). Exportin 5 is a RanGTP-
dependent dsRNA-binding protein that mediates nuclear export of pre-
miRNAs. RNA 10, 185-191. 
Boire, G., and Craft, J. (1989). Biochemical and immunological heterogeneity of the 
Ro ribonucleoprotein particles. Analysis with sera specific for the Ro(hY5) 
particle. Journal of Clinical Investigation 84, 270-279. 
Boire, G., Gendron, M., Monast, N., Bastin, B., and Ménard, H.A. (1995). 
Purification of antigenically intact Ro ribonucleoproteins; biochemical and 
immunological evidence that the 52-kD protein is not a Ro protein. Clinical 
and Experimental Immunology 100, 489-498. 
Boria, I., Gruber, A.R., Tanzer, A., Bernhart, S.H., Lorenz, R., Mueller, M.M., 
Hofacker, I.L., and Stadler, P.F. (2010). Nematode sbRNAs: Homologs of 
Vertebrate Y RNAs. Journal of Molecular Evolution 70, 346-358. 
Bouffard, P., Barbar, E., Briere, F., and Boire, G. (2000). Interaction cloning and 
characterization of RoBPI, a novel protein binding to human Ro 
ribonucleoproteins. RNA 6, 66-78. 
Boulanger, C., Chabot, B., Ménard, H.A., and Boire, G. (1995). Autoantibodies in 
human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clinical 
and Experimental Immunology 99, 29-36. 
Brameier, M., Herwig, A., Reinhardt, R., Walter, L., and Gruber, J. (2011). Human 
box C/D snoRNAs with miRNA like functions: expanding the range of 
regulatory RNAs. Nucleic Acids Research 39, 675-686. 
Burroughs, A.M., Ando, Y., de Hoon, M.L., Tomaru, Y., Suzuki, H., Hayashizaki, 
Y., and Daub, C.O. (2011). Deep-sequencing of human Argonaute-
associated small RNAs provides insight into miRNA sorting and reveals 
Argonaute association with RNA fragments of diverse origin. RNA Biology 8, 
158-177. 
Buzas, E.I., György, B., Nagy, G., Falus, A., and Gay, S. (2014). Emerging role of 
extracellular vesicles in inflammatory diseases. Nature Reviews 
Rheumatology 10, 356-364. 
Cambier, L., de Couto, G., Ibrahim, A., Echavez, A.K., Valle, J., Liu, W., Kreke, 
M., Smith, R.R., Marbán, L., and Marbán, E. (2017). Y RNA fragment in 
extracellular vesicles confers cardioprotection via modulation of IL-10 
expression and secretion. EMBO Molecular Medicine 9, 337-352. 
Casciola-Rosen, L.A., Anhalt, G., and Rosen, A. (1994). Autoantigens targeted in 
systemic lupus erythematosus are clustered in two populations of surface 
structures on apoptotic keratinocytes. The Journal of Experimental Medicine 
179, 1317-1330. 
Castello, A., Fischer, B., Hentze, M.W., and Preiss, T. (2013). RNA-binding 
proteins in Mendelian disease. Trends in Genetics 29, 318-327. 
Chakrabarti, A., Banerjee, S., Franchi, L., Loo, Y.-M., Gale, M., Núñez, G., and 
Silverman, Robert H. (2015). RNase L Activates the NLRP3 Inflammasome 
during Viral Infections. Cell Host & Microbe 17, 466-477. 
Chakrabortty, S.K., Prakash, A., Nechooshtan, G., Hearn, S., and Gingeras, T.R. 
(2015). Extracellular vesicle-mediated transfer of processed and functional 
RNY5 RNA. RNA 21, 1966-1979. 
Chan, S., Choi, E.-A., and Shi, Y. (2011). Pre-mRNA 3'-end processing complex 
assembly and function. Wiley interdisciplinary reviews. RNA 2, 321-335. 
Chen, C.-J., and Heard, E. (2013). Small RNAs derived from structural non-coding 
RNAs. Methods 63, 76-84. 
REFERENCES 
 
260 
 
Chen, X., Quinn, A.M., and Wolin, S.L. (2000). Ro ribonucleoproteins contribute to 
the resistance of Deinococcus radiodurans to ultraviolet irradiation. Genes 
and Development 14, 777-782. 
Chen, X., Sim, S., Wurtmann, E.J., Feke, A., and Wolin, S.L. (2014). Bacterial 
noncoding Y RNAs are widespread and mimic tRNAs. Rna 20, 1715-1724. 
Chen, X., Smith, J.D., Shi, H., Yang, D.D., Flavell, R.A., and Wolin, S.L. (2003). 
The Ro Autoantigen Binds Misfolded U2 Small Nuclear RNAs and Assists 
Mammalian Cell Survival after UV Irradiation. Current Biology 13, 2206-2211. 
Chen, X., Wurtmann, E.J., Van Batavia, J., Zybailov, B., Washburn, M.P., and 
Wolin, S.L. (2007). An ortholog of the Ro autoantigen functions in 23S rRNA 
maturation in D. radiodurans. Genes and Development 21, 1328-1339. 
Chen, X., Taylor, D.W., Fowler, C.C., Galan, J.E., Wang, H.W., and Wolin, S.L. 
(2013). An RNA degradation machine sculpted by Ro autoantigen and 
noncoding RNA. Cell 153, 166-177. 
Chiu, Y.-L., Witkowska, H.E., Hall, S.C., Santiago, M., Soros, V.B., Esnault, C., 
Heidmann, T., and Greene, W.C. (2006). High-molecular-mass APOBEC3G 
complexes restrict Alu retrotransposition. Proceedings of the National 
Academy of Sciences 103, 15588-15593. 
Chow, R.D., and Chen, S. (2018). Sno-derived RNAs are prevalent molecular 
markers of cancer immunity. Oncogene. 
Christov, C.P., Trivier, E., and Krude, T. (2008). Noncoding human Y RNAs are 
overexpressed in tumours and required for cell proliferation. British Journal of 
Cancer 98, 981-988. 
Christov, C.P., Gardiner, T.J., Szüts, D., and Krude, T. (2006). Functional 
requirement of noncoding Y RNAs for human chromosomal DNA replication. 
Molecular and Cellular Biology 26, 6993-7004. 
Christov, C.P., Dingwell, K.S., Skehel, M., Wilkes, H.S., Sale, J.E., Smith, J.C., 
and Krude, T. (2018). A NuRD Complex from Xenopus laevis Eggs Is 
Essential for DNA Replication during Early Embryogenesis. Cell Reports 22, 
2265-2278. 
Cole, C., Sobala, A., Lu, C., Thatcher, S.R., Bowman, A., Brown, J.W.S., Green, 
P.J., Barton, G.J., and Hutvagner, G. (2009). Filtering of deep sequencing 
data reveals the existence of abundant Dicer-dependent small RNAs derived 
from tRNAs. RNA 15, 2147-2160. 
Coleman, B.M., and Hill, A.F. (2015). Extracellular vesicles--Their role in the 
packaging and spread of misfolded proteins associated with 
neurodegenerative diseases. Seminars in Cell & Developmental biology 40, 
89-96. 
Collart, C., Christov, C.P., Smith, J.C., and Krude, T. (2011). The midblastula 
transition defines the onset of Y RNA-dependent DNA replication in Xenopus 
laevis. Molecular and Cellular Biology 31, 3857-3870. 
Colombo, M., Raposo, G., and Théry, C. (2014). Biogenesis, Secretion, and 
Intercellular Interactions of Exosomes and Other Extracellular Vesicles. 
Annual Review of Cell and Developmental Biology 30, 255-289. 
Cookson, M.R. (2017). RNA-binding proteins implicated in neurodegenerative 
diseases. Wiley Interdisciplinary Reviews: RNA 8. 
Cooper, D.A., Jha, B.K., Silverman, R.H., Hesselberth, J.R., and Barton, D.J. 
(2014). Ribonuclease L and metal-ion-independent endoribonuclease 
cleavage sites in host and viral RNAs. Nucleic Acids Research 42, 5202-5216. 
Crick, F. (1970). Central Dogma of Molecular Biology. Nature 227, 561-563. 
Crick, F.H.C. (1958). On Protein Synthesis. The Symposia of the Society for 
Experimental Biology 12, 138-163. 
Crooks, G.E., Hon, G., Chandonia, J.M., and Brenner, S.E. (2004). WebLogo: A 
sequence logo generator. Genome research 14, 1188-1190. 
REFERENCES 
 
261 
 
Cui, L., Guo, X., Qi, Y., Qi, X., Ge, Y., Shi, Z., Wu, T., Shan, J., Shan, Y., Zhu, Z., 
and Wang, H. (2010). Identification of microRNAs involved in the host 
response to enterovirus 71 infection by a deep sequencing approach. Journal 
of biomedicine & biotechnology 2010, 425939. 
Darty, K., Denise, A., and Ponty, Y. (2009). VARNA: Interactive drawing and editing 
of the RNA secondary structure. Bioinformatics 25, 1974-1975. 
Deng, W., Zhu, X., Skogerbo, G., Zhao, Y., Fu, Z., Wang, Y., He, H., Cai, L., Sun, 
H., Liu, C., Li, B., Bai, B., Wang, J., Jia, D., Sun, S., He, H., Cui, Y., Wang, Y., Bu, 
D., and Chen, R. (2006). Organization of the Caenorhabditis elegans small non-
coding transcriptome: genomic features, biogenesis, and expression. Genome 
Research 16, 20-29. 
Denli, A.M., Tops, B.B.J., Plasterk, R.H.A., Ketting, R.F., and Hannon, G.J. 
(2004). Processing of primary microRNAs by the Microprocessor complex. 
Nature 432, 231-235. 
Deutscher, S.L., Harley, J.B., and Keene, J.D. (1988). Molecular analysis of the 60-
kDa human Ro ribonucleoprotein. Proceedings of the National Academy of 
Sciences of the United States of America 85, 9479-9483. 
Dhahbi, J.M., Spindler, S.R., Atamna, H., Boffelli, D., and Martin, D.I. (2014). Deep 
Sequencing of Serum Small RNAs Identifies Patterns of 5' tRNA Half and Y 
RNA Fragment Expression Associated with Breast Cancer. Biomarkers in 
cancer 6, 37-47. 
Dhahbi, J.M., Spindler, S.R., Atamna, H., Boffelli, D., Mote, P., and Martin, D.I. 
(2013). 5'-Y RNA fragments derived by processing of transcripts from specific 
Y RNA genes and pseudogenes are abundant in human serum and plasma. 
Physiological Genomics 45, 990-998. 
Dominguez, D., Freese, P., Alexis, M.S., Su, A., Hochman, M., Palden, T., Bazile, 
C., Lambert, N.J., Van Nostrand, E.L., Pratt, G.A., Yeo, G.W., Graveley, 
B.R., and Burge, C.B. (2018). Sequence, Structure, and Context Preferences 
of Human RNA Binding Proteins. Molecular Cell 70, 854-867.e859. 
Dong, B., and Silverman, R.H. (1995). 2-5A-dependent RNase Molecules Dimerize 
during Activation by 2-5A. Journal of Biological Chemistry 270, 4133-4137. 
Donovan, J., Rath, S., Kolet-Mandrikov, D., and Korennykh, A. (2017). Rapid 
RNase L–driven arrest of protein synthesis in the dsRNA response without 
degradation of translation machinery. RNA 23, 1660-1671. 
Duarte Junior, F.F., Lima Neto, Q.A.D., Rando, F.D.S., Freitas, D.V.B.D., Pattaro 
Júnior, J.R., Polizelli, L.G., Munhoz, R.E.F., Seixas, F.A.V., and 
Fernandez, M.A. (2015). Identification and molecular structure analysis of a 
new noncoding RNA, a sbRNA homolog, in the silkworm Bombyx mori 
genome. Molecular BioSystems 11, 801-808. 
Duarte Junior, F.F., Bueno, S.A.A., Pedersen, S.L., Rando, F.D.S., Pattaro 
Junior, J.R. et al. (2019). Identification and characterization of stem-bulge 
RNAs in Drosophila melanogaster. RNA biology 16:3, 330-339 
Elbashir, S.M., Lendeckel, W., and Tuschl, T. (2001). RNA interference is mediated 
by 21- and 22-nucleotide RNAs. Genes and Development 15, 188-200. 
Emara, M.M., Ivanov, P., Hickman, T., Dawra, N., Tisdale, S., Kedersha, N., Hu, 
G.-F., and Anderson, P. (2010). Angiogenin-induced tRNA-derived Stress-
induced RNAs Promote Stress-induced Stress Granule Assembly. The 
Journal of Biological Chemistry 285, 10959-10968. 
Ender, C., Krek, A., Friedländer, M.R., Beitzinger, M., Weinmann, L., Chen, W., 
Pfeffer, S., Rajewsky, N., and Meister, G. (2008). A Human snoRNA with 
MicroRNA-Like Functions. Molecular Cell 32, 519-528. 
Espinosa, A., Zhou, W., Ek, M., Hedlund, M., Brauner, S., Popovic, K., Horvath, 
L., Wallerskog, T., Oukka, M., Nyberg, F., Kuchroo, V.K., and Wahren-
Herlenius, M. (2006). The Sjögren’s Syndrome-Associated Autoantigen Ro52 
REFERENCES 
 
262 
 
Is an E3 Ligase That Regulates Proliferation and Cell Death. The Journal of 
Immunology 176, 6277-6285. 
Fabini, G., Rutjes, S.A., Zimmermann, C., Pruijn, G.J.M., and Steiner, G. (2000). 
Analysis of the molecular composition of Ro ribonucleoprotein complexes. 
Identification of novel Y RNA-binding proteins. European Journal of 
Biochemistry 267, 2778-2789. 
Fabini, G., Raijmakers, R., Hayer, S., Fouraux, M.A., Pruijn, G.J., and Steiner, G. 
(2001). The heterogeneous nuclear ribonucleoproteins I and K interact with a 
subset of the ro ribonucleoprotein-associated Y RNAs in vitro and in vivo. The 
Journal of Biological Chemistry 276, 20711-20718. 
Fais, S., O'Driscoll, L., Borras, F.E., Buzas, E., Camussi, G., Cappello, F., 
Carvalho, J., Cordeiro Da Silva, A., Del Portillo, H., El Andaloussi, S., 
 icko Trček, T.,  urlan, R., Hendrix, A., Gursel, I., Kralj-Iglic, V., Kaeffer, 
B., Kosanovic, M., Lekka, M.E., Lipps, G., Logozzi, M., Marcilla, A., 
Sammar, M., Llorente, A., Nazarenko, I., Oliveira, C., Pocsfalvi, G., 
Rajendran, L., Raposo, G., Rohde, E., Siljander, P., Van Niel, G., 
Vasconcelos, M.H., Yáñez-Mó, M., Yliperttula, M.L., Zarovni, N., Zavec, 
A.B., and Giebel, B. (2016). Evidence-Based Clinical Use of Nanoscale 
Extracellular Vesicles in Nanomedicine. ACS nano 10, 3886-3899. 
Falaleeva, M., Pages, A., Matuszek, Z., Hidmi, S., Agranat-Tamir, L., Korotkov, 
K., Nevo, Y., Eyras, E., Sperling, R., and Stamm, S. (2016). Dual function 
of C/D box small nucleolar RNAs in rRNA modification and alternative pre-
mRNA splicing. Proceedings of the National Academy of Sciences of the 
United States of America 113, E1625-E1634. 
Farris, A.D., Gross, J.K., Hanas, J.S., and Harley, J.B. (1996). Genes for murine 
Y1 and Y3 Ro RNAs have class 3 RNA polymerase III promoter structures 
and are unlinked on mouse chromosome 6. Gene 174, 35-42. 
Farris, A.D., Puvion-Dutilleul, F., Puvion, E., Harley, J.B., and Lee, L.A. (1997). 
The ultrastructural localization of 60-kDa Ro protein and human cytoplasmic 
RNAs: Association with novel electron-dense bodies. Proceedings of the 
National Academy of Sciences of the United States of America 94, 3040-3045. 
Farris, A.D., Koelsch, G., Pruijn, G.J., van Venrooij, W.J., and Harley, J.B. (1999). 
Conserved features of Y RNAs revealed by automated phylogenetic 
secondary structure analysis. Nucleic Acids Research 27, 1070-1078. 
Filipowicz, W., Bhattacharyya, S.N., and Sonenberg, N. (2008). Mechanisms of 
post-transcriptional regulation by microRNAs: Are the answers in sight? 
Nature Reviews Genetics 9, 102-114. 
Fiorentino, D.F., Presby, M., Baer, A.N., Petri, M., Rieger, K.E., Soloski, M., 
Rosen, A., Mammen, A.L., Christopher-Stine, L., and Casciola-Rosen, L. 
(2016). PUF60: a prominent new target of the autoimmune response in 
dermatomyositis and Sjögren's syndrome. Annals of the Rheumatic Diseases 
75, 1145-1151. 
Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. 
(1998). Potent and specific genetic interference by double-stranded RNA in 
Caenorhabditis elegans. Nature 391, 806-811. 
Fouraux, M.A., Bouvet, P., Verkaart, S., van Venrooij, W.J., and Pruijn, G.J. 
(2002). Nucleolin associates with a subset of the human Ro ribonucleoprotein 
complexes. Journal of Molecular Biology 320, 475-488. 
Fragkos, M., Ganier, O., Coulombe, P., and Méchali, M. (2015). DNA replication 
origin activation in space and time. Nature Reviews Molecular Cell Biology 16, 
360. 
Frank, D.N., and Pace, N.R. (1998). Ribonuclease P: Unity and Diversity in a tRNA 
Processing Ribozyme. Annual Review of Biochemistry 67, 153-180. 
REFERENCES 
 
263 
 
Frank, M.B., McCubbin, V.R., and Heldermon, C. (1995). Expression and DNA 
binding of the human 52 kDa Ro/SSA autoantigen. The Biochemical Journal 
305 ( Pt 2), 359-362. 
Fu, H., Feng, J., Liu, Q., Sun, F., Tie, Y., Zhu, J., Xing, R., Sun, Z., and Zheng, X. 
(2009). Stress induces tRNA cleavage by angiogenin in mammalian cells. 
FEBS Letters 583, 437-442. 
Fuchs, G., Stein, A.J., Fu, C., Reinisch, K.M., and Wolin, S.L. (2006). Structural 
and biochemical basis for misfolded RNA recognition by the Ro autoantigen. 
Nature Structural & Molecular Biology 13, 1002-1009. 
Gallois-Montbrun, S., Holmes, R.K., Swanson, C.M., Fernández-Ocaña, M., 
Byers, H.L., Ward, M.A., and Malim, M.H. (2008). Comparison of Cellular 
Ribonucleoprotein Complexes Associated with the APOBEC3F and 
APOBEC3G Antiviral Proteins. Journal of Virology 82, 5636-5642. 
Garcia, E.L., Onafuwa-Nuga, A., Sim, S., King, S.R., Wolin, S.L., and Telesnitsky, 
A. (2009). Packaging of host mY RNAs by murine leukemia virus may occur 
early in Y RNA biogenesis. Journal of Virology 83, 12526-12534. 
Gardiner, T.J., Christov, C.P., Langley, A.R., and Krude, T. (2009). A conserved 
motif of vertebrate Y RNAs essential for chromosomal DNA replication. RNA 
15, 1375-1385. 
Gendron, M., Roberge, D., and Boire, G. (2001). Heterogeneity of human Ro 
ribonucleoproteins (RNPS): nuclear retention of Ro RNPS containing the 
human hY5 RNA in human and mouse cells. Clinical and Experimental 
Immunology 125, 162-168. 
Gerstberger, S., Hafner, M., and Tuschl, T. (2014). A census of human RNA-
binding proteins. Nature Reviews Genetics 15, 829-845. 
Ghildiyal, M., Xu, J., Seitz, H., Weng, Z., and Zamore, P.D. (2010). Sorting of 
Drosophila small silencing RNAs partitions microRNA* strands into the RNA 
interference pathway. RNA 16, 43-56. 
Ginisty, H., Sicard, H., Roger, B., and Bouvet, P. (1999). Structure and functions 
of nucleolin. Journal of cell science 112, 761-772. 
Glisovic, T., Bachorik, J.L., Yong, J., and Dreyfuss, G. (2008). RNA-binding 
proteins and post-transcriptional gene regulation. FEBS letters 582, 1977-
1986. 
Gottlieb, E., and Steitz, J.A. (1989). Function of the mammalian La protein: evidence 
for its action in transcription termination by RNA polymerase III. The EMBO 
Journal 8, 851-861. 
Gould, S.J., and Raposo, G. (2013). As we wait: Coping with an imperfect 
nomenclature for extracellular vesicles. Journal of extracellular vesicles 2. 
Green, C.D., Long, K.S., Shi, H., and Wolin, S.L. (1998). Binding of the 60-kDA Ro 
autoantigen to Y RNAs: Evidence for recognition in the major groove of a 
conserved helix. RNA 4, 750-765. 
Griffiths-Jones, S. (2006). miRBase: the microRNA sequence database. Methods in 
molecular biology 342, 129-138. 
Gruber, A.R., Lorenz, R., Bernhart, S.H., Neuböck, R., and Hofacker, I.L. (2008). 
The Vienna RNA websuite. Nucleic acids research 36, W70-74. 
Ha, M., and Kim, V.N. (2014). Regulation of microRNA biogenesis. Nature Reviews 
Molecular Cell Biology 15, 509-524. 
Hafner, M., Renwick, N., Brown, M., Mihailovic, A., Holoch, D., Lin, C., Pena, J.T., 
Nusbaum, J.D., Morozov, P., Ludwig, J., Ojo, T., Luo, S., Schroth, G., and 
Tuschl, T. (2011). RNA-ligase-dependent biases in miRNA representation in 
deep-sequenced small RNA cDNA libraries. RNA 17, 1697-1712. 
Haiser, H.J., Karginov, F.V., Hannon, G.J., and Elliot, M.A. (2008). 
Developmentally regulated cleavage of tRNAs in the bacterium Streptomyces 
coelicolor. Nucleic Acids Research 36, 732-741. 
REFERENCES 
 
264 
 
Hajdin, C.E., Bellaousov, S., Huggins, W., Leonard, C.W., Mathews, D.H., and 
Weeks, K.M. (2013). Accurate SHAPE-directed RNA secondary structure 
modeling, including pseudoknots. Proceedings of the National Academy of 
Sciences 110, 5498-5503. 
Hall, A.E. (2013). Biogenesis of Y RNA derived small RNAs. 
Hall, A.E., and Dalmay, T. (2013). Discovery of novel small RNAs in the quest to 
unravel genome complexity. Biochemical Society transactions 41, 866-870. 
Hall, A.E., Turnbull, C., and Dalmay, T. (2013). Y RNAs: Recent developments. 
Biomolecular concepts 4, 103-110. 
Hamilton, A.J., and Baulcombe, D.C. (1999). A species of small antisense RNA in 
posttranscriptional gene silencing in plants. Science (New York, N.Y.) 286, 
950-952. 
Hammond, S.M., Bernstein, E., Beach, D., and Hannon, G.J. (2000). An RNA-
directed nuclease mediates post-transcriptional gene silencing in Drosophila 
cells. Nature 404, 293-296. 
Han, J., Lee, Y., Yeom, K.H., Kim, Y.K., Jin, H., and Kim, V.N. (2004). The Drosha-
DGCR8 complex in primary microRNA processing. Genes and Development 
18, 3016-3027. 
Han, Y., Donovan, J., Rath, S., Whitney, G., Chitrakar, A., and Korennykh, A. 
(2014). Structure of Human RNase L Reveals the Basis for Regulated RNA 
Decay in the IFN Response. Science 343, 1244-1248. 
Haussecker, D., Huang, Y., Lau, A., Parameswaran, P., Fire, A.Z., and Kay, M.A. 
(2010). Human tRNA-derived small RNAs in the global regulation of RNA 
silencing. RNA 16, 673-695. 
Heichman, K., and Roberts, J. (1994). Rules to replicate by. Cell 79, 557–562. 
Hendrick, J.P., Wolin, S.L., Rinke, J., Lerner, M.R., and Steitz, J.A. (1981). Ro 
small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: 
Further characterization of the Ro and La small ribonucleoproteins from 
uninfected mammalian cells. Molecular and Cellular Biology 1, 1138-1149. 
Hizir, Z., Bottini, S., Grandjean, V., Trabucchi, M., and Repetto, E. (2017). RNY 
(Y RNA)-derived small RNAs regulate cell death and inflammation in 
monocytes/macrophages. Cell Death and Disease 8. 
Hoagland, M.B., Stephenson, M.L., Scott, J.F., Hecht, L.I., and Zamecnik, P.C. 
(1958). A soluble ribonucleic acid intermediate in protein synthesis. The 
Journal of Biological Chemistry 231, 241-257. 
Hofacker, I.L. (2003). Vienna RNA secondary structure server. Nucleic acids 
research 31, 3429-3431. 
Hogg, J.R., and Collins, K. (2007). Human Y5 RNA specializes a Ro 
ribonucleoprotein for 5S ribosomal RNA quality control. Genes & 
Development 21, 3067-3072. 
Holcik, M., and Sonenberg, N. (2005). Translational control in stress and apoptosis. 
Nature Reviews Molecular Cell Biology 6, 318-327. 
Horos, R., Alleaume, A.-M., Kleinendorst, R., Tarafder, A.K., Schwarzl, T., 
Zielonka, E.M., Adak, A., Castello, A., Huber, W., Sachse, C., and Hentze, 
M.W. (2017). The small non-coding vault RNA1-1 acts as a riboregulator of 
autophagy. bioRxiv. 
Houbaviy, H.B., Murray, M.F., and Sharp, P.A. (2003). Embryonic Stem Cell-
Specific MicroRNAs. Developmental Cell 5, 351-358. 
Hovanessian, A.G., Brown, R.E., and Kerr, I.M. (1977). Synthesis of low molecular 
weight inhibitor of protein synthesis with enzyme from interferon-treated cells. 
Nature 268, 537. 
 
 
 
 
REFERENCES 
 
265 
 
Hung, T., Pratt, G.A., Sundararaman, B., Townsend, M.J., Chaivorapol, C., 
Bhangale, T., Graham, R.R., Ortmann, W., Criswell, L.A., Yeo, G.W., and 
Behrens, T.W. (2015). The Ro60 autoantigen binds endogenous 
retroelements and regulates inflammatory gene expression. Science 350, 
455-459. 
Huntzinger, E., and Izaurralde, E. (2011). Gene silencing by microRNAs: 
Contributions of translational repression and mRNA decay. Nature Reviews 
Genetics 12, 99-110. 
Hussain, S., Sajini, Abdulrahim A., Blanco, S., Dietmann, S., Lombard, P., 
Sugimoto, Y., Paramor, M., Gleeson, Joseph G., Odom, Duncan T., Ule, 
J., and Frye, M. (2013). NSun2-Mediated Cytosine-5 Methylation of Vault 
Noncoding RNA Determines Its Processing into Regulatory Small RNAs. Cell 
Reports 4, 255-261. 
Hutvagner, G., and Simard, M.J. (2008). Argonaute proteins: Key players in RNA 
silencing. Nature Reviews Molecular Cell Biology 9, 22-32. 
Hutvágner, G., McLachlan, J., Pasquinelli, A.E., Bálint, É., Tuschl, T., and 
Zamore, P.D. (2001). A cellular function for the RNA-interference enzyme 
dicer in the maturation of the let-7 small temporal RNA. Science 293, 834-838. 
International Human Genome Sequencing Consortium. (2004). Finishing the 
euchromatic sequence of the human genome. Nature 431, 931-945. 
Ishikawa, T., Haino, A., Seki, M., Terada, H., and Nashimoto, M. (2017). The Y4-
RNA fragment, a potential diagnostic marker, exists in saliva. Non-coding 
RNA Research 2, 122-128. 
Ivanov, P., Emara, Mohamed M., Villen, J., Gygi, Steven P., and Anderson, P. 
(2011). Angiogenin-Induced tRNA Fragments Inhibit Translation Initiation. 
Molecular Cell 43, 613-623. 
Jayaprakash, A.D., Jabado, O., Brown, B.D., and Sachidanandam, R. (2011). 
Identification and remediation of biases in the activity of RNA ligases in small-
RNA deep sequencing. Nucleic acids research 39. 
Jöchl, C., Rederstorff, M., Hertel, J., Stadler, P.F., Hofacker, I.L., Schrettl, M., 
Haas, H., and Hüttenhofer, A. (2008). Small ncRNA transcriptome analysis 
from Aspergillus fumigatus suggests a novel mechanism for regulation of 
protein synthesis. Nucleic Acids Research 36, 2677-2689. 
Johnstone, R.M., Adam, M., Hammond, J.R., Orr, L., and Turbide, C. (1987). 
Vesicle formation during reticulocyte maturation. Association of plasma 
membrane activities with released vesicles (exosomes). The Journal of 
Biological Chemistry 262, 9412-9420. 
Jorgensen, R. (1990). Altered gene expression in plants due totrans interactions 
between homologous genes. Trends in Biotechnology 8, 340-344. 
Katibah, G.E., Qin, Y., Sidote, D.J., Yao, J., Lambowitz, A.M., and Collins, K. 
(2014). Broad and adaptable RNA structure recognition by the human 
interferon-induced tetratricopeptide repeat protein IFIT5. Proceedings of the 
National Academy of Sciences of the United States of America 111, 12025-
12030. 
Kato, N., Hoshino, H., and Harada, F. (1982). Nucleotide sequence of 4.5S RNA 
(C8 or hY5) from HeLa cells. Biochemical and Biophysical Research 
communications 108, 363-370. 
Kawashima, C.G., Yoshimoto, N., Maruyama-Nakashita, A., Tsuchiya, Y.N., 
Saito, K., Takahashi, H., and Dalmay, T. (2009). Sulphur starvation induces 
the expression of microRNA-395 and one of its target genes but in different 
cell types. Plant Journal 57, 313-321. 
Keam, S.P., and Hutvagner, G. (2015). tRNA-Derived Fragments (tRFs): Emerging 
New Roles for an Ancient RNA in the Regulation of Gene Expression. Life 5, 
1638-1651. 
REFERENCES 
 
266 
 
Kedersha, N.L., and Rome, L.H. (1986). Isolation and characterization of a novel 
ribonucleoprotein particle: Large structures contain a single species of small 
RNA. Journal of Cell Biology 103, 699-709. 
Kelekar, A., Saitta, M.R., and Keene, J.D. (1994). Molecular composition of Ro small 
ribonucleoprotein complexes in human cells. Intracellular localization of the 
60- and 52-kD proteins. The Journal of Clinical Investigation 93, 1637-1644. 
Ketting, R.F., Fischer, S.E.J., Bernstein, E., Sijen, T., Hannon, G.J., and Plasterk, 
R.H.A. (2001). Dicer functions in RNA interference and in synthesis of small 
RNA involved in developmental timing in C. elegans. Genes and Development 
15, 2654-2659. 
Kheir, E.G.A., and Krude, T. (2017). Non-coding Y RNAs associate with early 
replicating euchromatin concordantly with the origin recognition complex 
(ORC). Journal of Cell Science. 
Khvorova, A., Reynolds, A., and Jayasena, S.D. (2003). Functional siRNAs and 
miRNAs exhibit strand bias. Cell 115, 209-216. 
Kickhoefer, V.A., Rajavel, K.S., Scheffer, G.L., Dalton, W.S., Scheper, R.J., and 
Rome, L.H. (1998). Vaults are up-regulated in multidrug-resistant cancer cell 
lines. Journal of Biological Chemistry 273, 8971-8974. 
Kim, E., Lee, S., Mian, M.F., Yun, S.U., Song, M., Yi, K.-S., Ryu, S.H., and Suh, 
P.-G. (2006). Crosstalk between Src and major vault protein in epidermal 
growth factor-dependent cell signalling. The FEBS Journal 273, 793-804. 
Kim Kyoung, M., Abdelmohsen, K., Mustapic, M., Kapogiannis, D., and Gorospe, 
M. (2017). RNA in extracellular vesicles. Wiley Interdisciplinary Reviews: RNA 
8, e1413. 
Kim, V.N., Han, J., and Siomi, M.C. (2009). Biogenesis of small RNAs in animals. 
Nature Reviews Molecular Cellular Biology 10, 126-139. 
Kinoshita, T., Yip, K.W., Spence, T., and Liu, F.-F. (2016). MicroRNAs in 
extracellular vesicles: potential cancer biomarkers. Journal Of Human 
Genetics 62, 67. 
Kishore, S., and Stamm, S. (2006). The snoRNA HBII-52 Regulates Alternative 
Splicing of the Serotonin Receptor 2C. Science 311, 230-232. 
Kishore, S., Khanna, A., Zhang, Z., Hui, J., Balwierz, P.J., Stefan, M., Beach, C., 
Nicholls, R.D., Zavolan, M., and Stamm, S. (2010). The snoRNA MBII-52 
(SNORD 115) is processed into smaller RNAs and regulates alternative 
splicing. Human Molecular Genetics 19, 1153-1164. 
Kiss, T. (2001). Small nucleolar RNA‐guided post‐transcriptional modification of 
cellular RNAs. The EMBO Journal 20, 3617-3622. 
Kiss, T. (2002). Small Nucleolar RNAs: An Abundant Group of Noncoding RNAs with 
Diverse Cellular Functions. Cell 109, 145-148. 
Kobayashi, S., Hoshino, T., Hiwasa, T., Satoh, M., Rahmutulla, B., Tsuchida, S., 
Komukai, Y., Tanaka, T., Matsubara, H., Shimada, H., Nomura, F., and 
Matsushita, K. (2016). Anti-FIRs (PUF60) auto-antibodies are detected in the 
sera of early-stage colon cancer patients. Oncotarget 7, 82493-82503. 
Köhn, M., Pazaitis, N., and Hüttelmaier, S. (2013). Why Y RNAs? About Versatile 
RNAs and Their Functions. Biomolecules 3, 143. 
Köhn, M., Lederer, M., Wächter, K., and Hüttelmaier, S. (2010). Near-infrared 
(NIR) dye-labeled RNAs identify binding of ZBP1 to the noncoding Y3-RNA. 
RNA 16, 1420-1428. 
Köhn, M., Ihling, C., Sinz, A., Krohn, K., and Hüttelmaier, S. (2015). The Y3** 
ncRNA promotes the 3' end processing of histone mRNAs. Genes & 
Development 29, 1998-2003. 
Kolb, S.J., Battle, D.J., and Dreyfuss, G. (2007). Molecular functions of the SMN 
complex. Journal of Child Neurology 22, 990-994. 
Kowalski, M.P., and Krude, T. (2015). Functional roles of non-coding Y RNAs. The 
International Journal of Biochemistry & Cell Biology 66, 20-29. 
REFERENCES 
 
267 
 
Kowalski, M.P., Baylis, H.A., and Krude, T. (2015). Non-coding stem-bulge RNAs 
are required for cell proliferation and embryonic development in C. elegans. 
Journal of Cell Science 128, 2118-2129. 
Krämer, A. (1996). The Structure and Function of Proteins Involved in Mammalian 
Pre-mRNA Splicing. Annual Review of Biochemistry 65, 367-409. 
Krude, T., Jackman, M., Pines, J., and Laskey, R.A. (1997). Cyclin/Cdk-dependent 
initiation of DNA replication in a human cell-free system. Cell 88, 109-119. 
Krude, T. (2000). Initiation of human DNA replication in vitro using nuclei from 
cellsarrested at an initiation-competent state. Journal of Biological Chemistry 
275, 13699–13707. 
Krude, T., Christov, C.P., Hyrien, O., and Marheineke, K. (2009). Y RNA functions 
at the initiation step of mammalian chromosomal DNA replication. Journal of 
Cell Science 122, 2836-2845. 
Kruger, K., Grabowski, P.J., Zaug, A.J., Sands, J., Gottschling, D.E., and Cech, 
T.R. (1982). Self-splicing RNA: autoexcision and autocyclization of the 
ribosomal RNA intervening sequence of Tetrahymena. Cell 31, 147-157. 
Kültz, D. (2005). Molecular and evolutionary basis of the cellular stress response. In 
Annual Review of Physiology, pp. 225-257. 
Kumar, P., Kuscu, C., and Dutta, A. (2016). Biogenesis and Function of Transfer 
RNA-Related Fragments (tRFs). Trends in Biochemical Sciences 41, 679-
689. 
Kumar, P., Anaya, J., Mudunuri, S.B., and Dutta, A. (2014). Meta-analysis of tRNA 
derived RNA fragments reveals that they are evolutionarily conserved and 
associate with AGO proteins to recognize specific RNA targets. BMC Biology 
12, 78. 
Kwak, P.B., and Tomari, Y. (2012). The N domain of Argonaute drives duplex 
unwinding during RISC assembly. Nature Structural & Molecular Biology 19, 
145-151. 
Labbé, J.C., Hekimi, S., and Rokeach, L.A. (1999). The levels of the RoRNP-
associated Y RNA are dependent upon the presence of ROP-1, the 
Caenorhabditis elegans Ro60 protein. Genetics 151, 143-150. 
Langley, A.R., Chambers, H., Christov, C.P., and Krude, T. (2010). 
Ribonucleoprotein particles containing non-coding Y RNAs, Ro60, La and 
nucleolin are not required for Y RNA function in DNA replication. PloS one 5, 
e13673. 
Langmead, B. (2010). Aligning short sequencing reads with Bowtie. Current 
Protocols in Bioinformatics. 
Lau, N.C., Lim, L.P., Weinstein, E.G., and Bartel, D.P. (2001). An abundant class 
of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. 
Science 294, 858-862. 
Lee, R.C., Feinbaum, R.L., and Ambros, V. (1993). The C. elegans heterochronic 
gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 
75, 843-854. 
Lee, S.R., and Collins, K. (2005). Starvation-induced cleavage of the tRNA 
anticodon loop in Tetrahymena thermophila. Journal of Biological Chemistry 
280, 42744-42749. 
Lee, Y.S., Shibata, Y., Malhotra, A., and Dutta, A. (2009). A novel class of small 
RNAs: tRNA-derived RNA fragments (tRFs). Genes and Development 23, 
2639-2649. 
Lerner, M.R., and Steitz, J. (1979). Antibodies to small nuclear RNAs complexed 
with proteins are produced by patients with systemic lupus erythematosus. 
Proceedings of the National Academy of Sciences of the United States of 
America 76, 5495-5499. 
REFERENCES 
 
268 
 
Lerner, M.R., Boyle, J.A., Hardin, J.A., and Steitz, J.A. (1981a). Two novel classes 
of small ribonucleoproteins detected by antibodies associated with lupus 
erythematosus. Science 211, 400-402. 
Lerner, M.R., Andrews, N.C., Miller, G., and Steitz, J.A. (1981b). Two small RNAs 
encoded by Epstein-Barr virus and complexed with protein are precipitated by 
antibodies from patients with systemic lupus erythematosus. Proceedings of 
the National Academy of Sciences of the United States of America 78, 805-
809. 
Leung, A.K.L., and Sharp, P.A. (2007). microRNAs: A Safeguard against Turmoil? 
Cell 130, 581-585. 
Leung, A.K.L., and Sharp, P.A. (2010). MicroRNA Functions in Stress Responses. 
Molecular Cell 40, 205-215. 
Leung, K.N., Vallero, R.O., DuBose, A.J., Resnick, J.L., and LaSalle, J.M. (2009). 
Imprinting regulates mammalian snoRNA-encoding chromatin 
decondensation and neuronal nucleolar size. Human Molecular Genetics 18, 
4227-4238. 
Li, Y., Banerjee, S., Wang, Y., Goldstein, S.A., Dong, B., Gaughan, C., Silverman, 
R.H., and Weiss, S.R. (2016). Activation of RNase L is dependent on OAS3 
expression during infection with diverse human viruses. Proceedings of the 
National Academy of Sciences of the United States of America 113, 2241-
2246. 
Li, Z., Ender, C., Meister, G., Moore, P.S., Chang, Y., and John, B. (2012). 
Extensive terminal and asymmetric processing of small RNAs from rRNAs, 
snoRNAs, snRNAs, and tRNAs. Nucleic Acids Research 40, 6787-6799. 
Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change 
and dispersion for RNA-seq data with DESeq2. Genome biology 15, 550. 
Lu, Z.H., Books, J.T., and Ley, T.J. (2005). YB-1 is important for late-stage 
embryonic development, optimal cellular stress responses, and the prevention 
of premature senescence. Molecular and Cellular Biology 25, 4625-4637. 
Lukong, K.E., Chang, K.-w., Khandjian, E.W., and Richard, S. (2008). RNA-
binding proteins in human genetic disease. Trends in Genetics 24, 416-425. 
Lunde, B.M., Moore, C., and Varani, G. (2007). RNA-binding proteins: Modular 
design for efficient function. Nature Reviews Molecular Cell Biology 8, 479-
490. 
Maas, S.L.N., Breakefield, X.O., and Weaver, A.M. (2017). Extracellular Vesicles: 
Unique Intercellular Delivery Vehicles. Trends in cell biology 27, 172-188. 
Mannoor, K., Liao, J., and Jiang, F. (2012). Small nucleolar RNAs in cancer. 
Biochimica et biophysica acta 1826, 10.1016/j.bbcan.2012.1003.1005. 
Maraia, R., Sakulich, A.L., Brinkmann, E., and Green, E.D. (1996). Gene encoding 
human Ro-associated autoantigen Y5 RNA. Nucleic Acids Research 24, 
3552-3559. 
Maraia, R.J., and Lamichhane, T.N. (2011). 3′ processing of eukaryotic precursor 
tRNAs. Wiley Interdisciplinary Reviews: RNA 2, 362-375. 
Maraia, R.J., Kenan, D.J., and Keene, J.D. (1994a). Eukaryotic transcription 
termination factor La mediates transcript release and facilitates reinitiation by 
RNA polymerase III. Molecular and Cellular Biology 14, 2147-2158. 
Maraia, R.J., Sasaki-Tozawa, N., Driscoll, C.T., Green, E.D., and Darlington, G.J. 
(1994b). The human Y4 small cytoplasmic RNA gene is controlled by 
upstream elements and resides on chromosome 7 with all other hY scRNA 
genes. Nucleic Acids Research 22, 3045-3052. 
  
REFERENCES 
 
269 
 
Martens-Uzunova, E.S., Jalava, S.E., Dits, N.F., van Leenders, G.J.L.H., Møller, 
S., Trapman, J., Bangma, C.H., Litman, T., Visakorpi, T., and Jenster, G. 
(2011). Diagnostic and prognostic signatures from the small non-coding RNA 
transcriptome in prostate cancer. Oncogene 31, 978. 
Martinez, F.J., Lee, J.H., Lee, J.E., Blanco, S., Nickerson, E., Gabrie, S., Frye, M., 
Al-Gazali, L., and Gleeson, J.G. (2012). Whole exome sequencing identifies 
a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome. Journal 
of Medical Genetics 49, 380-385. 
Matera, A.G., Frey, M.R., Margelot, K., and Wolin, S.L. (1995). A perinucleolar 
compartment contains several RNA polymerase III transcripts as well as the 
polypyrimidine tract-binding protein, hnRNP I. The Journal of Cell Biology 129, 
1181-1193. 
Mattick, J.S. (2001). Non-coding RNAs: the architects of eukaryotic complexity. 
EMBO Reports 2, 986-991. 
Mattick, J.S. (2003). Challenging the dogma: the hidden layer of non-protein-coding 
RNAs in complex organisms. Bioessays 25, 930-939. 
Mattick, J.S. (2004). RNA regulation: a new genetics? Nature Reviews Genetics 5, 
316-323. 
Maxwell, E., and Fournier, M. (1995). The Small Nucleolar RNAs. Annual Review of 
Biochemistry 64, 897-934. 
Meiri, E., Levy, A., Benjamin, H., Ben-David, M., Cohen, L., Dov, A., Dromi, N., 
Elyakim, E., Yerushalmi, N., Zion, O., Lithwick-Yanai, G., and Sitbon, E. 
(2010). Discovery of microRNAs and other small RNAs in solid tumors. 
Nucleic acids research 38, 6234-6246. 
Meister, G. (2013). Argonaute proteins: Functional insights and emerging roles. 
Nature Reviews Genetics 14, 447-459. 
Minciacchi, V.R., Freeman, M.R., and Di Vizio, D. (2015). Extracellular vesicles in 
cancer: exosomes, microvesicles and the emerging role of large oncosomes. 
Seminars in cell & developmental biology 40, 41-51. 
Morris, K.V., and Mattick, J.S. (2014). The rise of regulatory RNA. Nature Reviews 
Genetics 15, 423. 
Mosig, A., Meng, G., Stadler, B.M.R., and Stadler, P.F. (2007). Evolution of the 
vertebrate Y RNA cluster. Theory in Biosciences 126, 9-14. 
Nandy, C., Mrázek, J., Stoiber, H., Grässer, F.A., Hüttenhofer, A., and Polacek, 
N. (2009). Epstein–Barr Virus-Induced Expression of a Novel Human Vault 
RNA. Journal of Molecular Biology 388, 776-784. 
Napoli, C., Lemieux, C., and Jorgensen, R. (1990). Introduction of a Chimeric 
Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression 
of Homologous Genes in trans. The Plant Cell 2, 279-289. 
Nicolas, F.E., Hall, A.E., Csorba, T., Turnbull, C., and Dalmay, T. (2012). 
Biogenesis of Y RNA-derived small RNAs is independent of the microRNA 
pathway. FEBS Letters 586, 1226-1230. 
Ninomiya, S., Kawano, M., Abe, T., Ishikawa, T., Takahashi, M., Tamura, M., 
Takahashi, Y., and Nashimoto, M. (2015). Potential small guide RNAs for 
tRNase ZL from human plasma, peripheral blood mononuclear cells, and 
cultured cell lines. PloS one 10, e0118631. 
Nolte-'t Hoen, E.N., Buermans, H.P., Waasdorp, M., Stoorvogel, W., Wauben, 
M.H., and t Hoen, P.A. (2012). Deep sequencing of RNA from immune cell-
derived vesicles uncovers the selective incorporation of small non-coding 
RNA biotypes with potential regulatory functions. Nucleic acids research 40, 
9272-9285. 
Nurse, P. (1994). Ordering S phase and M phase in the cell cycle. Cell 79, 547-550 
O'Brien, C.A., and Wolin, S.L. (1994). A possible role for the 60-kD Ro autoantigen 
in a discard pathway for defective 5S rRNA precursors. Genes and 
Development 8, 2891-2903. 
REFERENCES 
 
270 
 
 
O'Brien, C.A., Margelot, K., and Wolin, S.L. (1993). Xenopus Ro 
ribonucleoproteins: members of an evolutionarily conserved class of 
cytoplasmic ribonucleoproteins. Proceedings of the National Academy of 
Sciences of the United States of America 90, 7250-7254. 
Ogata, J., Sugiura, Y., Kanai, A., Tanaka, M., Matsui, H., Ohtsuka, M., Inaba, T., 
Otsuka, M., and Kotani, A. (2018). Identification of PTBP1 responsible for 
caspase dependent Y RNA cleavage. bioRxiv. 
Okamura, K., Phillips, M.D., Tyler, D.M., Duan, H., Chou, Y.T., and Lai, E.C. 
(2008). The regulatory activity of microRNA* species has substantial influence 
on microRNA and 3′ UTR evolution. Nature Structural and Molecular Biology 
15, 354-363. 
Ottosson, L., Hennig, J., Espinosa, A., Brauner, S., Wahren-Herlenius, M., and 
Sunnerhagen, M. (2006). Structural, functional and immunologic 
characterization of folded subdomains in the Ro52 protein targeted in 
Sjögren's syndrome. Molecular Immunology 43, 588-598. 
Page-McCaw, P.S., Amonlirdviman, K., and Sharp, P.A. (1999). PUF60: a novel 
U2AF65-related splicing activity. RNA (New York, N.Y.) 5, 1548-1560. 
Pakos‐Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., and Gorman, 
A.M. (2016). The integrated stress response. EMBO reports 17, 1374-1395. 
Palade, G.E. (1955). A small particulate component of the cytoplasm. The Journal of 
Biophysical and Biochemical Cytology 1, 59-68. 
Palazzo, A.F., and Lee, E.S. (2015). Non-coding RNA: what is functional and what 
is junk? Frontiers in Genetics 6, 2. 
Pall, G.S., and Hamilton, A.J. (2008). Improved northern blot method for enhanced 
detection of small RNA. Nature Protocols 3, 1077-1084. 
Pasquinelli, A.E., Reinhart, B.J., Slack, F., Martindale, M.Q., Kuroda, M.I., Maller, 
B., Hayward, D.C., Ball, E.E., Degnan, B., Muller, P., Spring, J., 
Srinivasan, A., Fishman, M., Finnerty, J., Corbo, J., Levine, M., Leahy, P., 
Davidson, E., and Ruvkun, G. (2000). Conservation of the sequence and 
temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86-
89. 
Patterson, D.G., Roberts, J.T., King, V.M., Houserova, D., Barnhill, E.C., 
Crucello, A., Polska, C.J., Brantley, L.W., Kaufman, G.C., Nguyen, M., 
Santana, M.W., Schiller, I.A., Spicciani, J.S., Zapata, A.K., Miller, M.M., 
Sherman, T.D., Ma, R., Zhao, H., Arora, R., Coley, A.B., Zeidan, M.M., Tan, 
M., Xi, Y., and Borchert, G.M. (2017). Human snoRNA-93 is processed into 
a microRNA-like RNA that promotes breast cancer cell invasion. npj Breast 
Cancer 3, 25. 
Pederson, T. (2010). Regulatory RNAs derived from transfer RNA? RNA 16, 1865-
1869. 
Peek, R., Pruijn, G.J.M., Van der Kemp, A.J.W., and Van Venrooij, W.J. (1993). 
Subcellular distribution of Ro ribonucleoprotein complexes and their 
constituents. Journal of Cell Science 106, 929-935. 
Pereira, B., Billaud, M., and Almeida, R. (2017). RNA-Binding Proteins in Cancer: 
Old Players and New Actors. Trends in cancer 3, 506-528. 
Perreault, J., Perreault, J.P., and Boire, G. (2007). Ro-associated Y RNAs in 
metazoans: evolution and diversification. Molecular Biology and Evolution 24, 
1678-1689. 
Perreault, J., Noël, J.-F., Brière, F., Cousineau, B., Lucier, J.-F., Perreault, J.-P., 
and Boire, G. (2005). Retropseudogenes derived from the human Ro/SS-A 
autoantigen-associated hY RNAs. Nucleic Acids Research 33, 2032-2041. 
REFERENCES 
 
271 
 
Persson, H., Kvist, A., Vallon-Christersson, J., Medstrand, P., Borg, Å., and 
Rovira, C. (2009). The non-coding RNA of the multidrug resistance-linked 
vault particle encodes multiple regulatory small RNAs. Nature Cell Biology 11, 
1268. 
Pfeffer, S., Zavolan, M., Grasser, F.A., Chien, M., Russo, J.J., Ju, J., John, B., 
Enright, A.J., Marks, D., Sander, C., and Tuschl, T. (2004). Identification of 
virus-encoded microRNAs. Science  304, 734-736. 
Pospiech, H., Grosse, F., and Pisani, F.M. (2010). The initiation step of eukaryotic 
DNA replication. Sub-Cellular Biochemistry 50, 79-104. 
Prüfer, K., Stenzel, U., Dannemann, M., Green, R.E., Lachmann, M., and Kelso, 
J. (2008). PatMaN: Rapid alignment of short sequences to large databases. 
Bioinformatics 24, 1530-1531. 
Pruijn, G.J., Slobbe, R.L., and van Venrooij, W.J. (1991). Analysis of protein--RNA 
interactions within Ro ribonucleoprotein complexes. Nucleic Acids Research 
19, 5173-5180. 
Pruijn, G.J.M., Wingens, P.A.E.T.M., Peters, S.L.M., Thijssen, J.H., and van 
Venrooij, W.J. (1993). Ro RNP associated Y RNAs are highly conserved 
among mammals. Biochimica et Biophysica Acta (BBA) - Gene Structure and 
Expression 1216, 395-401. 
Qi, Y., Tu, J., Cui, L., Guo, X., Shi, Z., Li, S., Shi, W., Shan, Y., Ge, Y., Shan, J., 
Wang, H., and Lu, Z. (2010). High-Throughput Sequencing of MicroRNAs in 
Adenovirus Type 3 Infected Human Laryngeal Epithelial Cells. Journal of 
Biomedicine and Biotechnology 2010, 915980. 
Quinlan, A.R. (2014). BEDTools: The Swiss-Army Tool for Genome Feature 
Analysis. Current protocols in bioinformatics 47, 11.12.11-34. 
Rao, P.N., and Johnson, R.T. (1970). Mammalian Cell Fusion : Studies on the 
Regulation of DNA Synthesis and Mitosis. Nature 225, 159. 
Ratajczak, J., Miekus, K., Kucia, M., Zhang, J., Reca, R., Dvorak, P., and 
Ratajczak, M.Z. (2006). Embryonic stem cell-derived microvesicles 
reprogram hematopoietic progenitors: evidence for horizontal transfer of 
mRNA and protein delivery. Leukemia 20, 847-856. 
Reinhart, B.J., Slack, F.J., Basson, M., Pasquinelli, A.E., Bettinger, J.C., 
Rougvie, A.E., Horvitz, H.R., and Ruvkun, G. (2000). The 21-nucleotide let-
7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 
403, 901-906. 
Rinke, J., and Steitz, J.A. (1982). Precursor molecules of both human 5S ribosomal 
RNA and transfer RNAs are bound by a cellular protein reactive with anti-La 
Lupus antibodies. Cell 29, 149-159. 
Rivas, F.V., Tolia, N.H., Song, J.J., Aragon, J.P., Liu, J., Hannon, G.J., and 
Joshua-Tor, L. (2005). Purified Argonaute2 and an siRNA form recombinant 
human RISC. Nature structural & molecular biology 12, 340-349. 
Rosa, M.D., Gottlieb, E., Lerner, M.R., and Steitz, J.A. (1981). Striking similarities 
are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and 
the adenovirus-associated ribonucleic acids VAI and VAII. Molecular and 
Cellular Biology 1, 785-796. 
Rother, S., and Meister, G. (2011). Small RNAs derived from longer non-coding 
RNAs. Biochimie 93, 1905-1915. 
Rutjes, S.A., van der Heijden, A., Utz, P.J., van Venrooij, W.J., and Pruijn, G.J. 
(1999a). Rapid nucleolytic degradation of the small cytoplasmic Y RNAs 
during apoptosis. Journal of Biological Chemistry 274, 24799-24807. 
Rutjes, S.A., Utz, P.J., van der Heijden, A., Broekhuis, C., van Venrooij, W.J., 
and Pruijn, G.J.M. (1999b). The La (SS-B) autoantigen, a key protein in RNA 
biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell 
death and differentiation 6, 976. 
REFERENCES 
 
272 
 
Schiffer, S., Rösch, S., and Marchfelder, A. (2002). Assigning a function to a 
conserved group of proteins: the tRNA 3′‐processing enzymes. The EMBO 
Journal 21, 2769-2777. 
Schotte, D., Chau, J.C., Sylvester, G., Liu, G., Chen, C., van der Velden, V.H., 
Broekhuis, M.J., Peters, T.C., Pieters, R., and den Boer, M.L. (2009). 
Identification of new microRNA genes and aberrant microRNA profiles in 
childhood acute lymphoblastic leukemia. Leukemia 23, 313-322. 
Schubert, T., Pusch, Miriam C., Diermeier, S., Benes, V., Kremmer, E., Imhof, A., 
and Längst, G. (2012). Df31 Protein and snoRNAs Maintain Accessible 
Higher-Order Structures of Chromatin. Molecular Cell 48, 434-444. 
Schwarz, D.S., Hutvagner, G., Du, T., Xu, Z., Aronin, N., and Zamore, P.D. (2003). 
Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208. 
Shen, Y., Yu, X., Zhu, L., Li, T., Yan, Z., and Guo, J. (2018). Transfer RNA-derived 
fragments and tRNA halves: biogenesis, biological functions and their roles in 
diseases. Journal of Molecular Medicine. 
Shi, H., O'Brien, C.A., Van Horn, D.J., and Wolin, S.L. (1996). A misfolded form of 
5S rRNA is complexed with the Ro and La autoantigens. RNA 2, 769-784. 
Shimamoto, Y., Sumizawa, T., Haraguchi, M., Gotanda, T., Jueng, H.C., 
Furukawa, T., Sakata, R., and Akiyama, S.I. (2006). Direct activation of the 
human major vault protein gene by DNA-damaging agents. Oncology Reports 
15, 645-652. 
Shukla, S., and Parker, R. (2017). PARN modulates Y RNA stability and its 3'-end 
formation. Molecular and Cellular Biology 37. 
Silverman, R.H. (2007). Viral Encounters with 2′,5′-Oligoadenylate Synthetase and 
RNase L during the Interferon Antiviral Response. Journal of Virology 81, 
12720-12729. 
Sim, S., and Wolin, S.L. (2011). Emerging roles for the Ro 60-kDa autoantigen in 
noncoding RNA metabolism. Wiley interdisciplinary reviews. RNA 2, 686-699. 
Sim, S., Weinberg, D.E., Fuchs, G., Choi, K., Chung, J., and Wolin, S.L. (2009). 
The Subcellular Distribution of an RNA Quality Control Protein, the Ro 
Autoantigen, Is Regulated by Noncoding Y RNA Binding. Molecular Biology 
of the Cell 20, 1555-1564. 
Sim, S., Yao, J., Weinberg, D.E., Niessen, S., Yates, J.R., 3rd, and Wolin, S.L. 
(2012). The zipcode-binding protein ZBP1 influences the subcellular location 
of the Ro 60-kDa autoantigen and the noncoding Y3 RNA. RNA 18, 100-110. 
Simons, F.H., Pruijn, G.J., and van Venrooij, W.J. (1994). Analysis of the 
intracellular localization and assembly of Ro ribonucleoprotein particles by 
microinjection into Xenopus laevis oocytes. The Journal of Cell Biology 125, 
981-988. 
Simons, F.H., Rutjes, S.A., van Venrooij, W.J., and Pruijn, G.J. (1996). The 
interactions with Ro60 and La differentially affect nuclear export of hY1 RNA. 
RNA 2, 264-273. 
Slobbe, R.L., Pluk, W., van Venrooij, W.J., and Pruijn, G.J. (1992). Ro 
ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-
protein interactions. Journal of Molecular Biology 227, 361-366. 
Slobbe, R.L., Pruijn, G.J., Damen, W.G., van der Kemp, J.W., and van Venrooij, 
W.J. (1991). Detection and occurrence of the 60- and 52-kD Ro (SS-A) 
antigens and of autoantibodies against these proteins. Clinical and 
Experimental Immunology 86, 99-105. 
Smith, J.A., Schmechel, S.C., Williams, B.R.G., Silverman, R.H., and Schiff, L.A. 
(2005). Involvement of the interferon-regulated antiviral proteins PKR and 
RNase L in reovirus-induced shutoff of cellular translation. Journal of Virology 
79, 2240-2250. 
Sobala, A., and Hutvagner, G. (2013). Small RNAs derived from the 5′ end of tRNA 
can inhibit protein translation in human cells. RNA Biology 10, 553-563. 
REFERENCES 
 
273 
 
Sorefan, K., Pais, H., Hall, A.E., Kozomara, A., Griffiths-Jones, S., Moulton, V., 
and Dalmay, T. (2012). Reducing ligation bias of small RNAs in libraries for 
next generation sequencing. Silence 3, 4. 
Spriggs, K.A., Bushell, M., and Willis, A.E. (2010). Translational Regulation of 
Gene Expression during Conditions of Cell Stress. Molecular Cell 40, 228-
237. 
Srivastava, M., and Pollard, H.B. (1999). Molecular dissection of nucleolin's role in 
growth and cell proliferation: New insights. FASEB Journal 13, 1911-1922. 
Stadler, P.F., Chen, J.J.L., Hackermüller, J., Hoffmann, S., Horn, F., Khaitovich, 
P., Kretzschmar, A.K., Mosig, A., Prohaska, S.J., Qi, X., Schutt, K., and 
Ullmann, K. (2009). Evolution of Vault RNAs. Molecular Biology and Evolution 
26, 1975-1991. 
Stefano, J.E. (1984). Purified lupus antigen la recognizes an oligouridylate stretch 
common to the 3′ termini of RNA polymerase III transcripts. Cell 36, 145-154. 
Stein, A.J., Fuchs, G., Fu, C., Wolin, S.L., and Reinisch, K.M. (2005). Structural 
insights into RNA quality control: the Ro autoantigen binds misfolded RNAs 
via its central cavity. Cell 121, 529-539. 
Steiner, E., Holzmann, K., Elbling, L., Micksche, M., and Berger, W. (2006). 
Cellular functions of vaults and their involvement in multidrug resistance. 
Current Drug Targets 7, 923-934. 
Steitz, J.A., Berg, C., Hendrick, J.P., La Branche-Chabot, H., Metspalu, A., Rinke, 
J., and Yario, T. (1988). A 5S rRNA/L5 complex is a precursor to ribosome 
assembly in mammalian cells. The Journal of Cell Biology 106, 545-556. 
Stocks, M.B., Moxon, S., Mapleson, D., Woolfenden, H.C., Mohorianu, I., Folkes, 
L., Schwach, F., Dalmay, T., and Moulton, V. (2012). The UEA sRNA 
workbench: A suite of tools for analysing and visualizing next generation 
sequencing microRNA and small RNA datasets. Bioinformatics 28, 2059-
2061. 
Storz, G. (2002). An expanding universe of noncoding RNAs. Science 296, 1260-
1263. 
Stuart, B.D., Choi, J., Zaidi, S., Xing, C., Holohan, B., Chen, R., Choi, M., 
Dharwadkar, P., Torres, F., Girod, C.E., Weissler, J., Fitzgerald, J., 
Kershaw, C., Klesney-Tait, J., Mageto, Y., Shay, J.W., Ji, W., Bilguvar, K., 
Mane, S., Lifton, R.P., and Garcia, C.K. (2015). Exome sequencing links 
mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere 
shortening. Nature Genetics 47, 512-517. 
Sunkar, R., Chinnusamy, V., Zhu, J., and Zhu, J.-K. (2007). Small RNAs as big 
players in plant abiotic stress responses and nutrient deprivation. Trends in 
Plant Science 12, 301-309. 
Taft, R.J., Glazov, E.A., Lassmann, T., Hayashizaki, Y., Carninci, P., and Mattick, 
J.S. (2009). Small RNAs derived from snoRNAs. RNA 15, 1233-1240. 
Takeda, D.Y., and Dutta, A. (2005). DNA replication and progression through S 
phase. Oncogene 24, 2827. 
Takisawa, H., Mimura, S., and Kubota, Y. (2000). Eukaryotic DNA replication: From 
pre-replication complex to initiation complex. Current Opinion in Cell Biology 
12, 690-696. 
  
REFERENCES 
 
274 
 
 
Tanaka, N., Chakravarty, A.K., Maughan, B., and Shuman, S. (2011). Novel 
Mechanism of RNA Repair by RtcB via Sequential 2′,3′-Cyclic 
Phosphodiesterase and 3′-Phosphate/5′-Hydroxyl Ligation Reactions. Journal 
of Biological Chemistry 286, 43134-43143. 
Telonis, A.G., Loher, P., Honda, S., Jing, Y., Palazzo, J., Kirino, Y., and 
Rigoutsos, I. (2015). Dissecting tRNA-derived fragment complexities using 
personalized transcriptomes reveals novel fragment classes and unexpected 
dependencies. Oncotarget 6, 24797-24822. 
Teunissen, S.W., Kruithof, M.J., Farris, A.D., Harley, J.B., Venrooij, W.J., and 
Pruijn, G.J. (2000). Conserved features of Y RNAs: a comparison of 
experimentally derived secondary structures. Nucleic Acids Research 28, 
610-619. 
Thompson, D.M., and Parker, R. (2009). The RNase Rny1p cleaves tRNAs and 
promotes cell death during oxidative stress in Saccharomyces cerevisiae. 
Journal of Cell Biology 185, 43-50. 
Thompson, D.M., Lu, C., Green, P.J., and Parker, R. (2008). tRNA cleavage is a 
conserved response to oxidative stress in eukaryotes. RNA 14, 2095-2103. 
Tkach, M., and Théry, C. (2016). Communication by Extracellular Vesicles: Where 
We Are and Where We Need to Go. Cell 164, 1226-1232. 
Tolkach, Y., Stahl, A.F., Niehoff, E.-M., Zhao, C., Kristiansen, G., Müller, S.C., 
and Ellinger, J. (2017). Y RNA expression predicts survival in bladder cancer 
patients. BMC Cancer 17, 749. 
Tolkach, Y., Niehoff, E.-M., Stahl, A.F., Zhao, C., Kristiansen, G., Müller, S.C., 
and Ellinger, J. (2018). Y RNA expression in prostate cancer patients: 
diagnostic and prognostic implications. World Journal of Urology 36, 1073-
1078. 
Turnbull, C. (2014). Sequence and structure requirements of Y RNA-derived small 
RNA biogenesis (University of East Anglia). 
Turner, M., and DÍaz-Muñoz, M.D. (2018). RNA-binding proteins control gene 
expression and cell fate in the immune system Nature Immunology 19, 120-
129. 
Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., and Lotvall, J.O. 
(2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel 
mechanism of genetic exchange between cells. Nature Cell Biology 9, 654-
659. 
van Gelder, C.W., Thijssen, J.P., Klaassen, E.C., Sturchler, C., Krol, A., van 
Venrooij, W.J., and Pruijn, G.J. (1994). Common structural features of the 
Ro RNP associated hY1 and hY5 RNAs. Nucleic Acids Research 22, 2498-
2506. 
Van Horn, D.J., Eisenberg, D., O'Brien, C.A., and Wolin, S.L. (1995). 
Caenorhabditis elegans embryos contain only one major species of Ro RNP. 
RNA 1, 293-303. 
Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., et al. (2001). The 
sequence of the human genome. Science 291, 1304-1351. 
Victoria Martinez, B., Dhahbi, J.M., Nunez Lopez, Y.O., Lamperska, K., 
Golusinski, P., Luczewski, L., Kolenda, T., Atamna, H., Spindler, S.R., 
Golusinski, W., and Masternak, M.M. (2015). Circulating small non-coding 
RNA signature in head and neck squamous cell carcinoma. Oncotarget 6, 
19246-19263. 
Vihervaara, A., Duarte, F.M., and Lis, J.T. (2018). Molecular mechanisms driving 
transcriptional stress responses. Nature Reviews Genetics 19, 385-397. 
  
REFERENCES 
 
275 
 
Vojtech, L., Woo, S., Hughes, S., Levy, C., Ballweber, L., Sauteraud, R.P., Strobl, 
J., Westerberg, K., Gottardo, R., Tewari, M., and Hladik, F. (2014). 
Exosomes in human semen carry a distinctive repertoire of small non-coding 
RNAs with potential regulatory functions. Nucleic Acids Research 42, 7290-
7304. 
Vollmar, F., Hacker, C., Zahedi, R.-P., Sickmann, A., Ewald, A., Scheer, U., and 
Dabauvalle, M.-C. (2009). Assembly of nuclear pore complexes mediated by 
major vault protein. Journal of Cell Science 122, 780-786. 
Wang, I., Kowalski, M.P., Langley, A.R., Rodriguez, R., Balasubramanian, S., 
Hsu, S.-T.D., and Krude, T. (2014). Nucleotide Contributions to the Structural 
Integrity and DNA Replication Initiation Activity of Noncoding Y RNA. 
Biochemistry 53, 5848-5863. 
Wang, W., Chen, X., Wolin, S.L., and Xiong, Y. (2018). Structural Basis for tRNA 
Mimicry by a Bacterial Y RNA. Structure 26, 1635-1644.e1633. 
Wassarman, K.M., Zhang, A., and Storz, G. (1999). Small RNAs in Escherichia coli. 
Trends in Microbiology 7, 37-45. 
Weinstein, L.B., and Steitz, J.A. (1999). Guided tours: from precursor snoRNA to 
functional snoRNP. Current Opinion in Cell Biology 11, 378-384. 
Wilkinson, K.A., Merino, E.J., and Weeks, K.M. (2006). Selective 2′-hydroxyl 
acylation analyzed by primer extension (SHAPE): quantitative RNA structure 
analysis at single nucleotide resolution. Nature Protocols 1, 1610. 
Wittmann, J., and Jäck, H.M. (2010). New surprises from the deep - The family of 
small regulatory RNAs increases. The Scientific World Journal 10, 1239-1243. 
Wolin, S.L., and Steitz, J.A. (1983). Genes for two small cytoplasmic Ro RNAs are 
adjacent and appear to be single-copy in the human genome. Cell 32, 735-
744. 
Wolin, S.L., and Steitz, J.A. (1984). The Ro small cytoplasmic ribonucleoproteins: 
Identification of the antigenic protein and its binding site on the Ro RNAs. 
Proceedings of the National Academy of Sciences of the United States of 
America 81, 1996-2000. 
Wolin, S.L., and Cedervall, T. (2002). The La protein. In Annual Review of 
Biochemistry, pp. 375-403. 
Wolin, S.L., Belair, C., Boccitto, M., Chen, X., Sim, S., Taylor, D.W., and Wang, 
H.W. (2013). Non-coding Y RNAs as tethers and gates: Insights from bacteria. 
RNA Biology 10, 1602-1608. 
Wreschner, D.H., McCauley, J.W., Skehel, J.J., and Kerr, I.M. (1981). Interferon 
action--sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. 
Nature 289, 414-417. 
Wurtmann, E.J., and Wolin, S.L. (2010). A role for a bacterial ortholog of the Ro 
autoantigen in starvation-induced rRNA degradation. Proceedings of the 
National Academy of Sciences of the United States of America 107, 4022-
4027. 
Xiao, Q., Sharp, T.V., Jeffrey, I.W., James, M.C., Pruijn, G.J., van Venrooij, W.J., 
and Clemens, M.J. (1994). The La antigen inhibits the activation of the 
interferon-inducible protein kinase PKR by sequestering and unwinding 
double-stranded RNA. Nucleic Acids Research 22, 2512-2518. 
Xu, P., Billmeier, M., Mohorianu, I., Green, D., Fraser, W.D., and Dalmay, T. 
(2015). An improved protocol for small RNA library construction using High 
Definition adapters. Methods in Next Generation Sequencing 2. 
Xue, D., Shi, H., Smith, J.D., Chen, X., Noe, D.A., Cedervall, T., Yang, D.D., 
Eynon, E., Brash, D.E., Kashgarian, M., Flavell, R.A., and Wolin, S.L. 
(2003). A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, 
a major lupus autoantigen. Proceedings of the National Academy of Sciences 
of the United States of America 100, 7503-7508. 
REFERENCES 
 
276 
 
Yamakawa, N., Okuyama, K., Ogata, J., Kanai, A., Helwak, A., Takamatsu, M., 
Imadome, K.-i., Takakura, K., Chanda, B., Kurosaki, N., Yamamoto, H., 
Ando, K., Matsui, H., Inaba, T., and Kotani, A. (2014). Novel functional small 
RNAs are selectively loaded onto mammalian Ago1. Nucleic Acids Research 
42, 5289-5301. 
Yamasaki, S., Ivanov, P., Hu, G.-f., and Anderson, P. (2009). Angiogenin cleaves 
tRNA and promotes stress-induced translational repression. The Journal of 
Cell Biology 185, 35-42. 
Yanez-Mo, M., Siljander, P.R., Andreu, Z., Zavec, A.B., Borras, F.E., Buzas, E.I., 
Buzas, K., Casal, E., Cappello, F., Carvalho, J., Colas, E., Cordeiro-da 
Silva, A., Fais, S., Falcon-Perez, J.M., Ghobrial, I.M., Giebel, B., Gimona, 
M., Graner, M., Gursel, I., Gursel, M., Heegaard, N.H., Hendrix, A., Kierulf, 
P., Kokubun, K., Kosanovic, M., Kralj-Iglic, V., Kramer-Albers, E.M., 
Laitinen, S., Lasser, C., Lener, T., Ligeti, E., Line, A., Lipps, G., Llorente, 
A., Lotvall, J., Mancek-Keber, M., Marcilla, A., Mittelbrunn, M., 
Nazarenko, I., Nolte-'t Hoen, E.N., Nyman, T.A., O'Driscoll, L., Olivan, M., 
Oliveira, C., Pallinger, E., Del Portillo, H.A., Reventos, J., Rigau, M., 
Rohde, E., Sammar, M., Sanchez-Madrid, F., Santarem, N., Schallmoser, 
K., Ostenfeld, M.S., Stoorvogel, W., Stukelj, R., Van der Grein, S.G., 
Vasconcelos, M.H., Wauben, M.H., and De Wever, O. (2015). Biological 
properties of extracellular vesicles and their physiological functions. Journal 
of Extracellular Vesicles 4, 27066. 
Zamore, P.D., Tuschl, T., Sharp, P.A., and Bartel, D.P. (2000). RNAi: double-
stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 
nucleotide intervals. Cell 101, 25-33. 
Zhang, A.T., Langley, A.R., Christov, C.P., Kheir, E., Shafee, T., Gardiner, T.J., 
and Krude, T. (2011). Dynamic interaction of Y RNAs with chromatin and 
initiation proteins during human DNA replication. Journal of Cell Science 124, 
2058-2069. 
Zhou, A., Paranjape, J., Brown, T.L., Nie, H., Naik, S., Dong, B., Chang, A., Trapp, 
B., Fairchild, R., Colmenares, C., and Silverman, R.H. (1997). Interferon 
action and apoptosis are defective in mice devoid of 2′,5′‐oligoadenylate‐
dependent RNase L. The EMBO Journal 16, 6355-6363. 
Zhu, L., Liu, X., Pu, W., and Peng, Y. (2018). tRNA-derived small non-coding RNAs 
in human disease. Cancer Letters 419, 1-7. 
  
APPENDICES 
 
277 
 
Appendices 
 
Appendix I 
 
Media, buffers and solutions 
 
Media and solutions for bacteria work 
 
LB -medium 1% (w/v) bacto tryptone (FormediumTM) 
1% (w/v) NaCl (Fisher Scientific) 
0.5% (w/v) yeast extract (FormediumTM) 
 
TYM medium Bacto-tryptone (10 g) 
Yeast extract (2.5g) 
NaCl (2.92 g) 
1 M MgCl2 (5 ml) 
dH2O up to 1 l 
 
Bacterial M9 minimum medium 5x M9 salts (40 ml) 
2 mM glucose (2.75 ml) 
water agar (157.25 ml) 
 
5x M9 salt solution Na2HPO4 x 7 H2O (6.78 g) 
KH2PO4 (3.0 g) 
NaCl (0.5 g) 
NH4Cl (1.0 g) 
 
Water agar  Bactoagar (3.0 g) 
dH2O (175.25 ml) 
 
TfbI resuspending solution 0.1 M KOAc (30 ml) 
0.5 M MnCl2 (10 ml) 
1 M KCl (10 ml) 
1 M CaCl2 (1 ml) 
Glycerol (15 ml) 
dH2O up to 100 ml 
 
Tfb II solution  0.1 M Na-MOPS (2.5 ml) 
1 M CaCl2 (1.875 ml) 
1 M KCl (0.25 ml) 
Glycerol (3.75 ml) 
dH2O up to 25 ml 
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Buffers and solutions 
 
0.5 x TBE buffer 45 mM Tris base (Fisher Scientific) 
45 mM Boric acid (Fisher Scientific) 
1 mM EDTA (Fisher Scientific) 
 
0.5 M EDTA EDTA (14.61 g), dissolve powder in 80 
ml water, adjust pH to 8.0 
Molecular grade water up to 100 ml 
 
2x RNA Loading buffer 95% (v/v) formamide 
5 mM EDTA 
1.9 mM xylene cyanol 
1.5 mM bromophenol blue 
 
10 x NEB2 buffer 500 mM NaCl 
100 mM Tris-HCl (pH 8.0) 
100 mM MgCl2 
10 mM DTT 
 
10% SDS 10 g of sodium dodecylsulfate were 
dissolved in 100 ml water 
 
20x SSC 3M NaCl (175.3 g) 
0.3 M Sodium citrate (88.2 g) 
Dissolve in 800 ml water 
Adjust pH at 7.0 
Fill up with water to 1l 
 
Northern blot washing buffer 0.2x SSC, 0.1 % SDS 
 
Northern blot stripping buffer 0.1% SDS (10 ml 10% SDS + 990 ml 
water) 
 
10x TBST-buffer 200 mM Tris 
1.5 M NaCl 
1% Tween-20 
 
10x PBS buffer 130 mM NaCl 
774 mM Na2HPO4 
226 mM Na2H2PO4 
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Appendix II 
 
II.1 Oligonucleotides used for generating 3’ end hY5 RNA mutants 
 
Table 0.1. List of DNA oligonucleotides used for hY5 gene amplification.  
In this table the DNA oligonucleotides that were used to amplify the entire hY5 RNA gene 
(including promoter and terminator) from genomic DNA are listed. The forward primer binds 
at the promoter and the reverse primer binds to the terminator of the hY5 RNA.  
Oligonucleotide Sequence from 5’ to 3’  
hY5 forward primer  AATACTAGTGAAGATCCATGGAGGTACATC 
hY5 reverse primer  GTAAACGTTGTCTACTACTGTTATTAGTGC  
 
Table 0.2. DNA oligonucleotides used for colony PCR.  
This table shows the DNA oligonucleotide sequences that are added to amplify the insert 
during colony PCR. These primers were used to confirm the successful insertion of the PCR 
product into the pGEMT easy vector.  
Oligonucleotide Sequence from 5’ to 3’  
pUC M13 forward primer  CGCCAGGGTTTTCCCAGTCACGAC 
pUC M13 reverse primer  TCACACAGGAAACAGCTATGAC 
 
Table 0.3. DNA oligonucleotides used for generating the 3’ end hY5 RNA 
mutants.  
This table shows the DNA oligonucleotide sequences that were used to introduce the 
mutations for the generation of 3’ end hY5 RNA mutants.  
 
Oligonucleotide Sequence from 5’ to 3’ 
Forward primer  AATACTAGTGAAGATCCATGGAGGTACATC 
L1-1 ACGTC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTGACGTGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-2 ACCGC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTGCGGTGGGGAGACAATGTTAAA 
TCAACTTAACAATAACCC 
L1-3 CACAC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTGTGTGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
APPENDIX II 
 
280 
 
L1-4 ATGGC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTGCCATGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-5 ACTGC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTGCAGTGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-6 GTCGG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTCCGACGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-7 TCAAA GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTTTGAGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-8 TTGAA GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTTCAAGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-9 TCGCG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTCGCGAGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-10 TCAAG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTCTTGAGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-CCACT GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTAGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-CCATC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTGATGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-CTACG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTCGTAGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-GACCT GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTAGGTCGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-GATCC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTGGATCGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-GAACC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTGGTTCGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-CTACA GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTAGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L1-TCACA GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGAGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L2-1 CCGTT GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L2-2 ACGTC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCAACGGTGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L2-3 CCGTC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGACGTTGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L2-4 CTGTC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGACGGTGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L2-5 CTGTG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGACAGTGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
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L2-6 GTCGG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCCACTGTGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L2-7 TCAAA GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGAGGTTGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L2-8 TTGAA GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCTTGTGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L2-9 TCGCG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCCCGAGTGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L2-10 TCAAG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGAACATGTGGGGGGAGACAATGTTAAATCAACTTAACAATA
ACCC 
L3-1 GTTTG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAACGCGGTTGTGGGGGGAGACAATGTTA 
L3-2 TGTAG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CTACAGCGGTTGTGGGGGGAGACAATGTTA 
L3-3 GTTCG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CGAACGCGGTTGTGGGGGGAGACAATGTTA 
L3-4 CGTTG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAACGGCGGTTGTGGGGGGAGACAATGTTA 
L3-5 CGTCG GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CGACGGCGGTTGTGGGGGGAGACAATGTTA 
L3-6 TCCCA GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
TGGGAGCGGTTGTGGGGGGAGACAATGTTA 
L3-7 TAATT GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
AATTAGCGGTTGTGGGGGGAGACAATGTTA 
L3-8 GAAAC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
ATTTCGCGGTTGTGGGGGGAGACAATGTTA 
L3-9 ATCTA GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
TAGATGCGGTTGTGGGGGGAGACAATGTTA 
L3-10 CGACC GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
GGTCGGCGGTTGTGGGGGGAGACAATGTTA 
T49 to A49 AGTTGGTCCGAGTGTTGTGGGTTATTGTTAAGTTGATTTAAC
ATTGTCACCCCCCACAACCGCG 
T49 to C49 AGTTGGTCCGAGTGTTGTGGGTTATTGTTAAGTTGATTTAAC
ATTGTCACCCCCCCCAACCGCG 
T49 to G49 AGTTGGTCCGAGTGTTGTGGGTTATTGTTAAGTTGATTTAAC
ATTGTCACCCCCCGCAACCGCG 
Δ 1 nt GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGGGAGACATGTTAAATCAACTTAACA 
Δ 2 nt GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGGGAGACTGTTAAATCAACTTAACA 
Δ 3 nt GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGGGAGATGTTAAATCAACTTAACA 
Δ 4 nt GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGGGATGTTAAATCAACTTAACA 
Δ 5 nt GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGGGATGTTAAATCAACTTAACA 
Δ 6 nt GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGGGTGTTAAATCAACTTAACA 
Δ 7 nt GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGGTGTTAAATCAACTTAACA 
Δ 8 nt GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGTGTTAAATCAACTTAACA 
Δ 9 nt GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGTGTTAAATCAACTTAACA 
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Loop M1 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGCGGAGACAATGTTAAATCAACTTA 
Loop M2 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGCGAGACAATGTTAAATCAACTTA 
Loop M3 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGAGAGACAATGTTAAATCAACTTA 
Loop M4 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGAGGAGACAATGTTAAATCAACTTA 
Loop M5 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGGCAGACAATGTTAAATCAACTTA 
Loop M6 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGCGAGACAATGTTAAATCAACTTA 
Loop M7 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGTGAGACAATGTTAAATCAACTTA 
Loop M8 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGAGAGACAATGTTAAATCAACTTA 
Loop M9 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGTTATTGTTAAATCAACTTA 
Loop M10 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGCCAGACAATGTTAAATC 
Loop M11 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGACAGACAATGTTAAATC 
Loop M12 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGCAAGACAATGTTAAATC 
Loop M13 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGCAAGACAATGTTAAATC 
Loop M14 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGGAGACAATGTTAAATCAACTTA 
Loop M15 GTAAACGTTGTCTACTACTGTTATTAGTGCAAAACAGCAAGCTAGT
CAAGCGCGGTTGTGGGAGACAATGTTAAATCAACTTA 
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Table 0.4. DNA oligonucleotides used for generating “balancing” DNA.  
In this table the DNA oligonucleotides that were used to generate the “balancing DNA” are 
listed. As the full length and plasmid bias hY5 RNA libraries start with the same 15 nucleotides 
a so called “balancing DNA” sequence was generated in order to introduce more 
heterogeneity and more sequence diversity into the sequencing pool so that the different 
library sets could be sequenced on one lane and be clustered separately.  
Oligonucleotide  Sequence  
Balancing DNA template  CGATCAGTTGGTCCGAGTGTTGTGGGTTATTGTTAAGT
TGATTTAACNNNNNNNNNNNNNNNNNNNNATTGTCTCC
AGCCACAACCGCTGGAATTCTCGGG 
Forward primer  AATGATACGGCGACCACCGAGATCTACACGTTCAGAGT
TCTACAGTCCGACGATCAGTTGGTCCGAGTGTTGTGG 
Reverse primer  CAAGCAGAAGACGGCATACGATACGAGATATATTAGTG
ACTGGAGTTCCATGGCACCCGAGAATTCCAGCGGTTGT
GGC 
Balancing DNA  AATGATACGGCGACCACCGAGATCTACACGTTCAGAGT
TCTACAGTCCGACGATCAGTTGGTCCGAGTGTTGTGGG
TTATTGTTAAGTTGATTTAACNNNNNNNNNNNNNNNNN
NNNATTGTCTCCAGCCACAACCGCTGGAATTCTCGGGT
GCCAAGGAACTCCAGTCACTAATATATCTCGTATGCCG
TCTTCTGCTTG 
Sequencing primer for full 
length and plasmid libraries 
GTCCGAGTGTTGTGGGTTATTGTTAAGTTGATTTAAC 
 
II.2 Oligonucleotides used for generating 5’ end hY5 RNA mutants 
Table 0.5. DNA oligonucleotides used to generate the hY5 mutant pool PCR products 
in strategy 1.  
In this table the DNA oligonucleotides that were used in the first strategy to introduce the 
mutations into the hY5 RNA by PCR are shown. In the first PCR reaction the forward primer 
and overlap reverse primer for mutant pool 4,5 and 6 were added to generate the first 
fragment. In a second PCR reaction the mutant pool 4, 5 and 6 forward mutagenesis short 
primers and the hY5 reverse primer were used.  The Ns indicate the random nucleotides that 
were introduced by PCR. The full length hY5 RNA sequence containing the introduced 
mutations was amplified in an overlap extension PCR.  
Oligonucleotide  Sequence from 5’ to 3’ 
Forward primer AATACTAGTGAAGATCCATGGAGGTACATC 
Overlap reverse primer Pool 4 & 5  CAACACTCGGACCAACTGTGTTATCCT 
Overlap reverse primer for Pool 6 CAATAACCCACAACACTCGGACCAACTGTGTT 
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Pool 4 forward mutagenesis short 
primer 
AGGATAACACAGTTGGTCCGAGTGTTGNNNNNTAT
TGTTAAGTTGATTTAACATTGTCTCCCCCCACACC
GC 
Pool 5 forward mutagenesis short 
primer  
AGTTGGTCCGAGTGTTGTGGGTNNNNNTTAAGTTG
ATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 forward mutagenesis short 
primer  
GTCCGAGTGTTGTGGGTTATTGNNNNNTTGATTTA
ACATTGTCTCCCCCCACAACCGCG 
Reverse primer  GTAAACGTTGTCTACTACTGTTATTAGTGC 
 
Table 0.6. DNA oligonucleotides used for generating 5’ end hY5 plasmid libraries.  
This table shows the DNA oligonucleotides that were used to amplify the PCR products during 
the generation of 5’ end hY5 plasmid bias libraries. For each library replicate a different 
Illumina multiplex sequencing index primer containing a unique 6 nt barcoded (shown the table 
underlined) in order to identify individual samples after Illumina sequencing.  
Oligonucleotide Sequence 5’ to 3’ 
First PCR reaction forward primer  GTTCAGAGTTCTACAGTCCGACGATCTAACACAGTT
GGTCCGAGTGTT 
First PCR reaction reverse primer  CCTTGGCACCCGAGAATTCCATTAGTGCAAAACAGC
AAGCT 
RP-3 CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACT
GGAGTTCCTTGGCACCCGAGAATTCCA 
RP-7 CAAGCAGAAGACGGCATACGAGATGATCTGGTGACT
GGAGTTCCTTGGCACCCGAGAATTCCA 
RP-10 CAAGCAGAAGACGGCATACGAGATAAGCTAGTGACT
GGAGTTCCTTGGCACCCGAGAATTCCA 
RP-17 CAAGCAGAAGACGGCATACGAGATCTCTACGTGACT
GGAGTTCCTTGGCACCCGAGAATTCCA 
RP-21 CAAGCAGAAGACGGCATACGAGATCGAAACGTGACT
GGAGTTCCTTGGCACCCGAGAATTCCA 
RP-23 CAAGCAGAAGACGGCATACGAGATCCACTCGTGACT
GGAGTTCCTTGGCACCCGAGAATTCCA 
RP-5 CAAGCAGAAGACGGCATACGAGATCACTGTGTGACT
GGAGTTCCTTGGCACCCGAGAATTCCA 
RP-6 CAAGCAGAAGACGGCATACGAGATATTGGCGTGACT
GGAGTTCCTTGGCACCCGAGAATTCCA 
RP-8 CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACT
GGAGTTCCTTGGCACCCGAGAATTCCA 
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Table 0.7. DNA oligonucleotides used to generate the hY5 mutant pool PCR products 
in strategy 2.  
In this table the DNA oligonucleotides that were used in the second strategy to introduce the 
mutations into the hY5 RNA by PCR are shown. In the second strategy the full length hY5 
RNA sequence had to be amplified using a truncated hY5 RNA sequence in order to avoid 
the overamplification of the hY5 RNA sequence. In the first PCR reaction to generate the 
plasmid DNA template 1 the forward primer and overlap reverse primers for pool 4, 5 and 6 
were used. For the plasmid DNA template 2 the forward primer for short template and reverse 
primer for short template were used.  The PCR products were cloned into pGEMT easy vector 
and the resulting  plasmid vectors were used as templates to introduce the mutations using 
the pool 4, 5 & 6 forward mutagenesis primers and the reverse primer. The short template 
was generated using the forward primer and overlap reverse primers. The full length hY5 RNA 
containing the mutagenized regions were amplified by overlap extension PCR using the 
forward primer and reverse primer. The Ns indicate the random nucleotides that were 
introduced by PCR. 
Oligonucleotide Sequence 5’ to 3’  
Forward primer  AATACTAGTGAAGATCCATGGAGGTACATC 
Overlap reverse primer Pool 4 & 5  CAACACTCGGACCAACTGTGTTATCCT 
Overlap reverse primer for Pool 6 CAATAACCCACAACACTCGGACCAACTGTGTT 
Forward primer for short template TTGATTTAACATTGTCTCCCCCCACAACCG 
Reverse primer for short template GTAAACGTTGTCTACTACTGTTATTAGTGC 
Pool 4 forward mutagenesis primer AGGATAACACAGTTGGTCCGAGTGTTGNNNNNTATTG
TTAAGTTGATTTAACATTGTCTCCCCCCACACCGC 
Pool 5 forward mutagenesis primer  AGTTGGTCCGAGTGTTGTGGGTNNNNNTTAAGTTGAT
TTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 forward mutagenesis primer  GTCCGAGTGTTGTGGGTTATTGNNNNNTTGATTTAAC
ATTGTCTCCCCCCACAACCGCG 
Reverse primer  GTAAACGTTGTCTACTACTGTTATTAGTGC 
 
Table 0.8. DNA oligonucleotides used for the final overlap extension PCR.  
In the table the DNA oligonucleotides are listed that were used to generate the whole hY5 
RNA gene including mutated regions and promoter and terminator sequence.  
Oligonucleotide Sequence 5’ to 3’  
Forward primer AATACTAGTGAAGATCCATGGAGGTACATC 
Reverse primer  GTAAACGTTGTCTACTACTGTTATTAGTGC 
 
APPENDIX II 
 
286 
 
Table 0.9. DNA oligonucleotides used for generating full length cDNA libraries 
The table shows the DNA oligonucleotides that were used for reverse transcription and  
generation of the hY5 full length cDNA libraries. The Illumina multiplex index sequences 
contain a 6 nt barcode sequence (underlined in the table) that were introduced by PCR for 
sample identification.  
Oligonucleotide Sequence 5’ to 3’  
hY5 full length RT primer AAACAGCAAGCTAGT 
First PCR reaction FL 
forward primer  
GTTCAGAGTTCTACAGTCCGACGATCAGTTGGTCCGAGTGT
TG 
First PCR reaction FL 
reverse primer  
CCTTGGCACCCGAGAATTCCAAACAGCAAGCTAGTCAAGCG 
RP5 CAAGCAGAAGACGGCATACGAGATCACTGTGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
RP6 CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
RP8 CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
RP9 CAAGCAGAAGACGGCATACGAGATCTGATCGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
RP10 CAAGCAGAAGACGGCATACGAGATAAGCTAGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
RP12 CAAGCAGAAGACGGCATACGAGATTACAAGGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
RP1 CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
RP2 CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
RP3 CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
RP19 CAAGCAGAAGACGGCATACGAGATTTTCACGTGACTGGAGT
TCCTTGGCACCCGAGAATTCCA 
 
Table 0.10. DNA oligonucleotides used for small RNA library construction of 5’ end 
derived YsRNA mutants. 
In the table YsRNA enrichment sequences with 5, 10 or 15 nt that were tested for YsRNA 
enrichment during YsRNA library construction are listed. 
Oligonucleotide Sequence 5’ to 3’  
RP1 hY5 enrichment 5 nt AATGATACGGCGACCACCGAGATCTACACGTTCAGAG
TTCTACAGTCCGACGACGATCAGTTG 
RP1 hY5 enrichment 10 nt AATGATACGGCGACCACCGAGATCTACACGTTCAGAG
TTCTACAGTCCGACGACGATCAGTTGGTCCG 
RP1 hY5 enrichment 15 nt  AATGATACGGCGACCACCGAGATCTACACGTTCAGAG
TTCTACAGTCCGACGACGATCAGTTGGTCCGAGTGT 
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Table 0.11. DNA oligonucleotides used for generating individual 5’ end derived hY5 
RNA mutant sequences.  
Oligonucleotide Sequence from 5’ to 3’ 
Forward primer AATACTAGTGAAGATCCATGGAGGTACATC 
Overlap reverse primer Pool 4 
& 5  
CAACACTCGGACCAACTGTGTTATCCT 
Overlap reverse primer for 
Pool 6 
CAATAACCCACAACACTCGGACCAACTGTGTT 
Mutagenesis primer  
Pool 4 CAACC AGGATAACACAGTTGGTCCGAGTGTTGCAACC
TATTGTTAAGTTGATTTAACATTGTCTCCCCC
CACAACCGCG 
Pool 4 TGGTT AGGATAACACAGTTGGTCCGAGTGTTGTGGTT
TATTGTTAAGTTGATTTAACATTGTCTCCCCC
CACAACCGCG 
Pool 4 CGGGT AGGATAACACAGTTGGTCCGAGTGTTGCGGGT
TATTGTTAAGTTGATTTAACATTGTCTCCCCC
CACAACCGCG 
Pool 4 AGGGT AGGATAACACAGTTGGTCCGAGTGTTGAGGGT
TATTGTTAAGTTGATTTAACATTGTCTCCCCC
CACAACCGCG 
Pool 4 TGAGT  AGGATAACACAGTTGGTCCGAGTGTTGTGAGT
TATTGTTAAGTTGATTTAACATTGTCTCCCCC
CACAACCGCG 
Pool 4 TGGCT  AGGATAACACAGTTGGTCCGAGTGTTGTGGCT
TATTGTTAAGTTGATTTAACATTGTCTCCCCC
CACAACCGCG 
  
Pool 4 TGGGA AGGATAACACAGTTGGTCCGAGTGTTGTGGGA
TATTGTTAAGTTGATTTAACATTGTCTCCCCC
CACAACCGC 
Pool 4 TGGGC AGGATAACACAGTTGGTCCGAGTGTTGTGGGC
TATTGTTAAGTTGATTTAACATTGTCTCCCCC
CACAACCGC 
Pool 4 TGGGG AGGATAACACAGTTGGTCCGAGTGTTGTGGGG
TATTGTTAAGTTGATTTAACATTGTCTCCCCC
CACAACCGC 
Pool 5 TATTG AGTTGGTCCGAGTGTTGTGGGTTATTGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 ATCGC AGTTGGTCCGAGTGTTGTGGGTATCGCTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 TATGG AGTTGGTCCGAGTGTTGTGGGTTATGGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 GTTCG AGTTGGTCCGAGTGTTGTGGGTGTTCGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 TGTCG AGTTGGTCCGAGTGTTGTGGGTTGTCGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
APPENDIX II 
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Pool 5 TATGA AGTTGGTCCGAGTGTTGTGGGTTATGATTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 TCCGC AGTTGGTCCGAGTGTTGTGGGTTCCGCTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 TTCCG AGTTGGTCCGAGTGTTGTGGGTTTCCGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 GGGCG AGTTGGTCCGAGTGTTGTGGGTGGGCGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 TCGAC AGTTGGTCCGAGTGTTGTGGGTTCGACTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 GCAAG AGTTGGTCCGAGTGTTGTGGGTGCAAGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 ACGTA AGTTGGTCCGAGTGTTGTGGGTACGTATTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 CACC AGTTGGTCCGAGTGTTGTGGGCACCTGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 AAAA AGTTGGTCCGAGTGTTGTGGGAAAATGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 ATAT AGTTGGTCCGAGTGTTGTGGGATATTGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 AAAT AGTTGGTCCGAGTGTTGTGGGAAATTGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 CCCC AGTTGGTCCGAGTGTTGTGGGCCCCTGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 CGTT AGTTGGTCCGAGTGTTGTGGGCGTTTGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 5 TTTT AGTTGGTCCGAGTGTTGTGGGTTTTTGTTAAG
TTGATTTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 TTAAG GTCCGAGTGTTGTGGGTTATTGTTAAGTTGAT
TTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 GGGAG GTCCGAGTGTTGTGGGTTATTGGGGAGTTGAT
TTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 GAGGG GTCCGAGTGTTGTGGGTTATTGGAGGGTTGAT
TTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 AGGAG GTCCGAGTGTTGTGGGTTATTGAGGAGTTGAT
TTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 TGGTT GTCCGAGTGTTGTGGGTTATTGTGGTTTTGAT
TTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 TGGTG GTCCGAGTGTTGTGGGTTATTGTGGTGTTGAT
TTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 GGGGA  GTCCGAGTGTTGTGGGTTATTGGGGGATTGAT
TTAACATTGTCTCCCCCCACAACCGCG 
Pool 6 GGGTG  GTCCGAGTGTTGTGGGTTATTGGGGTGTTGAT
TTAACATTGTCTCCCCCCACAACCGCG 
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II.3 Oligonucleotides used for Northern blotting 
Table 0.12. List of DNA oligonucleotides used for Northern blotting.  
In this table DNA oligonucleotides used as Northern blot probes are shown. The DNA 
oligonucleotide sequences were designed to correspond to the antisense sequence of the 
small RNA sequences of interest. 
Northern blot probes Sequence from 5’ to 3’ 
hY5 3’ end wild type probe AGCTAGTCAAGCGCGGTTGTGGGGG 
hY5 3’ end probe for detection of L1/2 
mutants 
AGCAAGCTAGTCAAGCGCGGT 
LNA 12 mer for detection of L3 mutants A*CAG*CAA*GCT*AG 
U6 snRNA loading control GCTAATCTTCTCTGTATCGTTCC 
hY5 5’ end wild type probe TAACCCACAACACTCGGACCAACT 
hY5 5’ end probe for detection of L4/5/6 
mutants 
CAACACTCGGACCAACT 
hY1 3’ end AGACTAGTCAAGTGCAGTAGTGAGAA 
hY1 5’ end TAACCCACAACACTCGGACCAACT 
hY3 3’ end TAGTCAAGTGAAGCAGTGGGAG 
hY3 5’ end AACACCACTGCACTCGGACCAGCC 
tRNA-His CAGAGTACTAACCACTATACGATCACGGCC 
tRNA-Pro CCGAGAATCATACCCCTAGACCAACGAGCC 
 
 
 
 
 
 
 
 
 
 
APPENDIX II 
 
290 
 
Appendix III 
 
Table 0.13. Sequencing information of 3’ end hY5 small RNA cDNA libraries.  
The table gives an overview about the number of total sequencing reads, reads mapping to 
the genome and reads mapping to hY5 RNA mutant sequences including the percentages of 
genome mapping reads and hY5 RNA mapping reads for each library replicate. The libraries 
1, 2 and 3 are shown in the table as L1, L2 and L3 including their three biological replicates.  
Total RNA was extracted and YsRNA cDNA libraries were constructed using a modified 
Illumina protocol and sent for NGS. After adapter removal the sequencing reads were mapped 
to the genome and all possible 1024 combinations of hY5 mutant sequences.  
 Total 
reads 
Genome 
mapping reads 
Genome mapping 
reads [%] 
Y5 mapping 
reads 
Y5 
mapping 
reads [%] 
L1-1 3095015 2161090 69.82 56653 1.83 
L1-2 3310825 2284251 68.99 70791 2.14 
L1-3 2353355 1587079 67.44 44746 1.90 
L2-1 5562010 4162303 74.83 95249 1.71 
L2-2 2701036 1902208 70.43 107289 3.97 
L2-3 2824250 2017230 71.43 105952 3.75 
L3-1 1444418 848693 58.76 145191 10.05 
L3-2 3787865 2174265 57.40 495631 13.08 
L3-3 1153145 677186 58.73 92146 7.99 
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Appendix IV 
 
Sequencing information of wild type and Ro60 -/- mES cDNA  
Libraries 
Table 0.14. General sequencing information of wild type and Ro60 -/- mES sRNA cDNA 
libraries either treated or untreated with poly (I:C).  
The table gives an overview about the number of total sequencing reads, reads mapping to 
the genome and reads mapping to hY5 RNA mutant sequences including the percentages of 
genome mapping reads and hY5 RNA mapping reads for each library replicate. The libraries 
were generated in three biological replicates. Total RNA was extracted and YsRNA cDNA 
libraries were constructed using a modified Illumina protocol and sent for NGS. After adapter 
removal the sequencing reads were mapped to the mouse genome. 
 
 
 
Ro60 KO 
1  
Ro60 KO 
2 
Ro60 KO 
3 
Ro60 KO 
poly(I:C) 
1 
Ro60 KO 
poly (I:C) 
2 
Ro60 KO 
poly (I:C) 
3 
Trimmed 12521810 11006607 7809998 16740090 12969950 9942964 
Mapped total 10328068 8013893 6457272 13185076 8936481 8496502 
Mapped 
unique 
433415 404450 320651 725926 512447 213763 
Mapping % 82.48 72.81 82.68 78.76 68.90 85.45 
 
 
 
 
 
 
 
 
 
 
 
 
MES WT 
1 
MES WT 
2 
MES WT 
3 
MES WT 
poly (I:C) 
1 
MES WT 
poly (I:C) 
2 
MES WT 
poly (I:C) 
3 
Trimmed 10029505 9004771 8834580 11909230 11677219 14688848 
Mapped total 8417398 7185996 7496927 9591872 8397299 12192779 
Mapped unique 357069 328363 229033 547665 469518 393481 
Mapping % 83.93 79.80 84.86 80.54 71.91 83.01 
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Table 0.15. Differential gene expression analysis of mY1 and mY3 in wild type and Ro60 
-/- cells untreated or treated with poly (I:C) using DESeq2. 
Locus baseMean log2FoldChange pvalue padj Gene ID  
6/47787768-47788203 13883.2 6.63395 3.32E-70 2.48E-66 Rny1 
6/47781599-47781778 2158.05 2.85508 1.17E-13 1.46E-10 Rny3 
 
 
Table 0.16. Differential gene expression analysis of SNORD 118, miR 296, miR 146a and 
miR 708 in wild type and Ro60 -/- cells untreated or treated with poly (I:C) using DEseq2.  
Locus Base 
Mean 
log2 Fold 
Change 
p-value Sequence Gene  
18/71961786-
71961805 
67.543 1.343 0.00212 TCTCCAATCATCATTTTCT SNORD118 
12/49279106-
49279123 
28.712 1.491 0.0021 GAGGGTTGGGTGGAGGCT miR296 
11/43374398-
43374457 
299.464 1.285 0.00798 TAACCCATGGAATTCAGTTCTCA miR146a 
7/96249426-
96249641 
3814.868 0.8913 0.00967 AAGGAGCTTACAATCTAGCTGGG miR708 
 
 
